internal_id,priority,session_title,session_type,abstract_title,diseases,indications,primary_drugs,secondary_drugs,comparator_drugs,drug_classes,firms,patient_subgroups,nct,acronym
1,Not Relevant,Opening Lectures,Congress Opening,Video Vienna,,,,,,,,,,
2,Not Relevant,Opening Lectures,Congress Opening,Welcome Words,,,,,,,,,,
3,Not Relevant,Opening Lectures,Congress Opening,Opening Lecture - A new classification for podocytopathies,Podocytopathy,Podocytopathy,,,,,,,,
4,Not Relevant,Opening Lectures,Congress Opening,Abstract Submission,,,,,,,,,,
5,Not Relevant,Opening Lectures,Congress Opening,Personal Highlights from the program,,,,,,,,,,
6,Not Relevant,Opening Lectures,Congress Opening,Congress official opening,,,,,,,,,,
7,Not Relevant,CME 2 - Kidney Transplantation,CME,Course Introduction,,,,,,,,,,
8,Not Relevant,CME 2 - Kidney Transplantation,CME,Nephrologists’ View on Frailty and Kidney Transplantation: Results from a European Survey,,,,,,,,,,
9,Not Relevant,CME 2 - Kidney Transplantation,CME,Aging in Chronic Kidney Disease: From Translational Basics to Clinical Practice,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
10,Not Relevant,CME 2 - Kidney Transplantation,CME,Should We Accept This Frail Patient for Transplant? PRO,,,,,,,,,,
11,Not Relevant,CME 2 - Kidney Transplantation,CME,Should We Accept This Frail Patient for Transplant? CON,,,,,,,,,,
12,Not Relevant,CME 2 - Kidney Transplantation,CME,"Speakers and coordinators debate, questions and answers",,,,,,,,,,
13,Not Relevant,CME 2 - Kidney Transplantation,CME,Take home message,,,,,,,,,,
14,Not Relevant,CME 3 - Cardio-kidney metabolic disease,CME,Course introduction,,Cardio-Kidney Metabolic Disease,,,,,,,,
15,Not Relevant,CME 3 - Cardio-kidney metabolic disease,CME,What are we doing here? The mechanism behind the pleiotropic effects of GLP1 agonists effects on cardio-kidney-metabolic health,,Cardio-Kidney Metabolic Disease,,,,GLP-1 Agonist,,,,
16,Not Relevant,CME 3 - Cardio-kidney metabolic disease,CME,State of the art and future concepts to reduce atherosclerotic vascular disease in chronic kidney disease,Atherosclerosis;Chronic Kidney Disease,Atherosclerosis;Chronic Kidney Disease,,,,,,,,
17,Not Relevant,CME 3 - Cardio-kidney metabolic disease,CME,Is a cardiologist needed for the diagnosis and management of HFpEF in every CKD patient? PRO,Chronic Kidney Disease;Heart Failure,Chronic Kidney Disease;Heart Failure,,,,,,,,
18,Not Relevant,CME 3 - Cardio-kidney metabolic disease,CME,Is a cardiologist needed for the diagnosis and management of HFpEF in every CKD patient? CON,Chronic Kidney Disease;Heart Failure,Chronic Kidney Disease;Heart Failure,,,,,,,,
19,Not Relevant,CME 3 - Cardio-kidney metabolic disease,CME,Panel Discussion,,Cardio-Kidney Metabolic Disease,,,,,,,,
20,Not Relevant,CME 3 - Cardio-kidney metabolic disease,CME,Take home message,,Cardio-Kidney Metabolic Disease,,,,,,,,
21,Not Relevant,CME 4 - Hemo and PD,CME,Course Introduction,,,,,,,,,,
22,Not Relevant,CME 4 - Hemo and PD,CME,Overview of evidence-based strategies for cardiovascular risk reduction in dialysis patients,Renal Failure,Kidney Failure,,,,,,,,
23,Not Relevant,CME 4 - Hemo and PD,CME,Should dialysate sodium be high?,,,,,,,,,,
24,Not Relevant,CME 4 - Hemo and PD,CME,What is the best dialysis strategy for which patient? HD point of view,Renal Failure,Kidney Failure,,,,,,,,
25,Not Relevant,CME 4 - Hemo and PD,CME,What is the best dialysis strategy for which patient? PD point of view,Renal Failure,Kidney Failure,,,,,,,,
26,Not Relevant,CME 4 - Hemo and PD,CME,Take home messages,,,,,,,,,,
27,Not Relevant,CME 5 - Acute kidney injury,CME,Course introduction,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
28,Not Relevant,CME 5 - Acute kidney injury,CME,Prevention of peri-operative AKI: anything new on the horizon?,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
29,Not Relevant,CME 5 - Acute kidney injury,CME,Fluid resuscitation and decongestion in AKI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
30,Not Relevant,CME 5 - Acute kidney injury,CME,RRT in AKI: Can we be greener?,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
31,Not Relevant,CME 5 - Acute kidney injury,CME,Post-AKI follow-up: is it possible in real life? Round Table,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
32,Not Relevant,CME 5 - Acute kidney injury,CME,Take home message,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
33,Not Relevant,HC 1: Morning Workshop - Vascular Access Catheter Placement,Work Shop,Introduction,,,,,,,,,,
34,Not Relevant,HC 1: Morning Workshop - Vascular Access Catheter Placement,Work Shop,Minimising catheter associated infection,,,,,,,,,,
35,Not Relevant,HC 1: Morning Workshop - Vascular Access Catheter Placement,Work Shop,Kinking and Tip position,,,,,,,,,,
36,Not Relevant,HC 1: Morning Workshop - Vascular Access Catheter Placement,Work Shop,Assessment and management of central vein stenosis and atrial thrombus,Atrial Thrombosis;Stenosis,Atrial Thrombosis;Central Vein Stenosis,,,,,,,,
37,Not Relevant,HC 1: Morning Workshop - Vascular Access Catheter Placement,Work Shop,Discussion,,,,,,,,,,
38,Not Relevant,HC 1: Morning Workshop - Vascular Access Catheter Placement,Work Shop,Demonstration Tunnelled Line Insertion & Non tunnelled Line insertion,,,,,,,,,,
39,Not Relevant,HC 1: Morning Workshop - Vascular Access Catheter Placement,Work Shop,Practice on Vascular Access Catheter Placement,,,,,,,,,,
40,Not Relevant,HC 3 - Morning Workshop: Renal Biopsy Techniques,Work Shop,Introduction,,,,,,,,,,
41,Not Relevant,HC 3 - Morning Workshop: Renal Biopsy Techniques,Work Shop,Indications and epidemiology of native kidney biopsy,,,,,,,,,,
42,Not Relevant,HC 3 - Morning Workshop: Renal Biopsy Techniques,Work Shop,Practical aspect of Biopsy (video),,,,,,,,,,
43,Not Relevant,HC 3 - Morning Workshop: Renal Biopsy Techniques,Work Shop,Practical pathology for Biopsy (Processing of the samples and tests),,,,,,,,,,
44,Not Relevant,HC 3 - Morning Workshop: Renal Biopsy Techniques,Work Shop,Complications of Kidney Biopsy,,,,,,,,,,
45,Not Relevant,HC 3 - Morning Workshop: Renal Biopsy Techniques,Work Shop,US demonstration,,,,,,,,,,
46,Not Relevant,HC 3 - Morning Workshop: Renal Biopsy Techniques,Work Shop,Kidney Biopsy demonstration and Practice,,,,,,,,,,
47,Not Relevant,HC 2: Afternoon Workshop - Vascular Access Catheter Placement (Repeat Session),Work Shop,Introduction,,,,,,,,,,
48,Not Relevant,HC 2: Afternoon Workshop - Vascular Access Catheter Placement (Repeat Session),Work Shop,Minimising catheter associated infection,,,,,,,,,,
49,Not Relevant,HC 2: Afternoon Workshop - Vascular Access Catheter Placement (Repeat Session),Work Shop,Kinking and Tip position,,,,,,,,,,
50,Not Relevant,HC 2: Afternoon Workshop - Vascular Access Catheter Placement (Repeat Session),Work Shop,Assessment and management of central vein stenosis and atrial thrombus,Atrial Thrombosis;Stenosis,Atrial Thrombosis;Central Vein Stenosis,,,,,,,,
51,Not Relevant,HC 2: Afternoon Workshop - Vascular Access Catheter Placement (Repeat Session),Work Shop,Discussion,,,,,,,,,,
52,Not Relevant,HC 2: Afternoon Workshop - Vascular Access Catheter Placement (Repeat Session),Work Shop,Demonstration Tunnelled Line Insertion & Non tunnelled Line insertion,,,,,,,,,,
53,Not Relevant,HC 2: Afternoon Workshop - Vascular Access Catheter Placement (Repeat Session),Work Shop,Practice on Vascular Access Catheter Placement,,,,,,,,,,
54,Not Relevant,HC 4: Afternoon Workshop - Renal Biopsy Techniques (Repeat Session),Work Shop,Introduction,,,,,,,,,,
55,Not Relevant,HC 4: Afternoon Workshop - Renal Biopsy Techniques (Repeat Session),Work Shop,Indications and epidemiology of native kidney biopsy,,,,,,,,,,
56,Not Relevant,HC 4: Afternoon Workshop - Renal Biopsy Techniques (Repeat Session),Work Shop,Practical aspect of Biopsy (video),,,,,,,,,,
57,Not Relevant,HC 4: Afternoon Workshop - Renal Biopsy Techniques (Repeat Session),Work Shop,Practical pathology for Biopsy (Processing of the samples and tests),,,,,,,,,,
58,Not Relevant,HC 4: Afternoon Workshop - Renal Biopsy Techniques (Repeat Session),Work Shop,Complications of Kidney Biopsy,,,,,,,,,,
59,Not Relevant,HC 4: Afternoon Workshop - Renal Biopsy Techniques (Repeat Session),Work Shop,US demonstration,,,,,,,,,,
60,Not Relevant,HC 4: Afternoon Workshop - Renal Biopsy Techniques (Repeat Session),Work Shop,Kidney Biopsy demonstration and Practice,,,,,,,,,,
61,Not Relevant,"CME 1 - Primary and secondary GN, vasculitis and autoimmune diseases",CME,Course introduction,Autoimmune Disorder;Vasculitis,Autoimmune Disease;Vasculitis,,,,,,,,
62,Not Relevant,"CME 1 - Primary and secondary GN, vasculitis and autoimmune diseases",CME,Prons & Cons - Plasma exchange in ANCA-associated vasculitis: is there still a role? PRO,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
63,Not Relevant,"CME 1 - Primary and secondary GN, vasculitis and autoimmune diseases",CME,Prons & Cons - Plasma exchange in ANCA-associated vasculitis: is there still a role? CON,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
64,Not Relevant,"CME 1 - Primary and secondary GN, vasculitis and autoimmune diseases",CME,It's not all about the kidney: what the nephrologist should know about extra-renal SLE,Systemic Lupus Erythematosus,Systemic Lupus Erythematosus,,,,,,,,
65,Not Relevant,"CME 1 - Primary and secondary GN, vasculitis and autoimmune diseases",CME,The use of C5 inhibition in secondary thrombotic microangiopathy,Thrombotic Microangiopathy,Secondary Thrombotic Microangiopathy,,,,C5 Inhibitor,,,,
66,Not Relevant,"CME 1 - Primary and secondary GN, vasculitis and autoimmune diseases",CME,Take home message,Autoimmune Disorder;Vasculitis,Autoimmune Disease;Vasculitis,,,,,,,,
67,Not Relevant,CME 10 - Renal pathology for nephrologists,CME,Course introduction,,,,,,,,,,
68,Not Relevant,CME 10 - Renal pathology for nephrologists,CME,Complement Stains and TMA spectrum: or alternatively: pitfalls in complement stains in C3GP and TMA,Thrombotic Microangiopathy,Thrombotic Microangiopathy,,,,,,,,
69,Not Relevant,CME 10 - Renal pathology for nephrologists,CME,Transplant Renal Pathology - Updates from the Banff 2024 meeting,,,,,,,,,,
70,Not Relevant,CME 10 - Renal pathology for nephrologists,CME,Brake,,,,,,,,,,
71,Not Relevant,CME 10 - Renal pathology for nephrologists,CME,AI in Renal Pathology,,,,,,,,,,
72,Not Relevant,CME 10 - Renal pathology for nephrologists,CME,Role of Novel Imaging techniques in renal pathology diagnosis,,,,,,,,,,
73,Not Relevant,CME 10 - Renal pathology for nephrologists,CME,Panel discussion,,,,,,,,,,
74,Not Relevant,CME 10 - Renal pathology for nephrologists,CME,Take home message,,,,,,,,,,
75,Not Relevant,CME 6 - Onconephrology and Electrolytes,CME,Why Onconephrology? How to start an Onconephrology clinic,,,,,,,,,,
76,Not Relevant,CME 6 - Onconephrology and Electrolytes,CME,Debate: Kidney biopsy versus biomarkers and new diagnostic tools in immune check point inhibitors AKI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
77,Not Relevant,CME 6 - Onconephrology and Electrolytes,CME,Debate: Kidney biopsy versus biomarkers and new diagnostic tools in immune check point inhibitors AKI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
78,Not Relevant,CME 6 - Onconephrology and Electrolytes,CME,"Cancer and advanced CKD: screening for neoplasia in dialysis and transplant waiting list, drug dosing and inclusion in oncological RCT",Cancer;Chronic Kidney Disease,Advanced Chronic Kidney Disease;Cancer,,,,,,Advanced,,
79,Not Relevant,CME 6 - Onconephrology and Electrolytes,CME,Clincal case: TMA and cancer. Questions to answer and new therapeutic approaches,Cancer;Tumors,Cancer;Tumor,,,,,,,,
80,Not Relevant,CME 6 - Onconephrology and Electrolytes,CME,Panel Discussion,,,,,,,,,,
81,Not Relevant,CME 6 - Onconephrology and Electrolytes,CME,Take home message,,,,,,,,,,
82,Not Relevant,CME 7 - Genetics for nephrologists,CME,Course introduction,,,,,,,,,,
83,Not Relevant,CME 7 - Genetics for nephrologists,CME,The role of genetic testing - whom do we test? PRO/CON,,,,,,,,,,
84,Not Relevant,CME 7 - Genetics for nephrologists,CME,The role of genetic testing - whom do we test? CON,,,,,,,,,,
85,Not Relevant,CME 7 - Genetics for nephrologists,CME,Ask the Expert: What's the current consensus in Alport syndrome? A focus on diagnostic strategies.,Alport Syndrome,Alport Syndrome,,,,,,,,
86,Not Relevant,CME 7 - Genetics for nephrologists,CME,Implementing ADPKD guidelines in clinical practice - expert guidance through clinical case examples,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
87,Not Relevant,CME 7 - Genetics for nephrologists,CME,RNA-therapeutics - chance and challenge in genetic kidney disease,Kidney Diseases,Kidney Disease,,,,,,,,
88,Not Relevant,CME 7 - Genetics for nephrologists,CME,Panel Discussion,,,,,,,,,,
89,Not Relevant,CME 7 - Genetics for nephrologists,CME,Take home message,,,,,,,,,,
90,Not Relevant,CME 8 - CKD MBD and nephrolithiasis: Bone and Cardiovascular health in CKD-MBD an update,CME,Course introduction,Chronic Kidney Disease;Nephrolithiasis,Chronic Kidney Disease-Mineral Bone Disorder;Nephrolithiasis,,,,,,,,
91,Not Relevant,CME 8 - CKD MBD and nephrolithiasis: Bone and Cardiovascular health in CKD-MBD an update,CME,It's time to be aware of the fracture burden in CKD: Nephrologist defines the fracture risk profile of your patient,Chronic Kidney Disease;Nephrolithiasis,Chronic Kidney Disease;Nephrolithiasis,,,,,,,,
92,Not Relevant,CME 8 - CKD MBD and nephrolithiasis: Bone and Cardiovascular health in CKD-MBD an update,CME,Vertebral fractures in chronic kidney disease: how to assess them and why,Chronic Kidney Disease,Chronic Kidney Disease;Vertebral Fracture,,,,,,,,
93,Not Relevant,CME 8 - CKD MBD and nephrolithiasis: Bone and Cardiovascular health in CKD-MBD an update,CME,Therapy in skeletal fragility with low or high turnover: Pros & Cons,Chronic Kidney Disease;Nephrolithiasis,Chronic Kidney Disease-Mineral Bone Disorder;Nephrolithiasis,,,,,,,,
94,Not Relevant,CME 8 - CKD MBD and nephrolithiasis: Bone and Cardiovascular health in CKD-MBD an update,CME,Romosozumab: when the statistician through numbers helps the physician,Chronic Kidney Disease;Nephrolithiasis,Chronic Kidney Disease-Mineral Bone Disorder;Nephrolithiasis,Romosozumab,,,Sclerostin-Inhibitor,,,,
95,Not Relevant,CME 8 - CKD MBD and nephrolithiasis: Bone and Cardiovascular health in CKD-MBD an update,CME,Take home message,Chronic Kidney Disease;Nephrolithiasis,Chronic Kidney Disease-Mineral Bone Disorder;Nephrolithiasis,,,,,,,,
96,Not Relevant,CME 9 - Artificial intelligence for Nephrologists,CME,Course introduction,,,,,,,,,,
97,Not Relevant,CME 9 - Artificial intelligence for Nephrologists,CME,AI and Machine Learning Demystified: Essential Concepts and Practical Insights,,,,,,,,,,
98,Not Relevant,CME 9 - Artificial intelligence for Nephrologists,CME,Exploring the power of AI in Nephrology: useful or dangerous? PRO,,,,,,,,,,
99,Not Relevant,CME 9 - Artificial intelligence for Nephrologists,CME,Exploring the power of AI in Nephrology: useful or dangerous? CON,,,,,,,,,,
100,Not Relevant,CME 9 - Artificial intelligence for Nephrologists,CME,Test you knowledge on AI and ML - dynamic session with poll and questions,,,,,,,,,,
101,Not Relevant,CME 9 - Artificial intelligence for Nephrologists,CME,Take home message,,,,,,,,,,
102,Not Relevant,General Assembly,Symposium,General Assembly,,,,,,,,,,
103,Not Relevant,Welcome Ceremony,Symposium,Welcome words and Local Presidential address,,,,,,,,,,
104,Not Relevant,Welcome Ceremony,Symposium,Welcome words and Presidential address (Austrian Soc. Neph.),,,,,,,,,,
105,Not Relevant,Welcome Ceremony,Symposium,Presidential address (ERA),,,,,,,,,,
106,Not Relevant,Welcome Ceremony,Symposium,Diplomas and thanks,,,,,,,,,,
107,Not Relevant,Welcome Ceremony,Symposium,ERA Awards,,,,,,,,,,
108,Not Relevant,Welcome Ceremony,Symposium,Special Closure,,,,,,,,,,
109,Not Relevant,Welcome Ceremony,Symposium,Adjourn and invitation for the reception,,,,,,,,,,
110,Not Relevant,Welcome Ceremony,Symposium,Video Glasgow,,,,,,,,,,
111,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Macrophage TREM2 deficiency attenuates ischemic acute kidney injury,Acute Kidney Injury;Ischemia,Ischemic Acute Kidney Injury,,,,,,,,
112,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Neutrophils protect against Staphylococcus aureus-induced kidney injury in part through the release of neutrophil extracellular traps,,Kidney Injury,,,,,,,,
113,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Teneligliptin alleviates acute kidney injury by exerting anti-ferroptotic effects on renal tubules,Acute Kidney Injury,Acute Kidney Injury,Teneligliptin,,,DPP4-Inhibitor,,,,
114,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Chemical Reprogramming of Macrophages to Facilitate Renal Repair After AKI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
115,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,The Contribution of Epigenetic Factors to CRS3 Development Induced by AKI: Role of Methyltransferase SET7,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
116,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Extracorporeal hemoadsorption therapy in the treatment of sepsis induced by Gram-negative bacteria: in vitro assessment of two new sorbent cartridges,Sepsis,Sepsis,,,,,,,,
117,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,The Role of Foxp2 in Kidney Ischemia-Reperfusion Injury,Ischemia,Kidney Ischemia,,,,,,,,
118,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Endotoxin and cytokines removal with new microporous (CA) sorbent prototypes,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
119,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Circular RNA circAASS inhibits renal fibrosis post AKI by modulating mitophagy and mitochondrial biogenesis in tubular epithelial cell,Acute Kidney Injury;Fibrosis,Acute Kidney Injury;Renal Fibrosis,,,,,,,,
120,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,SALL1 is essential for Histone H3K27 methyltransferase EZH2 to regulates apoptotic responses in renal ischemia/reperfusion injury,Ischemia,Renal Ischemia;Reperfusion Injury,,,,,,,,
121,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Intravital ATP imaging reveals unexpected associations between proximal tubular ATP levels and ischemia reperfusion injury severities in aged mice,Ischemia,Ischemia Reperfusion Injury,,,,,,,,
122,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,An ultrasmall ruthenium-based nanoparticle to protect acute kidney injury and promote renal repair,Acute Kidney Injury,Acute Kidney Injury,Ruthenium,,,Apoptosis Stimulant,,,,
123,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Engineering Primed Extracellular Vesicles with Enhanced Anti-inflammatory Properties and ROS-Responsive Drug Delivery for AKI Treatment,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
124,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,The short and long-term accuracy of Urinary C-C Motif Chemokine-14 in an ICU Population,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
125,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Evaluating Middle Cut-Off Membranes in Renal Support – Potential for Enhanced Cytokine Removal,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
126,Not Relevant,Chronic kidney disease,Focussed Oral,Roxadustat Treatment of Anaemia in Chronic Kidney Disease (CKD) in Real-World Clinical Practice: Observational Study Using Secondary Data from the QuaNT-Registry in Germany,Anemia;Chronic Kidney Disease,Anaemia;Chronic Kidney Disease,Roxadustat,,,HIF PH-Inhibitor,,,QuaNT,
127,Not Relevant,Chronic kidney disease,Focussed Oral,Evidence of impaired myocardial perfusion reserve in asymptomatic non-diabetic patients with advanced CKD,Chronic Kidney Disease,Advanced Non-Diabetic Chronic Kidney Disease,,,,,,Advanced,,
128,Not Relevant,Chronic kidney disease,Focussed Oral,Responsiveness to Roxadustat in Non-dialysis Chronic Kidney Disease Patients with Anemia by Baseline Iron Status: A Secondary Analysis of the ROXSTAR Registry,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,Roxadustat,,,HIF PH-Inhibitor,FibroGen,,ChiCTR2100046322;;ROXSTAR,
129,Not Relevant,E-Posters,e-Poster,Explaining the gap between guidelines and practice in myocardial infarction care for people with chronic kidney disease.,Chronic Kidney Disease;Myocardial Infarction,Chronic Kidney Disease;Myocardial Infarction,,,,,,,,
130,Not Relevant,Chronic kidney disease,Focussed Oral,Reduced arterial stiffness in children with CKD under long-term growth hormone treatment,Chronic Kidney Disease,Childhood Chronic Kidney Disease,,,,Hormonal Therapy,,Childhood,,
131,Not Relevant,Chronic kidney disease,Focussed Oral,Effects of long-term GH treatment on FGF23/Klotho axis in pediatric patients with CKD,Chronic Kidney Disease,Paediatric Chronic Kidney Disease,,,,Hormonal Therapy,,Paediatric,,
132,Not Relevant,Chronic kidney disease,Focussed Oral,"The kynurenine-to-tryptophan ratio in serum is a predictor of cardiovascular mortality in CKD, independent of gut microbiome",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
133,Not Relevant,Chronic kidney disease,Focussed Oral,Phenylacetylglutamine's role in the link between uremic toxins and cognition in chronic kidney disease: a CKD-REIN cohort study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,CKD-REIN;;NCT03381950,
134,Not Relevant,Chronic kidney disease,Focussed Oral,Severe chronic kidney disease increases the risk of appendicular fractures in postmenopausal women,Chronic Kidney Disease,Appendicular Fracture;Severe Chronic Kidney Disease,,,,,,Severe,,
135,Not Relevant,Chronic kidney disease,Focussed Oral,Modulating ER-Mitochondrial Crosstalk with Kunkuibaoshen Granules: A Novel Strategy to Combat Renal Fibrosis in CKD,Chronic Kidney Disease;Fibrosis,Chronic Kidney Disease;Renal Fibrosis,,,,,,,,
136,Not Relevant,Chronic kidney disease,Focussed Oral,Dysregulation in Slc20a1/Slc20a2 Associated with Myocardial-Bone Axis in Mild Chronic Kidney Disease – Mineral and Bone Disorder: Experimental Study,Chronic Kidney Disease,Mild Chronic Kidney Disease,,,,,,Mild,,
137,Not Relevant,Chronic kidney disease,Focussed Oral,An novel lectin-mediated sorting protocol for renal tubules as an innovative multi-purpose tool advancing kidney research,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
138,Not Relevant,Chronic kidney disease,Focussed Oral,Annexin A13 inhibits renal fibrosis by inhibiting senescence-associated secretory phenotype in tubular epithelial cells,Fibrosis,Renal Fibrosis,,,,,,,,
139,Not Relevant,Chronic kidney disease,Focussed Oral,Anti-Fibrotic Profile of a Next-Generation AT2 Receptor Agonist in Human Fibrotic Kidney Tissue,Chronic Kidney Disease,Chronic Kidney Disease,,,,Anti-Fibrotic;AT2 Receptor-Agonist,,,,
140,Not Relevant,Chronic kidney disease,Focussed Oral,"Pirfenidone, a drug intended to treat idiopathic pulmonary fibrosis, prevented CKD progression in an experimental model of hypertensive nephrosclerosis",Idiopathic Pulmonary Fibrosis;Nephrosclerosis,Hypertensive Nephrosclerosis;Idiopathic Pulmonary Fibrosis,Pirfenidone,,,Antifibrotic Agent,,,,
141,Not Relevant,Chronic kidney disease,Focussed Oral,"Clinical Frailty Scale, Surprise Question and one-year mortality in older patients approaching kidney failure",Renal Failure,Elderly Kidney Failure,,,,,,Elderly,,
142,Not Relevant,Chronic kidney disease,Focussed Oral,High dietary phosphate and disuse-induced bone loss blunt the acute rise in serum phosphate following an oral challenge,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
143,Not Relevant,Chronic kidney disease,Focussed Oral,A prospective observational cohort study analysing how infertility affects quality of life of patients with and without chronic kidney disease (CKD) using the FertiQOL questionnaire,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
144,Not Relevant,Chronic kidney disease,Focussed Oral,The Microbiome and Its Metabolites Promote Cardiac Remodeling in Chronic Kidney Disease via the AhR-IL17A Axis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
145,Not Relevant,Chronic kidney disease,Focussed Oral,"The Copper/Zinc balance and anemia in patients with reduced glomerular filtration rate, data from the National Health and Nutrition Examination Survey (NHANES).",Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,,,,,
146,Not Relevant,Chronic kidney disease,Focussed Oral,MHR as a biomarker for kidney function decline and cardiovascular disease in a large cohort of geriatric patients.,Cardiovascular Disease;Chronic Kidney Disease,Cardiovascular Disease;Chronic Kidney Disease,,,,,,,,
147,Not Relevant,Chronic kidney disease,Focussed Oral,Comparative Analysis of Roux-en-Y Gastric Bypass and Gastric Restrictive Surgery in Obese Patients with Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
148,Not Relevant,Chronic kidney disease,Focussed Oral,Fracture incidence and risk factors in peritoneal dialysis patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
149,Not Relevant,Chronic kidney disease,Focussed Oral,Bone Turnover and Bone Density in Chronic Kidney Disease: a Translational Study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
150,Not Relevant,Chronic kidney disease,Focussed Oral,Differentially expressed Bone miRNAs in Low and High Bone Turnover in Chronic Kidney Disease: a pilot study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
151,Not Relevant,Chronic kidney disease,Focussed Oral,CKD-associated osteoporosis in an academic dialysis unit: a wake-up call,Chronic Kidney Disease;Osteoporosis,Chronic Kidney Disease;Osteoporosis,,,,,,,,
152,Not Relevant,Chronic kidney disease,Focussed Oral,"Exploring the Impact of Medication Adherence, Beliefs, Perceptions, and Psychological Factors on Blood Pressure Control in Elderly CKD Patients",Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,,,Elderly,,
153,Not Relevant,E-Posters,e-Poster,Desidustat in Chronic Kidney Disease Anaemia: Real-World Experience and Outcomes,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,Desidustat,,,HIF PH-Inhibitor,,,,
154,Not Relevant,Creative Labs 1 - Top tips for the ESENeph exam,Symposium,Top tips for the ESENeph exam,,,,,,,,,,
155,Not Relevant,Dialysis,Focussed Oral,"Strong-HD-VIE - Prevalence of Strongyloides stercoralis infection in hemodialysis patients in Vienna, Austria",Infection;Renal Failure,Kidney Failure;Strongyloid Stercoralis Infection,,,,,,,Strong-HD-VIE,
156,Not Relevant,Dialysis,Focussed Oral,Utilization of Telemedicine for Patients Receiving In-center Hemodialysis in the United States,Renal Failure,Kidney Failure,,,,,,,,
157,Not Relevant,Dialysis,Focussed Oral,Symptoms burden in Dialysis Patients: Determinants and Impact on Mortality,Renal Failure,Kidney Failure,,,,,,,,
158,Not Relevant,Dialysis,Focussed Oral,Characteristics and Outcomes of Culturally and Linguistically Diverse Patients Receiving Kidney Replacement Therapy in Australia: Insights from a Nationwide Registry Study (CALD-KF study),,,,,,,,,CALD-KF,
159,Not Relevant,Dialysis,Focussed Oral,Sleep Disorders In Hemodialysis Patients Enrolled In A Tertiary Hospital In Davao City,Renal Failure;Sleep Disorder,Kidney Failure;Sleep Disorder,,,,,,,,
160,Not Relevant,Dialysis,Focussed Oral,Sodium Balance in Hemodialysis and Hemodiafiltration: Real-World Insights from Spanish Clinics,Renal Failure,Kidney Failure,,,,,,,,
161,Not Relevant,Dialysis,Focussed Oral,A Multidisciplinary Team Delivered Deprescribing Intervention for Patients with Chronic Kidney Disease in Qatar: A Pilot Randomized Controlled Trial,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
162,Not Relevant,Dialysis,Focussed Oral,Effect of individualized dialysate bicarbonate concentration on patient prognosis: A multicenter retrospective study,Renal Failure,Kidney Failure,,,,,,,,
163,Not Relevant,Dialysis,Focussed Oral,Impact of dialysis initiation on drug use patterns in older patients: Results from the French national renal replacement therapy registry matched with the national health data system (SNDS),Renal Failure,Kidney Failure,,,,,,,,
164,Not Relevant,Dialysis,Focussed Oral,Greenhouse gas emissions from the special waste incineration: a comparative analysis between a large Dialysis Center and a University Hospital.,Renal Failure,Kidney Failure,,,,,,,,
165,Not Relevant,Dialysis,Focussed Oral,Impact of fluid overload changes within the first 6 months of dialysis on hospitalization during a two-year follow-up,Renal Failure,Kidney Failure,,,,,,,,
166,Not Relevant,Dialysis,Focussed Oral,Mediterranean Diet and Serum Phosphorus in hemodialysis: Beyond Food Phosphorus Content.,Renal Failure,Kidney Failure,,,,,,,,
167,Not Relevant,Dialysis,Focussed Oral,Implementing a Clinical Governance and Performance Benchmarking Model in Dialysis: The DaVita Quality Index Experience in Brazil,Renal Failure,Kidney Failure,,,,,,,,
168,Not Relevant,Dialysis,Focussed Oral,The Impact of a Clinical Governance Program on Mortality and Hospitalization Rates in Dialysis: The DaVita Quality Index Experience in Brazil,Renal Failure,Kidney Failure,,,,,,,,
169,Not Relevant,Dialysis,Focussed Oral,Impact of haemodialysis timing before kidney transplant surgery on early postoperative outcomes,Renal Failure,Kidney Failure,,,,,,,,
170,Not Relevant,Dialysis,Focussed Oral,Loop Diuretics in Anuric Hemodialysis Patients: An Unexplored Avenue for Removal of ProteinBound Uremic Toxins,Renal Failure,Kidney Failure,Loop Diuretic,,,Loop Diuretic,,,,
171,Not Relevant,Dialysis,Focussed Oral,Role Of A Low-Protein Diet Based On Essential Amino Acids And Ketoanalogues In Cardioprotection In Shr Rats With Renal Dysfunction,RenaL Dysfunction,Renal Dysfunction,,,,,,,,
172,Not Relevant,Dialysis,Focussed Oral,Correlation between protein energy wasting and cognitive impairment in maintenance hemodialysis patients,Cognitive Impairment;Renal Failure,Cognitive Impairment;Kidney Failure,,,,,,,,
173,Not Relevant,Dialysis,Focussed Oral,Multi-Organ Ultrasound in Dialysis: A New Frontier in Blood Volume Quantification,Renal Failure,Kidney Failure,,,,,,,,
174,Not Relevant,Dialysis,Focussed Oral,Relationship between antioxidant nutrients intake and oxidative stress in patients treated with hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
175,Not Relevant,Dialysis,Focussed Oral,Age-Related Cardiovascular Disease Burden in Dialysis: Insights from ApolloDialDb,Cardiovascular Disease;Renal Failure,Cardiovascular Disease;Kidney Failure,,,,,,,ApolloDialDb,
176,Not Relevant,Dialysis,Focussed Oral,"Data-driven clustering of secretory bone markers to risk-stratify hemodialysis patients: Insights from a multicentric, prospective observational study",Renal Failure,Kidney Failure,,,,,,,,
177,Not Relevant,Dialysis,Focussed Oral,Integrating Palliative Care into Nephrology: A Single-Center “action-research” process,,,,,,,,,,
178,Not Relevant,Dialysis,Focussed Oral,Relationship between Changes in Bone Responsiveness to Parathyroid Hormone and Bone Mineral Density in Patients on Chronic Haemodialysis,Renal Failure,Kidney Failure,,,,,,,,
179,Not Relevant,Dialysis,Focussed Oral,Tenapanor administration combined with phosphate binders provides synergistic phosphate lowering effect,Renal Failure,Kidney Failure,Tenapanor,,,NHE3-Inhibitor;Phosphate Binder,,,,
180,Not Relevant,Dialysis,Focussed Oral,Effects of a group exercise program supported by audiovisual media on muscle strength of people on maintenance hemodialysis: a pilot study,Renal Failure,Kidney Failure,,,,,,,,
181,Not Relevant,Dialysis,Focussed Oral,Outcomes of Bioprosthetic and Mechanical Valve Replacement in Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
182,Not Relevant,Dialysis,Focussed Oral,Impact of Atrial Fibrillation on Cardiac Remodeling in Patients on Dialysis: Insights from a Longitudinal Study,Atrial Fibrillation,Atrial Fibrillation,,,,,,,,
183,Not Relevant,Dialysis,Focussed Oral,Feasibility And Safety Of A Group Exercise Program Supported By Audiovisual Media During Hemodialysis (Grexid): An Experimental Study,Renal Failure,Kidney Failure,,,,,,,GrExID;;NCT06660160,
184,Not Relevant,Dialysis,Focussed Oral,Real-World Effectiveness of Patiromer Among Hemodialysis (HD) Patients Prescribed Various Treatment Schedules Over a One-Year Follow-Up,Renal Failure,Kidney Failure,Patiromer,,,Potassium-Binder,,,,
185,Not Relevant,FC 2: More about the New Pillars of Treatment,Free Communication,The effect of canagliflozin dose on cardiovascular and renal outcomes in patients with type 2 diabetes and high cardiovascular risk,Type 2 Diabetes,Type 2 Diabetes,Canagliflozin,,,SGLT2-Inhibitor,,,,
186,Not Relevant,FC 2: More about the New Pillars of Treatment,Free Communication,"Impact Of Diabetes, Albuminuria, Acute Egfr Dip, And Disease Severity On The Effects Of Empagliflozin On Progression Of Chronic Kdiney Disease.",Albuminuria;Chronic Kidney Disease;Diabetes,Albuminuria;Chronic Kidney Disease;Diabetes,Empagliflozin,,,SGLT2-Inhibitor,,,,
187,Not Relevant,FC 2: More about the New Pillars of Treatment,Free Communication,Effect of finerenone on eGFR slope across different levels of baseline albuminuria: Insights from FINEARTS-HF,Albuminuria,Albuminuria,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,Bayer,,FINEARTS-HF;;NCT04435626,
188,Not Relevant,FC 2: More about the New Pillars of Treatment,Free Communication,Real-World Outcomes of Switching from steroidal mineralocorticoid receptor antagonists (sMRA) to Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes (T2DM): A Multicenter Study in Madrid Community.,Chronic Kidney Disease;Type 2 Diabetes,Chronic Kidney Disease;Type 2 Diabetes,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist;Steroidal Mineralocorticoid Receptor-Antagonist,,,,
189,Not Relevant,FC1: Genetics of Kidney Disease: from Big Data to Small Stones,Free Communication,"Deciphering the genetic architecture of inherited kidney disease using the 100,000 Genomes Project",Kidney Diseases,Inherited Kidney Disease,,,,,,,,
190,Not Relevant,FC1: Genetics of Kidney Disease: from Big Data to Small Stones,Free Communication,Genealogical Analysis in the Era of Big Data: Implications for Biomedical Research,Kidney Diseases,Kidney Disease,,,,,,,,
191,Not Relevant,FC1: Genetics of Kidney Disease: from Big Data to Small Stones,Free Communication,Enhancing Diagnostic Precision For Inherited Kidney Diseases: The Importance Of Databases.,Kidney Diseases,Inherited Kidney Disease,,,,,,,,
192,Not Relevant,FC1: Genetics of Kidney Disease: from Big Data to Small Stones,Free Communication,Urinary myeloid bodies as a biomarker for early diagnosis and monitoring of enzyme replacement therapy in Fabry disease,Fabry Disease,Fabry Disease,,,,Enzyme Replacement Therapy,,,,
193,Not Relevant,FC1: Genetics of Kidney Disease: from Big Data to Small Stones,Free Communication,SGLT2 Inhibitors in adult patients with Alport Syndrome: a single center Italian experience,Alport Syndrome,Adult Alport Syndrome,,,,,,Adult,,
194,Not Relevant,FC1: Genetics of Kidney Disease: from Big Data to Small Stones,Free Communication,Genetically determined reduction of renal carbonic anhydrase 12 is associated with decreased kidney function and increased serum urate,Kidney Diseases,Kidney Disease,,,,,,,,
195,Not Relevant,FC1: Genetics of Kidney Disease: from Big Data to Small Stones,Free Communication,Discovery of a rare vitamin D receptor defect as an inherited cause of kidney stones in Malta,,Kidney Stone,,,,,,,,
196,Not Relevant,Game changers in AKI diagnosis: coding out the creatinine,Symposium,Biomarkers vs AI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
197,Not Relevant,Game changers in AKI diagnosis: coding out the creatinine,Symposium,Patterns in the labs- can this tell us what we dont know,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
198,Not Relevant,Game changers in AKI diagnosis: coding out the creatinine,Symposium,Alphabet soup- Unleashing the data in free text to recognise AKI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
199,Not Relevant,Game changers in CKD and type 2 diabetes,Symposium,An update on GLP-1RA in Diabetic Kidney Disease: from ebb to FLOW,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,GLP-1 Receptor Agonist,Novo Nordisk,,FLOW;;NCT03819153,
200,Not Relevant,Game changers in CKD and type 2 diabetes,Symposium,Aldosterone pathway inhibition when treated with RASi and SGLT2i: gaining CONFIDENCE?,Chronic Kidney Disease;Type 2 Diabetes,Chronic Kidney Disease;Type 2 Diabetes,,,,Renin-Angiotensin System Inhibitor;SGLT2-Inhibitor,,,,
201,Not Relevant,Game changers in CKD and type 2 diabetes,Symposium,SGLT2 inhibition in diabetic kidney disease: what's new in the last year?,Diabetic Nephropathy,Diabetic Kidney Disease,,,,SGLT2-Inhibitor,,,,
202,Not Relevant,Game changers in genetic diseases: gene therapy,Symposium,CRISPR-Cas12 based in vivo gene-editing therapy for Primary Hyperoxaluria Type 1,,,,,,Gene Editing Therapy,,,,
203,Not Relevant,Game changers in genetic diseases: gene therapy,Symposium,Gene therapy for cystinosis,Cystinosis,Cystinosis,,,,Gene Therapy,,,,
204,Not Relevant,Game changers in genetic diseases: gene therapy,Symposium,Gene therapy perspectives for genetic podocytopathies,Podocytopathy,Podocytopathy,,,,Gene Therapy,,,,
205,Not Relevant,Game changers in Kidney Vasculitis,Symposium,CD19-targeting CAR T cells for ANCA vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,CD19-Targeting CAR T Cell,,,CAR T Cell Therapy,,,,
206,Not Relevant,Game changers in Kidney Vasculitis,Symposium,Complement inhibitors in ANCA-Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,,,,Complement-Inhibitor,,,,
207,Not Relevant,Game changers in Kidney Vasculitis,Symposium,Can we optimize clinicopathologic prognostication in AAV?,Vasculitis,Kidney Vasculitis,,,,,,,,
208,Not Relevant,Game changers in organ shortage: xenotransplantation?,Symposium,Social Implication of xenotransplantation,,,,,,,,,,
209,Not Relevant,Game changers in organ shortage: xenotransplantation?,Symposium,What's Next in Making Xenotransplantation a Reality for Our Patients?,,,,,,,,,,
210,Not Relevant,Game changers in organ shortage: xenotransplantation?,Symposium,Virus Safety of Xenotransplantation,,,,,,,,,,
211,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Trends in Diagnosis, Renal Progression, and Therapeutic Impact on Survival in AL Amyloidosis",Light-Chain Amyloidosis,Amyloid Light Chain Amyloidosis,,,,,,,,
212,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Predictors of disease activity in ANCA-associated vasculitis subtypes: A statistical and predictive analysis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,,,,,,,,
213,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Clinical significance of punctate podocyte IgG staining in primary diffuse podocytopathy,Podocytopathy,Primary Diffuse Podocytopathy,,,,,,,,
214,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Urinary Markers of Inflammation and Damage in Anti-GBM Disease Before and After Treatment with Imlifidase,Goodpasture's Syndrome,Anti-Glomerular Basement Membrane Disease,Imlifidase,,,Recombinant Cysteine Protease,,,,
215,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,The clinical and histological long-term effects of two different anti-CD20 regimens in a large series of Fibrillary Glomerulonephritis,Fibrillary Glomerulonephritis,Fibrillary Glomerulonephritis,,,,CD20-Targeted Therapy,,,,
216,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Plasma exosomal MiR-15a-5p levels are associated with SMAD7/TGFß1 podocyte signaling pathway in lupus nephritis,Lupus Nephritis,Lupus Nephritis,,,,,,,,
217,Low,Glomerular & tubulo-interstitial diseases,Focussed Oral,Serum Inflammatory Biomarkers in IgA nephropathy: Insights from a Swedish Cohort with 25 years of follow-up,IgA Nephropathy,IgA Nephropathy,,,,,,,,
218,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Modified NIH Activity and Chronicity Indices In IgA Nephropathy: Chronicity as a Predictor of Renal Outcomes,IgA Nephropathy,IgA Nephropathy,,,,,,,,
219,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Long-term safety and efficacy of the combination of Belimumab and Rituximab in the treatment of severe and refractory SLE: a preliminary report,Systemic Lupus Erythematosus,Severe/Refractory Systemic Lupus Erythematosus,Belimumab;Rituximab,,,BAFF-Inhibitor;CD20-Targeted Antibody,,Refractory;Severe,,
220,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Association of Complement deposition with clinical phenotype in Lupus nephropathies (LN),Lupus Nephritis,Lupus Nephritis,,,,,,,,
221,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Kidney Injury Molecule–1 and Beta-2-microglobuline significance in lupus nephritis,Lupus Nephritis,Lupus Nephritis,,,,,,,,
222,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Lupus nephritis outcomes in patients with acute kidney injury and rapidly progressive glomerulonephritis presentation - cohort of a tertiary center,Acute Kidney Injury;Crescentic Glomerulonephritis,Acute Kidney Injury;Rapidly Progressive Glomerulonephritis,,,,,,,,
223,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Complement 3 (C3) Staining and Glomerular Inflammation in Immunoglobulin A Nephropathy (IgAN): Real-World Biopsy Data in the United States (US),IgA Nephropathy,IgA Nephropathy,,,,,,,,
224,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Clinical characteristics and disease progression in primary IgA nephropathy patients in the Netherlands,IgA Nephropathy,Primary IgA Nephropathy,,,,,,,,
225,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Treatment response in lupus podocytopathy: Long-term experience of a tertiary center,Lupus Podocytopathy,Lupus Podocytopathy,,,,,,,,
226,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,CD163+ Macrophages: A Prognostic Marker In Anca Vasculitis?,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
227,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Long-term prognosis of lupus nephritis: comparison between pediatric, adult, and advanced age onset",Lupus Nephritis,Adult Lupus Nephritis;Pediatric Lupus Nephritis,,,,,,Adult;Paediatric,,
228,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Machine Learning-Based Plasma Proteome Signatures Including > 5,000 Protein Levels Distinguish Glomerulonephritis Subtypes",Glomerulonephritis,Glomerulonephritis,,,,,,,,
229,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Predictive Value of Gd-IgA1, Poly-IgA in the Treatment of IgA Nephropathy with Targeted Release Formulation-Budesonide.",IgA Nephropathy,IgA Nephropathy,Budesonide,,,Glucocorticoid Agonist,,,,
230,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Sparsentan reversibly decreases mesangial IgA deposition in gddY mice; a possible role for mesangial-cell -surface autoantigen expression.,Dysplasia;Tubulointerstitial Disease,Glomerular Ductal Dysplasia;Tubulointerstitial Disease,Sparsentan,,,Endothelin Receptor-Antagonist,,,,
231,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,Targeted release budesonide (TRB) can effectively reduce proteinuria when active lesions are present in IgA Nephropathy (IgAN) patients: A multicenter study,IgA Nephropathy;Proteinuria,IgA Nephropathy;Proteinuria,Budesonide,,,Glucocorticoid Agonist,,,,
232,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Association of cardiovascular and renal involvement in patients with granulomatosis with polyangiitis and microscopic polyangiitis,Microscopic Polyangiitis,Granulomatosis;Microscopic Polyangiitis,,,,,,,,
233,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Rapid diagnosis of membranous nephropathy based on serum Raman spectroscopy combined with deep learning methods,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
234,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Using national hospital discharge data to estimate the clinical and economic hospital burden and care pathways of patients with ANCA-associated vasculitis in Italy,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,,,,,,,,
235,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Effects of sodium-glucose cotransporter 2 inhibitors on proteinuria and kidney function in glomerulonephritis and glomerulopathy of different etiologies undergoing induction immunosuppression therapy,Glomerulonephritis;Renal Failure,Glomerulonephritis;Kidney Failure,,,,SGLT2-Inhibitor,,,,
236,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Nomogram-based prediction of tubulointerstitial lesions in lupus nephritis patients,Lupus Nephritis,Lupus Nephritis;Tubulointerstitial Lesion,,,,,,,,
237,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,The impact of kidney relapse on long-term kidney function in ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis;Kidney Relapse,,,,,,Relapsed,,
238,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Predictors and long-term outcomes of glucocorticoid discontinuation in an inception cohort of lupus nephritis patients with a 10-year follow-up,Lupus Nephritis,Lupus Nephritis,,,,,,,,
239,Not Relevant,E-Posters,e-Poster,Daratumumab-based regimens vs conventional clone-directed treatment in relapsed/refractory non-amyloid monoclonal immunoglobulin related kidney disease,Kidney Diseases,Relapsed/Refractory Non-Amyloid Monoclonal Immunoglobulin Related Kidney Disease,Daratumumab,,,CD38-Targeted Monoclonal Antibody,,Relapsed/Refractory,,
240,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Prognostic significance of Soluble urokinase-type plasminogen activator receptor (suPAR) in patients with glomerulonephritis: Association with renal outcomes,Glomerulonephritis,Glomerulonephritis,,,,,,,,
241,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Insights into Geographic Patterns, Urban-Rural Contrasts, and Healthcare Disparities in Glomerular Disease Incidence in a Canadian Province",Glomerular Disease,Glomerular Disease,,,,,,,,
242,Not Relevant,Hypertension & Diabetes,Focussed Oral,SGLT2 and HIF-PH inhibitors restore podocyte abnormalities in diabetes,Diabetes,Diabetes,,,,HIF PH-Inhibitor;SGLT2-Inhibitor,,,,
243,Not Relevant,Hypertension & Diabetes,Focussed Oral,The Effect of SGLT2 inhibitor therapy on urinary podocyte markers in diabetic kidney disease,Diabetic Nephropathy,Diabetic Kidney Disease,,,,SGLT2-Inhibitor Therapy,,,,
244,Not Relevant,Hypertension & Diabetes,Focussed Oral,Association of Intra-individual Differences in Estimated GFR by Creatinine versus Cystatin C with Incident Hypertension and the Mediating Role of TyG,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
245,Not Relevant,Hypertension & Diabetes,Focussed Oral,Impact of SGLT2 and Dual SGLT1/2 Inhibition on Salt-Sensitive Hypertension Progression in Dahl SS Rats,Hypertension,Progressive Salt Sensitive Hypertension,,,,SGLT1/2-Inhibitor;SGLT2-Inhibitor,,Progressive,,
246,Not Relevant,Hypertension & Diabetes,Focussed Oral,Atypical chemokine receptor 4 is involved in blood pressure regulation and ameliorates experimental glomerulonephritis,Glomerulonephritis,Glomerulonephritis,,,,,,,,
247,Not Relevant,Hypertension & Diabetes,Focussed Oral,Wide-proteome analysis on renal tissue samples reveals new intriguing outcomes on NA-Milan hypertensive rat strain phenotype,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
248,Not Relevant,Hypertension & Diabetes,Focussed Oral,The overlooked players: immunomodulatory endothelial cells in diabetic kidney disease,Diabetic Nephropathy,Diabetic Kidney Disease,,,,,,,,
249,Not Relevant,Hypertension & Diabetes,Focussed Oral,Mechanisms of GPCR19-Mediated Protection in Diabetic Kidney Disease: Regulation of Mitochondrial Homeostasis and Therapeutic Potential,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
250,Not Relevant,Hypertension & Diabetes,Focussed Oral,Antagonistic DcR2 peptides ameliorate renal fibrosis by inhibiting renal tubular cells senescence in diabetic nephropathy,Diabetic Nephropathy;Fibrosis,Diabetic Nephropathy;Renal Fibrosis,,,,DCR2 Peptide Inhibitor,,,,
251,Not Relevant,Hypertension & Diabetes,Focussed Oral,Single-cell transcription combined with spatial  transcriptome reveals the role of senescent proximal tubules in the progression of diabetic nephropathy,Diabetic Nephropathy,Diabetic Nephropathy,,,,,,,,
252,Not Relevant,Hypertension & Diabetes,Focussed Oral,Role of Total Flavonoids of Abelmoschus manihot (L.) Medic in Improving Renal Fibrosis in DKD via O-GlcNAc Glycosylation and FAO Pathway,Diabetic Nephropathy;Fibrosis,Diabetic Kidney Disease;Renal Fibrosis,,,,,,,,
253,Not Relevant,Hypertension & Diabetes,Focussed Oral,"Urinary and serum aminoacids may be associated to Podocyte, Proximal Tubule, and Renal Endothelial Injury in Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients",Diabetic Nephropathy;Type 2 Diabetes,Early Onset Diabetic Kidney Disease;Renal Endothelial Injury;Type 2 Diabetes Mellitus,,,,,,Early Onset,,
254,Not Relevant,Hypertension & Diabetes,Focussed Oral,Characterization and standard of care efficacy testing in a translational mouse model of cardiovascular-kidney-metabolic syndrome,Diabetes;Metabolic Syndrome,Cardiovascular Kidney Metabolic Syndrome;Diabetes,,,,,,,,
255,Not Relevant,Hypertension & Diabetes,Focussed Oral,Exploring the Role of KDM6A as a Regulator of Proximal Tubular Epithelial Cell Dysmetabolism in Diabetic Kidney Disease,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
256,Not Relevant,Hypertension & Diabetes,Focussed Oral,Oxidative status in chronic kidney disease. Effect of dialysis and kidney transplantation,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
257,Not Relevant,Kidney Transplantation,Focussed Oral,Prediction of BK Polyomavirus associated nephropathy by the NEPHROVIR method in kidney transplant recipients with BK Polyomavirus-DNAemia,Nephropathy,BK Polyomavirus Associated Nephropathy;BK Polyomavirus-DNAemia,,,,,,,,
258,Not Relevant,Kidney Transplantation,Focussed Oral,Impact Of Proton Pump Inhibitor Use On Renal Function In Kidney Transplant Recipients: A Longitudinal Cohort Study,,,,,,Proton Pump-Inhibitor,,,,
259,Not Relevant,Kidney Transplantation,Focussed Oral,SGLT2 inhbitors Reduce the eGFR Slope in Diabetic and Non-diabetic Renal Transplant Recipients,Diabetes,Diabetes,,,,SGLT2-Inhibitor,,,,
260,Not Relevant,Kidney Transplantation,Focussed Oral,Use of Radiofrequency Echographic Multi Spectrometry (REMS) and Cardio-Ankle Vascular Index (CAVI) to evaluate the effects of immunosuppressive (IS) drugs on bone and vessel disease in renal transplant (RTX) patients.,Bone Disease,Bone Disease;Kidney Vessel Disease,,,,Immunosuppressive Therapy,,,,
261,Not Relevant,Kidney Transplantation,Focussed Oral,Long Term Monitoring of Torque Teno Virus Load for the Detection of Infections in Kidney Transplantation,Infection,Infection,,,,,,,,
262,Not Relevant,Kidney Transplantation,Focussed Oral,Evaluating Causes of Diarrhea in Renal Transplant Recipients using Stool Multiplex PCR Assay and its Impact on Graft Function,Diarrhea,Diarrhea,,,,,,,,
263,Not Relevant,Kidney Transplantation,Focussed Oral,Association of Early Post-Donation Weight Gain with Kidney Function in Obese Living Kidney Donors,Obesity,Obesity,,,,,,,,
264,Not Relevant,Kidney Transplantation,Focussed Oral,CMV Infection in CMV-Seropositive Kidney Transplant Recipients: does pretransplant CMV IgG titer matter?,Cytomegaloviral Disease,CMV Infection,,,,,,,,
265,Not Relevant,Kidney Transplantation,Focussed Oral,Graph Neural Networks in the Nephropathological Diagnosis of Antibody-Mediated Rejection (AMR),,,,,,,,,,
266,Not Relevant,Kidney Transplantation,Focussed Oral,Glomerulitis and interstitial fibrosis in first year kidney transplant biopsies are associated with cardiovascular risk,Interstitial Fibrosis,Glomerulitis;Interstitial Fibrosis,,,,,,,,
267,Not Relevant,Kidney Transplantation,Focussed Oral,Legacy effect of pretransplant immunosuppression in kidney transplant recipients with crescentic glomerulonephritis,Crescentic Glomerulonephritis,Crescentic Glomerulonephritis,,,,,,,,
268,Not Relevant,Kidney Transplantation,Focussed Oral,Prolonged functional warm ischaemia is associated with metabolic and protease dysregulation in DCD kidneys,,,,,,,,,,
269,Not Relevant,Kidney Transplantation,Focussed Oral,Fluid Overload in Perioperative Kidney Transplantation: More Common Than Meets the Eye,,,,,,,,,,
270,Not Relevant,Kidney Transplantation,Focussed Oral,Gene Expression Profiles of PBMCs in Kidney vs. Lung Recipients Prior to Extracorporeal Photopheresis: Similarities and Differences,,,,,,,,,,
271,Not Relevant,Kidney Transplantation,Focussed Oral,Identifying risk factors for sedentarism in kidney transplatation,,,,,,,,,,
272,Not Relevant,Kidney Transplantation,Focussed Oral,Exploring Psychological Distress and Quality of Life in Kidney Transplant Patients: A Study of Gender Differences,,,,,,,,,,
273,Not Relevant,E-Posters,e-Poster,Depot-specific metabolic and thermogenic profiles in perirenal and renal sinus adipose tissue,,,,,,,,,,
274,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Development and characterization of 3D models based on Urine derived Renal Epithelial Cells,,Genetic Disease,,,,,,,,
275,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Mechanosensitive Cation Channel Piezo1 Regulates AQP2 Expression in Collecting Ducts of the Kidney,,Disease,,,,,,,,
276,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,A glomerulus-on-chip to study glomerular cell interactions,,Genetic Disease,,,,,,,,
277,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Discoidin Domain-containing Receptor 2 in pericyte plays a crucial role in AKI-CKD continuum,Acute Kidney Injury;Chronic Kidney Disease,Acute Kidney Injury;Chronic Kidney Disease,,,,,,,,
278,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Cysteinyl tRNA synthetase-2 is involved in cisplatin-induced acute kidney injury,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
279,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Epigenetic and transcriptional landscape of the kidney in heart failure with preserved ejection fraction,Heart Failure,Heart Failure,,,,,,,,
280,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Mettl3-mediated m6A methylation of Ndrg1 promotes acute kidney injury sensitivity in diabetic kidney diseases,Acute Kidney Injury;Diabetic Nephropathy,Acute Kidney Injury;Diabetic Kidney Disease,,,,,,,,
281,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Exploring Exosome-Mediated Effects on Renal Pathology in Anderson Fabry Disease,Fabry Disease,Anderson Fabry Disease,,,,,,,,
282,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,The nephronophthisis protein GLIS2/NPHP7 is required for the DNA damage response in kidney tubular epithelial cells,,Disease,,,,,,,,
283,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Primary Hyperparathyroidism induces Erythropoietin resistance through FGF23,Primary Hyperparathyroidism,Primary Hyperparathyroidism,,,,,,,,
284,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Establishing a co-culture system to identify key paracrine and endocrine interactions between myoblasts and osteoblasts,,Genetic Disease,,,,,,,,
285,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Mitochondrial Oxidative Phosphorylation in Human Proximal Tubular Epithelial Cells Is Impaired by Iron Deficiency-Additional Report-,Iron Deficiency Anemia,Iron Deficiency,,,,,,,,
286,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Myeloid Src-Family Kinases And Their Role In Various Forms Of Kidney Inflammation,Inflammation,Kidney Inflammation,,,,,,,,
287,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Pathological role of Neuroaminidase-1 in Nephrotic Syndrome,Nephritic Syndrome,Nephritic Syndrome,,,,,,,,
288,Not Relevant,Prevention and treatment of infections in haemodialysis patients – a real challenge of XXI century,Symposium,"Viral respiratory diseases – RSV, flu and COVID19",Coronavirus Infection;Influenza;Renal Failure,COVID-19;Flu;Kidney Failure,,,,,,,,
289,Not Relevant,Prevention and treatment of infections in haemodialysis patients – a real challenge of XXI century,Symposium,Clostridioides difficile infection,Clostridium Difficile Infection,Clostridioides Difficile Infection,,,,,,,,
290,Not Relevant,Prevention and treatment of infections in haemodialysis patients – a real challenge of XXI century,Symposium,Bacterial endocarditis,Bacterial Endocarditis,Bacterial Endocarditis,,,,,,,,
291,Not Relevant,Sex as a game changer in kidney diseases,Symposium,Role of estradiol in AKI Sensitivity,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
292,Not Relevant,Sex as a game changer in kidney diseases,Symposium,Women and kidney diseases: focus on hypertensive status in pregnancy and preeclampsia.,Kidney Diseases;Pre-Eclampsia,Kidney Disease;Preeclampsia,,,,,,,,
293,Not Relevant,Sex as a game changer in kidney diseases,Symposium,Why are females protected from kidney injury but develop preeclampsia?,Pre-Eclampsia,Kidney Injury;Preeclampsia,,,,,,,,
294,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,The platelet-to-white blood cell ratio is potentially the most predictive indicator of mortality among inflammatory markers based on complete blood counts in patients with acute kidney injury,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
295,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Multicentric Study Of Clinical Characteristics And Risk Factors Of Acute Renal Failure In Oncological Patients Under Treatment With Checkpoint Inhibitors,Acute Kidney Failure,Acute Renal Failure,,,,Immune Checkpoint Inhibitors,,,,
296,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Evaluating the McMahon score for predicting acute kidney injury and mortality during rhabdomyolysis: a Tunisian prospective study,Acute Kidney Injury;Rhabdomyolysis,Acute Kidney Injury;Rhabdomyolysis,,,,,,,,
297,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,The value of lactate dehydrogenase in predicting acute kidney injury during rhabdomyolysis: prospective evidence,Acute Kidney Injury;Rhabdomyolysis,Acute Kidney Injury;Rhabdomyolysis,,,,,,,,
298,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Risk factors and Long-term outcomes of Acute Kidney Disease in Hematopoietic Stem Cell Transplant – cohort study.,Acute Kidney Injury,Acute Kidney Injury,Hematopoietic Stem Cell,,,Stem Cell Therapy,,,,
299,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Are ICD-10 codes for acute kidney injury suitable for use in research? Evaluating sensitivity and positive predictive value in Denmark,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
300,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,NSAIDs: Painkillers or Kidney Killers? The ICU Perspective,Acute Kidney Injury,Acute Kidney Injury,,,,Nonsteroidal Anti-inflammatory Drug,,,,
301,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,"Abiraterone- related renal events: description, risk factors and association with mortality in a Spanish cohort of patients with advanced prostate cancer",,Advanced Prostate Cancer,,,,,,,,
302,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Renal Tubular Behavior in Patients with Acute Kidney Injury Associated with Sepsis and Cardiorenal Syndrome,Acute Kidney Injury;Cardio-Renal Syndrome;Sepsis,Acute Kidney Injury;Cardiorenal Syndrome;Sepsis,,,,,,,,
303,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Treatment of acute kidney injury with renal replacement therapy and CytoSorb in critically ill hospitalised patients,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
304,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Increased baseline circulating ACE2 activity and Gas6 levels predict COVID-19 severity,Coronavirus Infection,COVID-19,,,,,,,,
305,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Evaluation of the frequency of contrast-induced nephropathy and associated factors following fundus fluorescein angiography,Nephropathy,Nephropathy,,,,Diagnostic Agent,,,,
306,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,"Clinical, laboratory, and genetic risk factors of acute kidney injury after on-pump cardiac surgery in adult Caucasians – analysis of the INFLACOR prospective cohort study",Acute Kidney Injury,Acute Kidney Injury,,,,,,,INFLACOR;;NCT01020409,
307,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Comprehensive hemodynamic multi-organ ultrasound evaluation in AKI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
308,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,"Aggravated sepsis, acute kidney injury and microbiological resistance in four years pre-post COVID 19 outcome study",Acute Kidney Injury;Coronavirus Infection;Sepsis,Acute Kidney Injury;COVID-19;Sepsis,,,,,,,,
309,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,The Predictive Ability of β2 microglobulin for Survival in ICU Patients Requiring Continuous Renal Replacement Therapy,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
310,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Immune checkpoint inhibitors associated acute kidney injury: a case serie,Acute Kidney Injury,Acute Kidney Injury,,,,Immune Checkpoint-Inhibitor,,,,
311,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,"Obstructive AKI: post nephrostomy Mortality, Dialysis, and short-term Renal Function",Acute Kidney Injury,Obstructed Acute Kidney Injury,,,,,,,,
312,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,“Acute Kidney Injury In Patients With Kyasanur Forest Disease.”,Acute Kidney Injury;Kyasanur Forest Disease,Acute Kidney Injury;Kyasanur Forest Disease,,,,,,,,
313,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Risk Factors Associated With Acute Kidney Injury In Cancer Patients,Acute Kidney Injury;Cancer,Acute Kidney Injury;Cancer,,,,,,,,
314,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,A Case Report On Wunderlich Syndrome In A 32-Year-Old Male: Diagnostic And Clinical Challenges,Wunderlich Syndrome,Wunderlich Syndrome,,,,,,,,
315,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Elderly Patients with Acute Kidney Injury : What Predicts Mortality ?,Acute Kidney Injury,Elderly Acute Kidney Injury,,,,,,Elderly,,
316,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Incidence and Frequency of Immune-Related Nephropathy in Patients Treated with Immune Checkpoint Inhibitors: A FAERS Analysis (2020–2024),Nephropathy,Immune Related Nephropathy,,,,Immune Checkpoint-Inhibitor,,,,
317,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Proteinuria-Creatinuria Index As An Early Prognostic Marker In Patients With Acute Kidney Injury,Acute Kidney Injury;Proteinuria,Acute Kidney Injury;Proteinuria,,,,,,,,
318,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,The Role of pro-inflammatory Markers and Kidney Function in a Pediatric Retrospective Cohort Study,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
319,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,"Outcomes Of Acute Kidney Injury In Pediatric Patients With Severe Malaria: Observations In Khartoum, Sudan",Acute Kidney Injury;Malaria,Acute Kidney Injury;Pediatric Severe Malaria,,,,,,Paediatric;Severe,,
320,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Risk factors for hospitalization for a major acute cardiovascular event after acute kidney injury with full recovery: a single center experience,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
321,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Predictors and prevalence of hypomagnesemia in critically ill non oliguric acute kidney injury patients.,Hypomagnesemia,Hypomagnesemia,,,,,Guard Therapeutics,,,
322,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Citrate accumulation during therapeutic plasma exchange in acute on chronic liver failure,Acute Kidney Injury;Liver Failure,Acute Kidney Injury;Chronic Liver Failure,,,,,,,,
323,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Assessment of Correlation Between Effluent Fluid Ionized Calcium and Post-Filter Ionized Calcium Levels to Evaluate Regional Citrate Anticoagulant Effect in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
324,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Relation of serum creatinine twitches and outcomes among myocardial infarction patients,Myocardial Infarction,Myocardial Infarction,,,,,,,,
325,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,A Machine Learning Approach to Predict Acute Kidney Injury in Hospitalised Heart Failure Patients,Acute Kidney Injury;Heart Failure,Acute Kidney Injury;Heart Failure,,,,,,,,
326,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,A Phase 2b Dose Finding Study to Assess the Efficacy of RMC-035 on Renal Function in Participants at High Risk for Kidney Injury Following Open-Chest Cardiac Surgery (POINTER),,High-Risk Kidney Injury,RMC-035,,,Recombinant A1M,Guard Therapeutics,High-risk,NCT06475274;;POINTER,
327,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Baseline Data of the multiECCO2R Study: A safety and efficiency study to evaluate CO2 Removal in Combination with Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy,Acute Kidney Injury,Acute Kidney Injury,,,,,Fresenius Medical Care,,NCT04871893,multiECCO2R
328,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,High Volume Haemodiafiltration Outcomes in Obese Covid 19 Patients with Acute Kidney Injury and Respiratory Failure,Acute Kidney Injury;Coronavirus Infection;Respiratory Failure,Acute Kidney Injury;COVID-19;Respiratory Failure,,,,,,,,
329,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Polymethylmethacrylate Membranes: A Cost-Effective and Viable Strategy for Renal Recovery in Multiple Myeloma,Multiple Myeloma,Multiple Myeloma,,,,,,,,
330,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Amikacin Dosing in Pediatrics: Virtual Population Insights into Avoiding Nephrotoxicity,Acute Kidney Injury,Pediatric Acute Kidney Injury,Amikacin,,,Aminoglycoside Antibiotic,,Paediatric,,
331,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Unseen Hazards: Rhabdomyolysis in CKD Patients Due to Ticagrelor and Colchicine,Chronic Kidney Disease;Rhabdomyolysis,Chronic Kidney Disease;Rhabdomyolysis,,,,,,,,
332,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Effect of cytokine hemoadsorption with CytoSorb in patients with endocarditis receiving cardiac surgery: a systemic review and meta-analysis,Endocarditis,Endocarditis,,,,,Fresenius,,,
333,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Evaluation of eryptosis induced by different bacterial concentrations: a translational approach,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
334,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Plasmapheresis as a Life-Saving Intervention in Amiodarone-Induced Thyroid Storm,,Thyroid Storm,,,,,,,,
335,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Comparison Of Three Different Amikacin Guidelines For Pediatric Patients: Virtual Population Insight,Acute Kidney Injury,Acute Kidney Injury,Amikacin,,,Aminoglycoside Antibiotic,,,,
336,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Comparative Efficacy And Safety Of Diuretics In Acute Decompensated Heart Failure: A Network Meta-Analysis,Acute Decompensated Heart Failure,Acute Decompensated Heart Failure,,,,,Fresenius,,,
337,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Optimal Blood Pressure Levels and the Impact of Vasopressor Choise on Mortality and Renal Recovery in Critically Ill Patients Undergoing Renal Replacement Therapy:  A Systematic Review and Meta-Anaysis.,Acute Kidney Injury,Acute Kidney Injury,,,,Vasopressor,,,,
338,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,A Case Report On Wunderlich Syndrome In A 32-Year-Old Male: Diagnostic And Clinical Challenges,Wunderlich Syndrome,Wunderlich Syndrome,,,,,,,,
339,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Next generation extracorporeal albumin detoxification/dialysis (ECAD) but not MARS reverses leucocyte dysfunction caused by severe cholestasis.,Cholestasis;Renal Failure,Kidney Failure;Severe Cholestasis,,,,,,Severe,,
340,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,The Impact of Immunotherapy on renal function in Metastatic Cancer Patients: An Unseen Challenge in Onco-Nephrology,Cancer,Metastatic Cancer,,,,,,Metastatic,,
341,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,A data driven digital health approach to improve CRRT delivery in the ICU,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
342,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,"Severe Hyponatraemia: A Retrospective Cohort Study of Clinical Characteristics, Management Strategies, and Outcomes.",Hyponatremia,Severe Hyponatremia,,,,,,Severe,,
343,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Assessment of oXiris membrane adsorption towards Linezolid: implications for optimizing antibiotic therapy in critically ill patients,Acute Kidney Injury,Acute Kidney Injury,Linezolid,,,Antibiotic Therapy;Oxazolidinone Antibiotic,,,,
344,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,"Artificial diuresis, a miniaturized device for ultrafiltration: comparison between animal study and mathematical model to assess ultrafiltration",Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
345,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Extracellular Vesicles derived from ITGAM + innate immune cells augmented renal inflammation via activating CD8+ T cells in Acute Kidney Injury,Acute Kidney Injury;Inflammation,Acute Kidney Injury;Renal Inflammation,,,,,,,,
346,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,TES-AKI-01 Preserves Renal Function in a Rat Model of Ischemia-Reperfusion Injury,Ischemia,Ischemia-Reperfusion Injury,TES-AKI-01,,,ACMSD-Inhibitor,,,,
347,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,The Challenge Of Using Continuous Renal Replacement Therapy Anticoagulated With Citrate In Cirrhotic Patients,Acute Kidney Injury;Liver Cirrhosis,Acute Kidney Injury;Cirrhosis,,,,,,,,
348,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Extracellular vesicles from the in vitro AKI model promote cardiac cells stress,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
349,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Prolonged renal ischemia: time is ticking,Ischemia,Renal Ischemia,,,,,,,,
350,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Respiratory acidosis as risk factor for mortality in older patients with acute kidney injury that require dialysis,Acidosis;Acute Kidney Injury,Acute Kidney Injury;Respiratory Acidosis,,,,,,,,
351,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Outcome of Pregnancy-Related Acute Kidney Injury in Critically Ill Egyptian Patients: A 3 years’ Experience.,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
352,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Evolutionary profile of acute renal failure during pregnancy and postpartum.,Acute Kidney Failure,Acute Renal Failure,,,,,,,,
353,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Acute Kidney Injury in Iraqi Cancer patients treated with Immune Checkpoint Inhibitors. (Project ICI-AKI Iraq) interim analysis.,Acute Kidney Injury;Cancer,Acute Kidney Injury;Cancer,,,,Immune Checkpoint Inhibitors,,,,
354,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Incidence and Adverse Outcomes of Acute Kidney Disease: A Systematic Review and Meta-Analysis,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
355,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Association between Thyroid Stimulating Hormone Levels and Risk of Hospital-acquired Acute Kidney Injury: A Nationwide Retrospective Cohort Study,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
356,Not Relevant,AKI & Critical Care Nephrology,Moderated e-Poster,Direct Medical Cost of Hospital Care for Leptospirosis Among Adult Filipinos in the Philippine General Hospital,Leptospirosis,Adult Leptospirosis,,,,,,Adult,,
357,Not Relevant,Dialysis,Moderated e-Poster,Fragility Fractures in End-Stage Chronic Kidney Disease (CKD) Population: Patient-Related and CKD-Related Factor Analysis—A Single-Center Experience,Chronic Kidney Disease,End Stage Chronic Kidney Disease,,,,,, End Stage,,
358,Not Relevant,Dialysis,Moderated e-Poster,Indirect evaluation of bone metabolism in dialysis: do we all have the same bones?,Renal Failure,Kidney Failure,,,,,,,,
359,Not Relevant,Dialysis,Moderated e-Poster,"A Single-Centre, Cross-sectional Study of Frailty Prevalence and Its Related Risk Factors of Indonesian Hemodialysis Outpatients",Renal Failure,Kidney Failure,,,,,,,,
360,Not Relevant,Dialysis,Moderated e-Poster,Intradialysis Physical Exercise And Quality Of Life,Renal Failure,Kidney Failure,,,,,,,,
361,Not Relevant,Dialysis,Moderated e-Poster,Determinants Of Quality Of Life In Chronic Kidney Disease Patients On Conservative Management And On Dialysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
362,Not Relevant,Dialysis,Moderated e-Poster,SphygmoCor parameters in hemodialysis (HD) patients with or without advanced non-alcoholic fatty liver disease (NAFLD),Non Alcoholic Fatty Liver Disease;Renal Failure,Advanced Non Alcoholic Fatty Liver Disease;Kidney Failure,,,,,,Advanced,,
363,Not Relevant,Dialysis,Moderated e-Poster,Energy Protein Wasting Syndrome And Phase Angle: A Predictive Binomial Of Morbidity And Mortality In Hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
364,Not Relevant,Dialysis,Moderated e-Poster,Inflammatory Profile Of Incident Hemadialysis Patients: Role Of Sodium-Clucose Cotrnsporter 2 Inhibitors,Renal Failure,Kidney Failure,,,,SGLT2-Inhibitor,,,,
365,Not Relevant,Dialysis,Moderated e-Poster,Variability of symptoms and complaints in dialysis patients.,Renal Failure,Kidney Failure,,,,,,,,
366,Not Relevant,Dialysis,Moderated e-Poster,The effect of probiotic and synbiotic on the nutritional status in hemodialysis patients,Renal Failure,Kidney Failure,,,,Probiotic;Synbiotic,,,,
367,Not Relevant,Dialysis,Moderated e-Poster,A Multicenter Retrospective Study of Erythropoietin Combined with Low-Dose Roxadustat in the Treatment of Renal Anemia in Hemodialysis Patients,Anemia;Renal Failure,Kidney Failure;Renal Anemia,Erythropoietin;Roxadustat,,,Erythropoetin Receptor Agonist;HIF-PH Inhibitor,,,,
368,Not Relevant,Dialysis,Moderated e-Poster,Percutaneous Ethanol Injection Therapy (PEIT) for Refractory Secondary Hyperparathyroidism in Hemodialysis Patients Unfit for Surgery: Safety and Efficacy Evaluation,Renal Failure;Secondary Hyperparathyroidism,Kidney Failure;Refractory Secondary Hyperparathyroidism,Ethanol,,,Sclerosing Agent,,Refractory,,
369,Not Relevant,Dialysis,Moderated e-Poster,Intravesical Sodium Hialuronate For Treatment Of Radiation-Induced Hemorrhagic Cystitis In Hemodialyzed Patients: A Viable Option?,Hemorrhagic Cystitis,Hemorrhagic Cystitis,Sodium Hialuronate,,,Glycosaminoglycan,,,,
370,Not Relevant,Dialysis,Moderated e-Poster,Frailty and Sarcopenia in Patients on the Kidney Transplant Waiting List.,Sarcopenia,Sarcopenia,,,,,,,,
371,Not Relevant,Dialysis,Moderated e-Poster,Bleeding risk detection in chronic hemodialysis patients with non valvular atrial fibrillation on apixaban,Atrial Fibrillation;Chronic Kidney Disease,Chronic Kidney Failure;Non Valvular Atrial Fibrillation,Apixaban,,,Factor Xa-Inhibitor,,,,
372,Not Relevant,Dialysis,Moderated e-Poster,"A Pharmacist Intervention with Dose Optimization of Phosphate-binding medication (PIDO-P)?in dialysis patients: effects on phosphate, pill burden, and adherence?",Renal Failure,Kidney Failure,,,,Phosphate Binder,,,,
373,Not Relevant,Dialysis,Moderated e-Poster,Effect of cholecalciferol supplementation on anemia in hemodialysis patients with vitamin D deficiency.,Anemia;Renal Failure,Anemia;Kidney Failure,Cholecalciferol,,,Neurosteroid,,,,
374,Not Relevant,Dialysis,Moderated e-Poster,Prospective Evaluation of the FRAIL scale as a Predictor of Hospitalization and All-cause Mortality among patients with End Stage Renal Disease on Hemodialysis,End-Stage Renal Disease,End Stage Renal Disease,,,,,,,,
375,Not Relevant,Dialysis,Moderated e-Poster,Subcutaneous Lignocaine for CKDaP in a Haemodialysis Patient – Time to revisit an old remedy,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,Lignocaine,,,Sodium Channel-Inhibitor,,,,
376,Not Relevant,Dialysis,Moderated e-Poster,Correlation of the Geriatric Nutritional Risk Index (GNRI) with other indicators of nutrition in Chronic Hemodialysis patients,Renal Failure,Kidney Failure,,,,,,,,
377,Not Relevant,Dialysis,Moderated e-Poster,Relationship Between Regularly Used Laboratory Tests And Carotid-Femoral Pulse Wave Velocity As A Marker Of Arterial Stiffness,Renal Failure,Kidney Failure,,,,,,,,
378,Not Relevant,Dialysis,Moderated e-Poster,"Evaluation of toxic effect of cola containing beverages on blood calcium, phosphorus and magnesium level in hemodialysis patients",Renal Failure,Kidney Failure,,,,,,,,
379,Not Relevant,Dialysis,Moderated e-Poster,How novel drugs changed clinical practice in hemodialysis patients?,Renal Failure,Kidney Failure,,,,,,,,
380,Not Relevant,Dialysis,Moderated e-Poster,Assessment of cognitive function in patients receiving dialysis and its association with various parameters: a single-center cross-sectional study.,Renal Failure,Kidney Failure,,,,,,,,
381,Not Relevant,Dialysis,Moderated e-Poster,Serum activin A and  bone metabolism in patients undergoing hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
382,Not Relevant,Dialysis,Moderated e-Poster,"Effect of Tenapanor on Serum Phosphorus (Pi), Creatinine (Cre), and Body Weight (BW) Gain in Hemodialysis Patients",Renal Failure,Kidney Failure,Tenapanor,,,NHE3-Inhibitor,,,,
383,Not Relevant,Dialysis,Moderated e-Poster,Urodynamic finding and urinary symptoms in patienmts undergoing hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
384,Not Relevant,Dialysis,Moderated e-Poster,Itching in in dialysis rooms: multicenter survey on medical staff and patients.,Renal Failure,Kidney Failure,,,,,,,,
385,Not Relevant,Dialysis,Moderated e-Poster,Correlation between AMS score and hormone status in male hemodialysis patients:  A multi-center cross-sectional study,Renal Failure,Kidney Failure,,,,,,,,
386,Not Relevant,Dialysis,Moderated e-Poster,Arteriovenous Fistula Flow: Unlocking the Link to Cardiac Complications in Hemodialysis Patients,Arterio-Venous Fistula;Renal Failure,Arterio-Venous Fistula;Kidney Failure,,,,,,,,
387,Not Relevant,Dialysis,Moderated e-Poster,Unsolved water hemodialysis accidents,Renal Failure,Kidney Failure,,,,,,,,
388,Not Relevant,Dialysis,Moderated e-Poster,Insomnia in Hemodialysis patients: Prevalence and associated factors.,Insomnia;Renal Failure,Insomnia;Kidney Failure,,,,,,,,
389,Not Relevant,Dialysis,Moderated e-Poster,Bone density and vascular calcification association in patients on hemodialysis and peritoneal dialysis,Renal Failure,Kidney Failure;Vascular Calcification,,,,,,,,
390,Not Relevant,Dialysis,Moderated e-Poster,"""Adiposity In Haemodialysis Patients: Measuring obesity beyond Body Mass Index""",Renal Failure,Kidney Failure,,,,,,,,
391,Not Relevant,Dialysis,Moderated e-Poster,"Effect of probiotics and synbiotics on clinical and biochemical characteristics on hemodialysis patients,a randomized controlled trial",Renal Failure,Kidney Failure,,,,Probiotic;Synbiotic,,,,
392,Not Relevant,Dialysis,Moderated e-Poster,Cooled Dialysate in Hemodialysis: A Randomized control Trial Evaluating other potential Benefits Beyond Intradialytic Hypotension Prevention,Renal Failure,Kidney Failure,,,,,,,,
393,Not Relevant,Dialysis,Moderated e-Poster,When Less is Not More: Low Cholesterol and Mortality in Dialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
394,Not Relevant,E-Posters,e-Poster,Impact of Short Intradialytic Exercises on Frailty and Nutritional Indices in Hemodialysis Patients: A Prospective Study in a Developing Country.,,,,,,,,,,
395,Not Relevant,Dialysis,Moderated e-Poster,"Lipoprotein A, Cardiovascular Events, And Aortic Stenosis In Patients On Hemodialysis",Aortic Valve Stenosis;Renal Failure,Aortic Stenosis;Kidney Failure,,,,,,,,
396,Not Relevant,Dialysis,Moderated e-Poster,Evolution of Clinical Performance Metrics in Chronic Dialysis Patients: A Comparative Analysis of DaVita Kidney Care Brazil and Global Standards,Renal Failure,Kidney Failure,,,,,,,,
397,Not Relevant,Dialysis,Moderated e-Poster,Sudden Cardiac Arrest During Hemodialysis in the Setting of Acute Kidney Injury,Acute Kidney Injury;Renal Failure,Acute Kidney Injury;Kidney Failure,,,,,,,,
398,Not Relevant,Dialysis,Moderated e-Poster,The association between national dialysis catheter use and kidney transplantation activity,Renal Failure,Kidney Failure,,,,,,,,
399,Not Relevant,Dialysis,Moderated e-Poster,50 Years Demographic Change in the Okinawa Dialysis Study (OKIDS) registry (1971-2020),Renal Failure,Kidney Failure,,,,,,,,OKIDS
400,Not Relevant,Dialysis,Moderated e-Poster,PAn-european Registry Addressing Difelikefalin In Goal-oriented Medical treatment for chronic kidney disease-associated pruritus (PARADIGM): Study design and research goals,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,Difelikefalin,,,Kappa Opioid Receptor Agonist,,,PARADIGM,
401,Not Relevant,Dialysis,Moderated e-Poster,"Assessment of hydration status according to the percentage of relative overhydration (AVROH) due to electrical bioimpedance in patients of the CEDIMAT hemodialysis unit, period january-july 2024, Dominican Republic",Renal Failure,Kidney Failure,,,,,,,,
402,Not Relevant,Dialysis,Moderated e-Poster,Prevalence of smoking and smoking effect on the CKD-related mortality of French dialysis patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
403,Not Relevant,Dialysis,Moderated e-Poster,Demographic and Clinical Profile of Dialysis Patients in Brazil DaVita Kidney Care: A Comparative Analysis with Global Trends in Chronic Kidney Disease Epidemiology,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
404,Not Relevant,Dialysis,Moderated e-Poster,How to facilitate discussion and management of patient-reported outcome measures (PROMs) in routine Dutch dialysis care: a qualitative study,Renal Failure,Kidney Failure,,,,,,,,
405,Not Relevant,Dialysis,Moderated e-Poster,High-risk group is avalid predictor of all cause hospitalisation among patients on maintainance hemodialysis.,Renal Failure,Kidney Failure,,,,,,,,
406,Not Relevant,Dialysis,Moderated e-Poster,Recent trends in kidney replacement therapy in Latvia: room for improvement,Renal Failure,Kidney Failure,,,,,,,,
407,Not Relevant,Dialysis,Moderated e-Poster,"Association between chronic pain, quality of life and perceived social support among patients on maintenance hemodialysis",Renal Failure,Kidney Failure,,,,,,,,
408,Not Relevant,Dialysis,Moderated e-Poster,Should Dialysate Sodium Be Routinely Prescribed To Patients With Chronic Haemodialysis?,Renal Failure,Kidney Failure,,,,,,,,
409,Not Relevant,Dialysis,Moderated e-Poster,"Brazilian Dialysis Survey from 1999 to 2023: Trends in demographics, nutritional status, primary disease, and viral serology",Renal Failure,Kidney Failure,,,,,,,,
410,Not Relevant,Dialysis,Moderated e-Poster,Determinants of quality of life at twelve months in a multinational population on dialysis,Renal Failure,Kidney Failure,,,,,,,,
411,Not Relevant,Dialysis,Moderated e-Poster,Health Outcomes of Fasting During Ramadan Among Chronic Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
412,Not Relevant,Dialysis,Moderated e-Poster,Pre-dialysis bile acids level and peritoneal dialysis patient outcome,Renal Failure,Kidney Failure,,,,,,,,
413,Not Relevant,Dialysis,Moderated e-Poster,Quality Management in Dialysis: Dialysate Flow Optimization and Resource Use in DaVita Brazil Kidney Care,Renal Failure,Kidney Failure,,,,,,,,
414,Not Relevant,Dialysis,Moderated e-Poster,Network Analysis of Hemodialysis Patients' Symptoms,Renal Failure,Kidney Failure,,,,,,,,
415,Not Relevant,Dialysis,Moderated e-Poster,The prevalence and disease burden of CKD associated pruritus in Danish dialysis patients and current treatment practices,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,,,,,,,,
416,Not Relevant,Dialysis,Moderated e-Poster,Feel good and live longer: association of baseline quality of life and changes over one year with mortality in patients on hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
417,Not Relevant,Dialysis,Moderated e-Poster,Modifiable factors involved in sudden death risk in a large population on chronic hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
418,Not Relevant,Dialysis,Moderated e-Poster,Fatigue by the Chalder Questionnaire and Quality of Life Measures of the Kidney Disease Quality of Life Form in Hemodialysis Patients of Predominantly African Ancestry: The PROHEMO,Renal Failure,Kidney Failure,,,,,,,,PROHEMO
419,Not Relevant,E-Posters,e-Poster,The Kidney Failure Risk Equation in IgA nephropathy: External validation and model update,IgA Nephropathy;Renal Failure,IgA Nephropathy;Kidney Failure,,,,,,,,
420,Not Relevant,E-Posters,e-Poster,Variability and severity of HIF-PHIs’ adverse events in CKD population,Chronic Kidney Disease,Chronic Kidney Disease,,,,HIF-PH Inhibitor,,,,
421,Not Relevant,E-Posters,e-Poster,Efficacy of Ginger on Lipid Profile and Fasting Blood Glucose in Diabetic Patients Undergoing Peritoneal Dialysis: A Systematic Review & Meta-Analysis,Renal Failure,Kidney Failure,Ginger,,,Dietary Supplement,,,,
422,Not Relevant,E-Posters,e-Poster,The Impact of Low-Intensity Exercise on Glycemic Control and Cardiovascular Risk in Diabetic Patients with Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
423,Not Relevant,E-Posters,e-Poster,Impact of load and movement on arteriovenous fistula flow,Arterio-Venous Fistula,Arterio-Venous Fistula,,,,,,,,
424,Not Relevant,E-Posters,e-Poster,"AvacoStar, a real-world evidence study of avacopan in ANCA-associated vasculitis – baseline characteristics of initial patients",Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,Avacopan,,,C5a Receptor-Inhibitor,Vifor Fresenius,,AvacoStar;;NCT05897684,
425,Not Relevant,E-Posters,e-Poster,Skeletal Muscle Density measured in L3 computerized tomography is a prognostic marker in patients initiating hemodialysis.,Renal Failure,Kidney Failure,,,,,,,,
426,Not Relevant,E-Posters,e-Poster,Comparative Analysis of Predictive Criteria for Unassisted Maturation of AVF Using Post-Operative Ultrasound Measurement: UAB vs NKF-KDOQI,,,,,,,,,,
427,Not Relevant,E-Posters,e-Poster,Effectiveness of a Boosting mRNA COVID-19 Vaccine Dose among Hemodialysis Patients during the Omicron Era,Coronavirus Infection;Renal Failure,COVID-19;Kidney Failure,COVID-19 mRNA Vaccine,,,mRNA Vaccine,,,,
428,Not Relevant,E-Posters,e-Poster,Omentum wrapping of peritoneal dialysis catheter and peritoneal inflammation,Peritonitis,Peritoneal Inflammation,,,,,,,,
429,Not Relevant,E-Posters,e-Poster,"Weekly Patterns of Emergency Department Visits, Hospitalizations, and Mortality in Patients With End-Stage Kidney Disease: A Korean Nationwide Registry Analysis",Kidney Diseases,End Stage Kidney Disease,,,,,, End Stage,,
430,Not Relevant,E-Posters,e-Poster,Online Patient Education Improves Understanding of IgAN,IgA Nephropathy,IgA Nephropathy,,,,,,,,
431,Not Relevant,E-Posters,e-Poster,Effects of FGF23 on renal inflammation in an experimental model of diet-induced obesity: influence of sex.,Inflammation;Obesity,Obesity;Renal Inflammation,,,,,,,,
432,Not Relevant,E-Posters,e-Poster,The evolution of consultation practices with general practitioners and nephrologists for patients with CKD before and after the COVID-19 pandemic in France,Chronic Kidney Disease;Coronavirus Infection,Chronic Kidney Disease;COVID-19,,,,,,,,
433,Not Relevant,E-Posters,e-Poster,Association of SLC13A2 genotypes with the risk of kidney function decline in patients with nephrolithiasis in Ukraine,Nephrolithiasis,Nephrolithiasis,,,,,,,,
434,Medium,E-Posters,e-Poster,Ileum Delivery of Budesonide by 3D Micro-structure Design for the Treatment of IgA Nephropathy,IgA Nephropathy,IgA Nephropathy,Budesonide,,,Glucocorticoid,,,,
435,Not Relevant,E-Posters,e-Poster,Innovative Development Of Artificial Intelligence Image Identification Platformfor Peritoneal Dialysis Catheter Exit,Renal Failure,Kidney Failure,,,,,,,,
436,Not Relevant,E-Posters,e-Poster,"INShore: Phase III, Multicentre, Randomised, Open-Label Study of Efficacy and Safety of Obinutuzumab vs MMF in Patients With Childhood-Onset Idiopathic Nephrotic Syndrome",Idiopathic Nephrotic Syndrome,Childhood Onset Idiopathic Nephrotic Syndrome,Obinutuzumab,,Mycophenolate Mofetil,CD20-Targeted Monoclonal Antibody,Roche,Childhood,NCT05627557,INShore
437,Not Relevant,E-Posters,e-Poster,"The effect of Pravastatin on Insulin Resistance in patients with CKD stage 1-3. A randomized, placebo-controlled cross over trial",Chronic Kidney Disease,Stage I-III Chronic Kidney Disease,Pravastatin,,,HMG CoA Reductase-Inhibitor,,Stage I,,
438,Not Relevant,E-Posters,e-Poster,Effects Of Obinutuzumab On Urinary Renal Biomarkers In Lupus Nephritis: A Post Hoc Exploratory Analysis Of The Phase Ii Nobility Study,Lupus Nephritis,Lupus Nephritis,Obinutuzumab,,,CD20-Targeted Monoclonal Antibody,Roche,,NCT02550652,NOBILITY
439,Not Relevant,E-Posters,e-Poster,Advancing Coaching and Telehealth for CKD Care: The ACT-CKD Cohort Study Protocol,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
440,Not Relevant,E-Posters,e-Poster,Diet-induced kidney protection - a translational research approach,,,,,,,,,,
441,Not Relevant,E-Posters,e-Poster,Comparison of simulated dialysis efficacy and actual dialysis efficacy of hemodialysis patients.,Renal Failure,Kidney Failure,,,,,,,,
442,Not Relevant,E-Posters,e-Poster,Sex differences in the risk of bladder cancer among kidney transplant recipients and patients with kidney failure receiving hemodialysis,Bladder Cancer;Renal Failure,Bladder Cancer;Kidney Failure,,,,,,,,
443,Not Relevant,E-Posters,e-Poster,Shifts in Acute Kidney Injury Trends Post-Alert System Implementation: A Comprehensive Analysis,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
444,Not Relevant,E-Posters,e-Poster,Effective muscle index based on muscle mass and quality to diagnose sarcopenia and predict renal survival in CKD patients,Chronic Kidney Disease;Sarcopenia,Chronic Kidney Disease;Sarcopenia,,,,,,,,
445,Not Relevant,E-Posters,e-Poster,Can creatinine muscle index be a biomarker for diagnosing sarcopenia and predicting renal prognosis in CKD patients?,Chronic Kidney Disease;Sarcopenia,Chronic Kidney Disease;Sarcopenia,,,,,,,,
446,Not Relevant,E-Posters,e-Poster,"Parathyroid Hormone Levels, Rather Than Calcium or Phosphate, as Independent Predictor of Ischemic Heart Disease in CKD stages 3-5 Non-Dialysis Patients: A Retrospective Cohort Study",Chronic Kidney Disease;Ischemic Heart Disease,Ischemic Heart Disease;Stage III-V Chronic Kidney Disease,,,,,,Stage III,,
447,Not Relevant,E-Posters,e-Poster,Hypomagnesemia-induced Proximal Tubular Injury and Nephrocalcinosis in Rats: Insights into FHHNC Pathophysiology,Hypomagnesemia;Nephrocalcinosis,Hypomagnesemia;Nephrocalcinosis,,,,,,,,
448,Not Relevant,E-Posters,e-Poster,Deletion of hypoxia-inducible factors in erythroid progenitor cells does not significantly impair erythropoiesis,Hypoxia,Hypoxia,,,,,,,,
449,Not Relevant,E-Posters,e-Poster,"Success of Online, Interactive, Case-Based CME at Improving Nephrologists’ Competence and Confidence Related to DD-CKD-Anemia Diagnosis and Management",Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,,,,,
450,Not Relevant,E-Posters,e-Poster,Diabetic nephropathy evaluation in an non-genotypic animal model of type 2 diabetes,Diabetes;Nephropathy,Diabetes;Nephropathy,,,,,,,,
451,Not Relevant,E-Posters,e-Poster,Assessment of Frailty and Sarcopenia in Kidney Transplant Patients,Sarcopenia,Sarcopenia,,,,,,,,
452,Not Relevant,E-Posters,e-Poster,Association Between Skeletal Muscle Mass and Bone Mineral Density in Kidney Transplant Recipients: A Retrospective Cohort Study,,,,,,,,,,
453,Not Relevant,E-Posters,e-Poster,Comparison Of Thymoglobulin® Vs Grafalon® As Induction Treatment In Kidney Transplantation With Maastricht Type Iii Donor,,,Antithymocyte Globulin;Thymoglobulin,,Grafalon,T Cell Depleting Therapy,,,,
454,Not Relevant,E-Posters,e-Poster,Benefits Of Physical Activity For Organ Transplant Recipients: A Systematic Review Of Medical Publications,,,,,,,,,,
455,Not Relevant,E-Posters,e-Poster,Regulation of Renal Fibrosis via the RAGE Pathway by miR-214 and Host ncRNA in Diabetic Kidney Disease,Diabetes;Fibrosis,Diabetes;Renal Fibrosis,,,,,,,,
456,Not Relevant,E-Posters,e-Poster,Effect of rabbit anti-thymocyte globulin (rATG) induction in ABO-incompatible (ABOi) kidney transplantation: Single center retrospective cohort study,,,Anti-Thymocyte Globulin,,,Immunosuppressant,,,,
457,Not Relevant,E-Posters,e-Poster,The final hit-A case of IgA nephropathy with pembrolizumab,IgA Nephropathy,IgA Nephropathy,Pembrolizumab,,,PD1-Inhibitor,,,,
458,Not Relevant,E-Posters,e-Poster,Zileuton attenuates acute kidney injury in a glycerol-induced rhabdomyolysis by regulating myeloid-derived suppressor cells in mice.,Acute Kidney Injury;Rhabdomyolysis,Acute Kidney Injury;Rhabdomyolysis,Zileuton,,,5-LOX Inhibitor,,,,
459,Not Relevant,E-Posters,e-Poster,Post-transplantation management of calcium and parathyroid hormone levels and its association with kidney graft survival and fibrosis,Fibrosis,Fibrosis,,,,,,,,
460,Not Relevant,E-Posters,e-Poster,Genetic Insights into Renal Diseases in Armenian Children,Kidney Diseases,Childhood Renal Disease,,,,,,Childhood,,
461,Not Relevant,E-Posters,e-Poster,A case of MPO-ANCA positive dense deposit disease (DDD) with normal C3 levels presenting with end-stage renal disease (ESRD) at admission,Dense Deposit Disease;End-Stage Renal Disease,End Stage Renal Disease;MPO-Antibody Negative Dense Deposit Disease,,,,Antibody,,,,
462,Not Relevant,E-Posters,e-Poster,Erythropoiesis-Stimulating Agent Hyporesponsiveness and Malignancy Development in non-Dialysis-Dependent CKD Patients: A Prospective Cohort Study,Chronic Kidney Disease,Chronic Kidney Disease,,,,Erythropoiesis Stimulating Agent,,,,
463,Not Relevant,E-Posters,e-Poster,Exploring Differences in Cognitive and Behavioral Outcomes of Home-Based Self-Care Retraining in Peritoneal Dialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
464,Not Relevant,E-Posters,e-Poster,Prevalence of Functional Iron Deficiency and Its Impact on Mortality in Hemodialysis Patients in Hatay,Iron Deficiency Anemia;Renal Failure,Iron Deficiency;Kidney Failure,,,,,,,,
465,Not Relevant,E-Posters,e-Poster,Cancer screening examination can decrease the death with the functioning graft after living donor kidney transplantation,Cancer,Cancer,,,,,,,,
466,Not Relevant,E-Posters,e-Poster,Effect of Serum Albumin Levels at The Time of Peritoneal Dialysis Initiation on Technique Survival Period and Outcome,Renal Failure,Kidney Failure,,,,,,,,
467,Not Relevant,E-Posters,e-Poster,C3 Glomerulonephropathy Overlaps Hereditary Nephritis,Hereditary Nephritis,C3 Glomerulonephropathy;Hereditary Nephritis,,,,,,,,
468,Not Relevant,E-Posters,e-Poster,"Sarcopenia, Frailty, and Malnutrition in Hemodialysis Patients: An Emerging Clinical Challenge",Renal Failure;Sarcopenia,Kidney Failure;Sarcopenia,,,,,,,,
469,Not Relevant,E-Posters,e-Poster,Preserving Dialysis Continuity: The Efficacy of the Peri-Patch Device in Catheter Salvage,Renal Failure,Kidney Failure,,,,,,,,
470,Not Relevant,E-Posters,e-Poster,Inhibition of Histone deacetylase 6 restores kidney fibrosis in a mouse model of unilateral ureteral obstruction,Fibrosis;Ureteral Obstruction,Kidney Fibrosis;Ureteral Obstruction,,,,,,,,
471,Not Relevant,E-Posters,e-Poster,A Murine Model of Peritoneal Fibrosis in Adenine-Induced Chronic Kidney Disease,Chronic Kidney Disease;Fibrosis,Adenine-Induced Chronic Kidney Disease;Peritoneal Fibrosis,,,,,,,,
472,Not Relevant,E-Posters,e-Poster,"Comparative Prognostic Value of Glomerular Filtration Rate, Serum Cystatin C, Beta-2-Microglobulin and Albuminuria for Death and Chronic Kidney Disease Progression",Chronic Kidney Disease,Progressive Chronic Kidney Disease,,,,,,Progressive,,
473,Low,E-Posters,e-Poster,"Relationship between vascular biomarkers, NT-proBNP and renal function in chronic kidney disease, IgA nephropathy",Chronic Kidney Disease;IgA Nephropathy,Chronic Kidney Disease;IgA Nephropathy,,,,,,,,
474,Not Relevant,E-Posters,e-Poster,An Atypical Case of Atypical HUS,Hemolytic-Uremic Syndrome,Hemolytic Uremic Syndrome,,,,,,,,
475,Not Relevant,E-Posters,e-Poster,"Association between peritoneal uric acid clearance, inflammation, and peritoneal membrane function in normouricemic patients undergoing peritoneal dialysis",Renal Failure,Kidney Failure,,,,,,,,
476,Not Relevant,E-Posters,e-Poster,Pathogen Distribution and Clinical Outcomes of aHUS Patients on Peritoneal Dialysis,Atypical Hemolytic-Uremic Syndrome;Renal Failure,Atypical Hemolytic Uremic Syndrome;Kidney Failure,,,,,,,,
477,Not Relevant,E-Posters,e-Poster,Prognostic value of the red blood cell distribution width-to-albumin ratio in scrub typhus-associated acute kidney injury,Acute Kidney Injury,Acute Kidney Injury;Scrub Typhus,,,,,,,,
478,Not Relevant,E-Posters,e-Poster,Consideration of the amount of serum ferritin required to increase hemoglobin,,,,,,,,,,
479,Not Relevant,E-Posters,e-Poster,"The active ingredient in the Nuphar Lutea plant, 6,6′-Dihydroxythiobinupharidine (DTBN) ameliorates inflammation and anaemia in a mouse model of CKD",Anemia;Chronic Kidney Disease,Anaemia;Chronic Kidney Disease,,,,,,,,
480,Not Relevant,E-Posters,e-Poster,Investigate the effect of retinoid X receptor in renal tubular cell senescence,,,,,,,,,,
481,Not Relevant,E-Posters,e-Poster,Case Series of Posterior Reversible Encephalopathy Syndrome (PRES) with Diverse Etiologies,Encephalopathy,Posterior Reversible Encephalopathy Syndrome,,,,,,,,
482,Not Relevant,E-Posters,e-Poster,Protective effects of TRIM33 via inflammasome suppression on ischemia-reperfusion injury-induced kidney fibrosis in mice,Fibrosis;Ischemia,Ischemia-Reperfusion Injury;Kidney Fibrosis,,,,,,,,
483,Not Relevant,E-Posters,e-Poster,Limitations of Urine Dipstick Testing in Early Diagnosis of Diabetic Kidney Disease (DKD) and the Necessity of Measuring Urinary Albumin-to-Creatinine Ratio (UACR),Diabetes,Diabetes;Early Onset Diabetes,,,,,,Early Onset,,
484,Not Relevant,E-Posters,e-Poster,Impact of nutritional and inflammatory conditions on kidney outcomes and mortality in individuals with diabetes,Diabetes,Diabetes,,,,,,,,
485,Not Relevant,E-Posters,e-Poster,Metabolome-wide Mendelian Randomization Reveals Causal Effects of Betaine and N-acetylornithine on Impairment of Renal Function,,,Betaine;N-Acetylornithine,,,Methylating Agent;Ornithine Precursor,,,,
486,Not Relevant,E-Posters,e-Poster,Low serum Na-Cl difference level before alkali therapy is an independent predictor of rapid renal deterioration in CKDG3b-G5 patients with hyperkalemic metabolic acidosis,Acidosis,Hyperkalemic Metabolic Acidosis,,,,,,,,
487,Not Relevant,E-Posters,e-Poster,Association of Combined Hypomagnesemia and Hypouricemia With Mortality Risk in Hemodialysis Patients: A Cohort Study,Hypomagnesemia;Renal Failure,Hypomagnesemia;Kidney Failure,,,,,,,,
488,Not Relevant,E-Posters,e-Poster,Collagen 1a1 Depletion in Podocytes Increases Proteinuria,Proteinuria,Proteinuria,,,,,,,,
489,Not Relevant,E-Posters,e-Poster,Real-world practice of palliative care for advanced cancer in patients on maintenance hemodialysis.,Cancer;Renal Failure,Advanced Cancer;Kidney Failure,,,,,,Advanced,,
490,Not Relevant,E-Posters,e-Poster,From hospital acute kidney failure to chronic renal replacement therapy: a complex patient journey in a public health system.,Acute Kidney Failure,Acute Kidney Failure,,,,,,,,
491,Not Relevant,E-Posters,e-Poster,The Increase In The Level Expression Of The Pdl1 And Foxp3 Genes In Kidney Transplant Recipients With Extracorporeal Photopheresis,,,,,,,,,,
492,Not Relevant,E-Posters,e-Poster,Long-Term Consequences Of Covid-19 For The Kidneys: A Controlled Complication Or A Time Bomb?,Coronavirus Infection,COVID-19,,,,,,,,
493,Not Relevant,E-Posters,e-Poster,Factors Influencing Rapid eGFR Decline in Outpatients: A Retrospective Cohort Study,,,,,,,,,,
494,Not Relevant,E-Posters,e-Poster,Elucidating the Underlying Molecular Mechanisms of Shenshuai Ling Formulation in Enhancing Autophagy and Suppressing Apoptosis to Mitigate Adenine-Induced Renal Fibrosis in mice,Fibrosis,Renal Fibrosis,,,,,,,,
495,Not Relevant,E-Posters,e-Poster,Evaluation of Sequential Romosozumab-Denosumab Therapy for Osteoporosis in Maintenance Hemodialysis Patients.,Osteoporosis;Renal Failure,Kidney Failure;Osteoporosis,Denosumab;Romosozumab,,,RANKL-Inhibitor;Sclerostin-Inhibitor,,,,
496,Not Relevant,E-Posters,e-Poster,Effects of healthcare quality on renal outcomes in early-stage chronic kidney disease patients: a nationwide cohort study,Chronic Kidney Disease,Early Stage Chronic Kidney Disease,,,,,,Early-Stage,,
497,Not Relevant,E-Posters,e-Poster,Clinical and laboratory manifestations of kidney damage in various types of ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
498,Not Relevant,E-Posters,e-Poster,Correlation between proteinuria and soluble IL-33 receptor levels in kidney transplant recipients,Proteinuria,Proteinuria,,,,,,,,
499,Not Relevant,E-Posters,e-Poster,Association of POCUS and biomarkers of congestion in cardiorenal syndrome in a monographic nephrology consultation,Cardio-Renal Syndrome,Cardiorenal Syndrome,,,,,,,,
500,Not Relevant,E-Posters,e-Poster,Hemodialysis in Focus: Patient Survival Through the Lens of Time and Hazard Factors.,Renal Failure,Kidney Failure,,,,,,,,
501,Not Relevant,E-Posters,e-Poster,The effect of Valsartan on portal and systemic hemodynamics and on renal function in liver cirrhosis,Liver Cirrhosis,Liver Cirrhosis,Valsartan,,,Angiotensin II Receptor-Inhibitor,,,,
502,Not Relevant,E-Posters,e-Poster,Estimation Of Allergy Frequency With Tryptase In Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
503,Medium,E-Posters,e-Poster,Efficacy and Safety of Telitacicept in IgA Nephropathy: A Preliminary Report of the Large Single-center Observational Study,IgA Nephropathy,IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
504,Not Relevant,E-Posters,e-Poster,Comparative Performance of the New-Generation Large Language Model o1 pro and the Established Model GPT-4 on Japanese Nephrology Board Renewal Questions,,,,,,,,,,
505,Not Relevant,E-Posters,e-Poster,Continuous Renal Replacement Therapy in Octogenarian and Nonagenarian AKI Patients: Short- and Long-Term Outcomes by Age Group,Acute Kidney Injury,Non-Alcoholic Kidney Injury;Octogenarian Acute Kidney Injury,,,,,,,,
506,Not Relevant,E-Posters,e-Poster,Proximal Tubular Multiciliated Cells as Prognostic Markers in Glomerular Diseases,Glomerular Disease,Glomerular Disease,,,,,,,,
507,Not Relevant,E-Posters,e-Poster,interaction of Sleep Obstructive Apnea and Hyperuricemia on Albuminuria in General Population,Albuminuria;Hyperuricemia;Obstructive Sleep Apnea,Albuminuria;Hyperuricemia;Sleep Obstructive Apnea,,,,,,,,
508,Not Relevant,E-Posters,e-Poster,Serum Chloride Concentration and Progression to Impaired Kidney Function in General Population,Renal Failure,Kidney Failure,,,,,,,,
509,Not Relevant,E-Posters,e-Poster,Psychological Symptoms among Hemodialysis Patients in Thailand and Their Impact on Health-Status,Renal Failure,Kidney Failure,,,,,,,,
510,Not Relevant,E-Posters,e-Poster,Altered Mental Status in Patients Undergoing 5-Fluorouracil Based Chemotherapy: Think of the Zebras,,,5-Fluorouracil,,,TS-Inhibitor,,,,
511,Not Relevant,E-Posters,e-Poster,Clinical implications of diabetic retinopathy as a predictor of the severity of diabetic kidney injury and systemic inflammation in patient with type 2 diabetes mellitus: Focusing on a histologically confirmed diabetic nephropathy,Diabetic Nephropathy;Inflammation;Type 2 Diabetes,Diabetic Nephropathy;Systemic Inflammation;Type 2 Diabetes Mellitus,,,,,,Systemic,,
512,Not Relevant,E-Posters,e-Poster,Chronic kidney disease specific astrocyte is related with cognitive function,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
513,Not Relevant,E-Posters,e-Poster,Co-exposure of Environmental DEHP and Melamine Increases Adverse Kidney Outcomes in Patients with Early Chronic Kidney Disease – A Prospective Cohort Study,Chronic Kidney Disease,Early Onset Chronic Kidney Disease,,,,,AstraZeneca,Early Onset,,
514,Not Relevant,E-Posters,e-Poster,Establishment of urine-derived tubuloid system from pediatric leukemia patients on methotrexate treatment,Leukemia,Paediatric Leukemia,Methotrexate,,,DHFR-Inhibitor,,Paediatric,,
515,Not Relevant,E-Posters,e-Poster,Outcomes of medical and surgical peritoneal dialysis catheter insertion: a single centre experience,Renal Failure,Kidney Failure,,,,,,,,
516,Not Relevant,E-Posters,e-Poster,Kidney transplantation outcomes of racial minority groups in a Central European setting: a retrospective cohort study,,,,,,,,,,
517,Not Relevant,E-Posters,e-Poster,Monocyte-to-Lymphocyte Ratio Changes and Mortality in AKI Patients on CRRT,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
518,Not Relevant,E-Posters,e-Poster,Pericytes Mediate Renal Recovery after Acute Kidney Injury through CXCL12,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
519,Not Relevant,E-Posters,e-Poster,The Association Between Residual Urine Output and Quality of Life in Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
520,Not Relevant,E-Posters,e-Poster,Inhibition of histone 3 lysine 9 trimethylation improves kidney fibrosis in a mouse model of unilateral ureteral obstruction,Fibrosis;Ureteral Obstruction,Kidney Fibrosis;Ureteral Obstruction,,,,,,,,
521,Not Relevant,E-Posters,e-Poster,Association between Blood Pressure and Chronic Kidney Disease Progression in Patients with Advanced Chronic Kidney Disease: Findings from CRIC and KNOW-CKD Study,Chronic Kidney Disease,Advanced Chronic Kidney Disease;Progressive Chronic Kidney Disease,,,,,,Advanced;Progressive,CRIC;;KNOW-CKD;;NCT00304148;;NCT01630486,
522,Not Relevant,E-Posters,e-Poster,Regulatory T cells: a promising therapeutic strategy for AKI,Acute Kidney Injury,Acute Kidney Injury,Regulatory T Cell,,,T Cell Therapy,,,,
523,Not Relevant,E-Posters,e-Poster,case report : what is the impact of plasmapheresis in polyarteritis nodosa associated with HBV ?,Infection;Polyarteritis Nodosa,HBV Infection;Polyarteritis Nodosa,,,,,AstraZeneca,,,
524,Not Relevant,E-Posters,e-Poster,Histological analyses of kidney legion in IgA model mice induced by nasal treatment of Porphyromonas gingivalis,,,,,,,,,,
525,Not Relevant,E-Posters,e-Poster,"40-year renal survival rate in patients with IgA nephropathy: Analysis of 1,121 patients at a single center",IgA Nephropathy,IgA Nephropathy,,,,,,,,
526,Not Relevant,E-Posters,e-Poster,Tamoxifen induces antioxidants to attenuate ischemia-reperfusion renal injury,Ischemia;Renal Injury,Ischemia-Reperfusion Renal Injury,Tamoxifen,,,Selective Estrogen Receptor-Modulator,,,,
527,Not Relevant,E-Posters,e-Poster,Depressive mood and cognitive dysfunction to predict renal outcome and mortality in elderly patients,Cognitive Impairment;Depression,Elderly Cognitive Dysfunction;Elderly Depression,,,,,,Elderly,,
528,Not Relevant,E-Posters,e-Poster,Functional impairment as a Predictor of Renal Outcomes and Mortality in Elderly Patients,,,,,,,,,,
529,Not Relevant,E-Posters,e-Poster,Long-term follow-up study for Japanese patients with renal hypouricemia,Renal Hypouricemia,Renal Hypouricemia,,,,,,,,
530,Not Relevant,E-Posters,e-Poster,Latent Tuberculosis in advanced chronic kidney disease- single centre experience in the UK,Chronic Kidney Disease;Latent Tuberculosis Infection,Advanced Chronic Kidney Disease;Latent Tuberculosis,,,,,,Advanced,,
531,Not Relevant,E-Posters,e-Poster,Risk factors and long-term outcomes in a prospective acute kidney injury cohort in Korea,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
532,Medium,E-Posters,e-Poster,Telitacicept therapy for IgA nephropathy : A case series,IgA Nephropathy,IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
533,Not Relevant,E-Posters,e-Poster,Cardiovascular Risk in Systemic Lupus Erythematosus With and Without Lupus Nephritis: A cross-sectional comparative study,Systemic Lupus Erythematosus,Cardiovascular Disorder;Systemic Lupus Erythematosus,,,,,,,,
534,Not Relevant,E-Posters,e-Poster,Association between Haemodialysis Access Tape and Mortality,Renal Failure,Kidney Failure,,,,,,,,
535,Not Relevant,E-Posters,e-Poster,Dextran sulfate sodium-induced colitis causes production of degalactosylated mucosal IgA and glomerular IgA-IgG deposition in HIGA mice,Colitis,Colitis,,,,,,,,
536,Not Relevant,E-Posters,e-Poster,Improving Hemodialysis Care For The Population In Uzbekistan,Renal Failure,Kidney Failure,,,,,,,,
537,Not Relevant,E-Posters,e-Poster,Short-term effect of finerenone on albuminuria and potassium levels in patients with diabetic kidney disease: analysis in real clinical practice.,Albuminuria;Diabetic Nephropathy,Albuminuria;Diabetic Kidney Disease,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,,
538,Not Relevant,E-Posters,e-Poster,Arteriovenous Fistula for Haemodialysis as a Predictor of the Heart Failure in Kidney Transplant Recipients,Arterio-Venous Fistula;Renal Failure,Arterio-Venous Fistula;Kidney Failure,,,,,,,,
539,Not Relevant,E-Posters,e-Poster,Effect of erythropoiesis-stimulating agent types on malignancy in hemodialysis patients,Renal Failure,Kidney Failure,,,,Erythropoiesis-Stimulating Agent,,,,
540,Not Relevant,E-Posters,e-Poster,Association of albuminuria and POCUS in cardiorenal syndrome in a monographic nephrology consultation,Albuminuria;Cardio-Renal Syndrome,Albuminuria;Cardiorenal Syndrome,,,,,,,,
541,Not Relevant,E-Posters,e-Poster,Association between ultrafiltration variability and clinical outcomes in patients undergoing hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
542,Not Relevant,E-Posters,e-Poster,Nutritional status: The Silent Risk of Falls in Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
543,Not Relevant,E-Posters,e-Poster,"Circulating extracellular vesicles: a mediator of renal tubular oxidative stress, mitochondrial Ca2+ overload and SIRT1/PGCa axis suppression in obesity",Obesity,Obesity,,,,,,,,
544,Not Relevant,E-Posters,e-Poster,Artificial Intelligence in the Identification of Key Metabolites Associated with Diabetic Kidney Disease,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,,,,
545,Not Relevant,E-Posters,e-Poster,Real-World Use of HIF-PH Inhibitors and ESAs in Non-Dialysis-Dependent CKD with Anemia: Insights from a Japanese Database study,Anemia;Chronic Kidney Disease,Anemia;Non Dialysis Dependent Chronic Kidney Disease,,,,Erythropoiesis-Stimulating Agent;HIF-PH Inhibitor,,,,
546,Not Relevant,E-Posters,e-Poster,Association of Time-updated Body Mass Index with the Initiation of Kidney Replacement Therapy in Patients with Chronic Kidney Disease: Results from the KNOW-CKD Study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,KNOW-CKD;;NCT01630486,
547,Not Relevant,E-Posters,e-Poster,Efficacy and safety of telitacicept in patients with class III- V  lupus nephritis: a real-world retrospective cohort study,Lupus Nephritis,Class III-V Lupus Nephritis,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
548,Not Relevant,E-Posters,e-Poster,The Impact of Intradialytic Physical Activity on Inflammatory Markers in Patients with Diabetes Mellitus,Diabetes,Diabetes,,,,,,,,
549,Not Relevant,E-Posters,e-Poster,The prognostic significance of the Birmingham Vasculitis Activity Score on the Outcome of ANCA- Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
550,Not Relevant,E-Posters,e-Poster,IgA expressed by glomerular mesangial cells is involved in the pathogenesis of IgA nephropathy,IgA Nephropathy,IgA Nephropathy,,,,,,,,
551,Not Relevant,E-Posters,e-Poster,Association between pretransplant dialysis modality and long-term graft outcomes,Renal Failure,Kidney Failure,,,,,,,,
552,Not Relevant,E-Posters,e-Poster,Population-Based Analysis of Metabolic-Associated Steatotic Liver Disease as a Risk Factor for End-Stage Kidney Disease in Chronic Kidney Disease Patients,Chronic Kidney Disease;Kidney Diseases,Chronic Kidney Disease;End Stage Kidney Disease;Metabolic Associated Steatosis,,,,,, End Stage,,
553,Not Relevant,E-Posters,e-Poster,Ca-sensing receptor agonists can improve taste sensitivity in hemodialysis patients.,Renal Failure,Kidney Failure,,,,Calcium Sensing Receptor-Agonist,,,,
554,Not Relevant,E-Posters,e-Poster,A Pharmacogenetic and Body Weight-Informed Predictive Model for Tacrolimus Dosing in Taiwanese Kidney Transplant Recipients,,,Tacrolimus,,,Calcineurin-Inhibitor,,,,
555,Not Relevant,E-Posters,e-Poster,Utility Of Multi-Segmental Bioimpedance For The Diagnosis Of Sarcopenia And Sarcopenic Obesity In Dialysis,Obesity;Renal Failure;Sarcopenia,Kidney Failure;Sarcopenia;Sarcopenic Obesity,,,,,,,,
556,Not Relevant,E-Posters,e-Poster,Analysis of the Survival Rate of Patients on Kidney Replacement Therapy in a Large City: A Multicenter Prospective Cohort Observational Study,,,,,,,,,,
557,Not Relevant,E-Posters,e-Poster,Low Handgrip Strength predicts long term mortality in patients treated with Hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
558,Not Relevant,E-Posters,e-Poster,Prognostic indicators after treatment in IgA nephropathy.,IgA Nephropathy,IgA Nephropathy,,,,,,,,
559,Not Relevant,E-Posters,e-Poster,Development of new method for continuous kidney replacement therapy weaning,,,,,,,,,,
560,Not Relevant,E-Posters,e-Poster,Association Between Acid-Base Disorders at Dialysis Initiation and Mortality: A Multicenter Prospective Cohort Study in Japan,Renal Failure,Kidney Failure,,,,,,,,
561,Not Relevant,E-Posters,e-Poster,Structured Post-AKI Follow-Up: A Nurse-Led Kidney Health Check Model for Improved Pharmacological Interventions and secondary prevention,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
562,Not Relevant,E-Posters,e-Poster,Urinary exosome miRNAs as biomarkers associated with proteinuria and eGFR in lupus nephritis,Lupus Nephritis;Proteinuria,Lupus Nephritis;Proteinuria,,,,,,,,
563,Not Relevant,E-Posters,e-Poster,"Sleep Disorders And Sleep Quality Among Hemodialysis Patients In A Tertiary  Hospital In Valenzuela, Philippines: A One Center Cross Sectional Study",Renal Failure;Sleep Disorder,Kidney Failure;Sleep Disorder,,,,,,,,
564,Not Relevant,E-Posters,e-Poster,Evaluating the real-world efficacy and safety of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease – A single center long-term observation,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,Tolvaptan,,,Vasopressin V2 Receptor-Antagonist,,,,
565,Not Relevant,E-Posters,e-Poster,Association of Serum Selenium and Zinc Levels with Anemia Parameters and ESA Response in Different Dialysis Modalities,Anemia,Anemia,,,,,,,,
566,Not Relevant,E-Posters,e-Poster,SARC-F Questionnaire as a Screening Tool for Identifying Hemodialysis Patients at High Risk of Falls and Fractures,Renal Failure,Kidney Failure,,,,,,,,
567,Not Relevant,E-Posters,e-Poster,Inhibiting progression of abdominal aortic calcification by vitamin K2 in dialysis patients.,Renal Failure,Kidney Failure,Vitamin K2,,,Vitamin Supplement,,,,
568,Not Relevant,E-Posters,e-Poster,Cost-effectiveness analysis of voclosporin vs mycophenolate or belimumab in the treatment of patients with lupus nephritis from the Spanish National Healthcare System perspective,Lupus Nephritis,Lupus Nephritis,Voclosporin,,Belimumab;Mycophenolate,Calcineurin-Inhibitor,,,,
569,Not Relevant,E-Posters,e-Poster,The Influence of Vitamin D on Quality of Life in Patients with Lupus Nephritis,Lupus Nephritis,Lupus Nephritis,Vitamin D,,,Vitamin D Analog,,,,
570,Not Relevant,E-Posters,e-Poster,Chronic Kidney Disease Progression Assessment On The Basis Of Complex Treatment,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
571,Not Relevant,E-Posters,e-Poster,Renal replacement therapy is not associated with increased mortality in patients with sepsis and acute kidney injury in the intensive care unit,Acute Kidney Injury;Sepsis,Acute Kidney Injury;Sepsis,,,,,,,,
572,Not Relevant,E-Posters,e-Poster,Longitudinal follow-up of Health-related Quality of Life indicators in glomerulonephritis treated with immunosuppressants,Glomerulonephritis,Glomerulonephritis,,,,Immunosuppressant,,,,
573,Not Relevant,E-Posters,e-Poster,Kidney Transplantation And Fanctional State Of The Parathoid Glands,,,,,,,,,,
574,Not Relevant,E-Posters,e-Poster,The association of sodium-glucose transporter 2 inhibitor prescription and incident chronic kidney disease in a multi-ethnic Asian population: a retrospective cohort study using Singhealth Diabetes Registry,Chronic Kidney Disease,Chronic Kidney Disease,,,,SGLT2-Inhibitor,,,,
575,Not Relevant,E-Posters,e-Poster,Pilot Results from Evaluation of Autosomal Dominant Polycystic Kidney Disease Diagnosis Impact on the Patients’ Quality of Life,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
576,Not Relevant,E-Posters,e-Poster,Outcome Of The Peritoneal Dialysis Program In Patients With Heart Failure,Heart Failure,Heart Failure,,,,,,,,
577,Not Relevant,E-Posters,e-Poster,Single-cell RNA sequencing reveals immune landscape and cellular dynamics in peritoneal dialysis effluent,Renal Failure,Kidney Failure,,,,,,,,
578,Not Relevant,E-Posters,e-Poster,"Efficacy And Safety Of A Novel Anti-Cd20 Agent Ripertamab In Treatment Of Primary Membranous Nephropathy : A Multi-Center, Retrospective Study In China",Primary Membranous Nephropathy,Primary Membranous Nephropathy,Ripertamab,,,CD20-Targeted Monoclonal Antibody,,,,
579,Not Relevant,E-Posters,e-Poster,Urinary microcholesterol and progression of chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
580,Not Relevant,E-Posters,e-Poster,Development of the Nephrotic Syndrome Symptom and Impact Patient Reported Outcome (NephroSSI-PRO) Measure for Use in Adults and Adolescents with Primary Glomerulopathies,Glomerular Disease,Adolescent Primary Glomerular Disease;Adult Primary Glomerular Disease,,,,,,Adolescent;Adult,,
581,Not Relevant,E-Posters,e-Poster,Therapeutic Potential of Propylparaben in Modulating Pathophysiological Features of Fabry Nephropathy,Nephropathy,Fabry Nephropathy,Propylparaben,,,Antimicrobial Agent,,,,
582,Not Relevant,E-Posters,e-Poster,Denosumab versus Bisphosphonates for Medication-Related Osteonecrosis of the Jaw and Recurrent Clinical Fractures among Japanese Patients on Haemodialysis: A Target Trial Emulation,Renal Failure,Kidney Failure,Denosumab,,,Bisphosphonate;RANKL-Inhibitor,,,,
583,Medium,E-Posters,e-Poster,Efficacy and Safety of Telitacicept in IgA Nephropathy and IgA Vasculitis Nephropathy in Children: A Retrospective Single-Center Study,IgA Nephropathy;IgA Vasculitis;Nephropathy,Childhood IgA Nephropathy;Childhood IgA Vasculitis Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,Childhood,,
584,Not Relevant,E-Posters,e-Poster,Transcriptional Intermediary Factor 1γ Ameliorates Kidney Fibrosis by Enhancing Irisin Levels in Skeletal Muscle of db/db Mice,Fibrosis,Kidney Fibrosis,,,,,,,,
585,Not Relevant,E-Posters,e-Poster,Effectiveness of Chronic Kidney Disease Education in Patients with Advanced Stages: A Retrospective Study,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
586,Not Relevant,E-Posters,e-Poster,The Effect of Vitamin D on Pro-inflammatory Cytokines in Patients with Lupus Nephritis,Lupus Nephritis,Lupus Nephritis,Vitamin D,,,Vitamin D Supplement,,,,
587,Not Relevant,E-Posters,e-Poster,Albuminuria and Coronary Artery Calcium in a General Japanese Population,Albuminuria,Albuminuria,,,,,,,,
588,Not Relevant,E-Posters,e-Poster,Breaking Barriers in Nephroprotection for Advanced Chronic Kidney Disease: SGLT2 Inhibitors in the Treatment of CKD Stage 4-5,Chronic Kidney Disease,Stage IV/V Chronic Kidney Disease,,,,SGLT2-Inhibitor,,Metastatic,,
589,Not Relevant,E-Posters,e-Poster,"""Pink Cocaine"" (TUSI): A New Cause of Acute Kidney Injury?",Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
590,Not Relevant,E-Posters,e-Poster,The dialysis quality parameters as predictors of symptom burden in cluster analysis,Renal Failure,Kidney Failure,,,,,,,,
591,Not Relevant,E-Posters,e-Poster,Characteristics of Patients with a Diagnosis of De Novo Polycystic Kidney Disease,Polycystic Kidney Diseases,Polycystic Kidney Disease,,,,,,,,
592,Not Relevant,E-Posters,e-Poster,Development and Validation of Deep-Learning Model for Diagnosing Systemic Acidemia From the Electrocardiograms.,Acidemia,Systemic Acidemia,,,,,,Systemic,,
593,Not Relevant,E-Posters,e-Poster,Serum ß2-microglobulin is independently associated with left ventricular mass index in patients with stage 5 chronic kidney disease not undergoing dialysis,Chronic Kidney Disease,Stage V Chronic Kidney Disease,,,,,,,,
594,Not Relevant,E-Posters,e-Poster,The occurrence of CKD in the Aral Sea region,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
595,Not Relevant,E-Posters,e-Poster,Timing of Transition to Peritoneal Dialysis (PD) and Its Impact on Bacteremia Risk in PD Patients,Renal Failure,Kidney Failure,,,,,,,,
596,Not Relevant,E-Posters,e-Poster,The Role Of Molecular Genetics In The Etiological Diagnosis Of  Microscopic Hematuria,Hematuria,Hematuria,,,,,,,,
597,Not Relevant,E-Posters,e-Poster,Cystic Kidney Disease In X-Linled Alport Syndrome Children,Alport Syndrome;Cystic Kidney Diseases,Childhood X-Linked Alport Syndrome;Cystic Kidney Disease,,,,,,Childhood,,
598,Not Relevant,E-Posters,e-Poster,Non-invasive detection of calcineurin inhibitor toxicity using urinary mRNA expression in kidney transplant recipients,,,,,,,,,,
599,Not Relevant,E-Posters,e-Poster,Association between estimated glomerular filtration rate and mortality in elder population,,,,,,,,,,
600,Not Relevant,E-Posters,e-Poster,The effect of endogenous serotonin on vitamin K metabolism and vitamin K-dependent bone mineralization in an experimental model of chronic kidney disease in rats.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
601,Not Relevant,E-Posters,e-Poster,The treatment with β-blockers  reduced IL-6 and MMP-2/TIMP-2 system in patients with chronic kidney disease on conservative treatment.,Chronic Kidney Disease,Chronic Kidney Disease,,,,Beta-Blocker,,,,
602,Not Relevant,E-Posters,e-Poster,Antihypertensive Therapy Improves Cardiovascular Outcomes In Patients On Hemodialysis: An Updated Meta-Analysis Of Randomized Controlled Trials,Renal Failure,Kidney Failure,,,,,,,,
603,Not Relevant,E-Posters,e-Poster,Ambulatory Pulse Wave Velocity As A Predictor Of All-Cause Death Risk In Patients Receiving Peritoneal Dialysis: A Prospective Observational Study,Renal Failure,Kidney Failure,,,,,,,,
604,Not Relevant,E-Posters,e-Poster,Safety of Continued Belatacept Treatment After Kidney Graft Rejection,,,Belatacept,,,T Cell Costimulation-Inhibitor,,,,
605,Not Relevant,E-Posters,e-Poster,Evaluating Serum Alkaline Phosphatase Trajectories for Fracture Risk Prediction in Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
606,Not Relevant,E-Posters,e-Poster,Revisiting Frequent Premature Atrial Contractions and Cerebrovascular Events in Non-Dialysisv CKD patients,Chronic Kidney Disease,Chronic Kidney Disease;Premature Atrial Contraction,,,,,,,,
607,Not Relevant,E-Posters,e-Poster,"Observation of the therapeutic effect of finerenone, a novel non-steroidal mineralocorticoid receptor antagonist,  in patients with non-diabetic CKD",Chronic Kidney Disease,Non-Diabetic Chronic Kidney Disease,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,,
608,Not Relevant,E-Posters,e-Poster,"Association Between CKD-MBD and Mortality, Cardiovascular Events, and Fractures in Peritoneal Dialysis Patients",Chronic Kidney Disease,Chronic Kidney Disease-Mineral Bone Disorder,,,,,,,,
609,Not Relevant,E-Posters,e-Poster,Dickkopf-3 (DKK3) and the progression of diabetic kidney disease in primary health care,Diabetic Nephropathy,Diabetic Kidney Disease,,,,,,,,
610,Not Relevant,E-Posters,e-Poster,Cancer Mortality in Patients with Kidney Failure: Insights from the Korea Clinical Data Utilization Network (K-CURE) Database,Cancer;Renal Failure,Cancer;Renal Failure,,,,,,,,
611,Not Relevant,E-Posters,e-Poster,"High-sensitivity C-reactive protein levels and mortality, cardiovascular events, and adverse kidney outcomes in non-dialysis-dependent CKD patients",Chronic Kidney Disease,Non Dialysis Dependent Chronic Kidney Disease,,,,,,,,
612,Not Relevant,E-Posters,e-Poster,HIV-associated nephropathy in a patient with undetectable viral load: a case report,Human Immunodeficiency Virus Infection;Nephropathy,HIV-Associated Nephropathy,,,,,,,,
613,Not Relevant,E-Posters,e-Poster,Machine learning analysis of clinical determinants affecting gut microbiota in hemodialysis patients: a longitudinal study,Renal Failure,Kidney Failure,,,,,,,,
614,Not Relevant,E-Posters,e-Poster,The utility of Anifrolumab in Patients with Class III or IV Lupus Nephritis – the single center experience.,Lupus Nephritis,Class III/IV Lupus Nephritis,Anifrolumab,,,Type I Interferon Receptor-Antagonist,,,,
615,Not Relevant,E-Posters,e-Poster,The Relationship Between Serum Uric Acid Levels and Arteriovenous Fistula Thrombosis in Hemodialysis Patients,Arterio-Venous Fistula;Renal Failure,Arterio-Venous Fistula;Kidney Failure,,,,,,,,
616,Not Relevant,E-Posters,e-Poster,Impact of Dapagliflozin on the Kidney Failure Risk Equation (KFRE) in Patients with Stage G4 Chronic Kidney Disease,Chronic Kidney Disease,Stage IV Chronic Kidney Disease,Dapagliflozin,,,SGLT2-Inhibitor,,Metastatic,,
617,Not Relevant,E-Posters,e-Poster,Prevention Of Renal Fibrosis With Allogeneic Perinatal Stem Cells - A Long-Term Preclinical Model Of Kidney Injury,Fibrosis,Kidney Injury;Renal Fibrosis,Allogeneic Perinatal Stem Cell,,,Stem Cell Therapy,,,,
618,Not Relevant,E-Posters,e-Poster,The role of neutrophil extracellular traps in the animal model crystal-induced chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
619,Not Relevant,E-Posters,e-Poster,Efficacy and Safety of Dapagliflozin in Patients with Stage G4 Chronic Kidney Disease,Chronic Kidney Disease,Stage IV Chronic Kidney Disease,Dapagliflozin,,,SGLT2-Inhibitor,,Metastatic,,
620,Not Relevant,E-Posters,e-Poster,Evaluation of the Impact of COVID-19 Vaccines on Renal Function in Chronic Kidney Disease (CKD) Patients,Chronic Kidney Disease;Coronavirus Infection,Chronic Kidney Disease;COVID-19,COVID-19 Vaccine,,,Vaccine,,,,
621,Not Relevant,E-Posters,e-Poster,Dietary Management Strategies for Koreans with Chronic Kidney Disease: A Nutrient Intake Analysis Based on Korea National Health and Nutrition Examination Survey (KNHANES),Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
622,Not Relevant,E-Posters,e-Poster,Effect of genotype on renal outcome among the patients with inherited cystic kidney disease,Cystic Kidney Diseases,Inherited Cystic Kidney Disease,,,,,,,,
623,Not Relevant,E-Posters,e-Poster,Persistent higher trajectories of waist-to-hip ratio are associated with greater risk of cardio-renal outcomes: results from the KNOW-CKD study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,NCT01630486,KNOW-CKD
624,Not Relevant,E-Posters,e-Poster,Trajectories of serum total carbon dioxide and the risk of cardio-renal outcomes in chronic kidney disease: Results from the KNOW-CKD Study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,KNOW-CKD;;NCT01630486,
625,Not Relevant,E-Posters,e-Poster,"Prevalence and Trends of Cardiovascular-Kidney-Metabolic (CKM) Syndrome Among Korean Adults, 2013-2022",Metabolic Syndrome,Adult Cardiovascular Kidney Metabolic Syndrome,,,,,,Adult,,
626,Not Relevant,E-Posters,e-Poster,Fibroblast-Macrophage Dynamics and Midkine Signaling in ischemic induced renal fibrosis.,Fibrosis;Ischemia,Ischemic Renal Fibrosis,,,,,,,,
627,Not Relevant,E-Posters,e-Poster,Phospholipase A2 Receptor Antibody IgG and IgG4 Subclass by TRFIA Improves Sensitivity and Specificity in the Diagnosis of Primary Membranous Nephropathy,Primary Membranous Nephropathy,Primary Membranous Nephropathy,,,,,,,,
628,Not Relevant,E-Posters,e-Poster,Prospective Controlled Trial of the Effects of Different Renal Biopsy Needle Sizes on the Number of Glomeruli Collected and their Associated Complications,,,,,,,,,,
629,Not Relevant,E-Posters,e-Poster,Causal Association Between Constipation and Chronic Kidney Disease: A Two-Sample Mendelian Randomization Analysis,Chronic Kidney Disease;Constipation,Chronic Kidney Disease;Constipation,,,,,,,,
630,Not Relevant,E-Posters,e-Poster,Atopic dermatitis-like chronic inflammation may be associated with kidney inflammation,Atopic Dermatitis;Inflammation,Atopic Dermatitis;Kidney Inflammation,,,,,,,,
631,Not Relevant,E-Posters,e-Poster,Comparative study of safety of cuffed tunnelled catheter on patients on dual anti-platelets compared with standard indications.,,,,,,,,,,
632,Not Relevant,E-Posters,e-Poster,Telitacicept followed by Rituximab in highly active SLE:two successful cases,Systemic Lupus Erythematosus,Systemic Lupus Erythematosus,Telitacicept,Rituximab,,BLyS/APRIL Dual-Inhibitor,,,,
633,Not Relevant,E-Posters,e-Poster,Development of a Predictive Model for Nafamostat Mesylate Dosing in Hemodialysis,Renal Failure,Kidney Failure,Nafamostat Mesylate,,,Serine Protease Inhibitor,,,,
634,Not Relevant,E-Posters,e-Poster,The urinary proteome as a window to the transition from AKI to CKD after repeated acute kidney injuries,Acute Kidney Injury;Chronic Kidney Disease,Acute Kidney Injury;Chronic Kidney Disease,,,,,,,,
635,Not Relevant,E-Posters,e-Poster,Trandolapril attenuates renal fibrosis in rats with a dual-injury model of kidney disease progression.,Fibrosis;Kidney Diseases,Kidney Disease;Renal Fibrosis,Trandolapril,,,ACE-Inhibitor,,,,
636,Not Relevant,E-Posters,e-Poster,Trends in dialysis population in Albania over the last 5 years: rising age and increased mortality among Diabetic patients,Renal Failure,Kidney Failure,,,,,,,,
637,Not Relevant,E-Posters,e-Poster,Clinical Efficacy and Safety of Telitacicept in the Treatment of Renal Involvement in Primary Sjögren's Syndrome: A Report of 4 Cases,Primary Sjogren Syndrome,Primary Sjögren's Syndrome,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
638,Not Relevant,E-Posters,e-Poster,Rate of HMGCR gene  methylation in diabetic patients on hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
639,Not Relevant,E-Posters,e-Poster,Cognitive Impairment and Associated Factors in Patients Undergoing Hemodialysis,Cognitive Impairment;Renal Failure,Cognitive Impairment;Kidney Failure,,,,,Roche,,,
640,Not Relevant,E-Posters,e-Poster,"2-y crovalimab paroxysmal nocturnal haemoglobinuria (PNH) data for fatigue, a relevant symptom in atypical haemolytic uraemic syndrome (aHUS) and PNH",Hemolysis;Paroxysmal Nocturnal Hemoglobinuria,Atypical Hemolytic Urinary Syndrome;Paroxysmal Nocturnal Haemoglobinuria,Crovalimab,,,C5-Inhibitor,,Atypical,,
641,Not Relevant,E-Posters,e-Poster,Late Relapse of ANCA Associated Vasculitis presenting as obstructive nephropathy due to retroperitoneal fibrosis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;Nephropathy,ANCA-Associated Vasculitis;Obstructive Nephropathy,,,,,Roche,,,
642,Not Relevant,E-Posters,e-Poster,HNF4a Drives Metabolic Reprogramming in Podocytes through ChREBP/SREBP-Mediated Pathway and Promotes Cell Cycle Progression,,,,,,,Roche,,,
643,Not Relevant,E-Posters,e-Poster,The importance of anti-AT1R antibodies in patients with diabetic nephropathy,Diabetic Nephropathy,Diabetic Nephropathy,,,,Anti-AT1R Antibody,,,,
644,Not Relevant,E-Posters,e-Poster,"Trends and associations between decreased estimated glomerular filtration rate, metabolic syndrome, and non-alcoholic fatty liver disease in children and adolescents: a 15-Year data analysis",Metabolic Syndrome;Non Alcoholic Fatty Liver Disease,Adolescent Metabolic Syndrome;Childhood Non Alcoholic Fatty Liver Disease,,,,,,Adolescent;Childhood,,
645,Not Relevant,E-Posters,e-Poster,Efficacy of Rituximab-based Regimen in the Treatment of Obese Patients with Membranous Nephropathy,Membranous Nephropathy,Membranous Nephropathy,Rituximab,,,CD20-Targeted Monoclonal Antibody,,,,
646,Not Relevant,E-Posters,e-Poster,Survival and care trajectory of kidney graft patients after age 65 : Let’s look at the cardiovascular comorbidities rather than age,,,,,,,,,,
647,Not Relevant,E-Posters,e-Poster,ALOX5 Regulates Renal Fibrosis Through Modulation of Matrix Remodeling and Inflammatory Responses,Fibrosis,Renal Fibrosis,,,,,,,,
648,Not Relevant,E-Posters,e-Poster,Modeling ischemia-reperfusion injury in kidney organoids.,Ischemia,Ischemia-Reperfusion Injury,,,,,,,,
649,Medium,E-Posters,e-Poster,A comparison of the effectiveness of corticosteroids or telitacicept management alone in patients with IgA nephropathy: a retrospective observational study,IgA Nephropathy,IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor;Corticosteroid,,,,
650,Not Relevant,E-Posters,e-Poster,1111MicrosoftInternetExplorer402DocumentNotSpecified7.8 ?Normal0 Prospective Validation of Multiple Deep Learning Model Assisted Diagnostic Program for Glomerular Diseases Using Immunofluorescence Images,Glomerular Disease,Glomerular Disease,,,,,,,,
651,Not Relevant,E-Posters,e-Poster,Rituximab Based Regimen is Safe and Effective for Primary Membranous Nephropathy Patients presented with Nephrotic Syndrome and Advanced Renal Dysfunction,Nephrosis;RenaL Dysfunction,Advanced Renal Dysfunction;Nephrotic Syndrome,Rituximab,,,CD20-Targeted Monoclonal Antibody,,Advanced,,
652,Not Relevant,E-Posters,e-Poster,Analysis of the skeltal muscle index in hemodialys patients over 80 years old,Renal Failure,Hemodialysis Kidney Failure,,,,,,,,
653,Not Relevant,E-Posters,e-Poster,Preeclampsia In Women With Cronic Kidney Disease: Features Of Blood Coagulation Function,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
654,Not Relevant,E-Posters,e-Poster,Consumption of low-calorie sweeteners exacerbates the progression from acute kidney injury to chronic kidney disease and renal fibrosis,Chronic Kidney Disease;Fibrosis,Chronic Kidney Disease;Renal Fibrosis,,,,,,,,
655,Not Relevant,E-Posters,e-Poster,prevalence and characteristics of headache in chronic hemodialysis patients,Headache;Renal Failure,Headache;Kidney Failure,,,,,,,,
656,Not Relevant,E-Posters,e-Poster,Predicting long-term benefits of improvements in estimated glomerular filtration rate (eGFR) with iptacopan on delaying kidney failure in Complement 3 Glomerulopathy (C3G),Glomerulopathy;Renal Failure,Complement 3 Glomerulopathy;Kidney Failure,Iptacopan,,,C3-Inhibitor,,,,
657,Not Relevant,E-Posters,e-Poster,Arterial hypertension and markers of cardiovascular complications after kidney transplantation,Arterial Hypertension,Arterial Hypertension,,,,,,,,
658,Not Relevant,E-Posters,e-Poster,Prognostic value of urinary periostin in the frequent primary glomerulopathies of the adult.,Glomerular Disease,Adult Primary Glomerular Disease,,,,,,Adult,,
659,Not Relevant,E-Posters,e-Poster,Angiotensin II induces mitochondrial oxidative stress in podocyte,,,,,,,,,,
660,Not Relevant,E-Posters,e-Poster,Exploring the association between non-alcoholic fatty liver disease and chronic kidney disease: Insights from NHANES 1999-2016,Chronic Kidney Disease;Non Alcoholic Fatty Liver Disease,Chronic Kidney Disease;Non Alcoholic Fatty Liver Disease,,,,,,,,
661,Not Relevant,E-Posters,e-Poster,The Impact of Adolescent Smoking Initiation on the Risk of End-Stage Kidney Disease: A Nationwide Cohort Study,Kidney Diseases,Adolescent End Stage Kidney Disease,,,,,, End Stage;Adolescent,,
662,Not Relevant,E-Posters,e-Poster,Chronic kidney disease is a major risk factor for mortality in triglyceride deposit cardiomyovasculopathy patients,Chronic Kidney Disease,Chronic Kidney Disease;Triglycerid Deposit Cardiomyovasculopathy,,,,,,,,
663,Medium,E-Posters,e-Poster,Biomarkers for Predicting the Efficacy of Immunosuppressive Therapy in IgA Nephropathy: The Role of serum MCP-1 and TGF-ß,IgA Nephropathy,IgA Nephropathy,,,,Immunosuppressive Therapy,,,,
664,Not Relevant,E-Posters,e-Poster,Long-term treatment with medium cut-off dialyzer increase muscle mass in hemodialysis patients,Renal Failure,Kidney Failure,,,,,,,,
665,Not Relevant,E-Posters,e-Poster,Anemia as a predictor of peritoneal dialysis withdrawal in stable peritoneal dialysis patients,Anemia;Renal Failure,Anemia;Kidney Failure,,,,,,,,
666,Not Relevant,E-Posters,e-Poster,Prognostic value of Glasgow Prognostic Score and its derived scores in patients undergoing hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
667,Not Relevant,E-Posters,e-Poster,Osteoactivin levels are correlated with eGFR and proteinuria in diabetic kidney disease.,Diabetic Nephropathy;Proteinuria,Diabetic Kidney Disease;Proteinuria,,,,,,,,
668,Not Relevant,E-Posters,e-Poster,Severity of preeclampsia and fetal complications- potential association with serum albumin levels?,Pre-Eclampsia,Preeclampsia,,,,,,,,
669,Not Relevant,E-Posters,e-Poster,End-Stage Kidney Disease In People With Anca-Associated Vasculitis: A Systematic Review Of Outcomes,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;End-Stage Renal Disease,ANCA-Associated Vasculitis;End-Stage Kidney Disease,,,,,,,,
670,Not Relevant,E-Posters,e-Poster,Is urgent start peritoneal dialysis after percutaneous PD catheter placement by a nephrologist safe?,Renal Failure,Kidney Failure,,,,,,,,
671,Not Relevant,E-Posters,e-Poster,Comparison study of Human resourced ellipsoid method vs kidney volumetry using artificial intelligence in Polycystic kidney disease,Polycystic Kidney Diseases,Polycystic Kidney Disease,,,,,,,,
672,Not Relevant,E-Posters,e-Poster,Dialysate leaks in peritoneal dialysis patients – a retrospective review,Renal Failure,Kidney Failure,,,,,,,,
673,Not Relevant,E-Posters,e-Poster,SGLT2 Inhibitors in Patients with Chronic Kidney Disease and Solid Organ Tumor: A Retrospective Observational Study on Safety and Tolerability,Chronic Kidney Disease;Tumors,Chronic Kidney Disease;Solid Organ Tumor,,,,SGLT2-Inhibitor,,,,
674,Not Relevant,E-Posters,e-Poster,Complications Associated with Tunneled Hemodialysis Catheters: A Retrospective Study,Renal Failure,Kidney Failure,,,,,,,,
675,Not Relevant,E-Posters,e-Poster,Advanced kidney models to better understand tacrolimus-induced nephrotoxicity,Renal Toxicity,Nephrotoxicity,,,,,,,,
676,Not Relevant,E-Posters,e-Poster,Adult stem cell-derived kidney organoids (tubuloids) to model renal ciliopathies,Ciliopathy,Renal Ciliopathy,,,,,,,,
677,Not Relevant,E-Posters,e-Poster,Predictive Value of the ATRIA Score for Contrast-Induced Nephropathy in Patients Undergoing Primary Percutaneous Coronary Intervention for Non-ST-Segment Elevation Myocardial Infarction,Nephropathy;St-Elevation Myocardial Infarction,Nephropathy;Non-ST-Segment Elevation Myocardial Infarction,,,,,,,,
678,Not Relevant,E-Posters,e-Poster,Changes in Serum Bisphenol S (BPS) Concentrations in Dialysis Patients: Impact of Switching from Hemodialysis (HD) to On-line Hemodiafiltration (OHDF) and Changing the Dialysis Membrane from Polyethersulfone (PES) to Polysulfone (PS).,Renal Failure,Kidney Failure,,,,,,,,
679,Not Relevant,E-Posters,e-Poster,Urinary excretion of TNF-a and IL-9 in patients treated with immune checkpoint inhibitors. Potential application in the subclinical renal damage diagnosis.,,Renal Damage,,,,Immune Checkpoint Inhibitor,,,,
680,Not Relevant,E-Posters,e-Poster,Interplay between polymorphism in the EDNRA gene and endothelin-1 concentration in the blood of patients with chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
681,Not Relevant,E-Posters,e-Poster,Green Tea Polyphenol Sandwich-assisted Construction of Endothelial Biomimetic Coatings with HA Platform and NO Release for Hemodialysis Access Stents to Prevent Thrombosis and Restenosis,Renal Failure;Thrombosis,Kidney Failure;Thrombosis,,,,,,,,
682,Not Relevant,E-Posters,e-Poster,"The effect of Pravastatin on Insulin Resistance in kidney transplant recipients. A randomized, placebo-controlled cross over trial",,,Pravastatin,,,HMG CoA Reductase-Inhibitor,,,,
683,High,E-Posters,e-Poster,Real-life analysis of a monocentric cohort of IgA nephropathy patients,IgA Nephropathy,IgA Nephropathy,,,,,AstraZeneca,,,
684,Not Relevant,E-Posters,e-Poster,Differences in chronic kidney disease management based on identification and diagnosis in a population-based observational study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
685,Not Relevant,E-Posters,e-Poster,Renal Involvement in Sjögren’s Syndrome: A  Clinical and Biological Analysis,Sjogren's Syndrome,Sjogren's Syndrome,,,,,AstraZeneca,,,
686,Not Relevant,E-Posters,e-Poster,CKD with hyperuricemia vs CKD with wide plasma uric acid fluctuations --- two different types of CKD both with rapid eGFR decline,Chronic Kidney Disease;Hyperuricemia,Chronic Kidney Disease;Hyperuricemia,,,,,,,,
687,Not Relevant,E-Posters,e-Poster,Role of urinary biomarkers in the diagnosis of kidney damage due to immune checkpoint inhibitors,,Kidney Damage,,,,Immune Checkpoint Inhibitors,,,,
688,Not Relevant,E-Posters,e-Poster,Predictive Factors for Hospitalizations: Comparison Between Incremental Hemodialysis and Conventional Hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
689,Not Relevant,E-Posters,e-Poster,The effect of homocysteine correction on the quality of life in CKD patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
690,Not Relevant,E-Posters,e-Poster,"Improvement in Uncomfortable Dialysis-Related Symptoms Such as Daytime Itching, Nighttime Itching, Restless Legs and Leg Muscle Cramps by Switching from HD to OHDF Through Enhanced Removal Efficacy of Medium-Molecular-Weight Substances.",Renal Failure,Kidney Failure,,,,,,,,
691,Not Relevant,E-Posters,e-Poster,Importance Of Intrinsic Membrane Dysfunction As A Predictor Of  Survival In Peritoneal Dialysis,Renal Failure,Kidney Failure,,,,,,,,
692,Not Relevant,E-Posters,e-Poster,Eculizumab for Treatment-Resistant Lupus - A Friend or Foe? A Case Report,Systemic Lupus Erythematosus,Treatment Resistant Lupus,Eculizumab,,,Complement-Inhibitor,,Treatment-Resistant,,
693,Not Relevant,E-Posters,e-Poster,Benefits of Exercise in Octogenarians on Hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
694,Not Relevant,E-Posters,e-Poster,¿What Changes Can the Use of the IEXPAC Tool Induce in the Nurse Consultation for Advanced Chronic Kidney Disease?,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
695,Not Relevant,E-Posters,e-Poster,Kidney disease spectrum in patients with haematological malignancies.,Cancer;Kidney Diseases,Haematologic Malignancy;Kidney Disease,,,,,,,,
696,Not Relevant,E-Posters,e-Poster,Treatment outcomes of liver cyst infection in patients with autosomal dominant polycystic kidney disease.,Hepatic Cyst;Infection;Polycystic Kidney Diseases,Autoimmune Polycystic Kidney Disease;Liver Cyst Infection,,,,,,,,
697,Not Relevant,E-Posters,e-Poster,Subclinical Renal Tubular Dysfunction in Postmenopausal Women Exposed to Low-Level Environmental Cadmium,,Subclinical Renal Tubular Dysfunction,,,,,,Subclinical,,
698,Not Relevant,E-Posters,e-Poster,Analysis Of Primary Survival And Quality Indicators Of Native Arteriovenous Fistulas Performed During The Period 2020 – 2023.,Arterio-Venous Fistula,Arterio-Venous Fistula,,,,,,,,
699,Not Relevant,E-Posters,e-Poster,Ultrafiltration pattern in Automated Peritoneal Dialysis,Renal Failure,Kidney Failure,,,,,,,,
700,Not Relevant,E-Posters,e-Poster,“Use a machine learning model that estimates survival curves to identify patients at high risk of rapid progression of chronic kidney disease.”,Chronic Kidney Disease,High Risk Chronic Kidney Disease,,,,,,High-risk,,
701,Not Relevant,E-Posters,e-Poster,Resistin: a potential predictor of adverse outcomes in chronic kidney disease?,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
702,High,E-Posters,e-Poster,"ORIGIN 3 Study Design: A Global, Randomized, Controlled, Phase 3 Study of Atacicept in IgA Nephropathy",IgA Nephropathy,IgA Nephropathy,Atacicept,,,B Cell Activating Factor Receptor-Inhibitor,Vera Therapeutics,,NCT04716231,ORIGIN 3
703,Low,E-Posters,e-Poster,Colocalization of complement C3 and IgA in glomerular immune-complex deposits of patients with IgA nephropathy correlates with the Oxford classification MEST-C scores,IgA Nephropathy,IgA Nephropathy,,,,,Dimerix Bioscience,,,
704,Not Relevant,E-Posters,e-Poster,DMX-200 is effective in reducing urine monocyte chemoattractant protein 1 (MCP-1) levels in patients with FSGS without affecting plasma MCP-1 concentration,Focal Segmental Glomerulosclerosis,Focal Segmental Glomerulosclerosis,DMX-200,,,Chemokine Receptor-Antagonist,,,,
705,Not Relevant,E-Posters,e-Poster,DMX-200 does not induce a haemodynamic effect or an acute change in GFR and has a strong cardiovascular safety profile.,,,DMX-200,,,Chemokine Receptor-Antagonist,,,,
706,Not Relevant,E-Posters,e-Poster,Necrotizing histiocytic lymphadenitis (Kikuchi-Fujimoto disease): About a case,Lymphadenitis,Necrotizing Histiocytic Lymphadenitis,,,,,,,,
707,Not Relevant,E-Posters,e-Poster,Real-world outcomes of belimumab in systemic lupus erythematosus and lupus nephritis.,Lupus Nephritis;Systemic Lupus Erythematosus,Lupus Nephritis;Systemic Lupus Erythematosus,Belimumab,,,BAFF-Targeted Therapy,,,,
708,Low,E-Posters,e-Poster,Immune complex made by immunoglobulin A and Cnm Protein expressing in Streptococcus mutans might induce IgA nephropathy like kidney lesion.,IgA Nephropathy,IgA Nephropathy,,,,,,,,
709,Not Relevant,E-Posters,e-Poster,Pilot Insights from an Online Survey Study Interpreting Clinical Trials Outcome; Nephrologist Recall vs. Artificial Intelligence,,,,,,,,,,
710,High,E-Posters,e-Poster,ORIGIN Extend: A Long-Term Extension Study of Atacicept in IgA Nephropathy,IgA Nephropathy,IgA Nephropathy,Atacicept,,,B Cell Activating Factor Receptor-Inhibitor,Vera Therapeutics,,NCT06674577,ORIGIN EXTEND
711,Not Relevant,E-Posters,e-Poster,Nephrotic Syndrome that Changed the Course of Chronic myeloid leukemia Treatment,Chronic Myeloid Leukemia;Nephrosis,Chronic Myeloid Leukemia;Nephrotic Syndrome,,,,,,,,
712,Not Relevant,E-Posters,e-Poster,The association of cognitive dysfunction with markers of oxidative stress and vitamin K deficiency in Chronic Kidney Disease patients,Chronic Kidney Disease;Cognitive Impairment,Chronic Kidney Disease;Cognitive Dysfunction,,,,,,,,
713,Not Relevant,E-Posters,e-Poster,Atypical familial Mediterranean fever presenting AA amyloidosis,Familial Mediterranean Fever;Light-Chain Amyloidosis,Amyloid Light Chain Amyloidosis;Atypical Familial Mediterranean Fever,,,,,,Atypical,,
714,Not Relevant,E-Posters,e-Poster,Comparison of β-blocker with other anti-hypertensive drugs in patients with chronic kidney disease in Korea: A National Health Insurance Data,Chronic Kidney Disease,Chronic Kidney Disease,,,,Anti-Hypertensive Agent;Beta-Blocker,,,,
715,Not Relevant,E-Posters,e-Poster,Evaluation of embelin alone and its combination with metformin on diabetic nephropathy.,Diabetic Nephropathy,Diabetic Nephropathy,Embelin;Metformin,,,Biguanide;XIAP-Inhibitor,,,,
716,Not Relevant,E-Posters,e-Poster,Assessment of the Combined Antiurolithiatic Properties of Tribulus terrestris Fruit Extract in Conjunction with Selected Indian Medicinal Plants.,,,Tribulus Terrestris,,,Antiurolithiatic,,,,
717,Not Relevant,E-Posters,e-Poster,Urinary NGAL as a potential Biomarker to detect subclinical AKI post Fundus Fluorescein Angiography,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
718,Not Relevant,E-Posters,e-Poster,The influence of antibodies against angiotensin II type-1 receptor to kidney allograft function and their association to alloimmune sensitization,,,,,,,,,,
719,Not Relevant,E-Posters,e-Poster,Interdialytic weight gain and cardiac geometry in hemodialysis patients,Renal Failure,Kidney Failure,,,,,,,,
720,Not Relevant,E-Posters,e-Poster,"Severe Hyperkalaemia: A Retrospective Study of Clinical Characteristics, Aetiology, and Management.",Hyperkalemia,Severe Hyperkalemia,,,,,,Severe,,
721,Not Relevant,E-Posters,e-Poster,Prognostic Factors of Renal Survival in ANCA-Associated Vasculitis: A Retrospective Cohort Study from the Nephrology department of Monastir,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
722,Not Relevant,E-Posters,e-Poster,The effect of xCT modulation on ROS levels in a unilateral ureteral obstruction model,Ureteral Obstruction,Ureteral Obstruction,,,,,,,,
723,Not Relevant,E-Posters,e-Poster,Investigation of the gastrointestinal tract with capsule endoscopy in patients undergoing renal replacement therapies,,,,,,,,,,
724,Not Relevant,E-Posters,e-Poster,Axillary loop arteriovenous grafts as a rescue from vascular access failure: Long-term results at a single facility,,,,,,,,,,
725,High,E-Posters,e-Poster,Efficacy Evaluation of Telitacicept in IgA Nephropathy: a real-world study,IgA Nephropathy,IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
726,Not Relevant,E-Posters,e-Poster,A case report of a concurrent axonal neuropathy and focal segmental glomerulosclerosis treated with ocrelizumab and plasma exchange.,Focal Segmental Glomerulosclerosis;Neuropathy,Axonal Neuropathy;Focal Segmental Glomerulosclerosis,Ocrelizumab,,,CD20-Targeted Monoclonal Antibody,,,,
727,Not Relevant,E-Posters,e-Poster,Trends of Occurrence and Mortality in Dialysis Requiring Acute Kidney Injury,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
728,Not Relevant,E-Posters,e-Poster,Remission Rates Of Immunotherapy With Anti-Cd20 Monoclonal Antibody (Rituximab) In Patients With Membranous Nephropathy,Membranous Nephropathy,Membranous Nephropathy,Rituximab,,,CD20-Targeted Monoclonal Antibody,,,,
729,Not Relevant,E-Posters,e-Poster,Hyperkalemia: Treatment and Associated costs in Argentina,Hyperkalemia,Hyperkalemia,,,,,,,,
730,Not Relevant,E-Posters,e-Poster,Minimal changes disease in patients over 60 years of age,Minimal Change Disease,Minimal Change Disease,,,,,,,,
731,Not Relevant,E-Posters,e-Poster,Urinary Metabolomics Evaluation In Sensitized Kidney Transplant Recipients,,,,,,,,,,
732,Not Relevant,E-Posters,e-Poster,"Percutaneous native kidney biopsy performed by Nephrologists: Safety, desmopressin use and complications.",,,Desmopressin,,,Vasopressin Analog,AstraZeneca,,,
733,Not Relevant,E-Posters,e-Poster,SEARCH Project: Early diagnosis of chronic kidney disease in Argentina. Initial Results,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,SEARCH,
734,Not Relevant,E-Posters,e-Poster,Urinary CXCL16 correlates with renal function and proteinuria in diabetic chronic kidney disease,Chronic Kidney Disease;Proteinuria,Diabetic Chronic Kidney Disease;Proteinuria,,,,,AstraZeneca,,,
735,Not Relevant,E-Posters,e-Poster,Differences in expression dynamics and renoprotective effects between Klotho delivery using mRNA-LNP and AAV,,,,,,Gene Therapy,AstraZeneca,,,
736,Not Relevant,E-Posters,e-Poster,Percutaneous kidney biopsy and the histopathologic patterns of kidney diseases in children,Kidney Diseases,Childhood Kidney Disease,,,,,,Childhood,,
737,Not Relevant,E-Posters,e-Poster,A Novel Peritoneal Dialysis Catheter Insertion Technique to Reduce Catheter Migration,Renal Failure,Kidney Failure,,,,,,,,
738,Not Relevant,E-Posters,e-Poster,Venous Excess Ultrasound Score and Acute Kidney Injury in patients with decompensated heart failure,Acute Kidney Injury;Decompensated Heart Failure,Acute Kidney Injury;Decompensated Heart Failure,,,,,,,,
739,Not Relevant,E-Posters,e-Poster,"Temporal trends in acute kidney injury-related mortality across 43 countries, 1996-2021, with projections up to 2050: a global time series analysis and modelling study",Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
740,Not Relevant,E-Posters,e-Poster,Efficacy and Safety of Paediatric Continuous Veno-Venous Hemodialysis (CVVHD) with MultiFiltratePRO: A Prospective Multicenter Study,Renal Failure,Kidney Failure,,,,,,,,
741,Not Relevant,E-Posters,e-Poster,Maribavir Treatment in Resistant/Refractory Cytomegalovirus Infection Among Kidney Transplant Recipients: A Real-World Experience,Cytomegaloviral Disease,Resistant/Refractory Cytomegalovirus Infection,Maribavir,,,CMV UL97 Kinase-Inhibitor,,Refractory,,
742,Not Relevant,E-Posters,e-Poster,Prognostic value of triglyceride glucose (TyG) index in population with chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
743,Not Relevant,E-Posters,e-Poster,Machine Learning Approach Using CT-Based Morphological Features for Evaluating Acute Kidney Injury Severity,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
744,Not Relevant,E-Posters,e-Poster,Clinical Implications of the Triglyceride-Glucose Index in Hemodialysis Patients: A Multicenter Prospective Cohort Study,Renal Failure,Kidney Failure,,,,,,,,
745,Not Relevant,E-Posters,e-Poster,"Hepatitis, acute kidney injury and myositis due to atorvastatin",Acute Kidney Injury;Hepatitis,Acute Kidney Injury;Hepatitis,,,,,,,,
746,Not Relevant,E-Posters,e-Poster,Neoplasms In Patients With Renal Substitute Therapy And Evaluation Of The Use Of Check Point Inhibitors In This Population,Cancer,Neoplasm,,,,,,,,
747,Not Relevant,E-Posters,e-Poster,Nephrology and Primary Care: Integrated Care Program for Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
748,Not Relevant,E-Posters,e-Poster,Risk Factors associated with acute kidney injury during the postpartum period,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
749,Not Relevant,E-Posters,e-Poster,Von Willebrand Factor as a Predictor of Acute Kidney Injury and Hemodialysis Requirement in Severe Leptospirosis: A Prospective Cohort Study,Acute Kidney Injury;Leptospirosis,Acute Kidney Injury;Severe Leptospirosis,,,,,,Severe,,
750,Not Relevant,E-Posters,e-Poster,Association of ACE and IL-1B gene polymorphisms with erythropoietin resistance in dialysis patients with anemia,Anemia;Renal Failure,Anemia;Kidney Failure,,,,,,,,
751,Not Relevant,E-Posters,e-Poster,Histological and evolutionary profile of hypertension in patients with lupus nephropathy,Hypertension;Lupus Nephritis,Hypertension;Lupus Nephritis,,,,,,,,
752,Not Relevant,E-Posters,e-Poster,1 year follow up of bone density markers in patients dialyzed with a citric acid-vitC containing dialysate versus acetate dialysate.,,,,,,,,,,
753,Not Relevant,E-Posters,e-Poster,Effect of increasing age on pre-renal AKI incidence and severity in dehydrated and normohydrated rats,Acute Kidney Injury,Pre-Renal Acute Kidney Injury,,,,,,,,
754,Not Relevant,E-Posters,e-Poster,Dehydration and hypertension differently prime intrinsic and pre-renal AKI,Acute Kidney Injury;Hypertension,Acute Kidney Injury;Hypertension,,,,,,,,
755,Not Relevant,E-Posters,e-Poster,Outcomes of Sirolimus-Coated Balloon Angioplasty for Arteriovenous Fistula Stenosis: A Prospective Registry Analysis from a Single Center,Arterio-Venous Fistula;Stenosis,Arteriovenous Fistula Stenosis,Sirolimus,,,mTOR-Inhibitor,,,,
756,Not Relevant,E-Posters,e-Poster,Serum acrolein as a potential biomarker of aortic stiffness in patients with non-dialysis chronic kidney disease stage 3 to 5,Chronic Kidney Disease,Stage III Chronic Kidney Disease;Stage IV Chronic Kidney Disease,,,,,,Metastatic;Stage III,,
757,Not Relevant,E-Posters,e-Poster,The Influence Of Anemia On Quality Of Life Of Patients On Hemodialysis And Peritoneal Dialysis,Anemia;Renal Failure,Anemia;Kidney Failure,,,,,,,,
758,Not Relevant,E-Posters,e-Poster,A case of membranous nephropathy that reached remission with SGLT2 inhibitor alone,Membranous Nephropathy,Membranous Nephropathy,,,,SGLT2-Inhibitor,,,,
759,Not Relevant,E-Posters,e-Poster,Contrast Media in Hospitalized Patients with Acute Kidney Injury- Renal and Clinical Outcomes.,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
760,Not Relevant,E-Posters,e-Poster,"Dynamic Changes in Renal Hyperfiltration and Influences on Cardiovascular Events, Kidney Disease Progression, and Mortality: a nationwide prospective cohort study",Kidney Diseases,Kidney Disease,,,,,,,,
761,Not Relevant,E-Posters,e-Poster,"Beyond the Kidney: Unconventional Roles of Indoxyl Sulfate in Modulating Purinergic Receptors, Transporters, and Cytokines in Mouse Aorta",,,,,,,,,,
762,Not Relevant,E-Posters,e-Poster,"Investigating AKI in ICU Trauma Patients: Incidence, Risk Profiles, and Outcome Implications",Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
763,Not Relevant,E-Posters,e-Poster,From Covid  to GEPA: A systematic Vasculitis with Unexpected IgA Deposits,Coronavirus Infection,COVID-19;Gastrointestinal Endocrine Pancreatic Artery Syndrome,,,,,,,,
764,Not Relevant,E-Posters,e-Poster,"Cognitive Functions In Multymorbidity Patients With Atrial Fibrillation Depending On The Presence Of Concomitant Chronic Kidney Disease Stages 3A, 3B And 4",Atrial Fibrillation;Chronic Kidney Disease,Atrial Fibrillation;Chronic Kidney Disease,,,,,,,,
765,Not Relevant,E-Posters,e-Poster,Is hyponatremia at the beginning of peritoneal dialysis relevant?,Renal Failure,Hyponatremic Syndrome;Kidney Failure,,,,,,,,
766,Not Relevant,E-Posters,e-Poster,"Valuing overhydration in stable, non-dialysis stage 4 and 5 kidney disease patients.",Kidney Diseases,Stage IV Non Dialysis Kidney Disease,,,,,,Metastatic,,
767,Not Relevant,E-Posters,e-Poster,"Three years of kidney transplantation in the Yaounde General Hospital, Cameroon",,,,,,,,,,
768,Not Relevant,E-Posters,e-Poster,Proteinuria in Deceased Kidney Transplant Donors for Prediction of Chronic Lesions in Pre- Transplant Biopsies – a prospective multi-center study,Proteinuria,Chronic Lesion;Proteinuria,,,,,,,,
769,Not Relevant,E-Posters,e-Poster,Cardioprotective effect of a Low-Protein Diet in Patients with Type 2 Diabetes and Chronic Kidney Disease stages 3-4,Chronic Kidney Disease;Type 2 Diabetes,Chronic Kidney Disease;Type 2 Diabetes,,,,,,,,
770,Not Relevant,E-Posters,e-Poster,Effect of Low-Dose Tenapanol on Inflammation in Hemodialysis Patients,Renal Failure,Kidney Failure,Tenapanor,,,NHE3-Inhibitor,,,,
771,Not Relevant,E-Posters,e-Poster,"Unveiling the Role of Peroxiredoxins 1-5 as Markers in Early Diagnosis and Monitoring of IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis.",IgA Nephropathy;Lupus Nephritis;Membranous Nephropathy,IgA Nephropathy;Lupus Nephritis;Membranous Nephropathy,,,,,,,,
772,Not Relevant,E-Posters,e-Poster,Malignant Tumors Of The Urinary Bladder And Balkan Endemic Nephropathy - 70 Years After,Balkan Nephropathy;Tumors,Balkan Endemic Nephropathy;Malignant Tumor,,,,,,Malignant,,
773,Not Relevant,E-Posters,e-Poster,BRIGHT-HD - Brazil Research Investigation on public Health Gain comparing survival between hemodialysis and hemodiafiltration,Renal Failure,Kidney Failure,,,,,,,,BRIGHT-HD
774,Not Relevant,E-Posters,e-Poster,Glyoxylic acid induce crystalline nephropathy and Hair-Straightening Products : A case report,Nephropathy,Nephropathy,,,,,,,,
775,Not Relevant,E-Posters,e-Poster,Evaluation Of Outcomes And Challenges In Arteriovenous Fistulas As Hemodialysis Access In Pediatric Patients,Renal Failure,Kidney Failure,,,,,,,,
776,Not Relevant,E-Posters,e-Poster,Complication of Self-Catheterization in a Kidney Transplant Recipient : Psoas Abscess,Abscess,Psoas Abscess,,,,,,,,
777,Not Relevant,E-Posters,e-Poster,Assay validation and quantification of new urinary kidney safety biomarker candidates for the detection of glomerular injury,,Glomerular Injury,,,,,,,,
778,Not Relevant,E-Posters,e-Poster,Hereditary Minimal change disease (MCD) : About Three Cases reports,Minimal Change Disease,Hereditary Minimal Change Disease,,,,,,,,
779,Not Relevant,E-Posters,e-Poster,Estimated Glomerular Filtration Rate in Pediatric Neurogenic Bladder Patients using cystatin C and creatinine based CKiD and EKFC equations – usefulness of cystatin C,Neurogenic Lower Urinary Tract Dysfunction,Pediatric Neurogenic Bladder,,,,,,Paediatric,,
780,Not Relevant,E-Posters,e-Poster,Cardiac involvement in monoclonal gammopathies : A single center experience,Monoclonal Gammopathy,Monoclonal Gammopathy,,,,,,,,
781,Not Relevant,E-Posters,e-Poster,Experience in a single center with standard treatment of Lupus Nephritis.,Lupus Nephritis,Lupus Nephritis,,,,,,,,
782,Not Relevant,E-Posters,e-Poster,Nodular Glomerulosclerosis Complicating MIDD: Report of 2 Cases in Young Patients,Monoclonal Immunoglobulin Deposition Disease;Nodular Glomerulosclerosis,Monoclonal Immunoglobulin Deposition Disease;Nodular Glomerulosclerosis,,,,,,,,
783,Not Relevant,E-Posters,e-Poster,Hungry bone syndrome (HBS) as an outcome of Parathyroidectomy as a Treatment of Hyperparathyroidism in a third level hospital in a medium-income country,Hyperparathyroidism,Hunger Bone Syndrome;Hyperparathyroidism,,,,,,,,
784,Not Relevant,E-Posters,e-Poster,Evolution of renal function in patients with long-term mechanical circulatory support,,,,,,,,,,
785,Not Relevant,E-Posters,e-Poster,Predicting ICU Outcomes in Trauma Patients: The Prognostic Value of SOFA Score and AKI Severity,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
786,Not Relevant,E-Posters,e-Poster,Impact Of Medium Cut-Off Dialyzer Membrane And Dietary Modification On Serum P-Cresyl Sulfate And Indoxyl Sulfate Levels: A Randomized Controlled Trial,,,,,,,,,,
787,Not Relevant,E-Posters,e-Poster,Prognostic factors for cardiovascular events in pauci-immune glomerulonephritis: a retrospective cohort study,Glomerulonephritis,Pauci-Immune Glomerulonephritis,,,,,,,,
788,Not Relevant,E-Posters,e-Poster,Prevalence of hyperuricemia among patients undergoing hemodialysis,Hyperuricemia;Renal Failure,Hyperuricemia;Kidney Failure,,,,,,,,
789,Not Relevant,E-Posters,e-Poster,"Supply of probiotics with L. Rhamnosus and B. Longum Evaluation of the improvement of uremic gastrointestinal symptoms in patients aged 30 to 70 years, with hemodialysis treatment at the SENETO clinic, for 1 to 120 days.",Renal Failure,Kidney Failure,,,,Probiotic,,,,
790,Not Relevant,E-Posters,e-Poster,Association of Post-Transplant Apolipoprotein A-1 Levels with Cardiovascular Events and Graft Loss in Kidney Transplant Recipients: Results from the KOTRY Study,,,,,,,,,KOTRY,
791,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Quantitative hematuria predicts the proportion of crescents in IgA nephropathy population,IgA Nephropathy,IgA Nephropathy,,,,,,,,
792,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Immunomediated tubulo-interstitial nephritis. Acumulated experience in Infanta Sofía Hosptial (Madrid),Tubulointerstitial Nephritis,Tubulointerstitial Nephritis,,,,,,,,
793,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Epidémiologie des cas d'IgAN en France : évaluation à partir des bases de données médico-administratives hospitalières en France (PMSI),IgA Nephropathy,IgA Nephropathy,,,,,,,,
794,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Contemporary Epidemiological Analysis of Adult Inaugural Nephrotic Syndrome: Thirteen-year Experience of a Tertiary Center,Nephrosis,Adult Nephrotic Syndrome,,,,,,Adult,,
795,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Primary Focal Segmental Glomerulosclerosis: Renal Prognostic Factors,Focal Segmental Glomerulosclerosis,Primary Focal Segmental Glomerulosclerosis,,,,,,,,
796,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The Relative and Absolute Quantity of Qualitative Research in Nephrology Compared to Other specialities: A scoping review covering over two decades,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
797,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Mortality Profile Of Patients With Anca-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anca-Associated Vasculitis,,,,,,,,
798,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"A Case Report of Bartonella Henselae Endocarditits Presenting as a PR-3 Positive, Immune-complex, Necrotising Glomerulonephritis",Endocarditis;Glomerulonephritis,Bartonella Henselae Endocarditis;Necrotising Glomerulonephritis,,,,,,,,
799,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Thrombomodulin as a biomarker of endothelial dysfunction in glomerular diseases: findings from a cross-sectional study,Endothelial Dysfunction;Glomerular Disease,Endothelial Dysfunction;Glomerular Disease,,,,,,,,
800,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Autophagy Related Protein 5 Is a Promising Autophagy Marker in Lupus Nephritis with Good Predictive Value of Response to Treatment,Lupus Nephritis,Lupus Nephritis,,,,,,,,
801,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The Pattern of Renal Involvement in Relapsing Cryoglobulinemic Vasculitis After Successful Sustained Viral Response by Direct-Acting Antiviral Treatments,Vasculitis,Relapsed Cryoglobulinemic Vasculitis,,,,,,Relapsed,,
802,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Antiproteinuric effects of dapagliflozin in Lupus Nephritis,Lupus Nephritis,Lupus Nephritis,Dapagliflozin,,,SGLT2-Inhibitor,,,,
803,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Cardiometabolic risk, evaluation and control in Southeast Asians with lupus nephritis: A cross sectional study",Lupus Nephritis,Lupus Nephritis,,,,,,,,
804,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Beneficial effects of voclosporin on reducing proteinuria in lupus nephritis and extrarenal effects in SLE: insights form a small cohort with limited follow-up,Lupus Nephritis;Proteinuria,Lupus Nephritis;Proteinuria,Voclosporin,,,Calcineurin-Inhibitor,,,,
805,High,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Effect of On-Demand immunosuppressive therapy on long-term outcomes of patients with IgA nephropathy: a real-world cohort study,IgA Nephropathy,IgA Nephropathy,,,,Immunosuppressive Therapy,,,,
806,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Georeferencing of Patients with ANCA-Associated Vasculitis and Renal Involvement in Bogotá, Colombia, Between 2012 and 2023.",Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;Kidney Diseases,ANCA-Associated Vasculitis;Kidney Disease,,,,,,,,
807,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Assessing Safety and Efficacy of Kidney Biopsy by Nephrologists in Patients with Severely impaired Glomerular Filtration Rate,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
808,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Histological changes and a3ß1 Integrin and MMP-1 expressions in early Fabry Nephropathy in female patients,Nephropathy,Early Onset Fabry Nephropathy,,,,,,Early Onset,,
809,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Three years of avacopan treatment in patients with ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Avacopan,,,C5a Receptor-Inhibitor,,,,
810,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Use of avacopan-based therapy among adults with severe active ANCA-associated vasculitis (AAV): a cross-sectional survey of physicians in Germany and the UK,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Adult Severe ANCA-Associated Vasculitis,Avacopan,,,C5a Receptor-Inhibitor,,Adult;Severe,,
811,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Reduced Cumulative Glucocorticoid Toxicity in Patients with Minimal Change Disease Treated with Lower Dose Prednisolone and Activated Vitamin D: Results from the ADAPT Trial,Minimal Change Disease,Minimal Change Disease,Prednisolone;Vitamin D,,,Glucocorticoid;Vitamin Supplement,,,ADAPT;;NCT03210688,
812,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Long term survival and predictors of all-cause mortality in a Swedish cohort of patients with ANCA-associated vasculitis and kidney involvement,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;Kidney Diseases,ANCA-Associated Vasculitis;Kidney Disease,,,,,,,,
813,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Long-term Observational Study of Interstitial Lung Disease in ANCA-associated Vasculitis: European Multicentre study,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;Interstitial Lung Disease,ANCA-Associated Vasculitis;Interstitial Lung Disease,,,,,,,,
814,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Rare Presentation of a B-cell Lymphoproliferative Disorder with Renal AL Amyloidosis: A Case Study,Light-Chain Amyloidosis;Lymphoproliferative Disorder,B-Cell Lymphoproliferative Disorder;Renal AL Amyloidosis,,,,,,,,
815,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Waldenström macroglobulinemia-associated nephropathy: an unusual presentation,Nephropathy;Waldenstrom Macroglobulinemia,Nephropathy;Waldenström Macroglobulinemia,,,,,,,,
816,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Clinicopathological characteristics and predictors of survival and renal function in pulmonary-renal syndrome: A Single-Center experience,Pulmonary-Renal Syndrome,Pulmonary Renal Syndrome,,,,,,,,
817,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,A cluster analysis of a monocentric cohort of ANCA Vasculitis: implications on induction – maintenance therapeutic strategies and role of repeat renal biopsy,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
818,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Impact of HALP Score on Renal Prognosis in IgA Nephropathy,IgA Nephropathy,IgA Nephropathy,,,,,,,,
819,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Atypical haemolytic uremic syndrome in children: the 13-year experience of a tertiary paediatric center,Atypical Hemolytic-Uremic Syndrome,Childhood Atypical Hemolytic Uremic Syndrome,,,,,,Childhood,,
820,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Rosuvastatin Induced Acute Kidney Injury – A Case Report,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
821,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Obinutuzumab in rituximab-intolerant ANCA-associated vasculitis patients,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,Obinutuzumab,,,CD20-Targeted Therapy,,,,
822,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Fair skin at the cost of Kidney health! Case report of a young female with Membranous nephropathy,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
823,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"The ""Hairy"" Truth: A Rare Clue in CKD",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
824,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Clinical, Histological Characteristics, and Evolution of Fibrillary Glomerulonephritis in a Spanish Cohort.",Fibrillary Glomerulonephritis,Fibrillary Glomerulonephritis,,,,,,,,
825,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Rituximab in Minimal Change Disease: Reducing Hospitalizations and Steroid Use,Minimal Change Disease,Minimal Change Disease,Rituximab,,,CD20-Targeted Monoclonal Antibody;Steroid,,,,
826,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Predictors of Treatment Response in Lupus Nephritis: An Observational Analysis,Lupus Nephritis,Lupus Nephritis,,,,,,,,
827,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The Incidence of Biopsy-Proven Glomerulonephritis in the Republic of North Macedonia: A Five-Year Follow-Up,Glomerulonephritis,Glomerulonephritis,,,,,,,,
828,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,A rare case of Kallmann Syndrome combined with Primary Membranous Nephropathy,Kallmann Syndrome;Primary Membranous Nephropathy,Kallmann Syndrome;Primary Membranous Nephropathy,,,,,,,,
829,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,A New GN on the Block? Case of Unknown Glomerular Disease with Organized Deposits in a 76 Year Old Filipino Male,Glomerular Disease,Elderly Glomerular Disease,,,,,,Elderly,,
830,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Long-term Telitacicept Treatment for  Primary IgA nephropathy: Analysis of Five Cases,Nephritis,Primary IgA Nephritis,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
831,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Fifteen-year follow-up of outcomes of patients treated for membranous nephropathy,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
832,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Clinico-pathologic classification of focal segmental glomerulosclerosis to inform on treatment and prognosis,Focal Segmental Glomerulosclerosis,Focal Segmental Glomerulosclerosis,,,,,,,,
833,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Sex-based differences in glomerular lesions linked to intrarenal lipid accumulation.,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
834,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Sparsentan reduces glomerular dysfunction and proteinuria in a rat model of serum-factor-induced nephrotic syndrome,Nephrosis,Glomerular Dysfunction;Serum Factor-Induced Nephrotic Syndrome,Sparsentan,,,Endothelin Receptor-Antagonist,,,,
835,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Low Body Mass Index as Risk Factor for Complications Post- Percutaneous Kidney Biopsy,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
836,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Effects of SARS-CoV2 mRNA vaccine on human kidney tubular epithelial cells,Coronavirus Infection,COVID-19,SARS-CoV-2 mRNA Vaccine,,,mRNA Vaccine,,,,
837,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Tubuloreticular Inclusions in native kidney biopsies and recurrence after transplantation,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
838,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Serotonin receptor HTR2A drives parietal epithelial cell activation in glomerular disease downstream of platelet activation,Glomerular Disease,Glomerular Disease,,,,,,,,
839,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The Role of Neutrophil Extracellular Traps in the Pathogenesis of Tubular Damage in Primary Sjögren's Syndrome,Primary Sjogren Syndrome,Primary Sjögren's Syndrome,,,,,,,,
840,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Decoding Stromal Remodeling Associated with the Anti-Fibrotic Effects of a Ketogenic Diet at Single-Cell Resolution,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
841,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Case report of a granulomatous interstitial nephritis in chronic lymphocytic leukemia,Chronic Lymphocytic Leukemia;Interstitial Nephritis,Chronic Lymphocytic Leukemia;Granulomatous Interstitial Nephritis,,,,,,,,
842,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The Importance of the Japanese Classification System for Predicting Renal Prognosis in Chinese Patients with Histologically Confirmed Diabetic Kidney Disease,Diabetes;Diabetic Nephropathy,Diabetes;Diabetic Nephropathy,,,,,,,,
843,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Evaluating the Safety and Impact of Kidney Biopsy in Elderly Patients,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
844,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Alpost syndrome in genes, or Alpost syndrome on biopsy. That is the question",,Alpost Syndrome,,,,,,,,
845,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Correlation of GBP2 Expression with Histopathological and Clinical Findings in Prevalent Glomerulopathies,Glomerulopathy,GBP2 Expressing Glomerulopathy,,,,,,,,
846,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,"Sarcopenia-related Markers Derived from Creatinine and Cystatin C, GDF-15 and Adverse Outcomes in People with Diabetes",Diabetes;Sarcopenia,Diabetes;Sarcopenia,,,,,,,,
847,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,The inverse relationship of pulse pressure to LDL cholesterol in patients with type II diabetes and CKM (cardio kidney metabolic) disease,Type 2 Diabetes,Cardi-Kidney Metabolic Disease;Type 2 Diabetes,,,,,,,,
848,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Non-Proteinuric Kidney Disease and Type II Diabetes: CKM (Cardio Kidney Metabolic) Parameters and Current Recommended Treatment Modalities,Diabetes;Hypertension;Kidney Diseases,Diabetes;Hypertension;Non-Proteinuric Kidney Disease,,,,,,,,
849,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Emphysematous pyelonephritis: experience in a tertiary care hospital of Bangladesh,Pyelonephritis,Emphysematous Pyelonephritis,,,,,,,,
850,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Blood pressure variability in CKD patients with and without nocturnal hypertension.,Chronic Kidney Disease;Hypertension,Chronic Kidney Disease;Nocturnal Hypertension,,,,,,,,
851,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Renal biopsy in diabetic patients – 25 years of a single center experience,Diabetes,Diabetes,,,,,,,,
852,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Study Of Rational Nutrition And Specific Features Of The Diet Table In The Elderly With Cardiovascular Diseases,Cardiovascular Disease;Hypertension,Cardiovascular Disease;Hypertension,,,,,,,,
853,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Dyslipidemia and Statin use in diabetec patients with chronic kidney disease (TUNCKDD Survey),Chronic Kidney Disease;Diabetes,Chronic Kidney Disease;Diabetes,,,,,,,,
854,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Association Between Glycated Hemoglobin and Elevated Urinary Albumin-to-Creatinine Ratio: A Cross-sectional Analysis,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
855,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,The role of Renal Functional Reserve in eGFR decline over 2 years in hypertensives and normotensives with preserved renal function,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
856,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Age-specific relationship between Insulin Resistance and Obesity : A Machine Learning-Based Interpretation     Machine Learning-Based Interpretation,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
857,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Arterial Stiffness In Children And Adolescents With Type 1 Diabetes Mellitus And Excess Weight. A Cross-Sectional Study.,Type 1 Diabetes;Type 2 Diabetes,Adolescent Type I Diabetes;Childhood Type II Diabetes,,,,,,Adolescent;Childhood,,
858,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,The Role of Coronary Artery Calcification in Advanced Cardio-Kidney-Metabolic Syndrome Staging: Beyond Diabetes and Hypertension,Diabetes;Hypertension;Metabolic Syndrome,Advanced Cardio-Kidney-Metabolic Syndrome;Diabetes;Hypertension,,,,,,Advanced,,
859,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Podometric Findings in Arterial Hypertension and Diabetes Mellitus Type 2,Arterial Hypertension;Type 2 Diabetes,Arterial Hypertension;Diabetes Mellitus Type II,,,,,,,,
860,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Not Everything Is Diabetic Nephropathy. Analysis Of Kidney Biopsies In Type 2 Diabetic Patients On A 15-Year-Old Cohort,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,,,,
861,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,"Analyzing and Monitoring Cardiometabolic Data in Adolescent Patients with Type 1 Diabetes and Hypertension Using Wearable Technology in Mathura City, India",Hypertension;Type 1 Diabetes,Adolescent Type I Diabetes;Hypertension,,,,,,Adolescent,,
862,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Age Stratified Prevalence of Hypertension and Associated Cardio-Renal Risk Factors Among Subjects Residing in a Rural Community of Bangladesh,Cardiovascular Disease;Diabetes,Cardiovascular Disease;Diabetes,,,,,,,,
863,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Early to mid pregnancy renal parameters and adverse pregnancy outcomes in women with early stage chronic kidney disease,Chronic Kidney Disease,Early Stage Chronic Kidney Disease,,,,,,Early-Stage,,
864,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Primary Hypertension: First Cause Of Thrombotic Microangiopathy In Patients With Malignant Hypertension,Malignant Hypertension;Thrombotic Microangiopathy,Malignant Hypertension;Thrombotic Microangiopathy,,,,,,,,
865,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Spanish Plan For Hypertensive Disorders In The Puerperium: Zero Vascular And Renal Risk,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
866,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Pregnancy Outcomes In Chronic Hypertensive Patients With Superimposed Preeclampsia: A Nephrology Outpatient Experience.,Hypertension;Pre-Eclampsia,Chronic Hypertension;Preeclampsia,,,,,,,,
867,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Investigation of aldosterone breakthrough phenomenon after administration of angiotensin receptor neprilysin inhibitor (ARNI),Diabetes;Hypertension,Diabetes;Hypertension,,,,Angiotensin Receptor Neprilysin Inhibitor,,,,
868,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Renoprotective effects of dipeptidyl peptidase-4 inhibitors in diabetic kidney disease: A meta-analysis of randomized controlled trials,Diabetic Nephropathy,Diabetic Kidney Disease,,,,DPP-4 Inhibitor,,,,
869,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Hyperaldosteronemia and increased interleukin-6 as a cardiovascular risk factors in hemodialysis patients and kidney transplant recipients,Renal Failure,Hyperaldosteronemia;Kidney Failure,,,,,,,,
870,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Effect of Roxadustat on Anemia and Renal Function in Patients with Diabetic Kidney Disease,Anemia;Diabetes,Anemia;Diabetes,Roxadustat,,,HIF PH-Inhibitor,,,,
871,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Analysis of relationship between the glomerular filtration rate and temporal parameters of heart rate variability in comorbid patients with chronic kidney disease and type 2 diabetes mellitus.,Chronic Kidney Disease;Type 2 Diabetes,Chronic Kidney Disease;Type 2 Diabetes Mellitus,,,,,,,,
872,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Rehabilitation Of Patients After Myocardial Infarction,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
873,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Study of the role of biomarkers of the renin-angiotensin-aldosterone system activity in the pathogenesis of cardiorenal pathology in patients with arterial hypertension,Arterial Hypertension,Arterial Hypertension,,,,,,,,
874,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Efficiency Of Outpatient Treatment Of Patients With Arterial Hypertension By Introducing Electronic Document Management,Arterial Hypertension,Arterial Hypertension,,,,,,,,
875,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Organization Of Rational Regional Assistance To Patients With Type 2 Diabetes Mellitus With Nephrological Complications,Type 2 Diabetes,Type 2 Diabetes Mellitus,,,,,,,,
876,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Evaluation Of The Effect Of Mirabegron On Blood Pressure And Kidney Function Tests  In Oak Vale Medical Center Patients-Liverpool-Uk,Diabetes;Hypertension,Diabetes;Hypertension,Mirabegron,,,Beta 3 Adrenergic-Agonist,,,,
877,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Estimation of sodium intake can be improved by correcting 24-hour urinary sodium for  24-hour urine volume,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
878,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Higher dietary potassium intake and a lower dietary Na/K ratio are associated with a lower incidence of new-onset hypertension.,Hypertension,New Onset Hypertension,,,,,,,,
879,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,1024X768 Effect Of Sglt-2 Inhibitors On Ambulatory Blood Pressure In Patients With Type 2 Diabetes: An Updated Meta-Analysis Of Randomized Controlled Trials,Type 2 Diabetes,Type 2 Diabetes,,,,SGLT2-Inhibitor,,,,
880,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Fine with finerenone in Croatia –advancing renal care for our diabetic chronic kidney disease patients,Chronic Kidney Disease,Diabetic Chronic Kidney Disease,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,,
881,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,It is possible to predict the clinical course of chronic kidney disease in patients with type 2 diabetes: the significance of selected biomarkers.,Chronic Kidney Disease;Type 2 Diabetes,Chronic Kidney Disease;Type 2 Diabetes,,,,,,,,
882,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Long-term effects of Renal Denervation in Arterial Hypertension: A Systematic Review and Meta-analysis.,Arterial Hypertension,Arterial Hypertension,,,,,,,,
883,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Orthostatic Blood Pressure Reduction is Associated with Renal Organ Damage in Fit Elderly Patients with Arterial Hypertension,Arterial Hypertension,Elderly Arterial Hypertension,,,,,,Elderly,,
884,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,The Effects of Dapagliflozin on Renal Outcomes in Diabetes Mellitus Type II - A Systematic Review & Meta-Analysis,Type 2 Diabetes,Type 2 Diabetes Mellitus,Dapagliflozin,,,SGLT2-Inhibitor,,,,
885,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Urinary Albumin-to-Creatinine Ratio as a Biomarker for Predicting Coronary Artery Disease Severity,Coronary Artery Disease,Coronary Artery Disease,,,,,,,,
886,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Euglycemic diabetic ketoacidosis associated with the use of sodium-glucose cotransporter 2 inhibitors: a case series,Diabetes;Hypertension,Diabetes;Hypertension,,,,SGLT2-Inhibitor,,,,
887,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Differences between in-office and Ambulatory Blood Pressure Monitoring (ABPM) for cardiovascular risk stratification in a cohort of hypertensive patients.,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
888,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,The role of integrin a3ß1 in the development of morphological changes in renal tissue  in patients with diabetic nephropathy,Diabetic Nephropathy,Diabetic Nephropathy,,,,,,,,
889,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Klotho supplementation reverses senescence in aldosterone-salt hypertension,Hypertension,Aldosterone-Sodium Hypertension,,,,,,,,
890,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Hyperuricemia induces hypertension and kidney injury via endoplasmic reticulum stress,Hyperuricemia,Hyperuricemia;Kidney Injury,,,,,,,,
891,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Blood pressure modulation through altered Epithelial Sodium Channel (ENaC) expression induced by microbiome exchange between Milan normotensive and hypertensive rat strains,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
892,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Targeting N-Acetyltransferase 10 with Remodelin Ameliorates Renal Oxidative Stress in Diabetic Mice,Diabetes,Diabetes;Renal Oxidative Stress,Remodelin,,,N Acetyltransferase10-Inhibitor,,,,
893,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Inflammatory mediators predicting eGFR loss in diabetic kidney disease,Diabetic Nephropathy,Diabetic Kidney Disease,,,,,,,,
894,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,FTO-mediated m6A demethylation inhibits the senescence of renal endothelial cells in diabetic nephropathy,Diabetic Nephropathy,Diabetic Nephropathy,,,,,,,,
895,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Exploration of Cagrilintide’s Mechanism of Action in the Kidney,Diabetes;Hypertension,Diabetes;Hypertension,Cagrilintide,,,Amylin-Analog,,,,
896,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Gut derived metabolites as biomarkers of inflammation in incipient diabetic kidney disease,Diabetic Nephropathy,Diabetic Kidney Disease,,,,,,,,
897,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Renal AhR controls blood pressure regulation and cysteine metabolism in an in vivo model of Obstructive Sleep Apnea,Obstructive Sleep Apnea,Obstructive Sleep Apnea,,,,,,,,
898,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Unveiling Hesperidin: A Promising Agent for Managing Hypertension and Enhancing kidney Function in Rat Models,Diabetes;Hypertension,Diabetes;Hypertension,Hesperidin,,,Antioxidant,,,,
899,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Exercise Intensity and the Risk of End-Stage Renal Disease in Diabetes: A Nationwide Population-Based Study,Diabetes;End-Stage Renal Disease,Diabetes;End Stage Renal Disease,,,,,,,,
900,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,?Serum Ketone Bodies and Risk of Progression of Diabetic Kidney Disease to End-stage Renal Disease in Patients with Type 2 Diabetes Mellitus: A multi-cohort longitudinal study.??????,Diabetes;Diabetic Nephropathy;End-Stage Renal Disease,Diabetes;End Stage Renal Disease;Progressive Diabetic Kidney Disease,,,,,,Progressive,,
901,Not Relevant,Hypertension & Diabetes,Moderated e-Poster,Renal function determined by creatinine and cystatin C levels in patients with essential arterial hypertension and premature beats,Arterial Hypertension,Essential Arterial Hypertension,,,,,,,,
902,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Health inequalities and outcomes following acute kidney injury: a systematic review & meta-analyses of observational studies,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
903,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Neutrophil Gelatinase-Associated Lipocalin (NGAL) for the assessment of persistent renal dysfunction after acute kidney injury,Acute Kidney Injury;RenaL Dysfunction,Acute Kidney Injury;Persistent Renal Dysfunction,,,,,,Persistent,,
904,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Is Acute Hemodialysis Precluded in the Oldest-Old Patients?,Acute Kidney Injury;Renal Failure,Acute Kidney Injury;Kidney Failure,,,,,,,,
905,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Audit of the Clinical Implementation of Urinary NGAL in the Diagnostic Work-up of Acute Kidney Injury at an Irish Hospital,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
906,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Acute Kidney Injury in Acute Heart Failure patients undergoing aggressive diuresis and its impact on short term outcome,Acute Kidney Injury;Heart Failure,Acute Kidney Injury;Heart Failure,,,,,,,,
907,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Kidney injury post Covid-19 - a nationwide Swedish register study,Coronavirus Infection,COVID-19;Kidney Injury,,,,,,,,
908,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Prognostic value of changes in the serum indoxyl sulfate concentration in septic-shock-associated AKI: the Tox-AKI cohort study.,Acute Kidney Injury,Severe Acute Kidney Injury,,,,,,Severe,NCT03920982;;Tox-AKI,
909,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,"Acute Kidney Injury in the Very Elderly: Evolving Times, Evolving Epidemiology in an aging society",Acute Kidney Injury,Elderly Acute Kidney Injury,,,,,,Elderly,,
910,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Malaria is the leading cause of Acute Kidney Injury in paediatric patients in Nigeria.  Evidence from a Point-of-Care Creatinine Study in a Nigerian Primary Health Care Centre,Acute Kidney Injury;Malaria,Acute Kidney Injury;Paediatric Malaria,,,,,,Paediatric,,
911,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Kidney involvement in severe Legionnaire's disease in intensive care,Legionella Pneumophila Infection,Severe Legionnaires' Disease,,,,,,Severe,,
912,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Association between baseline serum creatinine/cystatin C (SCr/CYS) ratio and adverse events in patients receiving cisplatin or carboplatin: a prospective cohort study,Acute Kidney Injury,Acute Kidney Injury,Carboplatin;Cisplatin,,,Alkylating Agent,,,,
913,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Association between new-onset proteinuria during hospitalization and cardiovascular mortality among patients with atherosclerotic cardiovascular disease,Atherosclerosis,Atherosclerotic Cardiovascular Disease,,,,,,,,
914,Not Relevant,Chronic kidney disease,Focussed Oral,Features Of Post-Covid Kidney Damage In Children,Chronic Kidney Disease;Coronavirus Infection,Childhood COVID-19;Chronic Kidney Disease,,,,,,Childhood,,
915,Not Relevant,Chronic kidney disease,Focussed Oral,PF4 derived from endothelial cells induces vascular smooth muscle cells calcification via the CXCR3-PERK signaling,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
916,Not Relevant,Chronic kidney disease,Focussed Oral,Metabolic Dysfunction-Associated Fatty Liver Disease In Advanced Chronic Kidney Disease: Impact On Patient Survival.,Chronic Kidney Disease,Advanced Chronic Kidney Disease;Metabolic Dysfunction,,,,,,Advanced,,
917,Not Relevant,Chronic kidney disease,Focussed Oral,Progression of Cardiac Remodelling and Dysfunction is accompanied by altered metabolic profile in Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
918,Not Relevant,Chronic kidney disease,Focussed Oral,Serum Zinc Concentration and Long-Term Mortality in CKD Patients: Insights from NHANES (2011-2016),Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
919,Not Relevant,Chronic kidney disease,Focussed Oral,Serum Resistin and Other Predictors of CIMT and Cardiovascular Events in Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
920,Not Relevant,Chronic kidney disease,Focussed Oral,Prognostic Value of N-terminal Prohormone B-type Natriuretic Peptide Modified by Renal Function in Patients with Acute Heart Failure,Heart Failure,Acute Heart Failure,,,,,,,,
921,Not Relevant,Chronic kidney disease,Focussed Oral,Exploratory study on bone microarchitecture in post-mortem specimens of various skeletal sites from dialysis-dependent patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
922,Not Relevant,Chronic kidney disease,Focussed Oral,Promising Anemia Related Inhibitors of Vascular Calcification in Chronic Kidney Disease. Data from Systematic Review.,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,,,,,
923,Not Relevant,Chronic kidney disease,Focussed Oral,Prognostic Significance Of Coronary Artery Calcification And Epicardial Fat In Polymorbid Patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
924,Not Relevant,Chronic kidney disease,Focussed Oral,Homocitrulline is associated with cardiovascular outcomes in non-dialysis patients with chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
925,Not Relevant,E-Posters,e-Poster,Kidney function and the metabolome in the general population,,,,,,,,,,
926,Not Relevant,Chronic kidney disease,Focussed Oral,Gender disparities in CKD before and after referral to nephrology,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
927,Not Relevant,Chronic kidney disease,Focussed Oral,Unraveling the Biology of Adversity: Proteomic and Metabolomic Insights into Socioeconomic Disparities in Kidney Disease,Kidney Diseases,Kidney Disease,,,,,,,,
928,Not Relevant,Chronic kidney disease,Focussed Oral,Improving and personalizing nephrology care with the use of outcome data: examples of national and regional initiatives in the Netherlands.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
929,Not Relevant,Chronic kidney disease,Focussed Oral,Sex-specific temporal relationship between common comorbidity patterns and subsequent risk of chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
930,Not Relevant,Chronic kidney disease,Focussed Oral,Discordant results between creatinine- and cystatin C-based equations for estimating glomerular filtration rate: the equation matters,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
931,Not Relevant,Chronic kidney disease,Focussed Oral,Disease trajectory leading to cause of death among patients with chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
932,Not Relevant,Chronic kidney disease,Focussed Oral,Genetic screens of imaging-derived kidney volumes identify genes linked to kidney function,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
933,Not Relevant,Chronic kidney disease,Focussed Oral,"Risk of end-stage kidney disease, death and suicide attempts in men and women with migraine treated with topiramate",Kidney Diseases;Migraine,End Stage Kidney Disease;Migraine,Topiramate,,,Anticonvulsant,, End Stage,,
934,Not Relevant,Chronic kidney disease,Focussed Oral,Evaluating the Impact of AI-Driven Interventions on Hospital Admissions in End-Stage Kidney Disease (ESKD) Patients  Using Medicare and EMR Data.,Kidney Diseases,End Stage Kidney Disease,,,,,, End Stage,,
935,Not Relevant,Chronic kidney disease,Focussed Oral,Baseline analysis of the patterns of CKD care in an Implementation Trial using Future Health Today in Primary Care,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
936,Not Relevant,Chronic kidney disease,Focussed Oral,Management and Treatment of Chronic Kidney Disease in the Danish Lolland-Falster Health Study: Focus on Renoprotection and Cardiovascular Disease Prevention,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
937,Not Relevant,Creative Labs II - How to use stories/narratives to improve scientific communication,Symposium,How to use stories/narratives to improve scientific communication,,,,,,,,,,
938,Not Relevant,Cutting-Edge Clinical Trials and Future Perspectives in Nephrology,Symposium,Cutting-Edge Clinical Trials and Future Perspectives in Nephrology,,,,,,,,,,
939,Not Relevant,Dialysis,Focussed Oral,Projections of infection-related cost savings associated with treating CKD associated pruritus (CKD-aP) with difelikefalin in five European countries through the combination of clinical trial data and real-world evidence,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,Difelikefalin,,,Kappa Opioid Receptor-Agonist,,,,
940,Not Relevant,Dialysis,Focussed Oral,External validation of existing mortality prediction models for patients entering kidney replacement therapy,Renal Failure,Kidney Failure,,,,,,,,
941,Not Relevant,Dialysis,Focussed Oral,Physical Performance Outperforms Uremic Toxins in Predicting 10-Year Mortality in Dialysis Patients,Renal Failure,Kidney Failure,,,,,Fresenius,,,
942,Not Relevant,Dialysis,Focussed Oral,Dynamic impact of the COVID-19 pandemic on Health-related Quality of Life and Symptom Burden in Dutch Dialysis patients,Coronavirus Infection;Renal Failure,COVID-19;Kidney Failure,,,,,,,,
943,Not Relevant,Dialysis,Focussed Oral,Dialysate bicarbonate concentration is associated with an increased risk of cardiac arrhythmias in individuals receiving haemodialysis: results from a Danish multicentre cohort study (the CADDY study),Arrhythmia;Renal Failure,Cardiac Arrhythmia;Kidney Failure,,,,,,,CADDY;;NCT04841304,
944,Not Relevant,Dialysis,Focussed Oral,Health status in different subgroups of people receiving hemodiafiltration versus hemodialysis for renal replacement therapy: a subgroup analysis of the CONVINCE randomized controlled trial,Renal Failure,Kidney Failure,,,,,,,CONVINCE;;NTR7138,
945,Not Relevant,Dialysis,Focussed Oral,“Six hours per day” sedentarism: a strong risk factor in dialysis patients,Renal Failure,Kidney Failure,,,,,Fresenius,,,
946,Not Relevant,Dialysis,Focussed Oral,Arterial oxygen saturation trajectory during hemodialysis: an indication of bio-incompatibility?,Renal Failure,Kidney Failure,,,,,,,,
947,Not Relevant,Dialysis,Focussed Oral,Green Dialysis? Identifying Carbon Footprint Hotspots in a Hemodialysis Center in Poland,Renal Failure,Kidney Failure,,,,,,,,
948,Not Relevant,Dialysis,Focussed Oral,Recognition Of End Of Life In Patients With Chronic Hemodialysis In Lazio And Use Of Paliative Care: A Registry Study,Renal Failure,Kidney Failure,,,,,,,,
949,Not Relevant,Dialysis,Focussed Oral,"Non-Conventional Nutritional Parameters, Including Adipokines and Extracellular Water (ECW), in the First Three Years following Renal Replacement Therapy (RRT): Association with Long-Term Mortality in an End Stage Kidney Disease (ESKD) Cohort",Kidney Diseases,End Stage Kidney Disease,,,,,, End Stage,,
950,Not Relevant,Dialysis,Focussed Oral,Predicting Mortality in Unplanned Hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
951,Not Relevant,Dialysis,Focussed Oral,Comparison of Survival Between Hemodialysis and Peritoneal Dialysis in Patients Aged =80 Years: A Propensity Score Matched Analysis of a large Catalonia Registry cohort.,Renal Failure,Kidney Failure,,,,,,,,
952,Not Relevant,Dialysis,Focussed Oral,A Bleeding Concern: Incidence of Major Gastrointestinal Bleeding in Dialysis,Renal Failure,Kidney Failure,,,,,,,,
953,Not Relevant,Dialysis,Focussed Oral,"“When it’s bad, it can be debilitating”. A mixed-methods analysis of Chronic Kidney Disease Associated Pruritus in Irish dialysis patients",Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,,,,,,,,
954,Not Relevant,Dialysis,Focussed Oral,Development and External Validation of a Machine Learning Model for Cardiac Valve Calcification Early Screening in Dialysis Patients: A Multicenter Study,Renal Failure,Kidney Failure,,,,,,,,
955,Not Relevant,Dialysis,Focussed Oral,"The ameliorative effects of oral tacrolimus on treatment-resistant pruritus through interleukin 13 signaling pathways in hemodialysis patients: A double-blind, randomized, placebo-controlled trial",Pruritus;Renal Failure,Kidney Failure;Pruritus,Tacrolimus,,,Calcineurin-Inhibitor,,,,
956,Not Relevant,Dialysis,Focussed Oral,Nutritional issues among  hemodialysis patients - Deficiency and Excess Body Mass,Renal Failure,Kidney Failure,,,,,,,,
957,Not Relevant,Dialysis,Focussed Oral,Comparative analysis of blood metals and trace elements in Egyptian hemodialysis patients and their relatives in the same geographical area,Renal Failure,Kidney Failure,,,,,,,,
958,Not Relevant,Dialysis,Focussed Oral,Association of physical function and fear of falling with the number of falls over a 12-month period in patients on hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
959,Not Relevant,Dialysis,Focussed Oral,Association of physical function with chronic pain and sleep quality in patients on hemodialysis,Renal Failure,Chronic Pain;Kidney Failure,,,,,,,,
960,Not Relevant,Dialysis,Focussed Oral,Management of Resistant Hyperphosphatemia in Maintenance Hemodialysis (MHD) patients - Role of Sucroferric Oxyhydroxide (SFO): A prospective study,Hyperphosphatemia;Renal Failure,Kidney Failure;Resistant Hyperphosphatemia,Sucroferric Oxyhydroxide,,,Phosphate-Binder,,,,
961,Not Relevant,Dialysis,Focussed Oral,Effect of Bisphenols on Genomic Damage in Patients with Chronic Kidney Disease on Hemodialysis,Chronic Kidney Disease;Renal Failure,Chronic Kidney Disease;Kidney Failure,,,,,,,,
962,Not Relevant,Dialysis,Focussed Oral,Study Of Intradialysis Physical Activity And Quality Of Life In Patients On Hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
963,Not Relevant,Dialysis,Focussed Oral,"Development of Depression and Anxiety Symptoms in Chronic Hemodialysis Patients During ""Sward of Iron"" War",Chronic Kidney Disease,Chronic Kidney Failure,,,,,,,,
964,Not Relevant,Effect of AKI and other Organs,Symposium,AKI and ARDS,Acute Kidney Injury;Acute Respiratory Distress,Acute Kidney Injury;Acute Respiratory Distress Syndrome,,,,,,,,
965,Not Relevant,Effect of AKI and other Organs,Symposium,AKI and Cardiogenic shock,Acute Kidney Injury;Cardiogenic Shock,Acute Kidney Injury;Cardiogenic Shock,,,,,,,,
966,Not Relevant,Effect of AKI and other Organs,Symposium,AKI and distant organ dysfunction,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
967,Not Relevant,FC 3: Hemodialysis: Epidemiological Insights,Free Communication,Prevalence and Patterns of Intradialytic Arterial Oxygen Saturation Instability: Observations in a Large U.S. Hemodialysis Cohort,Renal Failure,Kidney Failure,,,,,,,,
968,Not Relevant,FC 3: Hemodialysis: Epidemiological Insights,Free Communication,Which patients benefit most from hemodiafiltration compared with hemodialysis: prediction of the individualized treatment effects,Renal Failure,Kidney Failure,,,,,,,,
969,Not Relevant,FC 3: Hemodialysis: Epidemiological Insights,Free Communication,Delivered Hemodialysis Treatment Time and Mortality Risk: A Retrospective Analysis,Renal Failure,Kidney Failure,,,,,,,,
970,Not Relevant,FC 3: Hemodialysis: Epidemiological Insights,Free Communication,Analysis of Characteristics of Blood Glucose Fluctuations and Risk Factors for Hypoglycemia in Older Adult Patients with Diabetes Undergoing Maintenance Hemodialysis: A Multicenter Observational Study,Hypoglycemia;Renal Failure,Elderly Diabetic Kidney Failure;Hypoglycemia,,,,,,Elderly,,
971,Not Relevant,FC 3: Hemodialysis: Epidemiological Insights,Free Communication,Associations Between Sodium Gradients and All-Cause Mortality in Maintenance Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
972,Not Relevant,FC 3: Hemodialysis: Epidemiological Insights,Free Communication,Impact of Phase Angle on Mortality in Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
973,Not Relevant,FC 4: The Basics of Acute Kidney Injury,Free Communication,Flow-cytometric quantification of urine kidney epithelial cells specifically reflects tubular damage in acute kidney diseases,Kidney Diseases,Acute Kidney Disease,,,,,,,,
974,Not Relevant,FC 4: The Basics of Acute Kidney Injury,Free Communication,Urinary CXCL9 in immune checkpoint inhibitor-associated acute interstitial nephritis (ICI-AIN),Acute Tubulo-Interstitial Nephritis,Acute Interstitial Nephritis,,,,,,,,
975,Not Relevant,FC 4: The Basics of Acute Kidney Injury,Free Communication,Ti@Mn Nanozymes as Nanotherapeutic Agents for ROS Scavenging and Inflammation Reduction in Acute Kidney Injury,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
976,Not Relevant,FC 4: The Basics of Acute Kidney Injury,Free Communication,Autophagy-associated FIP200 protects renal tubules against apoptosis following renal ischemia-reperfusion injury,Ischemia,Renal Ischemia-Reperfusion Injury,,,,,,,,
977,Not Relevant,FC 4: The Basics of Acute Kidney Injury,Free Communication,"Pharmacokinetics, Pharmacodynamics and Safety of TIN816 in Patients With Sepsis-Associated Acute Kidney Injury: Results From a Randomized Phase 2a Study",Acute Kidney Injury;Sepsis,Acute Kidney Injury;Sepsis,TIN-816,,,Enzyme Replacement,,,,
978,Not Relevant,FC 4: The Basics of Acute Kidney Injury,Free Communication,Examining variations in adherence to guideline-recommended post-acute kidney injury care in UK primary care,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
979,Not Relevant,FC 5: About ANCA and SLE Associated Glomerulonephritis,Free Communication,"Early-onset Lupus Nephritis: insights into clinical, laboratory and prognostic characteristics of monogenic forms",Lupus Nephritis,Early Onset Lupus Nephritis,,,,,,Early Onset,,
980,Not Relevant,FC 5: About ANCA and SLE Associated Glomerulonephritis,Free Communication,Predictors and long-term impact of sustained complete renal response in lupus nephritis patients over a 10-year follow up,Lupus Nephritis,Lupus Nephritis,,,,,,,,
981,Not Relevant,FC 5: About ANCA and SLE Associated Glomerulonephritis,Free Communication,Persistent Isolated Low C3 (PILC3) predicts long-term eGFR decline in lupus nephritis: a linear projection of total eGFR slopes from BLISS-LN trial data.,Lupus Nephritis,Lupus Nephritis,,,,,GlaxoSmithKline;Human Genome Sciences,,BLISS-LN;;NCT01639339,
982,Not Relevant,FC 5: About ANCA and SLE Associated Glomerulonephritis,Free Communication,Baseline C3 levels improves the predictive capacity of ANCA kidney risk score in patients with ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
983,Not Relevant,FC 5: About ANCA and SLE Associated Glomerulonephritis,Free Communication,3-months short course of avacopan in ANCA vasculitis with severe clinical involvement. A real-life experience.,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,Avacopan,,,C5a Receptor-Inhibitor,,,,
984,Not Relevant,FC 5: About ANCA and SLE Associated Glomerulonephritis,Free Communication,"Quality, power and fragility of randomised controlled trials in ANCA-associated vasculitis",Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
985,Not Relevant,FC 6: Kidney Transplantation: Epidemiological Insights,Free Communication,Integrating Pathomic and Clinical Data from Kidney Deceased Donors to Enhance Graft Function Prediction and Reduce Organ Discard: The ComPRePS Assessment Tool,,,,,,,,,,
986,Not Relevant,FC 6: Kidney Transplantation: Epidemiological Insights,Free Communication,Access to waitlisting & kidney transplantation for patients with incident kidney failure in Australia and the United Kingdom – a binational comparative analysis,Renal Failure,Kidney Failure,,,,,,,,
987,Not Relevant,FC 6: Kidney Transplantation: Epidemiological Insights,Free Communication,Is Living Kidney Donation with Expanded Criteria Safe for the Donor? Long-Term Follow-Up from the Catalan Registry,,,,,,,,,,
988,Not Relevant,FC 6: Kidney Transplantation: Epidemiological Insights,Free Communication,Trends in all-cause and cause-specific mortality in adult first kidney transplant recipients with and without diabetes as cause of kidney failure: an ERA Registry study,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,,,,
989,Low,FC 6: Kidney Transplantation: Epidemiological Insights,Free Communication,Recurrence of IgA nephropathy in a large multicenter cohort of kidney transplant recipients (DIVAT),IgA Nephropathy,Recurrent IgA Nephropathy,,,,,,Recurrent,,
990,Not Relevant,FC 6: Kidney Transplantation: Epidemiological Insights,Free Communication,Changes in Cerebral Blood Flow and Cognitive Function Before and One Year After Kidney Transplantation: The VINTAGE Study,,,,,,,,,VINTAGE,
991,Not Relevant,FC 7: CKD and Public Health: Part 2,Free Communication,"Frailty, Sarcopenia and Mortality Risk in Patients with Chronic Kidney Disease: A Nationally Representative Analysis",Chronic Kidney Disease;Sarcopenia,Chronic Kidney Disease;Sarcopenia,,,,,,,,
992,Not Relevant,FC 7: CKD and Public Health: Part 2,Free Communication,Evaluating KDIGO and KidneyintelX.dkd for Risk Stratification in Diabetic Kidney Disease: Insights from CANVAS and CREDENCE,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,Johnson & Johnson,,NCT01032629;;NCT02065791,CANVAS;;CREDENCE
993,Not Relevant,FC 7: CKD and Public Health: Part 2,Free Communication,Guideline-based management of chronic kidney disease and associated risk of cardio-renal outcomes,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
994,Not Relevant,FC 7: CKD and Public Health: Part 2,Free Communication,"What is the mortality of older adults opting for dialysis or conservative care, stratified by eligibility for dialysis?",Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,,,Elderly,,
995,Not Relevant,FC 7: CKD and Public Health: Part 2,Free Communication,"A Patient-Level Simulation Study Assessing the Clinical, Economic, and Environmental Burden of Chronic Kidney Disease in the Netherlands",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
996,Not Relevant,FC 7: CKD and Public Health: Part 2,Free Communication,Evaluating the Clinical and Economic Impact of SGLT-2 Inhibitors for CKD Management in the UK: Insights from the IMPACT CKD Microsimulation Model.,Chronic Kidney Disease,Chronic Kidney Disease,,,,SGLT2-Inhibitor,,,IMPACT CKD,
997,Not Relevant,FC 8: More about SGLT2 inhibitors,Free Communication,"SGLT2 inhibition triggers aestivation-like metabolic switches for water conservation in patients with heart failure - results from Dapa-Shuttle1, a randomized, placebo-controlled trial",Heart Failure,Heart Failure,,,,SGLT2-Inhibitor,,,NCT04080518,Dapa-Shuttle1
998,Not Relevant,FC 8: More about SGLT2 inhibitors,Free Communication,Cellular mediators involved in the nephroprotective mechanisms of Dapagliflozin: a study on human renal tubular cells,,,Dapagliflozin,,,SGLT2-Inhibitor,,,,
999,Not Relevant,FC 8: More about SGLT2 inhibitors,Free Communication,"Impact of Dapagliflozin on bone mineral metabolism in Non-diabetic Patients with Chronic Kidney Disease, Randomized, Double Blinded, Placebo controlled Trial",Chronic Kidney Disease,Chronic Kidney Disease,Dapagliflozin,,,SGLT2-Inhibitor,,,,
1000,Not Relevant,FC 8: More about SGLT2 inhibitors,Free Communication,Vicadrostat with and without empagliflozin reduces albuminuria across KDIGO risk class in chronic kidney disease,Albuminuria;Chronic Kidney Disease,Albuminuria;Chronic Kidney Disease,Vicadrostat,Empagliflozin,,Aldosterone Synthase-Inhibitor;SGLT2 Inhibitor,,,,
1001,Not Relevant,FC 8: More about SGLT2 inhibitors,Free Communication,Effect of SGLT2 Inhibitor (Dapagliflozin) on Aortic Calcification in Non-Diabetic CKD Patients: A randomized controlled study.,Chronic Kidney Disease,Non-Diabetic Chronic Kidney Disease,Dapagliflozin,,,SGLT2-Inhibitor,,,,
1002,Not Relevant,FC 8: More about SGLT2 inhibitors,Free Communication,Outcomes of Canagliflozin in Patients with Type 2 Diabetes with and without Progressive Renal Function Decline: Insights from the CREDENCE Trial,Renal Failure;Type 2 Diabetes,Progressive Renal Failure;Type 2 Diabetes,Canagliflozin,,,SGLT2-Inhibitor,Johnson & Johnson,Progressive,CREDENCE;;NCT02065791,
1003,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Association between relapse and long-term kidney outcomes in IgA nephropathy,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1004,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Loin pain in adults with IgA nephropathy: Insights from qualitative interviews with patients, families, and healthcare professionals",IgA Nephropathy,Adult IgA Nephropathy;Loin Pain,,,,,,Adult,,
1005,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Clinical and biological characteristics predictive of immune checkpoint inhibitors-induced acute tubulo-interstitial nephritis,Interstitial Nephritis,Acute Tubulio-Interstitial Nephritis,,,,Immune Checkpoint-Inhibitor,,,,
1006,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Cancer Incidence and Risk Factors in PLA2R-associated Membranous Nephropathy,Cancer;Membranous Nephropathy,Cancer;PLA2R-Associated Membranous Nephropathy,,,,,,,,
1007,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Metabolic disease assessment and control among adults diagnosed with severe podocytopathies,Podocytopathy,Adult Severe Podocytopathy,,,,,,Adult;Severe,,
1008,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,What characteristics are associated with a positive genetic study in patients suspected of Alport Syndrome?,Alport Syndrome,Alport Syndrome,,,,,,,,
1009,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Anti-Phospholipase A2 Receptor Antibody IgG4-to-IgG Ratio Predicts Remission of PLA2R-Associated Primary Membranous Nephropathy,Primary Membranous Nephropathy,PLA2R Associated Primary Membranous Nephropathy,,,,,,,,
1010,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Association of magnesium depletion score with kidney stones in patients with gout,Gout,Gout;Kidney Stone,,,,,,,,
1011,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Time to diagnosis in patients with rare kidney diseases: Findings form the European Rare Kidney Disease Registry,Kidney Diseases,Kidney Disease,,,,,,,,
1012,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Long-Term Outcomes in IgA Nephropathy: Findings from the ERKNet Patient Registry (ERKReg),IgA Nephropathy,IgA Nephropathy,,,,,,,,ERKReg
1013,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,The Effect Of Immunosuppression Based On Corticosteroids On Arterial Stiffness In Patients With Glomerulonephritis,Glomerulonephritis,Glomerulonephritis,,,,Corticosteroid,,,,
1014,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Long-term outcomes of patients developing acute kidney injury after CAR-T cell therapy for relapsed/refractory hematological malignancies,Acute Kidney Injury;Blood Cancer,Acute Kidney Injury;Relapsed/Refractory Hematologic Malignancy,CAR-T Cell,,,CAR T Therapy,,Relapsed/Refractory,,
1015,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Characterizing IgAN and assessing the role of International IgAN Prediction Tool in our population,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1016,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Hereditary Transthyretin Amyloidosis (ATTRv): finerenone along the spectrum of kidney and heart disease,Heart Disease;Hereditary Attr Amyloidosis;Kidney Diseases,Heart Disease;Hereditary Transthyretin Amyloidosis;Kidney Disease,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,,
1017,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Health related Quality of Life in Patients with Lupus Nephritis: A Cross-Sectional Survey based Study,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1018,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Real-world utility of the International IgA Nephropathy Prediction Tool in a tertiary referral centre of Nephrology,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1019,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Clinicopathological correlation of interstitial inflammation in Diabetic Nephropathy: A cross-sectional study,Diabetes;Inflammation,Diabetes;Interstitial Inflammation,,,,,,,,
1020,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Full recovery from lupus nephritis with no signs of CKD. Focused analysis,Chronic Kidney Disease;Lupus Nephritis,Chronic Kidney Disease;Lupus Nephritis,,,,,,,,
1021,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Multi-Center study of Anti-Nephrin Antibodies in Minimal Change Disease and Focal Segmental Glomerulosclerosis,Focal Segmental Glomerulosclerosis;Minimal Change Disease,Focal Segmental Glomerulosclerosis;Minimal Change Disease,,,,Nephrin-Targeted Antibody,,,,
1022,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Bacterial Diversity Of The Genital Tract In Lupus Nephritis Patients. A Pilot Microbiome Analysis,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1023,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"A study of calcineurin inhibitors in comparison with intravenous cyclophosphamide for initial induction treatment of lupus nephritis class ?, IV, ? in Chinese children",Lupus Nephritis,Childhood Lupus Nephritis,Cyclophosphamide,,,Alkylating Agent;Calcineurin-Inhibitor,,Childhood,,
1024,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Obinutuzumab in Steroid-Resistant Podocytopathies,Podocytopathy,Podocytopathy,Obinutuzumab,,,CD20-Targeted Monoclonal Antibody,,,,
1025,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Lupus Nephritis Treated With Belimumab. Experence In Canary Islands.,Lupus Nephritis,Lupus Nephritis,Belimumab,,,BAFF-Targeted Therapy,,,,
1026,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Randomised controlled trial comparing rituximab to mycophenolate mofetil in children and young adults with steroid-dependent idiopathic nephrotic syndrome,Nephritic Syndrome,Childhood Idiopathic Nephritic Syndrome;Young Adult Idiopathic Nephritic Syndrome,Rituximab,,Mycophenolate Mofetil,CD20-Targeted Monoclonal Antibody,,Childhood;Young Adult,,
1027,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Diagnostic Gaps in C3G and ic-MPGN: Findings of the CompCure Study Cohort,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,,,,,,,CompCure,
1028,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Predicting disease progression in IgA Nephropathy Portuguese patients: the role of inflammation and vascular damage markers beyond the IgAN PT.,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1029,Not Relevant,Hypertension & Diabetes,Focussed Oral,Angiotensin Dysregulation in Patients with Arterial Aneurysms,Aneurysm,Arterial Aneurysm,,,,,,,,
1030,Not Relevant,Hypertension & Diabetes,Focussed Oral,Predicting the risk of and days without albuminuria in patients with diabetes mellitus: a development and validation study,Albuminuria;Diabetes,Albuminuria;Diabetes Mellitus,,,,,,,,
1031,Not Relevant,Hypertension & Diabetes,Focussed Oral,Impact of Glycemic Variability on Mortality Risk in Patients with Diabetes and End-Stage Kidney Disease Undergoing Maintenance Dialysis,Diabetes;Kidney Diseases,Diabetes;End Stage Kidney Disease,,,,,, End Stage,,
1032,Not Relevant,Hypertension & Diabetes,Focussed Oral,The impact of Metformin on CKD Progression and Mortality in Diabetic Patients using SGLT2 inhibitors – a real world cohort study,Chronic Kidney Disease;Diabetes,Chronic Kidney Disease;Diabetes,Metformin,,,Biguanide,,,,
1033,Not Relevant,Hypertension & Diabetes,Focussed Oral,Sex differences in ambulatory central blood pressure and arterial stiffness in hemodialysis patients.,Renal Failure,Kidney Failure,,,,,,,,
1034,Not Relevant,Hypertension & Diabetes,Focussed Oral,Glucagon-like Peptide-1 Receptor Agonists and the Risk of Emergency Department Visits and Hospitalization in Patients Across the Spectrum of Kidney Disease,Diabetes;Hypertension,Diabetes;Hypertension,,,,GLP-1 Receptor Agonist,,,,
1035,Not Relevant,Hypertension & Diabetes,Focussed Oral,Heterogeneity in characteristics of target population and definitions of renal outcome on evaluating the renoprotective effect of GLP-1RA in patients with diabetes: a systematic review and meta-analysis of observational studies versus randomized controlled trials,Diabetes,Diabetes,,,,GLP1 Receptor-Agonist,,,,
1036,Not Relevant,Hypertension & Diabetes,Focussed Oral,Renal perfusion assessment by magnetic resonance imaging in patients with diabetic cardiac autonomic neuropathy,Autonomic Neuropathy,Diabetic Cardiac Autonomic Neuropathy,,,,,,,,
1037,Not Relevant,Hypertension & Diabetes,Focussed Oral,"Trends in the global, regional, and national burden of diabetic kidney disease from 1990 to 2021: A systematic analysis of the Global Burden of Disease Study 2021",Diabetic Nephropathy,Diabetic Kidney Disease,,,,,,,,
1038,Not Relevant,Hypertension & Diabetes,Focussed Oral,Early Dynamic Identification of Glomerular Hyperfiltration is Associated with Chronic Kidney Disease in Type 2 Diabetes,Chronic Kidney Disease,Chronic Kidney Disease;Glomerular Hyperfiltration,,,,,,,,
1039,Not Relevant,Hypertension & Diabetes,Focussed Oral,The association between oxidative balance score and its combination with advanced lung cancer inflammation index and risks of chronic kidney disease in hypertension: NHANES 1999-2018,Chronic Kidney Disease;Hypertension,Chronic Kidney Disease;Hypertension,,,,,,,,
1040,Not Relevant,Hypertension & Diabetes,Focussed Oral,Association of glomerular hyperfiltration with mortality in stroke: an analysis using pooled individual patient data from the MICON multi-centre collaboration,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
1041,Not Relevant,Kidney Transplantation,Focussed Oral,Monkeypox Infection in Kidney Transplant Recipients: A Systematic Review,Monkeypox,Monkeypox,,,,,,,,
1042,Not Relevant,Kidney Transplantation,Focussed Oral,Assessing urinary exfoliated proximal tubule cell multispectral autofluorescence to differentiate between causes of post-transplant graft dysfunction,,Graft Dysfunction,,,,,,,,
1043,Not Relevant,Kidney Transplantation,Focussed Oral,Association Of Hla System Alleles With The Occurrence Of Iga Nephropathy And Its Recurrence After Kidney Transplantation,IgA Nephropathy,Recurrent IgA Nephropathy,,,,,,Recurrent,,
1044,Not Relevant,Kidney Transplantation,Focussed Oral,Clinical Experience with Extracorporeal Photopheresis in BK Virus-Associated Nephropathy,Nephropathy,BK Virus-Associated Nephropathy,,,,,,,,
1045,Not Relevant,Kidney Transplantation,Focussed Oral,The multi-omic analysis identified CHI3L1 as a potential mediator of immune system deregulation in kidney transplant patients with chronic antibody-mediated rejection,,,,,,,,,,
1046,Not Relevant,Kidney Transplantation,Focussed Oral,Immunosuppressive treatment with two drugs (tacrolimus and prednisone) in older adult kidney transplant recipients.,,,Prednisone;Tacrolimus,,,Calcineurin-Inhibitor;Glucocorticoid,,,,
1047,Not Relevant,Kidney Transplantation,Focussed Oral,Delisting Strategy In Highly Sensitised Patients With Preformed Dsa,,,,,,,,,,
1048,Not Relevant,Kidney Transplantation,Focussed Oral,Trends In Creatinine And Blood Pressure After Stent Implantation In Patients With Significant Stenosis Of The Renal Arteries After Kidney Transplantation,Renal Artery Stenosis,Renal Artery Stenosis,,,,,,,,
1049,Not Relevant,Kidney Transplantation,Focussed Oral,Quantifying Donor-Derived Cell-Free DNA for Monitoring Kidney Transplant Recipients: a Head-to-Head Comparison of NGS and ddPCR Assays,,,,,,,,,,
1050,Not Relevant,Kidney Transplantation,Focussed Oral,Hemodynamic Impacts of Kidney Donation on the Abdominal Aorta: A Computational Fluid Dynamics Study,,,,,,,,,,
1051,Not Relevant,Kidney Transplantation,Focussed Oral,Unveiling Donor-Originated BKPyV Viremia in kidney transplant recipients,,BK Polyomavirus Viremia,,,,,,,,
1052,Not Relevant,Kidney Transplantation,Focussed Oral,Factors Associated With Early Mortality In Kidney Transplant Recipients =70 Years Old,,,,,,,,,,
1053,Not Relevant,Kidney Transplantation,Focussed Oral,Haemophagocytic histiolymphocytis after solid organ transplantation: preliminary data from a cohort study,,Haemophagocytic Histiolymphocytosis,,,,,,,,
1054,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Serum Metabolic Profiling Analysis of Gitelman Syndrome by Untargeted Metabolomics,Gitelman Syndrome,Gitelman Syndrome,,,,,,,,
1055,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Identification and characterization of genetic founder effects in Chuxiong-Yi populations with extremely high local incidence of Gitelman syndrome,Gitelman Syndrome,Gitelman Syndrome,,,,,,,,
1056,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Exome Sequencing In Patients With Medullary Sponge Kidney,Medullary Sponge Kidney,Medullary Sponge Kidney,,,,,,,,
1057,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,A phase 4 study to evaluate the safety and tolerability of higher infusion rates of agalsidase beta to shorten the infusion duration in Fabry disease – Preliminary data,Fabry Disease,Fabry Disease,Agalsidase Beta,,,Recombinant Alpha Galactosidase A,,,,
1058,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,"Not a cluster of grapes, but bananas: Cord-like three-dimensional structure of cysts in ADPKD supports tubular obstruction hypothesis",Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1059,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Safety and efficacy of Tolvaptan in real-world high-risk patients with ADPKD – A Single Center Experience,Autosomal Dominant Polycystic Kidney,High Risk Autosomal Dominant Polycystic Kidney Disease,Tolvaptan,,,Vasopressin V2 Receptor-Antagonist,,High-risk,,
1060,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Mitochondrial translation reveals a therapeutic vulnerability in Autosomal Dominant Polycystic Kidney Disease,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1061,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Genetic Fingerprinting of Inflammation in Anderson-Fabry Disease: The Role of NLRP3 Polymorphisms,Fabry Disease,Anderson-Fabry Disease,,,,,,,,
1062,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Genotyping and phenotyping early and very early Autosomal Dominant Polycystic Kidney Disease onset,Autosomal Dominant Polycystic Kidney,Early Onset/Very Early Onset Autosomal Dominant Polycystic Kidney,,,,,,Early Onset,,
1063,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Detecting MUC1 VNTR variants using VNtyper in Irish patients,,Disease,,,,,,,,
1064,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Application Of Molecular Genetic Methods In The Diagnosis Of Renal Tuberculosis,Renal Tuberculosis,Renal Tuberculosis,,,,,,,,
1065,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Pathway Analysis of Cosmic Kidney Disease: Just how bad does spaceflight get?,Kidney Diseases,Kidney Disease,,,,,,,,
1066,Not Relevant,Toward novel therapies for kidney genetic disorders?,Symposium,First in class compounds to treat NPH,Normal-Pressure Hydrocephalus,Normal Pressure Hydrocephalus,,,,,,,,
1067,Not Relevant,Toward novel therapies for kidney genetic disorders?,Symposium,Exon skipping as novel therapies in genetic disorders,,Genetic Disorder,,,,,,,,
1068,Not Relevant,Toward novel therapies for kidney genetic disorders?,Symposium,Chaperone therapies in inherited kidney diseases: a way to go?,Kidney Diseases,Inherited Kidney Disease,,,,,,,,
1069,Not Relevant,Pro & Cons: Organ donation after assisted suicide/euthanasia,Symposium,Introduction,,,,,,,,,,
1070,Not Relevant,Pro & Cons: Organ donation after assisted suicide/euthanasia,Symposium,"Outline of legal, procedural and safety issues",,,,,,,,,,
1071,Not Relevant,Pro & Cons: Organ donation after assisted suicide/euthanasia,Symposium,Outline the ethics issues,,,,,,,,,,
1072,Not Relevant,Pro & Cons: Organ donation after assisted suicide/euthanasia,Symposium,Patient’s perspective,,,,,,,,,,
1073,Not Relevant,Chronic kidney disease,Moderated e-Poster,Prospective observational cohort study on the treatment of anemia and iron deficiency with hypoxia-inducible factor prolyl hydroxylase inhibitor in patients with CKD,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,HIF PH Inhibitor,,,,
1074,Not Relevant,Chronic kidney disease,Moderated e-Poster,Creatinine Muscle Index (CMI) Is Independently Associated with Markers of Sarcopenia and Mortality in Chronic Kidney Disease,Chronic Kidney Disease;Sarcopenia,Chronic Kidney Disease;Sarcopenia,,,,,,,,
1075,Not Relevant,Chronic kidney disease,Moderated e-Poster,The association between cognitive impairment and brain imaging changes in chronic kidney disease and the impact of physical activity on this relationship: a systematic review,Chronic Kidney Disease;Cognitive Impairment,Chronic Kidney Disease;Cognitive Impairment,,,,,,,,
1076,Not Relevant,Chronic kidney disease,Moderated e-Poster,Chronic kidney disease facilitates TNF-A + neutrophils dysfunction in tumor microenvironment and fuels the progression of head and neck squamous cell carcinoma,Head and Neck Squamous Cell Carcinoma;Tumors,Head and Neck Squamous Cell Carcinoma;Tumor,,,,,,,,
1077,Not Relevant,Chronic kidney disease,Moderated e-Poster,"The anticholinergic burden in patients with chronic kidney disease: Patterns, risk factors, and the link with cognitive impairment",Chronic Kidney Disease;Cognitive Impairment,Chronic Kidney Disease;Cognitive Impairment,,,,Anticholinergic Agent,,,,
1078,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Impact of empagliflozin on metabolic profile, anthropometric indices, and renal function in chronic kidney disease patients with non-alcoholic fatty liver disease",Chronic Kidney Disease;Non Alcoholic Fatty Liver Disease,Chronic Kidney Disease;Non Alcoholic Fatty Liver Disease,Empagliflozin,,,SGLT2-Inhibitor,,,,
1079,Not Relevant,Chronic kidney disease,Moderated e-Poster,A safety and survival analysis of sequential systemic anticancer treatment in patients with end-stage kidney disease and metastatic renal cell carcinoma,Kidney Diseases;Renal Cell Carcinoma,End Stage Kidney Disease;Metastatic Renal Cell Carcinoma,,,,,, End Stage,,
1080,Not Relevant,Chronic kidney disease,Moderated e-Poster,Epidemiological Profile of Patients with Diabetic Kidney Disease and Heart Failure Initiating Finerenone: Insights from Real-World Data.,Diabetes;Heart Failure,Diabetes;Heart Failure,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,,
1081,Not Relevant,Chronic kidney disease,Moderated e-Poster,FGF23 as a predictor of multifocal atherosclerosis in patients with diabetes mellitus and chronic kidney disease,Chronic Kidney Disease;Diabetes,Chronic Kidney Disease;Diabetes Mellitus,,,,,,,,
1082,Not Relevant,Chronic kidney disease,Moderated e-Poster,Effect of denosumab on bone mineral density and microarchitecture assessed by HRpQCT in dialysis patients: a longitudinal study,Chronic Kidney Disease,Chronic Kidney Disease,Denosumab,,,RANKL-Inhibitor,,,,
1083,Not Relevant,Chronic kidney disease,Moderated e-Poster,Exploring roxadustat effect on oxidative stress: a pilot study in patients with CKD.,Chronic Kidney Disease,Chronic Kidney Disease,Roxadustat,,,HIF PH-Inhibitor,,,,
1084,Not Relevant,Chronic kidney disease,Moderated e-Poster,Retrospective single center analysis of Desidustat in CKD Anemia,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,Desidustat,,,HIF PH-Inhibitor,,,,
1085,Not Relevant,Chronic kidney disease,Moderated e-Poster,Effectiveness of bariatric surgery in patients with chronic kidney disease and obesity,Chronic Kidney Disease;Obesity,Chronic Kidney Disease;Obesity,,,,,,,,
1086,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Three years’ experience of multidisciplinary patient´s care in Centre for Renal Osteopathy and Calciphylaxis (CROC), University Hospital Hradec Králové, Czech Republic",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1087,Not Relevant,Chronic kidney disease,Moderated e-Poster,Navigating Caloric Restriction and Glucose Control in Chronic Kidney Disease After Gastric Bypass,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1088,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Insights into the adoption of consensus guidelines for hyperkalemia management in Spain: a national, multicenter, descriptive analysis",Hyperkalemia,Hyperkalemia,,,,,,,,
1089,Not Relevant,Chronic kidney disease,Moderated e-Poster,Evolution of Anemia Treatment with HIF-PH Inhibitors in Europe,Anemia,Anemia,,,,,,,,
1090,Not Relevant,Chronic kidney disease,Moderated e-Poster,Desidustat in CKD Anemia: A single center experience,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,Desidustat,,,HIF-PH Inhibitor,,,,
1091,Not Relevant,Chronic kidney disease,Moderated e-Poster,Burden of disease and management of hyperkalemia in patients with type 2 diabetes mellitus and chronic kidney disease managed at Spanish endocrinology services.,Chronic Kidney Disease;Hyperkalemia;Type 2 Diabetes,Chronic Kidney Disease;Hyperkalemia;Type 2 Diabetes Mellitus,,,,,,,,
1092,Not Relevant,Chronic kidney disease,Moderated e-Poster,Baseline characteristics and decision-making in the management of incident and recurrent Hyperkalaemia in Spain: Interim results from the prospective TRACK study,Hyperkalemia,Recurrent Hyperkalaemia,,,,,AstraZeneca,Recurrent,NCT05408039,TRACK
1093,Not Relevant,Chronic kidney disease,Moderated e-Poster,Hypophosphatemia Following Intravenous Iron in Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease;Hypophosphatmia,Iron,,,Mineral Supplement,,,,
1094,Not Relevant,Chronic kidney disease,Moderated e-Poster,A postbiotic-based approach to reduce the risk of developing cardiovascular complications seen in patients with chronic kidney disease (CKD),Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1095,Not Relevant,Chronic kidney disease,Moderated e-Poster,Challenges in treatment approaches in Calciphylaxis: Insights from Two Case Studies,Calciphylaxis,Calciphylaxis,,,,,,,,
1096,Not Relevant,Chronic kidney disease,Moderated e-Poster,Empiric antibiotic treatment deviates from antibiogram suggested treatment in chronic kidney disease: A single center study.,Chronic Kidney Disease,Chronic Kidney Disease,,,,Antibiotic,,,,
1097,Not Relevant,Chronic kidney disease,Moderated e-Poster,Predictive Value of Blood Cellular Indices for Thromboembolic Events in End-Stage Renal Disease,End-Stage Renal Disease,End Stage Renal Disease,,,,,,,,
1098,Not Relevant,Chronic kidney disease,Moderated e-Poster,Correction of Functional Iron Deficiency & Iron Sequestration in Patients with Chronic Kidney Disease with Desidustat: A Retrospective Study,Chronic Kidney Disease,Chronic Kidney Disease,Desidustat,,,HIF PH-Inhibitor,,,,
1099,Not Relevant,Chronic kidney disease,Moderated e-Poster,Creatinine and cystatin C: refining stratification risk of adverse outcomes in a high cardiovascular risk population.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1100,Not Relevant,Chronic kidney disease,Moderated e-Poster,Klotho Protein Associated With Worse Cognitive Function In Chronic Kidney Disease Patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,AstraZeneca,,,
1101,Not Relevant,Chronic kidney disease,Moderated e-Poster,Managing PASC in CKD Patients: Implications for Long-Term Care and Health Outcomes,Chronic Kidney Disease,Chronic Kidney Disease;Pulmonary Arterial Syndrome,,,,,,,,
1102,Not Relevant,Chronic kidney disease,Moderated e-Poster,Characteristics of patients with chronic kidney disease and inadequately controlled hypertension: Insights from the EnligHTN study,Chronic Kidney Disease;Hypertension,Chronic Kidney Disease;Hypertension,,,,,,,,EnligHTN
1103,Not Relevant,Chronic kidney disease,Moderated e-Poster,Patients’ perspectives on the use of the Kidney Failure Risk Equation and shared decision making in multimorbidity and frailty: a qualitative interview study,Renal Failure,Kidney Failure,,,,,,,,
1104,Not Relevant,Chronic kidney disease,Moderated e-Poster,Evaluation of Multidisciplinary Care Pathways on Renal Function in Patients with Advanced Chronic Kidney Disease: a multicentric study,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
1105,Not Relevant,Chronic kidney disease,Moderated e-Poster,Clinical Tools to Stratify Conservative Kidney Management Patients with Different Care Needs,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1106,Not Relevant,Chronic kidney disease,Moderated e-Poster,Relationship Between Hgb And Ckd,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1107,Not Relevant,Chronic kidney disease,Moderated e-Poster,Multimarkers based response to SGLT2 inhibitors in patients with Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,SGLT2-Inhibitor,,,,
1108,Not Relevant,Chronic kidney disease,Moderated e-Poster,Disease trajectory among patients with chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1109,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Association of plasma trace element levels and Mini Mental State Examination scores in HD, PD and CKD patients",Chronic Kidney Disease;End-Stage Renal Disease;Renal Failure,Chronic Kidney Disease;End Stage Renal Disease;Kidney Failure,,,,,,,,
1110,Not Relevant,Chronic kidney disease,Moderated e-Poster,Assessing performance of creatinine and cystatin-c based estimating glomerular filtration rate equations in South Asian populations: A systematic review and meta-analysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1111,Not Relevant,Chronic kidney disease,Moderated e-Poster,An Overview Of 67 National-Level Factors Potentially Related To The Incidence Of Kidney Replacement Therapy Across European Countries,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1112,Not Relevant,Chronic kidney disease,Moderated e-Poster,Goals of frail older people living with chronic kidney disease,Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,,,Elderly,,
1113,Not Relevant,Chronic kidney disease,Moderated e-Poster,A Study of Hidden Germs and Superbugs in CKD patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1114,Not Relevant,Chronic kidney disease,Moderated e-Poster,Insights from Native Kidney Biopsies: A Step Towards Establishing a Renal Biopsies Database in Latvia,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1115,Not Relevant,Chronic kidney disease,Moderated e-Poster,Physical activity in patients with chronic kidney disease: the effects of caregivers and residential factors.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1116,Not Relevant,Chronic kidney disease,Moderated e-Poster,Diet-by-polygenic score interaction effects on kidney function,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1117,Not Relevant,Chronic kidney disease,Moderated e-Poster,Effectiveness & cost-effectiveness of post-discharge transitional care programmes for fluid overload readmissions amongst chronic kidney disease patients in Singapore,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1118,Not Relevant,Chronic kidney disease,Moderated e-Poster,Results Of The Study Of The Opinion Of Patients Of Nephrological Departments On The Quality Of Outpatient And Inpatient Medical Care,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1119,Not Relevant,Chronic kidney disease,Moderated e-Poster,Asymmetric dimethylarginine (ADMA) and citrulline are risk factors for cardiovascular disease independently of both estimated and measured GFR,Cardiovascular Disease,Cardiovascular Disease,,,,,,,,
1120,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Epidemiology of Autosomal Dominant Polycystic Kidney Disease among patients incident on kidney replacement therapy between 1990-2022, in Northwest Portugal",Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney,,,,,,,,
1121,Not Relevant,Chronic kidney disease,Moderated e-Poster,Spanish Renal Health Cohort: Mulagua Study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,Otsuka Pharmaceutical,,,Mulagua
1122,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Factors Associated with Hyperkalemia and Hyperphosphatemia in Non-dialysis Dependent CKD: The Role of Dietary Knowledge, Attitude, and Behaviour",Chronic Kidney Disease;Hyperkalemia;Hyperphosphatemia,Chronic Kidney Disease;Hyperkalemia;Hyperphosphatemia,,,,,,,,
1123,High,Chronic kidney disease,Moderated e-Poster,Disease Progression and Its Association with Proteinuria Among Patients with Primary Immunoglobulin A Nephropathy (IgAN): Results from a Real-World Study in China,IgA Nephropathy,Primary IgA Nephropathy,,,,,,,,
1124,Not Relevant,Chronic kidney disease,Moderated e-Poster,Dietary Fiber Intake and Frailty in Patients with and without Chronic Kidney Disease: A Nationally Representative Analysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,Otsuka Pharmaceutical,,,
1125,Not Relevant,Chronic kidney disease,Moderated e-Poster,Assessment and Analysis of Knowledge on Hemodialysis in Patients with Stage 5 Chronic Kidney Disease,Chronic Kidney Disease,Stage V Chronic Kidney Disease,,,,,,,,
1126,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Multimorbidity, Frailty and Body Composition in Chronic Kidney Disease",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1127,Not Relevant,Chronic kidney disease,Moderated e-Poster,Peroxidasin expression in Alport Syndrome associates with histological kidney tissue damage.,Alport Syndrome,Alport Syndrome,,,,,,,,
1128,Not Relevant,Chronic kidney disease,Moderated e-Poster,Responsiveness to Roxadustat in Non-dialysis Chronic Kidney Disease Patients with Anemia by Baseline Hemoglobin: A Secondary Analysis of the ROXSTAR Registry,Anemia;Chronic Kidney Disease,Anemia;Non Dialysis Chronic Kidney Disease,Roxadustat,,,HIF PH-Inhibitor,FibroGen,,ChiCTR2100046322;;ROXSTAR,
1129,Not Relevant,Chronic kidney disease,Moderated e-Poster,To sleep or not to sleep: that is the (renal) question,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1130,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Impact of a single hemodialysis session with MCO and High-flux membranes on FGF-23, phosphorus, and endothelial function in patients with CKD",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1131,Not Relevant,Chronic kidney disease,Moderated e-Poster,Correlation of homocysteine levels with lipid profile and coronary heart disease in chronic kidney disease patients on hemodialysis- Preliminary findings.,Chronic Kidney Disease;Coronary Artery Disease,Chronic Kidney Disease;Coronary Heart Disease,,,,,,,,
1132,Not Relevant,Chronic kidney disease,Moderated e-Poster,Risk Factors and Characteristics of Gastrointestinal Lesions in Chronic Kidney Disease Patients with Anemia Admitted in a Tertiary Hospital: A Single-Center Retrospective Study,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,,,,,
1133,Not Relevant,Chronic kidney disease,Moderated e-Poster,Assessment Of Efficacy Of A Sglt2 Inhibitors In Kidney Transplant Recipients With Diabetes,Diabetes,Diabetes,,,,SGLT2-Inhibitor,,,,
1134,Not Relevant,Chronic kidney disease,Moderated e-Poster,Chemosensory Function And Food Preferences Among Long Term Hemodialysis Patients And Correlation With Nutritional Status,Chronic Kidney Disease,Chronic Kidney Failure,,,,,,,,
1135,Not Relevant,Chronic kidney disease,Moderated e-Poster,Decoding Vascular Calcification: Aortic Calcium Scoring in Non-Diabetic CKD Patients – Insights from a Cohort Analysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1136,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Interplay of Hepcidin, Erythropoietin Levels, and Anemia in Chronic Kidney Disease: Insights from a Cohort Study",Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,,,,,
1137,Not Relevant,Chronic kidney disease,Moderated e-Poster,Avascular Necrosis and Risk Factors in Kidney Transplant Recipients: A Single-Center Experience,Osteonecrosis,Avascular Necrosis,,,,,,,,
1138,Not Relevant,Chronic kidney disease,Moderated e-Poster,Tumor-Like Calcification in patients undergoing haemodyalisis,Renal Failure,Kidney Failure,,,,,,,,
1139,Not Relevant,Chronic kidney disease,Moderated e-Poster,Role and mechanism of interaction between autophagy and ferroptosis in regulating osteogenic transformation of vascular smooth muscle cells in vascular calcification,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1140,Not Relevant,Chronic kidney disease,Moderated e-Poster,Adherence to a Healthy Plant-Based Diet and Cardiovascular-Kidney-Metabolic Risk Factors Among Patients With Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1141,Not Relevant,Chronic kidney disease,Moderated e-Poster,Observational Study of the Clinical Use of Roxadustat for Treatment of Chronic Kidney Disease-Related Anaemia in Sweden: The MOROCCO study,Anemia;Chronic Kidney Disease,Anaemia;Chronic Kidney Disease,Roxadustat,,,HIF PH-Inhibitor,,,MOROCCO,
1142,Not Relevant,Chronic kidney disease,Moderated e-Poster,Prognostic Significance of Kidney Dysfunction in the Development of Liver Fibrosis in Patients with Chronic Heart Failure (CHF),Heart Failure;Liver Fibrosis,Chronic Heart Failure;Liver Fibrosis,,,,,,,,
1143,Not Relevant,Chronic kidney disease,Moderated e-Poster,Association between Serum Zinc and Anemia in Chronic Kidney Disease: A Population-Based Study from the NHANES (2011–2016),Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,,,,,
1144,Not Relevant,Chronic kidney disease,Moderated e-Poster,Assessment of the effect of renal dysfunction on the course of CHF and systolic function of the left ventricle,Heart Failure,Chronic Heart Failure,,,,,,,,
1145,Not Relevant,Dialysis,Moderated e-Poster,Survival Outcomes Following Dialysis Initiation in Geriatric Population,Renal Failure,Kidney Failure,,,,,,,,
1146,Not Relevant,Dialysis,Moderated e-Poster,Prevalence Of Uremic Pruritus And Its Impact On Quality Of Life In Dialysis Patients,Renal Failure;Uremic Pruritus,Kidney Failure;Uremic Pruritus,,,,,,,,
1147,Not Relevant,Dialysis,Moderated e-Poster,Cognitive Decline In Hemodialysis Patients : A Prospective Cross-Sectional Study Analysing Sociodemographic And Clinical Determinants.,Renal Failure,Kidney Failure,,,,,Fresenius,,,
1148,Not Relevant,Dialysis,Moderated e-Poster,Arteriovenous dialysis access use and haemodiafiltration are associated with lower frequency and severity of intradialytic symptoms in a Singapore cohort,Renal Failure,Kidney Failure,,,,,,,,
1149,Not Relevant,Dialysis,Moderated e-Poster,"Association of rate of decline in residual kidney function with risk of cognitive impairment in haemodialysis: A prospective, longitudinal analysis of the BISTRO study cohort",Cognitive Impairment;Renal Failure,Cognitive Impairment;Kidney Failure,,,,,,,BISTRO;;ISRCTN11342007,
1150,Not Relevant,Dialysis,Moderated e-Poster,Clinical and Echocardiographic Profile of Patients Initiating Unplanned Haemodialysis due to Cardiorenal Syndrome,Cardio-Renal Syndrome;Renal Failure,Cardiorenal Syndrome;Kidney Failure,,,,,,,,
1151,Not Relevant,Dialysis,Moderated e-Poster,“Measuring for Improvement: Changes in the Perception of Care in Haemodialysis Patients over four years”,Renal Failure,Kidney Failure,,,,,,,,
1152,Not Relevant,Dialysis,Moderated e-Poster,Implementation of a holistic quality improvement framework is associated with lower mortality in hemodialysis patients across 6 countries,Renal Failure,Kidney Failure,,,,,,,,
1153,Not Relevant,Dialysis,Moderated e-Poster,"Multi-stream data analysed by machine learning experiments confirmed factors influencing    dialysis tolerability and patient recovery time: BP, pulse, dialysis vintage, age",Renal Failure,Kidney Failure,,,,,,,,
1154,Not Relevant,Dialysis,Moderated e-Poster,Association between Dialysis Adequacy and Health Related Quality of Life in Patients on Maintenance Hemodialysis,Renal Failure,Kidney Failure,,,,,Fresenius,,,
1155,Not Relevant,Dialysis,Moderated e-Poster,The Detrimental Effect of Proteinuria on Residual Renal Function in Hemodialysis Patients,Proteinuria;Renal Failure,Kidney Failure;Proteinuria,,,,,,,,
1156,Not Relevant,Dialysis,Moderated e-Poster,"Access to Hemodialysis in Haiti, a Low-Income, Conflict-Affected Country",Renal Failure,Kidney Failure,,,,,,,,
1157,Not Relevant,Dialysis,Moderated e-Poster,"""Quality of Life in Haemodialysis: Are We Improving? Comparison 2022-2024""",Renal Failure,Kidney Failure,,,,,,,,
1158,Not Relevant,Dialysis,Moderated e-Poster,Peritoneal Dialysis for Heart Transplant Recipients with End-Stage Renal Disease : A Tertiary Hospital Experience,End-Stage Renal Disease,End Stage Renal Disease,,,,,,,,
1159,Not Relevant,Dialysis,Moderated e-Poster,Assessing Middle-Molecular and Protein-Bound Uremic Toxins: A Six-Month Study of ATA vs PS Membranes in Hemodiafiltration,Renal Failure,Kidney Failure,,,,,,,,
1160,Not Relevant,Dialysis,Moderated e-Poster,Therapeutic Plasma Exchange: 13-year center experience,Renal Failure,Kidney Failure,,,,,,,,
1161,Not Relevant,Dialysis,Moderated e-Poster,Efficiency Of Different Medium Cut-Off Membranes In Maintenance Hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
1162,Not Relevant,Dialysis,Moderated e-Poster,Optimizing Phosphate Removal: Is an Extended Dialyzer the Answer?,Renal Failure,Kidney Failure,,,,,,,,
1163,Not Relevant,Dialysis,Moderated e-Poster,Can the prediction power of mechanistic models be augmented by using clinically acquired data?,Renal Failure,Kidney Failure,,,,,,,,
1164,Not Relevant,Dialysis,Moderated e-Poster,High-volume plasmapheresis algorithm in patients waiting for OLTx,Renal Failure,Kidney Failure,,,,,,,,
1165,Not Relevant,Dialysis,Moderated e-Poster,Role of Dialyzer Biocompatibility in the Development of Intradialytic Stress Measured by Oxygen Extraction Ratio,Renal Failure,Kidney Failure,,,,,,,,
1166,Not Relevant,Dialysis,Moderated e-Poster,Continuous renal replacement therapy in severe metformin associated lactic acidosis and acute kidney injury: a single-center experience,Acidosis;Acute Kidney Injury,Acute Kidney Injury;Severe Metformin Associated Lactic Acidosis,,,,,,Severe,,
1167,Not Relevant,Dialysis,Moderated e-Poster,Comparison of methods for determining Kt/V,Renal Failure,Kidney Failure,,,,,,,,
1168,Not Relevant,Dialysis,Moderated e-Poster,Benefit of Central Concentrate Delivery System for Health Care Workers in Hemodialysis unit: A Questionnaire Survey,Renal Failure,Kidney Failure,,,,,,,,
1169,Not Relevant,Dialysis,Moderated e-Poster,Hyperglycaemia impact on the accuracy of plasma sodium levels estimated by the 6008 CAREsystem hemodialysis monitor,Hyperglycemia;Renal Failure,Hyperglycemia;Kidney Failure,,,,,,,,
1170,Not Relevant,Dialysis,Moderated e-Poster,Intradialytic clearances and reduction ratios for middle molecular weight uremic toxins and protein-bound uremic toxins: comparison of hemodiafiltration with asymmetric cellulose triacetate vs hemodiafiltration with helycoidal polysulfone during a 6-month follow-up,Renal Failure,Kidney Failure,,,,,,,,
1171,Not Relevant,Dialysis,Moderated e-Poster,Impact of Medium Cut-Off Dialysis Membranes on Outcomes in COVID-19 Patients with Acute Kidney Injury,Acute Kidney Injury;Coronavirus Infection,Acute Kidney Injury;COVID-19,,,,,,,,
1172,Not Relevant,Dialysis,Moderated e-Poster,Ultrasound evaluation of fluid overload in hemodialysis patients: Comparison between VExUS Score and Lung ultrasound in a cross-sectional study,Renal Failure,Kidney Failure,,,,,,,,
1173,Not Relevant,Dialysis,Moderated e-Poster,Comparison Between Different Methods In Evaluating Haemodialysis Adequacy,Renal Failure,Kidney Failure,,,,,,,,
1174,Not Relevant,Dialysis,Moderated e-Poster,Intradialytic hypotension and associated factors in chronic hemodialysis patients: a descriptive study,Hypotension;Renal Failure,Intradialytic Hypotension;Kidney Failure,,,,,,,,
1175,Not Relevant,Dialysis,Moderated e-Poster,Utilization of Peritoneal Dialysis (PD) in ESKD with refractory ascites: A CASE SERIES,Ascites;Kidney Diseases,End Stage Kidney Disease;Refractory Ascites,,,,,, End Stage;Refractory,,
1176,Not Relevant,Dialysis,Moderated e-Poster,Evaluation of parameters related to quality of life in a cohort of patients on peritoneal dialysis,Renal Failure,Kidney Failure,,,,,,,,
1177,Not Relevant,Dialysis,Moderated e-Poster,Hemodialysis session effects on autonomic nervous system function: hemodynamic responses and baroreflex sensitivity.,Renal Failure,Kidney Failure,,,,,,,,
1178,Not Relevant,Dialysis,Moderated e-Poster,Transfer of patients from cinacalcet to etelcalcetide: a retrospective cohort study in real world practice,Renal Failure,Kidney Failure,Etelcalcetide,,,Calcium Sensing Receptor-Agonist,,,,
1179,Not Relevant,Dialysis,Moderated e-Poster,Hyperphosphatemia in hemodialysis patients may be driven by the consumption of ultraprocessed foods,Hyperphosphatemia;Renal Failure,Hyperphosphatemia;Kidney Failure,,,,,,,,
1180,Not Relevant,Dialysis,Moderated e-Poster,Impact of Hemodialysis Treatment Start Time on Intradialytic Sleep Apnea Patterns,Renal Failure;Sleep Apnea,Kidney Failure;Sleep Apnea,,,,,,,,
1181,Not Relevant,Dialysis,Moderated e-Poster,Increased levels of tissue factor is associated with upregulation of d-dimer and decreased levels of thrombin generation in end stage renal disease,End-Stage Renal Disease,End Stage Renal Disease,,,,,,,,
1182,Not Relevant,Dialysis,Moderated e-Poster,Annual Aortic Valve Velocity as a Predictor of Systemic Calcification and Mortality: A Novel Monitoring Approach in Dialysis,Renal Failure,Kidney Failure,,,,,,,,
1183,Not Relevant,Dialysis,Moderated e-Poster,Adrenal Insufficiency in Hemodialysis Patients May Be a More Frequent Problem Than We Thought.,Renal Failure,Adrenal Insufficiency;Kidney Failure,,,,,,,,
1184,Not Relevant,Dialysis,Moderated e-Poster,Case report of CyberKnife radiosurgery treatment for secondary hyperparathyroidism in a patient undergoing dialysis,Secondary Hyperparathyroidism,Secondary Hyperparathyroidism,,,,,,,,
1185,Not Relevant,Dialysis,Moderated e-Poster,The efficacy and safety of using various combinations of antithrombotic therapy in patients with AF and ESKD undergoing program hemodialysis,Kidney Diseases,End Stage Kidney Disease,,,,,, End Stage,,
1186,Not Relevant,Dialysis,Moderated e-Poster,"Evolution Of Vascular Risk Factors Control In Hemodialysis Patients In Spain Following The Intervention Of The ""Objetivo En El Punto De Mira"" (Opm) Study",Renal Failure,Kidney Failure,,,,,,,OPM,
1187,Not Relevant,Dialysis,Moderated e-Poster,Role of Intradialytic Nutrition in Modulating Dialytic Hypoxic Stress,Renal Failure,Kidney Failure,,,,,,,,
1188,Not Relevant,Dialysis,Moderated e-Poster,The effects of  interventions synbiotics  on serum metabolic profiles in hemodialysis patients.,Renal Failure,Kidney Failure,,,,,,,,
1189,Not Relevant,Dialysis,Moderated e-Poster,The relationship between low serum magnesium levels and frailty among hemodialysis patients in the West Bank: a cross-sectional study,Renal Failure,Kidney Failure,,,,,,,,
1190,Not Relevant,Dialysis,Moderated e-Poster,"Erythropoietin Resistance Index (ERI) independently predicts mortality in hemodialysis patients. So, what's beneath the surface?",Renal Failure,Kidney Failure,,,,,,,,
1191,Not Relevant,Dialysis,Moderated e-Poster,Phase angle following intradialytic neuromuscular electrical stimulation and oral protein supplementation in patients undergoing chronic hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
1192,Not Relevant,Dialysis,Moderated e-Poster,Assessment of Bone Mineral Density and its Predictors in Dialysis Patients Using Quantitative Computed Tomography,Renal Failure,Kidney Failure,,,,,,,,
1193,Not Relevant,Dialysis,Moderated e-Poster,Evaluation Of Sleep Disorders In Peritoneal Dialysis And Hemodialysis Patients,Renal Failure,Kidney Failure;Peritoneal Dialysis,,,,,,,,
1194,Not Relevant,Dialysis,Moderated e-Poster,Construction and evaluation of risk prediction model for peritoneal dialysis patients with volume overload,Renal Failure,Kidney Failure,,,,,,,,
1195,Not Relevant,Dialysis,Moderated e-Poster,Single center experience: Peritoneal Dialysis in Acute Kidney Injury in Severe Lupus Nephritis,Acute Kidney Injury;Lupus Nephritis,Acute Kidney Injury;Severe Lupus Nephritis,,,,,,Severe,,
1196,Not Relevant,Dialysis,Moderated e-Poster,"""Is assisted peritoneal dialysis a valid alternative in dependent patients undergoing renal replacement therapy techniques?""",Renal Failure,Kidney Failure,,,,,,,,
1197,Not Relevant,Dialysis,Moderated e-Poster,Development of a Support System for Patients on dialysis: Functionality for Assisting Dietary Therapy,Renal Failure,Kidney Failure,,,,,,,,
1198,Not Relevant,Dialysis,Moderated e-Poster,how to increase PD based on cost-effectivenes analysis in Polish heathcare system,Renal Failure,Kidney Failure,,,,,,,,
1199,Not Relevant,Dialysis,Moderated e-Poster,Does peritoneal dialysis have an actual impact on normal respiratory physiology? Our first experience with nocturnal polygraphy monitoring.,Renal Failure,Kidney Failure,,,,,,,,
1200,Not Relevant,Dialysis,Moderated e-Poster,Revolutionizing Dialysis Care for the Elderly: Lessons from the AHHD Program,Renal Failure,Kidney Failure,,,,,,,,
1201,Not Relevant,Dialysis,Moderated e-Poster,Effect Of Agave Inulin On Constipation And Quality Of Life In Peritoneal Dialysis Patients,Constipation;Renal Failure,Constipation;Kidney Failure,Agave Inulin,,,Prebiotic,,,,
1202,Not Relevant,Dialysis,Moderated e-Poster,Impact On Peritoneal Dialysis (PD) Uptake Through Implementation Of Patient Sharing Session With Chronic Kidney Disease (CKD) Stage 5 Patients - A Single Centre Retrospective Review,Chronic Kidney Disease;Renal Failure,Chronic Kidney Disease;Stage Five Kidney Failure,,,,,,,,
1203,Not Relevant,Dialysis,Moderated e-Poster,Time And Motion Study In A Peritoneal Dialysis Program Using Sharesource Analytics 1.0 Remote Patient Management,Renal Failure,Kidney Failure,,,,,,,,
1204,Not Relevant,Dialysis,Moderated e-Poster,The SarQoL score is a novel tool for assessing sarcopenia risk and well-being in chronic peritoneal dialysis patients: a pilot study,Chronic Kidney Disease;Sarcopenia,Chronic Kidney Failure;Sarcopenia,,,,,,,,
1205,Not Relevant,Dialysis,Moderated e-Poster,Dialysis Symptoms Relation with Medication  Beliefs and Medication Compliance  in Dialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
1206,Not Relevant,Dialysis,Moderated e-Poster,Not Just an Itch: A Rare Dermatological Manifestation in Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1207,Not Relevant,Dialysis,Moderated e-Poster,Remote Monitoring of Peritoneal Dialysis via Telemedicine: A Solution for Volume Management in Refractory Heart Failure,Heart Failure,Refractory Heart Failure,,,,,,Refractory,,
1208,Not Relevant,Dialysis,Moderated e-Poster,Innovative Tools for Peritoneal Dialysis Catheter Insertion: Impact on Clinical Skills and PD Adoption,Renal Failure,Kidney Failure,,,,,,,,
1209,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"""Epigenetic and Metabolic Regulation: The Role of HDAC2  in Drug Resistance in Steroid Resistant Nephrotic syndrome""",Nephritic Syndrome,Steroid Resistent Nephritic Syndrome,,,,Steroid,,,,
1210,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Molecular Phenotype Shifts in Podocytes of Primary FSGS: Insights into WT-1, Podocin, and Mesenchymal Markers",Focal Segmental Glomerulosclerosis,Primary Focal Segmental Glomerulosclerosis,,,,,,,,
1211,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Regulation of mRNA, miRNAs, and Alternative Splicing Events in an FSGS-like Zebrafish Injury Model",Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
1212,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Recurrent admissions with life threatening hypokalaemia due to acquired distal renal tubular acidosis.,Distal Renal Tubular Acidosis;Hypokalemia,Acquired Distal Renal Tubular Acidosis;Hypokalaemia,,,,,,,,
1213,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Prediction of response to intensified immunosuppression in childhood steroid-resistant nephrotic syndrome by multimodal machine learning,Nephrosis,Childhood Steroid Resistant Nephrotic Syndrome,,,,,,Childhood;Steroid-resistant,,
1214,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Thromboembolic risk in nephrotic syndrome: single-center experience,Nephrosis,Nephrotic Syndrome,,,,,,,,
1215,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Fibrillary Glomerulonephritis: Analysis Of Cases Diagnosed Over 14 Years,Fibrillary Glomerulonephritis,Fibrillary Glomerulonephritis,,,,,,,,
1216,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The Role of Antithrombin III Deficiency in Hypercoagulability of Nephrotic Syndrome: Insights from a Cross-Sectional Study,Antithrombin III Deficiency;Nephrosis,Antithrombin III Deficiency;Hypercoagulable Nephrotic Syndrome,,,,,,,,
1217,High,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Real world experience with SGLT2 inhibitors in IgA nephropathy: a case-control study,IgA Nephropathy,IgA Nephropathy,,,,SGLT2-Inhibitor,,,,
1218,Low,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The impact of remission occurrence on long-term renal survival in IgA Nephropathy,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1219,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Sex Differences in Glomerular Diseases and Their Long-Term Outcomes,Glomerular Disease,Glomerular Disease,,,,,,,,
1220,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Mortality and Kidney failure among adults with primary podocytopathies,Podocytopathy,Adult Primary Podocytopathy,,,,,,Adult,,
1221,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Report Of The Croatian Registry Of Native Kidney Biopsies 2019.-2023.,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
1222,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Plasma Metabolomics Analysis of Renal Dysfunction in Patients Undergoing Immune Checkpoint Inhibitor Treatment,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,Immune Checkpoint Inhibitors,,,,
1223,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Real-world experience of Iptacopan in C3 Glomerulopathy,C3 Glomerulopathy,C3 Glomerulopathy,Iptacopan,,,C3-Inhibitor,,,,
1224,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Real-life experience with the second-generation anti-CD20 antibodies for treatment of  immune-mediated glomerular diseases,Glomerulonephritis,Immune-Mediated Glomerulonephritis,,,,CD20-Targeted Antibody,,,,
1225,Medium,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Two Case Reports of Telitacicept Treatment in Primary IgAN with Low eGFR,IgA Nephropathy,Primary IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
1226,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Recommendations on management of adult-onset IgA vasculitis proposed by the European IgA Vasculitis Study Group,IgA Vasculitis,Adult Onset IgA Vasculitis,,,,,,Adult,,
1227,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Adherence to ANCA-Associated Vasculitis Guidelines in Clinical Practice: A Survey Investigating Facilitators and Barriers to Implementation,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
1228,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Real-world effectiveness and safety of voclosporin in the treatment of lupus nephritis with poor prognostic clinical and histological factors,Lupus Nephritis,Lupus Nephritis,Voclosporin,,,Calcineurin-Inhibitor,,,,
1229,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,First small steps…A pilot study on changes in Immunoglobulin G N-glycome during immunosuppressive treatment of ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Immunoglobulin G,,,Immunosuppressive Therapy,,,,
1230,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Normolipidemic lipoprotein glomerulopathy with IgA nephropathy — ApoE Kyoto Mutation: A case report,IgA Nephropathy;Lipoprotein Glomerulopathy,IgA Nephropathy;Lipoprotein Glomerulopathy,,,,,,,,
1231,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Infectious Complications in Glomerular Disease: Experience from a tertiary care centre in Eastern India,Glomerular Disease,Glomerular Disease,,,,,,,,
1232,Low,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Evaluating Albuminuria as a Risk Factor for ESKD in IgA Nephropathy: Insights from a Tertiary Center Cohort,Albuminuria;IgA Nephropathy;Kidney Diseases,Albuminuria;End Stage Kidney Disease;IgA Nephropathy,,,,,, End Stage,,
1233,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The rare within the uncommon; highlighting the broad spectrum of clinical presentations of podocytopathies,Podocytopathy,Podocytopathy,,,,,,,,
1234,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Acute kidney injury in multiple myeloma patients: Experience of the Nephrology Department of Monastir,Acute Kidney Injury;Multiple Myeloma,Acute Kidney Injury;Multiple Myeloma,,,,,,,,
1235,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Incidence of Infection and its relationship with Ig G level and B cell subset post rituximab infusion in Sussex Kidney Unit in Royal Sussex and County Hospital in Brighton.,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,Rituximab,,,CD20-Targeted Therapy,,,,
1236,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Subtle Thrombotic Microangiopathy Induced by Gemcitabine in a Splenectomized Patient: A Comprehensive Case Analysis,Thrombotic Microangiopathy,Thrombotic Microangiopathy,,,,,,,,
1237,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Combination cyclophosphamide and rituximab with early glucocorticoid withdrawal for the treatment of ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Cyclophosphamide;Rituximab,,,Alkylating Agent;CD20-Targeted Monoclonal Antibody,,,,
1238,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Inflammation Markers as Independent Predictors of End-Stage Renal Disease in IgA Nephropathy,End-Stage Renal Disease;IgA Nephropathy,End Stage Renal Disease;IgA Nephropathy,,,,,,,,
1239,High,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Real-World Study on the Effectiveness and Safety of Telitacicept in Treating IgA Nephropathy,IgA Nephropathy,IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
1240,Medium,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The clinical efficacy and safety of taicercept in the treatment of IgA nephropathy,IgA Nephropathy,IgA Nephropathy,Taicercept;Telitaccept,,,BLyS/APRIL Dual-Inhibitor,,,,
1241,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Prediction model for renal outcomes in Latin American mestizo population with proliferative lupus nephritis: a multicenter retrospective analysis,Proliferative Lupus Nephritis;Renal Failure,Proliferative Lupus Nephritis;Renal Failure,,,,,,,,
1242,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Adult Henoch-Schönlein Purpura Nephritis Presenting as RPGN: Staggered Symptoms and Management Dilemmas,Crescentic Glomerulonephritis;Nephritis,Adult Henoch-Henoch-Schönlein Nephritis;Rapidly Progressive Glomerulonephritis,,,,,,Adult,,
1243,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Patient characteristics and treatment patterns in ANCA-Associated Vasculitis: an observational study based on the DEMONSTRATE database, Uppsala, Sweden",Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,DEMONSTRATE,
1244,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Remission and Relapses in lupus nephritis among multi-racial Southeast Asians: a single center retrospective study,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1245,Medium,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The successful use of budesonide in IgA pediatric patients: a case series,IgA Nephropathy,IgA Nephropathy,Budesonide,,,Glucocorticoid,,,,
1246,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Critical role of renal biopsy for an unusual cause of hypercalcemia with acute kidney injury in a patient treated with immune checkpoint inhibitors,Acute Kidney Injury;Hypercalcemia,Acute Kidney Injury;Hypercalcemia,,,,Immune Checkpoint Inhibitor,,,,
1247,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Renal Thrombotic Microangiopathies: Etiological Spectrum and Prognostic Factors,Thrombosis,Renal Thrombosis,,,,,,,,
1248,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Laser microdissection combined with RNAseq reveals glomerulus-specific transcriptome profiles to discriminate class IV from class V Lupus Nephritis,Lupus Nephritis,Class IV/V Lupus Nephritis,,,,,,,,
1249,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,A delayed diagnosis of pauci-immune glomerulonephritis and vasculitis is associated with increased severity of disease presentation and higher probability of death,Glomerulonephritis;Vasculitis,Pauci-Immune Glomerulonephritis;Vasculitis,,,,,,,,
1250,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Anti-Glomerular Basement Membrane Disease: A Contemporary Case Series from a Large University Hospital Center,Goodpasture's Syndrome,Anti-Glomerular Basement Membrane Disease,,,,,,,,
1251,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Telemedicine Impact in Glomerular Diseases,Glomerular Disease,Glomerular Disease,,,,,,,,
1252,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Th17.1 cells in glomerulonephritis. Potential differences between primary and secondary glomerulonephritis.,Glomerulonephritis,Glomerulonephritis,,,,,,,,
1253,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Dysmorphic Vs Isomorphic Microhematuria In The Diagnostic Approach Of Glomerular Diseases,Glomerular Disease,Glomerular Disease;Microhematuria,,,,,,,,
1254,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Predicting outcomes in lupus nephritis: the role of histological and immunocytochemical findings,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1255,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,A thematic analysis of healthcare provider perspectives on the care pathway and unmet needs in C3G and primary IC-MPGN in the US and Europe,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,,,,,,,,
1256,Medium,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,A mechanistic biopsy study of the effect of iptacopan on immunopathology in patients with IgA nephropathy (IgAN),IgA Nephropathy,IgA Nephropathy,Iptacopan,,,C3-Inhibitor,,,,
1257,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Echocardiographic and cardiac magnetic resonance imaging abnormalities in patients with sustained remission of ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
1258,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,A  case of abrupt worsening of cryofibrinogen-associated glomerulopathy following the occurrence of a monoclonal IgG-kappa paraprotein promoting cryoprecipitation,Glomerulopathy,CryoFibrinogen Associated Glomerulopathy,,,,,,,,
1259,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Renal DNase1 expression is associated with disease activity in human lupus nephritis,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1260,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Real-World Treatment Patterns of Patients with Immunoglobulin A Nephropathy (IgAN) in the United States,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1261,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Urinary red blood cells correlation with Histopathology of Lupus Nephritis – single tertiary center,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1262,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Chronic Kidney Disease (Ckd) In Patients With Lupus Nephritis (Ln): Predictors Of Hard Endpoints: End Stage Kidney Disease (Eskd) Or Death.,Chronic Kidney Disease;End-Stage Renal Disease;Lupus Nephritis,Chronic Kidney Disease;End Stage Renal Disease;Lupus Nephritis,,,,,,,,
1263,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Are the hematological parameters of inflammation predictors of IgA nephropathy in adults with chronic nephritic syndrome?,IgA Nephropathy;Nephritis,Adult Chronic Nephritis;IgA Nephropathy,,,,,,Adult,,
1264,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The pathway to diagnosis and institution of therapy in patients with pauci-immune glomerulonephritis,Glomerulonephritis,Pauci-Immune Glomerulonephritis,,,,,,,,
1265,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Proteolytic rewiring and signaling through the human complement system,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
1266,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Kidney biopsy in patients with lupus nephritis, what it can add to diagnosis and therapy?",Lupus Nephritis,Lupus Nephritis,,,,,,,,
1267,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Proximal tubule RAGE accelerates the progression of lupus nephritis via activation of immune cells,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1268,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Fibrillary Glomerulonephritis : A report and follow up of two cases highlighting different clinical and pathologic presentations but similar outcomes,Fibrillary Glomerulonephritis,Fibrillary Glomerulonephritis,,,,,,,,
1269,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Kidney Biopsy Practices Among Nephrologists in India: A Nationwide Survey,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
1270,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Building CRESCENDO – a global registry of crescentic glomerulonephritis,Crescentic Glomerulonephritis,Crescentic Glomerulonephritis,,,,,,,CRESCENDO,
1271,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The use of patient reported outcomes in lupus nephritis clinical trials: A narrative review,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1272,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Safety And Efficacy Of Sglt2 Inhibitors In The Elderly With Ckd,Chronic Kidney Disease,Chronic Kidney Disease,,,,SGLT2-Inhibitor,,,,
1273,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Addressing Unmet Needs and Therapeutic Opportunities in Complement 3 Glomerulopathy (C3G),Glomerulopathy,Complement 3 Glomerulopathy,,,,,,,,
1274,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Are metabolic kidney stone clinics clinically effective?,,Kidney Stone,,,,,,,,
1275,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Evaluation Of The Diagnostic And Therapeutic Management Of Hyponatremia In A Tertiary Hospital: Are We Doing It Right?,,Hyponatremic Syndrome,,,,,,,,
1276,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Cystine-binding drugs are poorly available for the treatment of cystinuria.,Cystinuria,Cystinuria,,,,,,,,
1277,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,GPT Chat Performance in solving Medical Residency Questions in Nephrology: A Pilot Study in Brazil,,Disease,,,,,,,,
1278,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Stone Analysis and 24-hour Urine Characteristics of Kidney Stone Patients in Thailand,,Kidney Stone,,,,,,,,
1279,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Oral Acid load for distal tubular acidosis diagnosis: are urinary ratio usefull?,Acidosis,Distal Tubular Acidosis,,,,,,,,
1280,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Life-threatening hyperkalemia and metabolic acidosis after positively charged amino acid infusion for renal protection during Peptide receptor radionuclide therapy for metastatic neuroendocrine tumor: A case report and proposed mechanisms,Hyperkalemia;Neuroendocrine Cancer,Hyperkalemia;Metastatic Neuroendocrine Tumor,,,,,,Metastatic,,
1281,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Association between Body Mass Index and nephrolithiasis markers in the Mexican Population,Nephrolithiasis,Nephrolithiasis,,,,,,,,
1282,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Tailored kidney stone prevention improves metabolic risk factors and urinary crystallization risk indices and reduces renal colic and urological intervention rates,,Kidney Stone,,,,,,,,
1283,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Monogenic causes of nephrolithiasis and nephrocalcinosis in children and adults – a single center experience,Nephrolithiasis,Adult Nephrolithiasis;Childhood Nephrolithiasis,,,,,,Adult;Childhood,,
1284,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Role of microRNA in diabetes mellitus and mineral-bone disorders,Diabetes,Diabetes Mellitus;Mineral Bone Disorder,,,,,,,,
1285,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,The miRNA Expression of Urinary Extracellular Vesicles in Patients with Gitelman Syndrome: The Role of Hsa-let-7d-3p,Gitelman Syndrome,Gitelman Syndrome,,,,,,,,
1286,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Urinary Uromodulin Levels in Febrile Children: a Prospective Study,,Disease,,,,,,,,
1287,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Blood cellular indices in relation with d-dimer and thrombin levels in patients with end stage renal disease,End-Stage Renal Disease,End Stage Renal Disease,,,,,,,,
1288,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Theranostics in organ cross-talk: the impact of serum albumin in blood extracellular vesicles characterization by AFM-IR,,Genetic Disease,,,,,,,,
1289,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Targeting Autophagy Dysfunction and Oxidative Stress to Protect Against Obesity-Induced Kidney Damage,Obesity,Obesity,,,,,,,,
1290,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Role and relationship between vitamin D and arterial stiffness in non-dialysis-dependent chronic kidney disease in old aged patients,Chronic Kidney Disease,Chronic Kidney Disease,Vitamin D,,,Vitamin D Supplement,,,,
1291,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,A novel identification of anti-hypertensive drug Spironolactone as an inhibitor of Paraoxonase 2 lactonase and anti-ROS activities,,Disease,Spironolactone,,,Anti-Hypertensive Agent;PON2-Inhibitor;ROS-Targeted Therapy,,,,
1292,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Metabolic reprogramming and profibrotic behavior characterize tubular epithelial cells in Bardet Biedl syndrome,Bardet-Biedl Syndrome,Bardet Biedl Syndrome,,,,,,,,
1293,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Case report in Heart Center Kazakhstan: Successful application of Hemadsorption techniques using Jafron HA 280.,,Genetic Disease,,,,,,,,
1294,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Diabetes Insipidus Induced by Eosinophilic Granuloma from Pulmonary Paragonimiasis: A Case Report,Diabetes Insipidus;Paragonimiasis,Diabetes Insipidus;Eosinophilic Granulomatosis;Pulmonary Paragonimiasis,,,,,,,,
1295,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Developing a model for nephrotoxicity testing from human proximal tubular epithelial cells derived from kidney biopsy,,,,,,,,,,
1296,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Significant association between B lymphocytes and their subpopulations with peripheral T follicular cells is evident in patients with Systemic Lupus Erythematosus (SLE) at remission,Systemic Lupus Erythematosus,Systemic Lupus Erythematosus,,,,,,,,
1297,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Procalcitonin levels at hospital admission are increased in cyst infection in patients with autosomal dominant polycystic kidney disease,Autosomal Dominant Polycystic Kidney;Infection,Autosomal Dominant Polycystic Kidney Disease;Cyst Infection,,,,,,,,
1298,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Description of a familial renal ApoCII amyloidosis associated with a p.Lys41Thr mutation.,Renal Amyloidosis,Familial Renal Amyloidosis,,,,,,,,
1299,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Genotype of Autosomal Dominant Polycystic Kidney Disease in Greek Patients,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1300,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Unveiling the Impact of Rare and Low-Frequency Variants in Genes on Lupus Nephritis Susceptibility,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1301,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,First report of Kidney Failure in PEX6-Related Peroxisomal Disorder,Peroxisomal Disorders;Renal Failure,Kidney Failure;Pex6 Related Peroxisomal Disorder,,,,,,,,
1302,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Extrarenal manifestations-clinical marker for early onset of renal replacement therapy in COL4 nephropathy.,Nephropathy,COL4 Nephropathy,,,,,,,,
1303,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Genetic testing for kidney disease - single centre experience,Kidney Diseases,Kidney Disease,,,,,,,,
1304,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Genetic testing in adults with nephrocalcinosis enables precision diagnosis,Nephrocalcinosis,Adult Nephrocalcinosis,,,,,,Adult,,
1305,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,PKD1 gene mutations as a key determinant of early onset and accelerated progression in Autosomal Dominant Polycystic Kidney Disease,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1306,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Genotypic and Phenotypic Characteristics of Autosomal Dominant Polycystic Kidney Disease in Patients Without a Positive Family History,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney,,,,,,,,
1307,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Epigenetic clock and Fabry disease,Fabry Disease,Fabry Disease,,,,,,,,
1308,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Leveraging AI for Early Detection of Chronic Kidney and Hereditary Kidney Diseases: A Focus on Alport Syndrome,Alport Syndrome;Chronic Kidney Disease;Kidney Diseases,Alport Syndrome;Chronic Kidney Disease;Hereditary Kidney Disease,,,,,,,,
1309,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,"""Unraveling the Genetic Complexity of Autosomal Dominant Polycystic Kidney Disease: Insights from Gene Conversion Events""",Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1310,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Family planning in patients with Autosomal Dominant Polycystic Kidney Disease – Results from the DIPAK consortium,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney,,,,,,,DIPAK,
1311,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,HNF1B Genotype-Phenotype Correlation in Renal Patients from Galicia,Kidney Diseases,HNF1B Gene Variant Phenotypic Disorder;Renal Disease,,,,,,,,
1312,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,The impact of pregnancy on renal function in women with ADPKD: a retrospective analysis,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1313,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Correlating Symptom Burden with Polycystic Liver Volume Progression in Autosomal Dominant Polycystic Kidney Disease,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney,,,,,,,,
1314,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Renal protective effect of SGLT2 inhibitors in patients with Fabry disease,Fabry Disease,Fabry Disease,,,,SGLT2-Inhibitor,,,,
1315,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Next-Generation Sequencing in Chronic Kidney Disease of Unknown Etiology: A Step Toward Precision Medicine,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1316,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Genetically unresolved kidney cystic patients: the neglected population,,Kidney Cyst,,,,,,,,
1317,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Why is the genetic test for the ADTKD subtype MUC1 so complex and what alternative diagnostic procedures are available?,Autosomal Dominant Tubulointerstitial Kidney Disease,MUC1-Related Autosomal Dominant Tubulointerstitial Kidney Disease,,,,,,,,MUC1
1318,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,The Effect of Fluconazole on Polyuria and Urine Concentration Ability in Nephrogenic Diabetes Insipidus,Nephrogenic Diabetes Insipidus;Polyuria,Nephrogenic Diabetes Insipidus;Polyuria,Fluconazole,,,Azole Antifungal,,,,
1319,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,A gain-of-function mutation in ATP6V0A4 drives primary distal renal tubular alkalosis with enhanced V-ATPase activity,,Primary Distal Renal Tubular Alkalosis,,,,,,,,
1320,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Collagen IV diseases - genetic testing yield of a single-center cohort,,Collagen IV Disease,,,,,,,,
1321,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Treatment of chronic hypomagnesemia with SGLT2-inhibitor in a patient with Gitelman syndrome – a case report,Gitelman Syndrome;Hypomagnesemia,Chronic Hypomagnesemia;Gitelman Syndrome,,,,SGLT2-Inhibitor,,,,
1322,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Improvement of the diagnostic delay of primary hyperoxaluria,Primary Hyperoxaluria,Primary Hyperoxaluria,,,,,,,,
1323,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Is the generic treatment as effective as the original drug? A comparative study of the treatment with tolvaptan in Autosomal Dominant Polycystic Kidney Disease at the Virgen Macarena University Hospital,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney,Tolvaptan,,,Vasopressin V2 Receptor-Antagonist,,,,
1324,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,When Fabry Wasn'T The One To Blame,Fabry Disease,Fabry Disease,,,,,,,,
1325,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,The Use of Demoralization Scale in Patients with Fabry Disease: Preliminary Data.,Fabry Disease,Fabry Disease,,,,,,,,
1326,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Genetic Testing in Chronic Kidney Disease: Clinical and Genetic Insights into Autosomal Dominant Tubulointerstitial Kidney Disease in a Chinese Cohort,Autosomal Dominant Tubulointerstitial Kidney Disease;Chronic Kidney Disease,Autosomal Dominant Tubulointerstitial Kidney Disease;Chronic Kidney Disease,,,,,,,,
1327,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Longitudinal factors to consider when modelling home blood pressure as an endpoint in clinical trials of autosomal dominant polycystic kidney disease (ADPKD),Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1328,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Renal Involvement And Functional Impact In The Pediatric Age Of A Cohort Of Patients With Tuberous Sclerosis Complex (Tsc) And Contiguous Gene Syndrome (Cgs),Tuberous Sclerosis Complex,Paediatric Contiguous Gene Syndrome;Pediatric Tuberous Sclerosis Complex,,,,,,Paediatric,,
1329,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,An In Vivo Study Of Novel Genetic Modifiers In Autosomal Recessive Polycystic Kidney Disease (Arpkd),"	Autosomal Recessive Polycystic Kidney Disease",Autosomal Recessive Polycystic Kidney Disease,,,,,,,,
1330,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Renal Magnesium Handling In Mouse Model Of Fanconi-Bickel Syndrome,Glycogen Storage Disease Type XI,Fanconi Bickel Syndrome,,,,,,,,
1331,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Efficacy and safety of ravulizumab for the maintenance of aHUS remission after kidney transplant,Atypical Hemolytic-Uremic Syndrome,Atypical Hemolytic Uremic Syndrome,Ravulizumab,,,C5-Inhibitor,,,,
1332,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Genetic Insights into Persistent Hypouricemia in Adults: Novel Findings from a Nephrogenetic Clinic,,Adult Persistent Hypuricemia,,,,,,Adult;Persistent,,
1333,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Twelve Years of Genetic Studies in Polycystic Kidney Disease: A Descriptive Review in a Tertiary Center,Polycystic Kidney Diseases,Polycystic Kidney Disease,,,,,,,,
1334,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Genetic Insights into Tubulopathies: A Retrospective Study of Unexplained Renal Disorders,Kidney Diseases,Renal Disorder,,,,,,,,
1335,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Renal Biopsy: A Key Tool for Diagnosing Hyperoxaluria,Hyperoxaluria,Hyperoxaluria,,,,,,,,
1336,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,The Role of Kidney Biopsy in Genetic Evaluation: Analysis of a Hereditary Renal Diseases Consultation,Kidney Diseases,Hereditary Renal Disease,,,,,,,,
1337,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,"Usage of Genetic Testing, Awareness Levels, and Barriers in Nephrology Practice in Turkey: A National Survey Study",,Genetic Disease,,,,,,,,
1338,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Exploring Prognostic Markers In Autosomal Dominant Polycystic Kidney Disease,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1339,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Clinical course of Autosomal Recessive Polycystic Kidney Disease in adults,,Adult Autosomal Recessive Polycystic Kidney,,,,,,Adult,,
1340,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Evolutionary Roots of Renal Tubulopathies: Integrating Homer Smith’s Hypothesis with Novel Phylogenomic Methodologies,Renal Tubulopathy,Renal Tubulopathy,,,,,,,,
1341,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,On the origin of kidney stem/progenitor cells derived from neonatal urine: insights from single cell RNA sequencing,,Genetic Disease,,,,,,,,
1342,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Genetic testing outcomes: Insights from a decade of experience at a single center,,Genetic Disease,,,,,,,,
1343,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Computational Modelling to Predict Genotype-Phenotype Relationships in Autosomal Recessive Polycystic Kidney Disease,"	Autosomal Recessive Polycystic Kidney Disease",Autosomal Recessive Polycystic Kidney Disease,,,,,,,,
1344,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,ADTKD diagnosis: an evolving challenge,Autosomal Dominant Tubulointerstitial Kidney Disease,Autosomal Dominant Tubulointerstitial Kidney Disease,,,,,,,,
1345,Not Relevant,"Physiology, cell biology & genetic diseases",Moderated e-Poster,Beyond Clinical Limits: Genetic Testing As A Key Tool To Correctly Identify The Cause Of Microscopic Hematuria,Hematuria,Microscopic Hematuria,,,,,,,,
1346,Not Relevant,Plenary Lecture 1 - APOL1 and precision nephrology,Plenary Lecture,APOL1 and precision nephrology,,,,,,,,,,
1347,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Role of Roxadustat for Prevention of Severe Contrast-induced Acute Kidney Injury in Rats,Acute Kidney Injury,Severe Contrast-Induced Acute Kidney Injury,Roxadustat,,,HIF PH-Inhibitor,,Severe,,
1348,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,"Tubular epithelial cells are the primary source of Flt3L in acute kidney injury, independent of immune cells",Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1349,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Conventional amphotericin B versus liposomal amphotericin B: effects of treatment with dapagliflozin on kidney function and hemodynamics,Acute Kidney Injury,Acute Kidney Injury,Amphotericin B;Dapagliflozin,,Amphotericin B,Polyene Macrolide;SGLT2-Inhibitor,,,,
1350,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Plasma extracellular cold-inducible RNA-binding protein (eCIRP) is associated with acute kidney injury in patients after cardiac arrest,Acute Kidney Injury;Cardiac Arrest,Acute Kidney Injury;Cardiac Arrest,,,,,,,,
1351,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Exploring the physiopathological role of labile iron in acute kidney injury: A model of porcine polymicrobial septic shock,Acute Kidney Injury;Sepsis,Acute Kidney Injury;Severe Sepsis,,,,,,Severe,,
1352,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Defective Autophagy Drives Ferroptosis via Mitochondrial ROS in Diabetic Kidney Disease.,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,,,,
1353,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Activated HIF-1a accelerates tubular repair in Acute kidney injury via cell proliferation,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1354,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,ALOX5 activation promotes ferroptosis in renal ischemia-reperfusion injury,Ischemia,Renal Ischemia-Reperfusion Injury,,,,,,,,
1355,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,TREM2 macrophages ameliorate the transition from acute kidney injury to chronic kidney disease via a PI3K/AKT Signalling Pathway,Acute Kidney Injury;Chronic Kidney Disease,Acute Kidney Injury;Chronic Kidney Disease,,,,,,,,
1356,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Insulin-like growth factor-binding protein is upregulated after acute kidney injury in those with major adverse kidney events at day 90,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1357,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Kidney injury released circulating acetylated HMGB1 is a pathogenic factor in the development of acute lung injury,Acute Lung Injury,Acute Lung Injury;Kidney Injury,,,,,,,,
1358,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Heat acclimation protects against acute kidney injury in mice with heat stroke by inhibiting ferroptosis through activation of  mitophagy,Acute Kidney Injury;Heat Stroke,Acute Kidney Injury;Heat Stroke,,,,,,,,
1359,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,"Quality of Life after Acute Kidney Injury, Not Just an Acute Problem",Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1360,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Glomerular Filtration Rate and Albuminuria Predicts Outcomes in Patients with Acute Kidney Disease,Acute Kidney Injury;Albuminuria,Acute Kidney Injury;Albuminuria,,,,,,,,
1361,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Acute Kidney Injury in Critically Ill Cancer Patients: Risk Factors and Impact on Survival,Acute Kidney Injury;Cancer,Acute Kidney Injury;Cancer,,,,,,,,
1362,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Pre-operative CKD Stages IIIb-IV in Renal Cancer Surgery: Are AKI and ESRD Inevitable? Insights from Real-Life experience,Acute Kidney Injury;Chronic Kidney Disease;Kidney Cancer,Acute Kidney Injury;Chronic Kidney Disease;Renal Cancer,,,,,,,,
1363,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,The impact of acute kidney injury in rhabdomyolysis: renal outcomes and mortality,Acute Kidney Injury;Renal Failure,Acute Kidney Injury;Renal Failure,,,,,,,,
1364,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Impact of Sodium-Glucose Cotransporter-2 inhibitors on Outcomes in Patients with Type 1 Diabetes with Acute Kidney Disease,Acute Kidney Failure;Type 1 Diabetes,Acute Kidney Failure;Type 1 Diabetes,,,,SGLT2-Inhibitor,,,,
1365,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Global Trends and Adverse Events of SGLT2 Inhibitor Use in Acute Kidney Disease,Kidney Diseases,Acute Kidney Disease,,,,SGLT2-Inhibitor,,,,
1366,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Clinicopathological Features and Outcomes of Acute Kidney Injury in Patients Undergoing Diagnostic Native Kidney Biopsy,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1367,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Pseudo-AKI in Ribociclib-treated patients: insights from the PAKY STUDY,Acute Kidney Injury,Acute Kidney Injury,Ribociclib,,,CDK4/6-Inhibitor,,,,PAKY
1368,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Kidney Function Associated With Mortality In Hantavirus Infection: A Cohort Study In Brazil,Hantavirus Disease,Hantavirus Infection,,,,,,,,
1369,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Association between admission serum phosphate level and in-hospital acute kidney injury,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1370,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Differences Between Cystatin C- and Creatinine-Based Estimated Glomerular Filtration Rate and Association with Postoperative Complications in a Mixed Surgical Population: A Cohort Study of the UK Biobank,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1371,Not Relevant,Artificial intelligence and home dialysis,Symposium,Can artificial intelligence predict dialysis adequacy and dialysis access complications more accurately?,Renal Failure,Kidney Failure,,,,,,,,
1372,Not Relevant,Artificial intelligence and home dialysis,Symposium,Public policy and home dialysis utilization,Renal Failure,Kidney Failure,,,,,,,,
1373,Not Relevant,Artificial intelligence and home dialysis,Symposium,Effect of Remote and Virtual Technology on Home Dialysis,Renal Failure,Kidney Failure,,,,,,,,
1374,Not Relevant,Chronic kidney disease,Focussed Oral,Aryl hydrocarbon receptor promotes renal fibrosis via accelerating cell senescence in tubular epithelial cells,Fibrosis,Renal Fibrosis,,,,,,,,
1375,Not Relevant,Chronic kidney disease,Focussed Oral,In-vitro effect of cholecalciferol on immune and vascular function in chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,Cholecalciferol,,,Vitamin D Analog,,,,
1376,Not Relevant,Chronic kidney disease,Focussed Oral,The DNA Methyltransferase Inhibitor 5-Azacytidine Alleviates Podocyte Injury By Reversing DNA Hypermethylation-Mediated Inhibition of INSR In Podocytes Of Diabetic db/db Mice,Diabetes,Diabetes,5-Azacytidine,,,DNA Hypermethylation Mediated-Inhibitor;DNA Methyltransferase-Inhibitor,,,,
1377,Not Relevant,Chronic kidney disease,Focussed Oral,A new calcimimetic inhibiting vascular calcification: the endogenous VIF peptide,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1378,Not Relevant,Chronic kidney disease,Focussed Oral,Intestinal microbiota prevents worsening of sepsis-related outcomes in chronic kidney disease,Chronic Kidney Disease;Sepsis,Chronic Kidney Disease;Sepsis,,,,,,,,
1379,Not Relevant,Chronic kidney disease,Focussed Oral,Blockade of Translocator Protein Ameliorates Intrarenal Lipid Accumulation and Kidney Injury in Obesity-induced Chronic Kidney Disease,Chronic Kidney Disease;Obesity,Chronic Kidney Disease;Obesity,,,,,,,,
1380,Not Relevant,Chronic kidney disease,Focussed Oral,Uremic toxin receptor AhR promotes renal fatty acid synthesis and fibrosis via accelerating ubiquitin degradation of NR1D1,Fibrosis,Fibrosis;Renal Fatty Acid Synthesis,,,,,,,,
1381,Not Relevant,Chronic kidney disease,Focussed Oral,A new model of CKD in naturally aged swine,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1382,Not Relevant,Chronic kidney disease,Focussed Oral,Intra-coronary VEGF therapy rescues cardiac VEGF signaling and improves cardiac function in experimental CKD-HFpEF,Chronic Kidney Disease;Heart Failure,Chronic Kidney Disease;Heart Failure,,,,VEGF-Targeted Therapy,,,,
1383,Not Relevant,Chronic kidney disease,Focussed Oral,Interferon regulatory factor 5 in myeloid cells promotes obstructive nephropathy-induced renal fibrosis in vivo,Fibrosis;Nephropathy,Obstructive Nephropathy;Renal Fibrosis,,,,,,,,
1384,Not Relevant,Chronic kidney disease,Focussed Oral,Sweat-Based Protocols for Reliable Determination of Creatine and Cystatin-C in Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1385,Not Relevant,Chronic kidney disease,Focussed Oral,The role of uremic toxins and inflammation in eryptosis and renal anemia among dialysis patients.,Anemia;Renal Failure,Kidney Failure;Renal Anemia,,,,,,,,
1386,Not Relevant,Chronic kidney disease,Focussed Oral,Underestimate of the diagnosis and treatment of chronic kidney disease for in-hospital cardiovascular disease patients—A nationwide cross-section study in China,Cardiovascular Disease;Chronic Kidney Disease,Cardiovascular Disease;Chronic Kidney Disease,,,,,,,,
1387,Not Relevant,Chronic kidney disease,Focussed Oral,Impact of Cardiorenal Unit Management on Care Outcomes: The Role of Heart Failure Therapy Optimization.,Heart Failure,Heart Failure,,,,,,,,
1388,Not Relevant,Chronic kidney disease,Focussed Oral,Impact of Kidney Transplantation on Chronic Kidney Disease-Associated Pruritus,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,,,,,,,,
1389,Not Relevant,Chronic kidney disease,Focussed Oral,Renin-angiotensin-aldosterone system inhibitor utilization and hyperkalemia in patients with chronic kidney disease – Results from ZORA China,Chronic Kidney Disease;Hyperkalemia,Chronic Kidney Disease;Hyperkalemia,,,,Renin-Angiotensin-Aldosterone System Inhibitor,,,ZORA,
1390,Not Relevant,Chronic kidney disease,Focussed Oral,"Tumor Necrosis Factor alpha and high phosphate increase platelet adhesion, by modifying endothelial anti-thrombotic properties",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1391,Not Relevant,Chronic kidney disease,Focussed Oral,High glucose worsens calcium deposition and osteoblastic differentiation induced by high phosphate treatment in human aortic endothelial cells,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1392,Not Relevant,Chronic kidney disease,Focussed Oral,The impact of comorbid type 2 diabetes on the prevalence of chronic kidney disease-associated pruritus and its effects on quality of life: Data from the CENSUS-EU study.,Chronic Kidney Disease;Type 2 Diabetes,Chronic Kidney Disease;Type 2 Diabetes,,,,,Vifor,,CENSUS-EU;;NCT05524467,
1393,Not Relevant,Chronic kidney disease,Focussed Oral,Hemoglobin increases faster at high altitude in CKD patients treated with SGLT2 inhibitors: the SGaLTitude study,Chronic Kidney Disease,Chronic Kidney Disease,,,,SGLT2-Inhibitor,,,SGaLTitude,
1394,Not Relevant,E-Posters,e-Poster,Time in target range of systolic blood pressure and cardiovascular disease in patients with chronic kidney disease: A Korean nationwide cohort study,Cardiovascular Disease;Chronic Kidney Disease,Cardiovascular Disease;Chronic Kidney Disease,,,,,,,,
1395,Not Relevant,Chronic kidney disease,Focussed Oral,Causal assessment of CKD-MBD phenotypes and CKD progression through a g-formula analysis – Insights from the EQUAL Study,Chronic Kidney Disease,Chronic Kidney Disease;Mineral Bone Disorder,,,,,,,EQUAL,
1396,Not Relevant,Chronic kidney disease,Focussed Oral,Understanding cardiovascular benefits of finerenone:  the role of central arterial stiffness,Chronic Kidney Disease,Chronic Kidney Disease,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,,
1397,Not Relevant,Chronic kidney disease,Focussed Oral,Predictive Ability Of Carotid Intima Media Thickness For Cardiovascular Events In Patients With Chronic Kidney Disease On Dialysis : Indian Cohort,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1398,Not Relevant,CKD in the elderly,Symposium,Healthy ageing and the kidney: Lessons from centenarians,Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,,,Elderly,,
1399,Not Relevant,CKD in the elderly,Symposium,The burden of CKD in aging societies,Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,,,Elderly,,
1400,Not Relevant,CKD in the elderly,Symposium,"Aging Societies: Insights, Interventions, and Nephrology Challenges",Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,,,Elderly,,
1401,Not Relevant,Dialysis,Focussed Oral,"Comparative effectiveness of etelcalcetide versus cinacalcet for the treatment of secondary hyperparathyroidism in patients in haemodialysis: a population-based study in Lazio, Italy",Renal Failure;Secondary Hyperparathyroidism,Kidney Failure;Secondary Hyperparathyroidism,Etelcalcetide,,Cinacalcet,Calcium Sensing Receptor-Agonist,,,,
1402,Not Relevant,Dialysis,Focussed Oral,European Hemoglobin Target Range Supported when Assessing Association between Observed Hemoglobin and All-Cause Mortality in Hemodialysis Patients Treated with Erythropoietin Stimulating Agents,Renal Failure,Kidney Failure,,,,Erythropoietin Stimulating Agent,,,,
1403,Not Relevant,Dialysis,Focussed Oral,Two Decades of Dialysis in 41 Countries: the new MONitoring Dialysis Outcomes (MONDO) initiative dataset,Renal Failure,Kidney Failure,,,,,,,,
1404,Not Relevant,Dialysis,Focussed Oral,Ultrasound for Median Nerve Evaluation in Dialysis Patients: A Reliable Tool for Detecting Carpal Tunnel Syndrome,Carpal Tunnel Syndrome;Renal Failure,Carpal Tunnel Syndrome;Kidney Failure,,,,,,,,
1405,Not Relevant,Dialysis,Focussed Oral,Haemodialysis patients and nephrology health care professionals from Ireland exhibit concordance with the hierarchy of biomedical and patient related outcome measures proposed by the SONG-HD consortium: A single centre study,Renal Failure,Kidney Failure,,,,,,,,SONG-HD
1406,Not Relevant,Dialysis,Focussed Oral,Novel biomarkers for cardiac evaluation in obese and non-obese hemodialysis patients,Renal Failure,Kidney Failure,,,,,,,,
1407,Not Relevant,Dialysis,Focussed Oral,Correlation Between Right Ventricle Diastolic Function And Systemic Venous Congestion In Patients With Chronic Kidney Disease On Renal Replacement Therapy And Hemodialysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1408,Not Relevant,Dialysis,Focussed Oral,Roles of antiHLA antibodies in the onset of MACE in a population of patients on dialysis and on the waiting list for kidney transplant. A retrospective single-center study,Renal Failure,Kidney Failure,,,,,,,,
1409,Not Relevant,Dialysis,Focussed Oral,Malnutrition Is Prevalent In Dalmatian Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
1410,Not Relevant,Dialysis,Focussed Oral,A randomized clinical trial on the effect of PEGylated granulocyte-colony stimulating factor on antibody response in hemodialysis patients who had not responded to routine hepatitis B virus vaccine,Hepatitis B;Infection;Renal Failure,Hepatitis B Virus Infection;Kidney Failure,Pegylated Granulocyte Colony Stimulating Factor,,,Leukocyte Growth Factor,,,,
1411,Not Relevant,Dialysis,Focussed Oral,Behavior Of Left Ventricular Diastolic Dysfunction During The Dialysis Session,Renal Failure,Kidney Failure,,,,,,,,
1412,Not Relevant,Dialysis,Focussed Oral,"First-In-Human Trial to Evaluate the Safety and Efficacy of Neokidney, a New Portable Hemodialysis Device",Renal Failure,Kidney Failure,,,,,,,,
1413,Not Relevant,Dialysis,Focussed Oral,Heparin use on hemodialysis – influencing factors,Renal Failure,Kidney Failure,Heparin,,,Anti-Coagulant,,,,
1414,Not Relevant,Dialysis,Focussed Oral,Impact of Adipose Tissue on Estimating Extracellular Resistance in Hemodialysis Patients Using a Two-Compartment Model,Renal Failure,Kidney Failure,,,,,,,,
1415,Not Relevant,Dialysis,Focussed Oral,The Choice of Anti-Inflammatory Influences the Elimination of Protein-Bound Uremic Toxins,Renal Failure,Kidney Failure,,,,,,,,
1416,Not Relevant,Dialysis,Focussed Oral,Effects of super high-flux vitamin E-coated and medium cut-off dialyzers on uremic toxins removal and biocompatibility: the E-FLUX randomized controlled study,Renal Failure,Kidney Failure,Vitamin E,,,Antioxidant,,,E-FLUX;;NCT05610683,
1417,Not Relevant,Dialysis,Focussed Oral,Removal of Middle Molecules With Hemoadsorption plus Hemodiafiltration in Kidney Failure Patients,Renal Failure,Kidney Failure,,,,,,,,
1418,Not Relevant,Dialysis,Focussed Oral,A single-centre service evaluation of patient-centred twice-weekly dialysis delivery,Renal Failure,Kidney Failure,,,,,,,,
1419,Not Relevant,Dialysis,Focussed Oral,Dialysis Less Frequently in the Elderly:  The D-LITE Pilot Trial,Renal Failure,Kidney Failure,,,,,,,D-LITE;;NCT03787719,
1420,Not Relevant,Dialysis,Focussed Oral,A randomized prospective crossover study on the effects of medium cut-off membranes on FGF-23 and inflammatory mediators in patients receiving regular haemodialysis,Renal Failure,Kidney Failure,,,,,,,,
1421,Not Relevant,Dialysis,Focussed Oral,Intradialytic Exercise Modulates Vascular Biomarkers in CKD: Implications for Cardiovascular Health in Hemodiafiltration Patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1422,Not Relevant,Dialysis,Focussed Oral,Fluid management in hemodialysis based on apparative methods and patient-reported outcome measures: A quality improvement project,Renal Failure,Kidney Failure,,,,,,,,
1423,Not Relevant,Dialysis,Focussed Oral,Efficiency And Safety Of Expanded (Hdx) And High-Flux Hemodialysis In The Era Of Green Dialysis,Renal Failure,Kidney Failure,,,,,,,,
1424,Not Relevant,Dialysis,Focussed Oral,Insights into the Itching Burden Experience of Patients with Hemodialysis-Associated Pruritus: A Social Media Listening Study,Pruritus;Renal Failure,Kidney Failure;Pruritus,,,,,,,,
1425,Not Relevant,Dialysis,Focussed Oral,Long-term efficacy and impact on quality of life of difelikefalin treatment in haemodialysed patients with moderate-to-severe chronic kidney disease associated pruritus,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,Difelikefalin,,,Kappa Opioid Receptor-Agonist,,,,
1426,Not Relevant,Dialysis,Focussed Oral,Lung Ultrasound Guided Management of Pulmonary Congestion in Hemodialysis: A Multi-center Randomized Controlled Trial,Pulmonary Edema;Renal Failure,Kidney Failure;Pulmonary Congestion,,,,,,,,
1427,Not Relevant,Dialysis,Focussed Oral,Pleural effusions among patients on maintenance hemodialysis patients,Renal Failure,Kidney Failure,,,,,,,,
1428,Not Relevant,Dialysis,Focussed Oral,Calciphylaxis: a qualitative study of patient experiences,Renal Failure,Kidney Failure,,,,,,,,
1429,Not Relevant,Dialysis,Focussed Oral,Upacicalcet Preserves Albumin Levels in Hemodialysis Patients with Secondary Hyperparathyroidism: A Post-hoc Analysis of a Randomized Trial,Renal Failure;Secondary Hyperparathyroidism,Kidney Failure;Secondary Hyperparathyroidism,Upacicalcet,,,Calcium Sensing Receptor-Agonist,,,,
1430,Not Relevant,Dialysis,Focussed Oral,Large Language Models for Algorithm-Based Management of Bone Mineral Disorders in Patients with Hemodialysis,Renal Failure,Bone Mineral Disorder;Kidney Failure,,,,,,,,
1431,Not Relevant,Dialysis,Focussed Oral,The Impact of Serum Uromodulin on Aortic Arch Vascular Calcification in Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
1432,Not Relevant,Dialysis,Focussed Oral,Effectiveness of  microwave ablation in the treatment of non-primary hyperparathyroidism in dialysis patients,Primary Hyperparathyroidism,Non-Primary Hyperparathyroidism,,,,,,,,
1433,Not Relevant,Dialysis,Focussed Oral,Efficacy of Vitamin C Supplementation in Patients Undergoing Hemodiafiltration: A Comparison Between Oral and Intravenous Administration,Renal Failure,Kidney Failure,Vitamin C,,,Antioxidant,,,,
1434,Not Relevant,Dialysis,Focussed Oral,Trajectories of Muscle Mass Changes in Hemodialysis Patients: A Two-Year Prospective Cohort Study Analyzing Clinical Factors,Renal Failure,Kidney Failure,,,,,,,,
1435,Not Relevant,Dialysis,Focussed Oral,Ultrafiltration rate and interleukin-6 levels are independent predictors of erythropoietin resistance in chronic hemodialysis patients,Renal Failure,Kidney Failure,,,,,,,,
1436,Not Relevant,Emerging concepts on pathophysiology of hypertension,Symposium,Kidney meets aging: is chronodisruption a concept relevant to hypertension and CKD?,Chronic Kidney Disease;Hypertension,Chronic Kidney Disease;Hypertension,,,,,,,,
1437,Not Relevant,Emerging concepts on pathophysiology of hypertension,Symposium,Potassium regulation and BP levels: a new road for treatment?,Hypertension,Hypertension,,,,,,,,
1438,Not Relevant,Emerging concepts on pathophysiology of hypertension,Symposium,Autonomic nervous system dysfunction in CKD and ESKD,Chronic Kidney Disease;Kidney Diseases,Chronic Kidney Disease;End Stage Kidney Disease,,,,,, End Stage,,
1439,Not Relevant,FC 10: The Basics of Chronic Kidney Disease,Free Communication,Mesangial cell injury-aggravated CKD in Jak2-mutated myeloproliferative neoplasms,Chronic Kidney Disease;Myeloproliferative Neoplasm,Chronic Kidney Disease;Jak2-Mutated Myeloproliferative Neoplasm,,,,,,JAK2-Mutant,,
1440,Not Relevant,E-Posters,e-Poster,Collagen Type Iv Alpha-1 (Co4A1) Is Necessary For Glomerular Regeneration Through Pax2 Regulation,,,,,,,,,,
1441,Not Relevant,FC 10: The Basics of Chronic Kidney Disease,Free Communication,Impaired renal progenitor regeneration and polyploid tubular cell progression underlie physiological kidney tubule aging,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1442,Not Relevant,FC 10: The Basics of Chronic Kidney Disease,Free Communication,Activation of the TGF-β2-TβRIII Signaling Pathway in Glomerular Endothelial Cells during the Progression of Diabetic Kidney Disease,Diabetes;Renal Failure,Diabetes;Progressive Kidney Failure,,,,,,Progressive,,
1443,Not Relevant,FC 10: The Basics of Chronic Kidney Disease,Free Communication,Chemokine Ligand 14 Acts as a Pro-Fibrotic Stimulus in Chronic Kidney Disease Progression through Regulation of the GATA2 Transcription Factor,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1444,Not Relevant,FC 10: The Basics of Chronic Kidney Disease,Free Communication,Sustained activation of the PI3K/Akt/mTOR pathway in proximal tubular cells promotes tubular albuminuria by decreasing the expression of endocytic receptors,Albuminuria;Chronic Kidney Disease,Albuminuria;Chronic Kidney Disease,,,,,,,,
1445,Not Relevant,FC 11: Highs and Lows: The Hemodialysis Rollercoaster,Free Communication,A novel system to continuously estimate blood pressure in real time during haemodialysis: comparison against standard brachial cuff blood pressures.,Renal Failure,Kidney Failure,,,,,,,,
1446,Not Relevant,FC 11: Highs and Lows: The Hemodialysis Rollercoaster,Free Communication,Plasma endothelin-1 concentration before hemodialysis is related to the direction of blood pressure changes during hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
1447,Not Relevant,FC 11: Highs and Lows: The Hemodialysis Rollercoaster,Free Communication,Intradialytic blood pressure dynamics in a large U.S. hemodialysis population: Unexpected rates of intradialytic hypotension and hypertension,Hypotension;Renal Failure,Hypotension;Kidney Failure,,,,,,,,
1448,Not Relevant,FC 11: Highs and Lows: The Hemodialysis Rollercoaster,Free Communication,Therapeutic Approach to the Management of Intradialytic Complications: From Combating Hypoxemia to Improving Hemodialysis Tolerance,Hypoxia;Renal Failure,Hypoxia;Kidney Failure,,,,,,,,
1449,Not Relevant,FC 11: Highs and Lows: The Hemodialysis Rollercoaster,Free Communication,Prognostic significance of visit-to-visit ultrafiltration volume variability in hemodialysis patients,Renal Failure,Kidney Failure,,,,,,,,
1450,Not Relevant,FC 11: Highs and Lows: The Hemodialysis Rollercoaster,Free Communication,Coexistence of malnutrition and sarcopenia and its impact on mortality in patients on hemodialysis: Results from the SARC-HD Study,Renal Failure;Sarcopenia,Kidney Failure;Sarcopenia,,,,,,,,SARC-HD
1451,Not Relevant,FC 9: ADPKD: Finding Mechanisms of Disease and Treatment,Free Communication,PCK1 loss contributes to kidney disease progression by altering mitochondrial fitness through its cataplerotic function,Kidney Diseases,Progressive Kidney Disease,,,,,,Progressive,,
1452,Not Relevant,FC 9: ADPKD: Finding Mechanisms of Disease and Treatment,Free Communication,Monoallelic IFT172 Variants as a Genetic Contributor to the ADPKD Spectrum,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1453,Not Relevant,FC 9: ADPKD: Finding Mechanisms of Disease and Treatment,Free Communication,Genetic heterogeneity of ADPKD: A total of 21 different genes identified in a population-based ADPKD cohort,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1454,Not Relevant,FC 9: ADPKD: Finding Mechanisms of Disease and Treatment,Free Communication,Deep phenotyping predicts genotype and refines prognosis in lower risk ADPKD genotypes,Autosomal Dominant Polycystic Kidney,Lower Risk Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1455,Not Relevant,FC 9: ADPKD: Finding Mechanisms of Disease and Treatment,Free Communication,Exploring the Role of Polygenic Risk Scores in Aneurysm Risk Among ADPKD Patients – A Collaborative Study,Autosomal Dominant Polycystic Kidney;Dementia,Aneurysmal Dementia;Autosomal Dominant Polycystic Kidney,,,,,,,,
1456,Not Relevant,FC 9: ADPKD: Finding Mechanisms of Disease and Treatment,Free Communication,A novel monoclonal antibody against PAPP-A significantly inhibits disease progression in three mouse models of autosomal dominant polycystic kidney disease,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney,,,,PAPP-A-Targeted Monoclonal Antibody,,,,
1457,Not Relevant,Game changers in diagnosis and treatment of complement-mediated kidney disease,Symposium,Biomarkers of complement: how to diagnose a complementopathy,Kidney Diseases,Complement-Mediated Kidney Disease,,,,,,,,
1458,Not Relevant,Game changers in diagnosis and treatment of complement-mediated kidney disease,Symposium,"Monoclonal, Genetic and Autoimmune:the different etiologies of C3G",Kidney Diseases,Complement-Mediated Kidney Disease,,,,,,,,
1459,Not Relevant,Game changers in diagnosis and treatment of complement-mediated kidney disease,Symposium,Why we need so many different drugs for complement inhibition?,Kidney Diseases,Complement-Mediated Kidney Disease,,,,,,,,
1460,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Validation and clinical application of the Vasculitis quality of life (VASQLIFE) survey: An AAV-Specific Patient-Reported Outcome Measure for use in routine clinic practice,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
1461,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Predicting Kidney Outcomes In Anca Vasculitis: Which Histological Scores Should We Use?,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
1462,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Chronic Kidney Disease in Sjögren’s Syndrome: Key Predictive Factors Revealed in a 133-Patient Cohort,Chronic Kidney Disease;Sjogren's Syndrome,Chronic Kidney Disease;Sjogren's Syndrome,,,,,,,,
1463,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Insights into Early Crescentic Glomerulonephritis via Single-Nuclei Sequencing,Crescentic Glomerulonephritis,Early Crescentic Glomerulonephritis,,,,,,Early Onset,,
1464,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Long-term patients and kidney prognosis of pure membranous compared to mixed lupus nephritis: an Italian multicenter study of 195 patients,Lupus Nephritis,Mixed Lupus Nephritis,,,,,,,,
1465,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Evaluation of the proposed clinical and histological prognostic scores in patients with ANCA-associated vasculitis: A single-center retrospective study,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,,,,,,,,
1466,Low,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Plasma endothelial biomarkers in relation to albuminuria, kidney function and CKD progression in IgA-nephropathy",Albuminuria;Chronic Kidney Disease;IgA Nephropathy,Albuminuria;Chronic Kidney Disease;IgA Nephropathy,,,,,,,,
1467,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Neutrophils Ferroptosis restrict Treg activity through metabolic reprogramming in systemic lupus erythematosus,Systemic Lupus Erythematosus,Systemic Lupus Erythematosus,,,,,,,,
1468,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Cardiac autonomic dysfunction and arterial stiffness in patients with sustained remission of ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,,,,,,,,
1469,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Hemorrhagic stroke as an uncommon complication of granulomatosis with polyangiitis,Brain Hemorrhage;Granulomatosis with Polyangiitis,Granulomatosis With Polyangiitis;Hemorrhagic Stroke,,,,,,,,
1470,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Cardiorenal outcomes and long-term kidney function decline in IgA Nephropathy compared with chronic kidney disease patients with and without diabetes - FinnGen study,Chronic Kidney Disease;IgA Nephropathy,Chronic Kidney Disease;IgA Nephropathy,,,,,,,FinnGen,
1471,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Anti-drug antibodies are common in Membranous Nephropathy and affect response to rituximab: a multicenter study,Membranous Nephropathy,Membranous Nephropathy,Rituximab,,,CD20-Targeted Monoclonal Antibody,,,,
1472,Not Relevant,Hypertension & Diabetes,Focussed Oral,Study of renal blood flow and severity of coronary atherosclerosis in patients with ischemic heart disease who underwent myocardial revascularization,Coronary Arteriosclerosis;Ischemic Heart Disease,Coronary Atherosclerosis;Ischemic Heart Disease,,,,,,,,
1473,Not Relevant,Hypertension & Diabetes,Focussed Oral,"Stromal Cell-Derived Factor-1, P-Selectin, And Advanced Oxidation Protein Products May Be Associated With Cerebral Vessels In Normoalbuminuric Diabetic Kidney Disease",Diabetic Nephropathy,Normoalbuminuric Diabetic Kidney Disease,,,,,,,,
1474,Not Relevant,Hypertension & Diabetes,Focussed Oral,"Real-Life Study Of Finerenone, Efficacy And Safety Assessment",Diabetes;Hypertension,Diabetes;Hypertension,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,,
1475,Not Relevant,Hypertension & Diabetes,Focussed Oral,Role of ACE2 in the prediction of preeclampsia,Pre-Eclampsia,Preeclampsia,,,,,,,,
1476,Not Relevant,Hypertension & Diabetes,Focussed Oral,Prevalence of Hypertensive Disorders of Pregnancy and Predictors of Adverse Outcomes: 5-year Retrospective Review in a Tertiary Referral Center,Hypertensive Disorders,Hypertensive Disorder,,,,,,,,
1477,Not Relevant,Hypertension & Diabetes,Focussed Oral,Clinical Significance of Proteinuria Burden at Serial Health Screenings in Patients with Diabetes Mellitus - A Nationwide Cohort Study,Diabetes;Proteinuria,Diabetes;Proteinuria,,,,,,,,
1478,Not Relevant,Hypertension & Diabetes,Focussed Oral,The association between hemoglobin A1c and complications among individuals with diabetes and severe chronic kidney disease,Chronic Kidney Disease;Diabetes,Diabetes;Severe Chronic Kidney Disease,,,,,,Severe,,
1479,Not Relevant,Hypertension & Diabetes,Focussed Oral,Incremental hemodialysis with thight control of overhydration as an option for pregnant woman in RRT,Renal Failure,Kidney Failure;Overdose,,,,,,,,
1480,Not Relevant,Hypertension & Diabetes,Focussed Oral,Sex related disparities in the management of Diabetic Kidney Disease: A Retrospective Analysis in a Health Region,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
1481,Not Relevant,Hypertension & Diabetes,Focussed Oral,Eosinophilic Infiltration in Biopsies of Patients with Diabetic Nephropathy.,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
1482,Not Relevant,Hypertension & Diabetes,Focussed Oral,"Pregnancy, primary aldosteronism and renal tubular disorders: A systematic review of the utility of amiloride in pregnancy",Kidney Tubular Disorder;Primary Hyperaldosteronism,Primary Aldosteronism;Renal Tubular Disorder,Amiloride,,,ENaC-Inhibitor,,,,
1483,Not Relevant,Hypertension & Diabetes,Focussed Oral,Childhood Takayasu arteritis: a multicentre retrospective cohort study,Aortic Arch Syndrome,Childhood Takayasu Arteritis,,,,,,Childhood,,
1484,Not Relevant,Learn by Practice: Weight loss for CKD: are GLP-1 receptor agonists the solution for all patients?,Symposium,"Case 1: A patient with type 2 DM, HbA1c of 7.4%, BMI of 27 kg/m², and a UACR of 300 mg/g",Type 2 Diabetes,Type II Diabetes,,,,,,,,
1485,Not Relevant,Learn by Practice: Weight loss for CKD: are GLP-1 receptor agonists the solution for all patients?,Symposium,"Case 2: A non-diabetic patient with presumed secondary FSGS, BMI of 34 kg/m² and a UACR of 2 g/g",Focal Segmental Glomerulosclerosis,Secondary Focal Segmental Glomerulosclerosis,,,,,,,,
1486,Not Relevant,Nephrology breakthroughs: editors‘ panel on innovation,Symposium,Introduction,,,,,,,,,,
1487,Not Relevant,Nephrology breakthroughs: editors‘ panel on innovation,Symposium,CKD,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1488,Not Relevant,Nephrology breakthroughs: editors‘ panel on innovation,Symposium,Glomerular disease,Glomerular Disease,Glomerular Disease,,,,,,,,
1489,Not Relevant,Nephrology breakthroughs: editors‘ panel on innovation,Symposium,Dialysis,Renal Failure,Kidney Failure,,,,,,,,
1490,Not Relevant,Nephrology breakthroughs: editors‘ panel on innovation,Symposium,Transplantation,,,,,,,,,,
1491,Not Relevant,Nephrology breakthroughs: editors‘ panel on innovation,Symposium,Concluding remarks,,,,,,,,,,
1492,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Population modelling depicts the mutational burden of NPHS2 (podocin) nephropathy and reveals an undiagnosed later onset genetic cohort,Nephropathy,Nephropathy,,,,,,,,
1493,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Whole Exome Sequencing Analysis In Patients With Loin Pain Hematuria Syndrome Vs. Isolated Hematuria,Hematuria,Hematuria;Loin Pain,,,,,,,,
1494,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,A novel CT -based radiomics approach for kidney function evaluation in ADPKD,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1495,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Kidney involvement in MELAS/MIDD syndrome: a multicentric description of 104 patients.,Acidosis;Maternally Inherited Diabetes and Deafness;Stroke,Maternally Inherited Diabetes And Deafness;Mitochondrial Encephalomyopathy Lactic Acidosis Stroke-Like Episodes,,,,,,,,
1496,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,"Renal uric acid microcrystals drive hyperinflammation, cystogenesis and disease progression in ADPKD",Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease;Hyperinflammatory Syndrome,,,,,,,,
1497,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Diffusion tensor imaging for tissue characterization and risk stratification in atypical ADPKD patients,Autosomal Dominant Polycystic Kidney,Atypical Autosomal Dominant Polycystic Kidney Disease,,,,,,Atypical,,
1498,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Inhibition of c-Maf and Chemokine receptros prevents the progression of Fabry Disease nephropathy,Fabry Disease;Nephropathy,Fabry Disease Nephropathy,,,,,,,,
1499,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Kidney volume based on multi-dimensional orthogonal ultrasound measurements is more accurate than kidney length in evaluation of kidney growth in paediatric ADPKD,Autosomal Dominant Polycystic Kidney,Paediatric Autosomal Dominant Polycystic Kidney Disease,,,,,,Paediatric,,
1500,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Association of Renal Diameters with ADPKD Gene Variants: Focus on PKD2 Truncating Mutations,Polycystic Kidney Diseases,Polycystic Kidney Disease,,,,,,,,
1501,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Evaluation of eGFR slope and ht-TKV After One Year of Treatment with Dapagliflozin in ADPKD Patients: A Retrospective Case Series Analysis,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,Dapagliflozin,,,SGLT2-Inhibitor,,,,
1502,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Genotype and phenotype in autosomal dominant tubulointerstitial kidney disease: a case series,Autosomal Dominant Tubulointerstitial Kidney Disease,Autosomal Dominant Tubulointerstitial Kidney Disease,,,,,,,,
1503,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Kidney Involvement in Non-MELAS/MIDD Mitochondrial Diseases: A Report on 58 Patients.,Acidosis;Maternally Inherited Diabetes and Deafness;Stroke,Non-Maternally Inherited Diabetes And Deafness;Non-Mitochondrial Encephalomyopathy Lactic Acidosis Stroke-Like Episodes,,,,,,,,
1504,Not Relevant,Standing between rare and common,Symposium,COL4A3 / 4 pathogenic variants: disease or risk factor?,,,,,,,,,,
1505,Not Relevant,Standing between rare and common,Symposium,Common variants effect on rare diseases,Rare Disease,Rare Disease,,,,,,,,
1506,Not Relevant,Standing between rare and common,Symposium,Genetic forms of hypomagnesemia,Hypomagnesemia,Hypomagnesemia,,,,,,,,
1507,Not Relevant,Tolerance induction - a game changing innovation,Symposium,It takes two: combining bone marrow and Tregs,,,,,,,,,,
1508,Not Relevant,Tolerance induction - a game changing innovation,Symposium,How far can CARs go?,,,,,,,,,,
1509,Not Relevant,Tolerance induction - a game changing innovation,Symposium,Donor modified immune cells,,,,,,,,,,
1510,Not Relevant,Chronic kidney disease,Focussed Oral,"Minimally invasive percutaneous intrarenal inoculation of extracellular vesicles (EV), derived from mesenchymal stem cells (MSC), as a therapeutic strategy for experimental chronic kidney disease",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1511,Not Relevant,Chronic kidney disease,Focussed Oral,Mesenchymal stem cells (MSC) delivered directly into the kidney through a minimally invasive percutaneous ultrasound-guided technique:  A new therapeutic approach to abrogate CKD progression,Chronic Kidney Disease,Chronic Kidney Disease,Mesenchymal Stem Cell,,,Stem Cell Therapy,,,,
1512,Not Relevant,Chronic kidney disease,Focussed Oral,ITGA6 as a Potential Therapeutic Target for Inhibiting the Progression of Diabetic nephropathy,Diabetic Nephropathy,Progressive Diabetic Nephropathy,,,,,,Progressive,,
1513,Not Relevant,Chronic kidney disease,Focussed Oral,"Biosensors for measuring cystatin c, creatinine and urea in human sweat",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1514,Not Relevant,Chronic kidney disease,Focussed Oral,Tubule-specific cyclin-dependent kinase 12 knockdown promotes fatty acid oxidation disorder by down-regulating PPAR? in chronic kidney disease,Chronic Kidney Disease;Fatty Acid Oxidation Disorder,Chronic Kidney Disease;Fatty Acid Oxidation Disorder,,,,,,,,
1515,Not Relevant,Chronic kidney disease,Focussed Oral,Sex-specific metabolic dysfunction and reduced lifespan induced by long-term and low-dose dietary phosphorus loading in mice,,Metabolic Dysfunction,,,,,,,,
1516,Not Relevant,Chronic kidney disease,Focussed Oral,A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis,Atherosclerosis;Chronic Kidney Disease,Atherosclerosis;Chronic Kidney Disease,,,,,,,,
1517,Not Relevant,Chronic kidney disease,Focussed Oral,Fetuin-A supplementation as a key treatment strategy to mitigate acute kidney injury and prevent its progression to chronic disease,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1518,Not Relevant,Chronic kidney disease,Focussed Oral,Polyploid tubular cells drive functional recovery after nephron mass loss and can be employed to determine likelyhood of CKD progression,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1519,Not Relevant,Chronic kidney disease,Focussed Oral,A pregnancy reduces kidney lifespan in Col4a3-/- mice with Alport Nephropathy. Impact of a renoprotective triple combination therapy on maternal kidney outcomes.,Alport Syndrome;Chronic Kidney Disease,Alport Syndrome;Chronic Kidney Disease,,,,,,,,
1520,Not Relevant,Chronic kidney disease,Focussed Oral,"Exogenous a-Klotho Supplementation Significantly Prolongs Survival in a Mouse Model of Alport Syndrome, With Comparable Outcomes to RASi",Alport Syndrome,Alport Syndrome,,,,,,,,
1521,Not Relevant,Chronic kidney disease,Focussed Oral,Single-nuclear transcriptomics identifies novel therapeutic targets in a translational model of chronic kidney disease in swine,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1522,Not Relevant,Chronic kidney disease,Focussed Oral,Endothelial-specific CDK12 knockdown potentiates cardiorenal injury through SPNS2-mediated cell apoptosis,,Cardiorenal Injury,,,,,,,,
1523,Not Relevant,Chronic kidney disease,Focussed Oral,Salvianolic acid C mitigates sepsis-induced kidney injury through promotion of renal gluconeogenesis,Sepsis,Kidney Injury;Sepsis,Salvianolic Acid C,,,Anti-Inflammatory,,,,
1524,Not Relevant,Chronic kidney disease,Focussed Oral,Nanoparticle-mediated Klotho Gene Therapy Prevents Kidney Disease Progression via PPARa Pathway,Chronic Kidney Disease,Chronic Kidney Disease,,,,Gene Therapy,,,,
1525,Not Relevant,Chronic kidney disease,Focussed Oral,The shadow of renal dysfunction on guideline-directed medical therapy in HFrEF: insights from a cardio-nephrology perspective in Eastern Europe,Heart Failure;Renal Failure,Heart Failure;Kidney Failure,,,,,,,,
1526,Not Relevant,Chronic kidney disease,Focussed Oral,Association of parathyroid hormone and alkaline phosphatase with fracture risk in patients with chronic kidney disease not on dialysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1527,Not Relevant,Chronic kidney disease,Focussed Oral,"Clinical characteristics and Healthcare Resource Utilization, and Costs associated in Patients with Diagnosed and Undetected hyperkalemia: IBERIK+ Study",Hyperkalemia,Hyperkalemia,,,,,,,IBERIK+,
1528,Not Relevant,Chronic kidney disease,Focussed Oral,Senescence: a translational perspective for uremic cardiomyopathy,Cardiomyopathy,Uremic Cardiomyopathy,,,,,,,,
1529,Not Relevant,Chronic kidney disease,Focussed Oral,Assessment of safety from a European difelikefalin managed access programme,Chronic Kidney Disease,Chronic Kidney Disease,Difelikefalin,,,Kappa Opioid Receptor-Agonist,,,,
1530,Not Relevant,Chronic kidney disease,Focussed Oral,Impact of Renal Impairment on Cardiac Fibrosis and Inflammation in Stage 3 Diabetic Kidney Disease patients: Insights from Cardiac MRI and  serum Biomarkers,Cardiac Fibrosis;Diabetes;Renal Impairment,Cardiac Fibrosis;Diabetes;Renal Impairment,,,,,,,,
1531,Not Relevant,Chronic kidney disease,Focussed Oral,"A Retrospective, Multicenter Study on the Efficacy and Safety of Desidustat in Chronic Kidney Disease-Induced Anemia",Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,Desidustat,,,HIF PH-Inhibitor,,,,
1532,Not Relevant,Chronic kidney disease,Focussed Oral,"The association of malondiadehyde, catalase and superoxide dismutase with kidney function and vitamin K status in chronic kidney disease",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1533,Not Relevant,Chronic kidney disease,Focussed Oral,Impact of Body Mass Index (BMI) on Renal Function Decline in High-Risk Renal Cell Carcinoma: Implications for First-Line Systemic Therapy Eligibility,Renal Cell Carcinoma,High Risk Renal Cell Carcinoma,,,,,,High-risk,,
1534,Not Relevant,Chronic kidney disease,Focussed Oral,SGLT2 Inhibitors Awaken the Norns: Unraveling Novel Erythropoietic Mechanisms in Diabetic Nephropathy,Chronic Kidney Disease;Diabetes,Chronic Kidney Disease;Diabetes,,,,SGLT2-Inhibitor,,,,
1535,Not Relevant,Chronic kidney disease,Focussed Oral,Between the Rhythm and the Function: Atrial Fibrillation in Chronic Kidney Disease,Atrial Fibrillation;Chronic Kidney Disease,Atrial Fibrillation;Chronic Kidney Disease,,,,,,,,
1536,Not Relevant,Chronic kidney disease,Focussed Oral,"Cognitive Functions In Elderly And Senile Patients With Arterial Hypertension, Depending On The Presence Of Concomitant Chronic Kidney Disease Stage 3A And 3B",Arterial Hypertension,Elderly Arterial Hypertension,,,,,,Elderly,,
1537,Not Relevant,Chronic kidney disease,Focussed Oral,"The association of dephosphorylated, uncarboxylated Matrix Gla Protein with vascular calcification and oxidative stress in Chronic Kindey Disease patients",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1538,Not Relevant,Chronic kidney disease,Focussed Oral,Evaluating the association between iron deficiency status and outcomes in patients with non-dialysis dependent chronic kidney disease,Chronic Kidney Disease;Iron Deficiency Anemia,Iron Deficiency;Non Dialysis Dependent Chronic Kidney Disease,,,,,,,,
1539,Not Relevant,Chronic kidney disease,Focussed Oral,Re-defining carboplatin dosage using eGFR-CR-CYS compared to Cockcroft Gault and impact on platinum-associated adverse events,Chronic Kidney Disease,Chronic Kidney Disease,Carboplatin,,,DNA Crosslinking Agent,,,,
1540,Not Relevant,Chronic kidney disease,Focussed Oral,Impact of Geriatric Nutritional Risk Index on Renal Function in Elderly Chronic Kidney Disease Patients Treated with SGLT2 Inhibitors,Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,SGLT2-Inhibitor,,Elderly,,
1541,Not Relevant,Chronic kidney disease,Focussed Oral,"Associations between modifiable medical, behavioral and sociopsychological factors with the risk of dementia in chronic kidney disease",Chronic Kidney Disease;Dementia,Chronic Kidney Disease;Dementia,,,,,,,,
1542,Not Relevant,Chronic kidney disease,Focussed Oral,Frequency Of Retinopathy In Children With Kidney Disease: A Clinical And Epidemiological Analysis,Kidney Diseases;Retinopathy,Childhood Kidney Disease;Retinopathy,,,,,,Childhood,,
1543,Not Relevant,Chronic kidney disease,Focussed Oral,Disease Burden of Chronic Kidney Disease Attributable to Modifiable Risk Factors: Findings from the Global Burden of Disease Study 2021,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1544,Not Relevant,Chronic kidney disease,Focussed Oral,Kidney Function and Acute Severe Infection: Observational and Mendelian Randomization Analyses,Chronic Kidney Disease;Infection,Acute Severe Infection;Chronic Kidney Disease,,,,,,Severe,,
1545,Not Relevant,Chronic kidney disease,Focussed Oral,Burden of pruritus in older CKD stage 4-5 patients: 7-year follow-up of the EQUAL study,Chronic Kidney Disease,Elderly Stage IV-V Chronic Kidney Disease,,,,,,Elderly;Metastatic,EQUAL,
1546,Not Relevant,Chronic kidney disease,Focussed Oral,Persistent effects of territorial and gender inequalities on the care trajectory of dialysis patients: access to transplantation and CKD-related mortality before and after transplantation.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1547,Not Relevant,Chronic kidney disease,Focussed Oral,Changes in nutritional intakes over time and subsequent risk of CKD progression - The CKD-REIN cohort study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,CKD-REIN;;NCT03381950,
1548,Not Relevant,Chronic kidney disease,Focussed Oral,Proteinuria in preeclampsia and later maternal kidney and cardiovascular disease: a population-based cohort study,Cardiovascular Disease;Kidney Diseases;Pre-Eclampsia;Proteinuria,Maternal Cardiovascular Disease;Maternal Kidney Disease;Preeclampsia;Proteinuria,,,,,,,,
1549,Not Relevant,Chronic kidney disease,Focussed Oral,Application of estimated glomerular filtration rate equations in patients with neurogenic lower urinary tract dysfunction,Neurogenic Lower Urinary Tract Dysfunction,Neurogenic Lower Urinary Tract Dysfunction,,,,,,,,
1550,Not Relevant,Chronic kidney disease,Focussed Oral,Dose-response analysis of serum uric acid levels and the risk of developing chronic kidney disease in patients with gout,Chronic Kidney Disease;Gout,Chronic Kidney Disease;Gout,,,,,,,,
1551,Not Relevant,Chronic kidney disease,Focussed Oral,Association between Furosemide and Serum Uremic Toxins Levels in Patients with Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,Furosemide,,,Loop Diuretic,,,,
1552,Not Relevant,Chronic kidney disease,Focussed Oral,Artificial Intelligence in the Prediction of Congenital Urological Anomalies from Perinatal Characteristics,,Congenital Urological Anomaly,,,,,,,,
1553,Not Relevant,Chronic kidney disease,Focussed Oral,Prediction of chronic kidney disease using multidimensional data and foundation model,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1554,Not Relevant,Chronic kidney disease,Focussed Oral,Psychosocial factors and risk of chronic kidney disease: a prospective cohort analysis in UK Biobank,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1555,Not Relevant,Chronic kidney disease,Focussed Oral,Exploring Sex-Based Variations in Prescription Patterns and Adverse Drug Reactions in Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1556,Not Relevant,Chronic kidney disease,Focussed Oral,Association Between the Number of Parity and the Prevalence of Chronic Kidney Disease: A Cross-Sectional Study Using KoGES-HEXA Data,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,KoGES-HEXA,
1557,Not Relevant,Chronic kidney disease,Focussed Oral,Trend of major cardiovascular events and bleeding in patients with advanced chronic kidney disease: a nationwide study,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
1558,Not Relevant,Chronic kidney disease,Focussed Oral,Physical function clusters in an Australian outpatient kidney care clinic,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1559,Not Relevant,Chronic kidney disease,Focussed Oral,Hypocalcemia and other bone and mineral disorders associated with denosumab across the spectrum of kidney function: the Stockholm CREAtinine Measurements (SCREAM) project,Hypocalcemia,Bone Disorder;Hypocalcemia,Denosumab,,,RANKL-Inhibitor,,,NCT06239129;;SCREAM,
1560,Not Relevant,Chronic kidney disease,Focussed Oral,Age and Kidney Failure Etiology: Global Profiles in ApolloDialDb,Renal Failure,Kidney Failure,,,,,,,ApolloDialDb,
1561,Not Relevant,Chronic kidney disease,Focussed Oral,"Iohexol Clearance, but not estimated GFR, reveals a steeper GFR decline in persons with prediabetes. -A population-based study-",,Prediabetes,,,,,,,,
1562,Not Relevant,Chronic kidney disease,Focussed Oral,"Serum interleukin-8 concentrations, associated factors, and associated cardiovascular risk in patients with moderate-to-advanced chronic kidney disease",Chronic Kidney Disease,Moderate/Advanced Chronic Kidney Disease,,,,,,Advanced;Moderate,,
1563,Not Relevant,Chronic kidney disease,Focussed Oral,Do Lifestyle Interventions Including Exercise Using Digital Apps and Medical Services Reduce CKD Progression? - A Systematic Review and Meta-Analysis –,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1564,Not Relevant,Chronic kidney disease,Focussed Oral,Promoting Gender Balance in Nephrology: Insights from a Pilot Survey by the Women of ERA Task Force,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1565,Not Relevant,Chronic kidney disease,Focussed Oral,CREATIVE (Comparison of Renal Estimation Approaches Through Investigating Various Equations): A Comprehensive Evaluation of eGFR Methods in CKD Staging and Management,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,CREATIVE;;NCT06143995,
1566,Not Relevant,Chronic kidney disease,Focussed Oral,Renal multiparametric MRI detects changes in renal blood flow and microstructure related to macroalbuminuria in Stage 3 Diabetic Kidney Disease patients,Diabetes,Macroalbuminuric Stage III Diabetes,,,,,,Stage III,,
1567,Not Relevant,Chronic kidney disease,Focussed Oral,Hyperkalaemia Prevalence and Risk Factors in Chronic Kidney Disease and Heart Failure: Insights from iCaReMe Registry Middle East and Africa Cohort,Heart Failure,Heart Failure,,,,,AstraZeneca,,NCT03549754,iCaReMe
1568,Not Relevant,Chronic kidney disease,Focussed Oral,Impact of Potassium Binders on RASi Continuation and Outcomes in Patients with CKD and Heart Failure: A Swedish National Cohort Study (DEMONSTRATE),Chronic Kidney Disease;Heart Failure,Chronic Kidney Disease;Heart Failure,,,,Potassium Binder;Renin–Angiotensin System Inhibitor,,,DEMONSTRATE,
1569,Not Relevant,Creative Labs III - the optimal diet for CKD patients and Kidney Transplant Recipients,Symposium,the optimal diet for CKD patients and Kidney Transplant Recipients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1570,Not Relevant,Dialysis,Focussed Oral,“Bringing the world in” – experiences of an art programme in renal dialysis units,,,,,,,,,,
1571,Not Relevant,Dialysis,Focussed Oral,Oral Health Care among Dialysis Patients in France and impact on Survival,Renal Failure,Kidney Failure,,,,,,,,
1572,Not Relevant,Dialysis,Focussed Oral,Trying to Reduce Unnecessary Carbon in Haemodialysis (TRUNC-HD) – a regional sustainability quality improvement project,Renal Failure,Kidney Failure,,,,,,,TRUNC-HD,
1573,Not Relevant,Dialysis,Focussed Oral,Global home medication practices in dialysis patients – applying NDC-to-ATC mapping,Renal Failure,Kidney Failure,,,,,,,,
1574,Not Relevant,Dialysis,Focussed Oral,First 100 Patients Undergoing Nocturnal Every-Other-Day Online Hemodiafiltration: Clinical Outcomes and Patient and Technique Survival,Renal Failure,Kidney Failure,,,,,,,,
1575,Not Relevant,Dialysis,Focussed Oral,Recurrence of CKD-associated pruritus after discontinuation of long-term difelikefalin: a national real-life study.,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,Difelikefalin,,,Kappa Opioid Receptor Agonist,,,,
1576,Not Relevant,Dialysis,Focussed Oral,AI-Powered Identification of UFR-Sensitive and Insensitive Patients to Mitigate Intradialytic Hypotension,Renal Failure,Kidney Failure,,,,,,,,
1577,Not Relevant,Dialysis,Focussed Oral,Incidence of Occult Hepatitis B Infection Among Dialysis Cohort in Malaysia,Hepatitis B,Hepatitis B,,,,,,,,
1578,Not Relevant,Dialysis,Focussed Oral,Assessment Of Health-Related Of Quality-Of-Life In Hemodialysis Patients In Colombia.,Renal Failure,Kidney Failure,,,,,,,,
1579,Not Relevant,Dialysis,Focussed Oral,"Exploring Intradialytic Symptoms, Post-Dialysis Recovery, and Quality of Life in Haemodialysis Patients: Insights from a Taiwan Cohort",Renal Failure,Kidney Failure,,,,,,,,
1580,Not Relevant,Dialysis,Focussed Oral,Primary Hyperoxaluria: A Collaboration Project Among Hemodialysis Centers for Screening Patients with Chronic Kidney Disease of Unclear Diagnosis,Chronic Kidney Disease;Primary Hyperoxaluria,Chronic Kidney Failure;Primary Hyperoxaluria,,,,,,,,
1581,Not Relevant,Dialysis,Focussed Oral,Severe Mental Illness And End-Stage Chronic Kidney Disease With Aggressive Or Anti-Treatment Behaviour: A Retrospective National Cohort Study,Psychiatric Disorder,Severe Mental Disorder,,,,,,Severe,,
1582,Not Relevant,Dialysis,Focussed Oral,Understanding the challenges nephrologists face in managing patients with severe mental illness and chronic kidney disease,Chronic Kidney Disease;Psychiatric Disorder,Chronic Kidney Disease;Severe Mental Illness,,,,,,Severe,,
1583,Not Relevant,Dialysis,Focussed Oral,"LACE-HD for prediction of 30 days re-hospitalization risk in patients on maintenance Hemodialysis, Diaverum Saudi Arabia experience",Renal Failure,Kidney Failure,,,,,,,,
1584,Not Relevant,Dialysis,Focussed Oral,Predictive Value of Galectin-3 for Acute Heart Failure and Mortality in New Hemodialysis Patients: A Prospective Cohort Study,Acute Kidney Failure,Acute Kidney Failure,,,,,,,,
1585,Not Relevant,Dialysis,Focussed Oral,Tryptophan metabolites clearance by hemodialysis and hemodiafiltration: an influence of comorbidities,Renal Failure,Kidney Failure,,,,,,,,
1586,Not Relevant,Dialysis,Focussed Oral,Monitoring of Anti-Xa Activity of Enoxaparin in Hemodialysis,Renal Failure,Kidney Failure,Enoxaparin,,,Low Molecular Weight Heparin,,,,
1587,Not Relevant,Dialysis,Focussed Oral,On-Line Haemodiafiltration And Expanded Haemodialysis: Real-Life Comparison Of Medium-Sized Uraemic Toxin Removal,Renal Failure,Kidney Failure,,,,,,,,
1588,Not Relevant,Dialysis,Focussed Oral,Online prediction of dialysis adequacy failure in hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
1589,Not Relevant,Dialysis,Focussed Oral,Protein-Bound Uremic Toxins Removal with Post-Dilutional Hemodiafiltration with High Convective Volume: A Transversal Study from Hospital Clinic Barcelona,Renal Failure,Kidney Failure,,,,,,,,
1590,Not Relevant,Dialysis,Focussed Oral,Green Nephrology by Low Convection Volume Replacement in Post-dilution Online Hemodiafiltration,,,,,,,,,,
1591,Not Relevant,Dialysis,Focussed Oral,The role of therapeutic plasma exchange in hypertriglyceridemia induced pancreatitis: single-centre experience,Hypertriglyceridemia;Pancreatitis,Hypertriglyceridemia;Pancreatitis,,,,,,,,
1592,Not Relevant,Dialysis,Focussed Oral,Intermediate monocyte and platelet activation within the extracorporeal hemodialysis circuit: novel tools assessing HD-induced thrombo-inflammation,Renal Failure,Kidney Failure,,,,,,,,
1593,Not Relevant,Dialysis,Focussed Oral,Switching from hemodialysis to high-volume hemodiafiltration does not require adjustment of dialysate sodium in clinical practice,Renal Failure,Kidney Failure,,,,,,,,
1594,Not Relevant,Dialysis,Focussed Oral,Volume status in haemodialysis patients at extreme body habitus,Renal Failure,Kidney Failure,,,,,,,,
1595,Not Relevant,Dialysis,Focussed Oral,Incremental hemodialysis: A single center experience from Singapore,Renal Failure,Kidney Failure,,,,,,,,
1596,Not Relevant,Dialysis,Focussed Oral,Intrapatient Relationship Between Plasma Refill and Ultrafiltration: Is It More Linear Than We Think?,Renal Failure,Kidney Failure,,,,,,,,
1597,Not Relevant,Dialysis,Focussed Oral,"Expanded Hemodialysis Vs. Online Hemodiafiltration: Comparison Of Mom Control, Anemia, And Molecular Clearance Over 4 Years Of Follow-Up. Are There Differences?",Anemia;Renal Failure,Anemia;Kidney Failure,,,,,,,,
1598,Not Relevant,Dialysis,Focussed Oral,Dialyzer data sheets revisited: the need for more information,Renal Failure,Kidney Failure,,,,,,,,
1599,Not Relevant,Dialysis,Focussed Oral,Overhydration and time to recovery after hemodialysis treatment before and after the introduction of a new routine for adjusting target weight (Recova-Recovery),Renal Failure,Kidney Failure,,,,,,,,
1600,Not Relevant,Dialysis,Focussed Oral,Low Gla Rich Protein Serum Levels are associated with increased Left Ventricle Hypertrophy And Pulse Pressure In Peritoneal Dialysis Patients,Renal Failure,Kidney Failure;Peritoneal Dialysis,,,,,,,,
1601,Not Relevant,Dialysis,Focussed Oral,"Assessment Of Arsenic Toxicity In Cigarette Smokers Hemodialysis Patients, Its Correlation With Anemia And Metabolic Bone Disease And Evaluation Of The Role Of High Flux Hemodialysis In Arsenic Clearance",Anemia;Renal Failure,Anemia;Kidney Failure,,,,,,,,
1602,Not Relevant,Dialysis,Focussed Oral,The Effect Of Low Dialysate Sodium Concentration On Ambulatory Aortic Blood Pressure And Arterial Stiffness In Patients With Intradialytic Hypertension: A Randomized Crossover Study,Hypertension,Intradialytic Hypertension,,,,,,,,
1603,Not Relevant,Dialysis,Focussed Oral,Association Of Dialysis Shift With Morning Surge In Blood Pressure And Dipping Pattern,Renal Failure,Kidney Failure,,,,,,,,
1604,Not Relevant,Dialysis,Focussed Oral,Effect of Dapagliflozin in Patients with End-Stage Renal Disease on Hemodialysis,End-Stage Renal Disease;Renal Failure,End Stage Renal Disease;Kidney Failure,Dapagliflozin,,,SGLT2-Inhibitor,,,,
1605,Not Relevant,Dialysis,Focussed Oral,The role of Intravenous Etelcalcitide in Haemodialysis Patients with mid-range serum Parathyroid Hormone levels.,Renal Failure,Kidney Failure,Etelcalcitide,,,Calcium Sensing Receptor-Agonist,,,,
1606,Not Relevant,Dialysis,Focussed Oral,Improvement of serum calcification propensity in dialysis patients: Comparison between low-flux and medium cut-off dialyzers,Renal Failure,Kidney Failure,,,,,,,,
1607,Not Relevant,Dialysis,Focussed Oral,"Control Of Vascular Risk Factors Among Patients With Stage 5D Chronic Kidney Disease In Spain. Preliminary Results Of The ""Objetivo En El Punto De Mira"" (Opm) Study",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,OPM,
1608,Not Relevant,Dialysis,Focussed Oral,Oral Nutritional Support of Hemodialysis Patients: an intradialytic meal model intake and adherence analysis,Renal Failure,Kidney Failure,,,,,,,,
1609,Not Relevant,Dialysis,Focussed Oral,Implementation fidelity of a pharmacist-led intervention program to improve hyperphosphatemia in Dutch hemodialysis patients,Hyperphosphatemia;Renal Failure,Hyperphosphatemia;Kidney Failure,,,,,,,,
1610,Not Relevant,Dialysis,Focussed Oral,Advanced Analysis of High-Frequency Intradialytic Data Using Artificial Intelligence,Renal Failure,Kidney Failure,,,,,,,,
1611,Not Relevant,Dialysis,Focussed Oral,Novel AI-Based Recipe Recommendation System for Dialysis Patients Using Retrieval-Augmented Generation,Renal Failure,Kidney Failure,,,,,,,,
1612,Not Relevant,Dialysis,Focussed Oral,Evaluating ChatGPT for Dietary Support: Photo-Based Ingredient Recognition for Dialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
1613,Not Relevant,Dialysis,Focussed Oral,The diagnosis of T-score based osteoporosis in patients undergoing hemodialysis treatment is a particular challenge: a multiple bone site approach,Osteoporosis;Renal Failure,Kidney Failure;Osteoporosis,,,,,,,,
1614,Not Relevant,Dialysis,Focussed Oral,Sclerostin And Bone Morphogenetic Protein-7 (Bmp-7) In Haemodialysis (Hd) Patients And Their Correlation With Calcium And Phosphorus Metabolism,Renal Failure,Kidney Failure,,,,,,,,
1615,Not Relevant,ERA Registry,Symposium,The prevalence of reduced kidney function across Europe: a comparison of KDIGO and age-adapted definitions of CKD,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1616,Not Relevant,ERA Registry,Symposium,Treatment trajectories of patients on kidney replacement therapy,,,,,,,,,,
1617,Not Relevant,ERA Registry,Symposium,Premature kidney ageing as a cause of kidney failure,,,,,,,,,,
1618,Not Relevant,FC 12: Of Membranous Nephropathy and Other Rare Diseases,Free Communication,New therapies for membranous nephropathy,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
1619,Not Relevant,FC 12: Of Membranous Nephropathy and Other Rare Diseases,Free Communication,Effectiveness and Remission Predictors of Obinutuzumab in Primary Membranous Nephropathy,Primary Membranous Nephropathy,Primary Membranous Nephropathy,Obinutuzumab,,,CD20-Targeted Monoclonal Antibody,,,,
1620,Not Relevant,FC 12: Of Membranous Nephropathy and Other Rare Diseases,Free Communication,Serum C3 levels are associated with glomerulosclerosis in membranous nephropathy and ANCA associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;Glomerulosclerosis;Membranous Nephropathy,ANCA-Associated Vasculitis;Glomerulosclerosis;Membranous Nephropathy,,,,,,,,
1621,Not Relevant,FC 12: Of Membranous Nephropathy and Other Rare Diseases,Free Communication,Kidney outcomes and effects of proteinuria in Alport Syndrome: a longitudinal analysis of 1175 patients from the UK National Registry of Rare Kidney Diseases (RaDaR),Alport Syndrome;Proteinuria,Alport Syndrome;Proteinuria,,,,,,,RaDaR,
1622,Low,FC 12: Of Membranous Nephropathy and Other Rare Diseases,Free Communication,Development of a multiple biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy,Fibrosis;IgA Nephropathy,Primary IgA Nephropathy;Tubulinterstitial Fibrosis,,,,,,,,
1623,Not Relevant,FC 12: Of Membranous Nephropathy and Other Rare Diseases,Free Communication,Proteinuria as a clinical trial endpoint in focal segmental glomerulosclerosis: Validation of PARASOL findings in RaDaR,Focal Segmental Glomerulosclerosis;Proteinuria,Focal Segmental Glomerulosclerosis;Proteinuria,,,,,,,PARASOL,
1624,Not Relevant,FC 12: Of Membranous Nephropathy and Other Rare Diseases,Free Communication,"Stopping Eculizumab Treatment Safely in Atypical HUS: A Multicentre, Open-Label, Prospective, Single-Arm Trial of the Safety and Impact of Eculizumab Withdrawal",Atypical Hemolytic-Uremic Syndrome,Atypical Hemolytic Uremic Syndrome,Eculizumab,,,Complement C5-Inhibitor,,,,
1625,Not Relevant,FC 13: The Basics of Glomerular- and Tubular Disease,Free Communication,Outcomes of Covid-19 Vaccine-Associated Glomerular Diseases (CVAGD),Coronavirus Infection;Glomerular Disease,COVID-19;Glomerular Disease,COVID-19 Vaccine,,,Vaccine,,,,
1626,Not Relevant,FC 13: The Basics of Glomerular- and Tubular Disease,Free Communication,NOX2-independent NETosis enriched in oxidized mitochondrial DNA via cGAS/STING pathway as a therapeutic target for inflamed acute kidney injury in chronic granulomatous disease mice,Acute Kidney Injury;Chronic Granulomatous Disease,Chronic Granulomatous Disease;Inflamed Acute Kidney Injury,,,,,,,,
1627,Not Relevant,FC 13: The Basics of Glomerular- and Tubular Disease,Free Communication,NPT2b Deficiency Mitigates Tubulointerstitial Fibrosis via Mitochondrial Restoration and Suppression of Partial Epithelial-Mesenchymal Transition in Renal Tubular Cells,Deficiency;Fibrosis,NPT2B Deficiency;Tubulointerstitial Fibrosis,,,,,,,,
1628,Not Relevant,FC 13: The Basics of Glomerular- and Tubular Disease,Free Communication,"Immune Phenotyping of Checkpoint Inhibitor-Induced Acute Interstitial Nephritis Uncovers Distinct Profiles Associated with Clinico-biological Features, treatment Response and outcome",Acute Tubulo-Interstitial Nephritis,Acute Interstitial Nephritis,,,,,,,,
1629,Medium,FC 13: The Basics of Glomerular- and Tubular Disease,Free Communication,High-resolution nanoliquid chromatography-mass spectrometry of circulating IgA1 glycosylation provides novel insight in the pathogenesis of IgA nephropathy.,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1630,Not Relevant,FC 13: The Basics of Glomerular- and Tubular Disease,Free Communication,Glomerulonephritis-induced changes in epithelial lipid composition reveal a signature of prominent proximal tubules metabolic switch,Glomerulonephritis,Glomerulonephritis,,,,,,,,
1631,Not Relevant,FC 13: The Basics of Glomerular- and Tubular Disease,Free Communication,Single urinary extracellular vesicle proteome analysis reveals CD35 as novel biomarkers of Sepsis-associated acute kidney injury,Sepsis,Sepsis,,,,,,,,
1632,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Stratification of IgA nephropathy using similarity network fusion: clinical, biochemical, and biopsy-based clusters with prognostic implications.",IgA Nephropathy,IgA Nephropathy,,,,,,,,
1633,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,The dual role of hyperuricemia and hyperglycemia in mice with CKD,Chronic Kidney Disease;Hyperglycemia;Hyperuricemia,Chronic Kidney Disease;Hyperglycemia;Hyperuricemia,,,,,,,,
1634,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Unsupervised Deep Learning Approach for Kidney Pathology Image Analysis and Clinical Correlation in Glomerulonephritis,Glomerulonephritis,Glomerulonephritis,,,,,,,,
1635,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Trametinib ameliorated Adriamycin-induced podocyte injury through METTL3 modified m6A RCAN1 mRNA methylation,,m6A RCAN1 mRNA-Methylated Podocyte Injury;METTL3-Mediated Podocyte Injury,Trametinib,,,MEK-Inhibitor,,,,
1636,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"The effects of early or late Empagliflozin, Liraglutide & combined therapy on the a-Klotho/Autophagy pathway in renal and pancreatic-ß cells in diabetic db/db mice model.",Diabetes,Diabetes,Empagliflozin;Liraglutide,,,GLP1 Receptor-Agonist;SGLT2-Inhibitor,,,,
1637,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,IgA nephropathy with membranoproliferative pattern and resistance to immunosuppressive therapy in patients with cofactor I pathogenic variant.,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1638,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Single-cell transcriptome combined with spatial transcriptome reveals molecular characteristics of human glomerular endothelial cells.,,Glomerular Endothelium Disease;Tubulio-Interstitial Disease,,,,,,,,
1639,Low,Glomerular & tubulo-interstitial diseases,Focussed Oral,Differential Impacts of APRIL and APRIL/BAFF Inhibition on Immune Populations: Implications for IgAN Treatment and Protective Immunity,IgA Nephropathy,IgA Nephropathy,,,,APRIL Inhibitor;APRIL/BAFF Dual Inhibitor,,,,
1640,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Urinary Acidification and Pharmacological Inhibition of anionic transporters reduce the Severity of Experimental Vancomycin-Induced Acute Kidney Injury,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1641,Low,Glomerular & tubulo-interstitial diseases,Focussed Oral,Mesangioproliferative activity of IgA1-IgG immune complexes in IgA nephropathy requires complement C3 and can be inhibited by a broad-spectrum kinase inhibitor,IgA Nephropathy,IgA Nephropathy,,,,Broad Spectrum Kinase-Inhibitor,,,,
1642,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Can we diagnose diabetes-related kidney disease without kidney biopsy using proteomics?,Diabetes;Kidney Diseases,Diabetes;Kidney Disease,,,,,,,,
1643,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Progressive predominant tubular damage through constitutive activation of the NF-kB pathway in renin lineage cells,Glomerular Disease,Glomerular Disease;Tubulointerstial Disease,,,,,,,,
1644,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Primary Renal Bilateral Diffuse Large B Cell Lymphoma: A Case Report.,Diffuse Large B-Cell Lymphoma,Primary Renal Bilateral Diffuse Large B Cell Lymphoma,,,,,,Bilateral,,
1645,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Single-nucleus multi-omic profiling identified different extent of podocyte injury and podocyte-parietal epithelial cell communication in podocytopathy,Podocytopathy,Podocytopathy,,,,,,,,
1646,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Exploring the mechanism and clinical validation of mitochondrial dynamics-related genes in membranous nephropathy based on Mendelian randomization study and bioinformatics analysis,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
1647,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Role of the Wieslab test in identifying the hyperactivation of the complement lectin pathway and its application in membranous nephropathy,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
1648,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Dapagliflozin In Inactive Lupus Nephritis: A Randomized Cross-Over Trial,Lupus Nephritis,Inactive Lupus Nephritis,Dapagliflozin,,,SGLT2-Inhibitor,,,,
1649,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Involvement Of The Complement System In Iga Nephropathy: A Different Perspective,IgA Nephropathy,IGA Nephropathy,,,,,,,,
1650,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Association of Anti-Neutrophil Cytoplasmic Antibody (ANCA) Serology and Concentration with Incidence, Renal Trajectories and Mortality in ANCA-Associated Vasculitis",Vasculitis,Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis,,,,Antibody,,,,
1651,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,Targeted-Release Budesonide (TRB) treatment may have different effects on the inflammatory process in IgAN patients with recent and old diagnosis,IgA Nephropathy,IgA Nephropathy,Budesonide,,,Glucocorticoid,,,,
1652,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Prevalence and associated factors of sexual dysfunction in female patients with Lupus Nephritis: A cross-sectional study at AIIMS, New Delhi",Lupus Nephritis;Sexual Dysfunction,Lupus Nephritis;Sexual Dysfunction,,,,,,,,
1653,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Evaluation of Objective Nutritional Indexes as Predictors of Renal Progression in IgA Nephropathy Patients,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1654,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Temporal trends of severe infections in patients with lupus nephritis and CKD:  a nationwide study,Chronic Kidney Disease;Lupus Nephritis,Chronic Kidney Disease;Severe Lupus Nephritis,,,,,,Severe,,
1655,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Nine-year’ experience of severe ANCA-associated glomerulonephritis treatment: a single-center retrospective study,Glomerulonephritis,Severe ANCA-Associated Glomerulonephritis,,,,,,Severe,,
1656,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Open label, single arm, multicenter, prospective study on oral enteric coated budesonide therapy for primary IgA nephropathy. An inter-rim report",IgA Nephropathy,Primary IgA Nephropathy,Budesonide,,,Glucocorticoid Receptor Agonist,,,,
1657,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Development and validation of nomograms for predicting the activity index of lupus nephritis,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1658,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Single-cell RNA sequencing of circulating leukocytes from patients with IgA nephropathy and age- and kidney function-matched controls,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1659,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,Long-term efficacy and safety of telitacicept in the treatment of IgAN,IgA Nephropathy,IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
1660,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Protein fragments predict venous thromboembolic events in ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,,,,,,,,
1661,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Associations of systemic complement, kidney deposition and gene polymorphisms with patient and renal outcomes in ANCA-associated vasculitis – a systematic review",Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
1662,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Clinical and Pathological Significance of Exostosin1/Exostosin2 in Membranous Lupus Nephritis: A Retrospective Single-Center Study in China,Lupus Nephritis,Membranous Lupus Nephritis,,,,,,,,
1663,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Are there differences in the impact of induction immunosuppression on kidney outcomes according to ANCA Renal Risk Score in patients with ANCA-associated vasculitis?,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
1664,Not Relevant,Hot Topics in ADPKD: PRO and CONS,Symposium,Genetic Testing for all ADPKD adult patients: PRO,Autosomal Dominant Polycystic Kidney,Adult Autosomal Dominant Polycystic Kidney Disease,,,,,,Adult,,
1665,Not Relevant,Hot Topics in ADPKD: PRO and CONS,Symposium,Genetic Testing for all ADPKD adult patients:CON,Autosomal Dominant Polycystic Kidney,Adult Autosomal Dominant Polycystic Kidney Disease,,,,,,Adult,,
1666,Not Relevant,Kidney Transplantation,Focussed Oral,Time trends in European paediatric kidney transplantation: an ESPN/ERA Registry study,,,,,,,,,,
1667,Not Relevant,Kidney Transplantation,Focussed Oral,"Frequency, Risk Factors and Long-term Outcomes of Erythrocytosis in Kidney Transplant Patients",Erythrocytosis,Erythrocytosis,,,,,,,,
1668,Not Relevant,Kidney Transplantation,Focussed Oral,Graft Survival in Kidney Transplantation: A Comparative Analysis of IgA Nephropathy vs non-IgAN kidney disease and the Impact of Recurrent IgAN,Nephritis,Recurrent IgA Nephritis,,,,,,Recurrent,,
1669,Not Relevant,Kidney Transplantation,Focussed Oral,Impact of diabetes and low age- and sex-specific eGFR on post-transplant kidney function recovery in living kidney donors,Diabetes,Diabetes,,,,,,,,
1670,Not Relevant,Kidney Transplantation,Focussed Oral,Vitamin K dependent proteins and bone quality in the first year after kidney transplantation,,,,,,,,,,
1671,Not Relevant,Kidney Transplantation,Focussed Oral,Glomerular Morphometric Feature Machine Learning-Driven Analysis of Deceased Donor Procurement Biopsies: The ComPrePS Assessment Tool,,,,,,,,,,
1672,Not Relevant,Kidney Transplantation,Focussed Oral,Categorical state sequence analysis to identify pre - transplantation care trajectories among chronic kidney disease patients in France,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1673,Not Relevant,Kidney Transplantation,Focussed Oral,Association between sex and hospitalisation during the period prior to kidney transplantation in France,,,,,,,,,,
1674,Not Relevant,Kidney Transplantation,Focussed Oral,GlycA and all-cause mortality in kidney transplant recipients: Results of the TransplantLines Biobank and Cohort Study,,,,,,,,,,
1675,Not Relevant,Kidney Transplantation,Focussed Oral,Single vs. repeated measurements of 24-hour urinary potassium excretion and long-term outcomes after kidney transplantation,,,,,,,,,,
1676,Not Relevant,Kidney Transplantation,Focussed Oral,"Carboxyhemoglobin, Smoking Exposure, and Mortality in Kidney Transplant Recipients",,,,,,,,,,
1677,Not Relevant,Kidney Transplantation,Focussed Oral,Posttransplant Malignancies in Kidney Transplant Recipients - A single center Experience,Cancer,Post-Transplant Malignancy,,,,,,,,
1678,Not Relevant,Kidney Transplantation,Focussed Oral,"SGLT2 Inhibitors in Kidney Transplant Recipients: Renal, Cardiovascular and Safety Outcomes: A Narrative Review",,,,,,SGLT2-Inhibitor,,,,
1679,Not Relevant,Kidney Transplantation,Focussed Oral,Safety And Efficacy Of Sglt2I In Non-Diabetic Kidney Transplant Recipients,,,,,,SGLT2-Inhibitor,,,,
1680,Not Relevant,Kidney Transplantation,Focussed Oral,Basiliximab versus anti-thymocyte immunoglobulin: renal and infectious outcomes in kidney transplant recipients,Infection;Renal Failure,Infection;Renal Failure,Basiliximab,,Anti-Thymocyte Immunoglobulin,Immunosuppressant;Interleukin 2 Receptor Alpha Antagonist,,,,
1681,Not Relevant,Kidney Transplantation,Focussed Oral,Beyond DSAs: Unraveling the Complexities of Antibody-Mediated Rejection in Kidney Transplants,,,,,,,,,,
1682,Not Relevant,Personalized approach in cardiometabolic kidney disease,Symposium,Metabolic communications by SGLT2 inhibition.,Kidney Diseases,Cardiometabolic Kidney Disease,,,,SGLT2-Inhibitor,,,,
1683,Not Relevant,Personalized approach in cardiometabolic kidney disease,Symposium,"Combination therapy for the treatment of kidney disease in people with type 2 diabetes. How, Who, when.",Kidney Diseases;Type 2 Diabetes,Kidney Disease;Type 2 Diabetes,,,,,,,,
1684,Not Relevant,Personalized approach in cardiometabolic kidney disease,Symposium,Resistance to novel kidney protective agents: a concept to be developed.,Kidney Diseases,Cardiometabolic Kidney Disease,,,,,,,,
1685,Not Relevant,Pro/Con Machine perfusion,Symposium,Machine perfusion - PRO,,,,,,,,,,
1686,Not Relevant,Pro/Con Machine perfusion,Symposium,Machine perfusion -CON,,,,,,,,,,
1687,Not Relevant,Pro/Cons: Inhibition of aldosterone synthase: are they an advantage over classical MRA?,Symposium,Inhibition of aldosterone synthase: are they an advantage over classical MRA? PRO,,,,,,Aldosterone Synthase-Inhibitor;Mineralocorticoid Receptor-Antagonist,,,,
1688,Not Relevant,Pro/Cons: Inhibition of aldosterone synthase: are they an advantage over classical MRA?,Symposium,Inhibition of aldosterone synthase: are they an advantage over classical MRA? CON,,,,,,Aldosterone Synthase-Inhibitor;Mineralocorticoid Receptor-Antagonist,,,,
1689,Not Relevant,Pro-Cons: Membranous nephropathy,Symposium,"Are the ""new antigens"" useful for the diagnosis and monitoring of patients with MN? PRO",Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
1690,Not Relevant,Pro-Cons: Membranous nephropathy,Symposium,"Are the ""new antigens"" useful for the diagnosis and monitoring of patients with MN? CON",Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
1691,Not Relevant,The fragile and the very old in dialysis,Symposium,Dialysis versus conservative management,Renal Failure,Kidney Failure,,,,,,,,
1692,Not Relevant,The fragile and the very old in dialysis,Symposium,HD versus PD,Pulmonary Disease;Renal Failure,Kidney Failure;Pulmonary Disorder,,,,,,,,
1693,Not Relevant,The fragile and the very old in dialysis,Symposium,Exercise and physical rehabilitation,Renal Failure,Kidney Failure,,,,,,,,
1694,Not Relevant,The path for an environmental responsible (and sustainable) nephrology,Symposium,How to green the Dialysis prescription?,Renal Failure,Kidney Failure,,,,,,,,
1695,Not Relevant,The path for an environmental responsible (and sustainable) nephrology,Symposium,Hemodialysis Unit – Let’s look at it as a circular economy. Everything you throw out has its value,Renal Failure,Kidney Failure,,,,,,,,
1696,Not Relevant,The path for an environmental responsible (and sustainable) nephrology,Symposium,How do I evaluate the carbon footprint of my Unit?,,,,,,,,,,
1697,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Longer time on polymyxin- B direct hemoperfusion for sepsis control prevents kidney injury on day 28; A multicenter retrospective observational study (PMX-OPTIC).,Sepsis,Kidney Injury;Sepsis,Polymyxin B,,,Polypeptide Antibiotic,,,,PMX-OPTIC
1698,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Concomitant use of renin-angiotensin system inhibitors and bortezomib were associated with a higher incidence of hyponatremia,,Hyponatremic Syndrome,Bortezomib,,,Proteasome-Inhibitor;Renin Angiotensin System-Inhibitor,,,,
1699,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Urinary CXCL9 and renal outcome in Acute Kidney Injury,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1700,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Acute Kidney Injury associated with immune-checkpoint inhibitors in cancer patients: a single centre retrospective study,Acute Kidney Injury;Cancer,Acute Kidney Injury;Cancer,,,,Immune Checkpoint Inhibitors,,,,
1701,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,"Time trends and Predictors of Acute Kidney Injury in the complete region of Stockholm, Sweden",Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1702,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Demographic variations in Acute kidney injury risk during Hot weather: A nationwide case-crossover analysis of a million AKI alerts,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1703,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Demographic and Clinical Profile of Hospitalized Patients Requiring Dialysis: Insights from the DaVita Brazil Hospital Service 2023-2024,Renal Failure,Kidney Failure,,,,,,,,
1704,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Continuous Renal Replacement Therapy (CRRT) in Critically Ill Patients: A Nationwide Analysis from DaVita Brazil,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1705,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Histopathological and clinical characterstics of biopsy proven pregnancy related Acute kidney injury,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1706,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Acute Kidney Injury and Renal Replecement Therapy after Heart Transplantation: epidemiology and short-term outcomes,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1707,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Acute Kidney Injury In Critical Care Patients In Brazil: A Prospective Cohort Study,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1708,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,The alternative pathway of the Renin Angiotensin Aldosterone System is overactivated in severe COVID-19 at baseline,Coronavirus Infection,Severe COVID-19,,,,,,Severe,,
1709,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Pulmonary Hypertension And Chronic Kidney Disease: An Intergroup Variability Of Kidney Function Determinants,Chronic Kidney Disease;Pulmonary Hypertension,Chronic Kidney Disease;Pulmonary Hypertension,,,,,,,,
1710,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Acute Kidney Injury and associated factors in people living with HIV/AIDS hospitalized for Disseminated Histoplasmosis in a referral hospital in Brazil,Acute Kidney Injury;Histoplasmosis,Acute Kidney Injury;Disseminated Histoplasmosis,,,,,,Disseminated,,
1711,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,No Weekend Penalty: AKI Outcomes Remain Consistent Across Admission Days,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1712,Not Relevant,Chronic kidney disease,Focussed Oral,Motor coordination disorders in patients with chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease;Motor Coordination Disorder,,,,,,,,
1713,Not Relevant,Chronic kidney disease,Focussed Oral,Study of the degree of change in the structural and functional state of the kidneys in patients with arterial hypertension,Arterial Hypertension,Arterial Hypertension,,,,,,,,
1714,Not Relevant,Chronic kidney disease,Focussed Oral,Empagliflosin  Improves FMD in CKD: Modulation by the 786T>C Polymorphism of eNOS.,Chronic Kidney Disease,Chronic Kidney Disease,Empagliflosin,,,SGLT2-Inhibitor,,,,
1715,High,Chronic kidney disease,Focussed Oral,"Efficacy and safety of HRS-5965 in patients with primary immunoglobulin A nephropathy (IgAN): a randomized, double-blind, parallel, placebo-controlled phase 2 trial",IgA Nephropathy,Primary IgA Nephropathy,HRS-5965,,,Complement Factor B-Inhibitor,,,,
1716,Not Relevant,Chronic kidney disease,Focussed Oral,Self Management and Realisation of Target Blood Pressure in Chronic Kidney Disease (SMaRT BP CKD),Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,ISRCTN56336493;;SMaRT BP CKD,
1717,Not Relevant,Chronic kidney disease,Focussed Oral,Low Rate Of Infusion-Related Reactions And High Treatment Adherence With Obinutuzumab In Patients With Active Lupus Nephritis: Analysis Of The Nobility And Regency Studies,Active Lupus Nephritis,Active Lupus Nephritis,Obinutuzumab,,,CD20-Targeted Monoclonal Antibody,Roche,,NCT02550652;;NCT04221477,Nobility;;Regency
1718,Not Relevant,Chronic kidney disease,Focussed Oral,"Design and baseline characteristics of MIRO-CKD: a Phase IIb, Randomised, Double-Blind Clinical Trial to Evaluate Effects of Balcinrenone in Combination with Dapagliflozin vs. Dapagliflozin in Patients with CKD",Chronic Kidney Disease,Chronic Kidney Disease,Balcinrenone;Dapagliflozin,,Dapagliflozin,Mineralocorticoid Receptor-Modulator;SGLT2-Inhibitor,AstraZeneca,,MIRO-CKD;;NCT06350123,
1719,Not Relevant,Chronic kidney disease,Focussed Oral,Finerenone as a Novel Non-Steroidal Mineralocorticoid Receptor Antagonist: A Potential Therapeutic Option for Lupus Nephritis,Lupus Nephritis,Lupus Nephritis,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,,
1720,Not Relevant,Chronic kidney disease,Focussed Oral,Monitoring of renal impairment in rheumatoid arthritis patients with different levels of disease activity the role of cystatin C,Renal Impairment;Rheumatoid Arthritis,Renal Impairment;Rheumatoid Arthritis,,,,,,,,
1721,Not Relevant,Chronic kidney disease,Focussed Oral,Treatment Patterns of Primary Immunoglobulin A Nephropathy (IgAN) in China: Evidence from a Real-World Study using Regional Electronic Health Record Data,IgA Nephropathy,Primary IgA Nephropathy,,,,,,,,
1722,Not Relevant,Chronic kidney disease,Focussed Oral,Exogenous Ketosis increases Renal Function and Sodium Excretion in Healthy Subjects,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1723,Not Relevant,Chronic kidney disease,Focussed Oral,"AMPLITUDE, a Ph2/3 Adaptive Trial of Inaxaplin in APOL1-mediated Kidney Disease",Kidney Diseases,APOL1-Mediated Kidney Disease,Inaxaplin,,,APOL1-Targeted Therapy,Vertex Pharmaceuticals,,NCT05312879,AMPLITUDE
1724,Not Relevant,Chronic kidney disease,Focussed Oral,Evaluation of Clinical Sensitivity and Limit of Detection for Neutrophils of the Homodimer Neutrophil Gelatinase-Associated Lipocalin (H-NGAL) Rapid Test in Patients with Peritoneal Dialysis-Related Peritonitis (PDRP),Peritonitis,Peritoneal Dialysis;Peritonitis,,,,,,,,
1725,Not Relevant,Chronic kidney disease,Focussed Oral,An application of urinary peptidomics and in silico methods to guide multifactorial intervention in chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1726,Not Relevant,Chronic kidney disease,Focussed Oral,Optimal Timing for Dialysis Preparation in Diabetic Nephropathy,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,,,,
1727,Not Relevant,Chronic kidney disease,Focussed Oral,The new era of glycomics for the identification of prognostic and diagnostic biomarkers of kidney disease: ExoGAG.,Kidney Diseases,Kidney Disease,,,,,,,,
1728,Not Relevant,Chronic kidney disease,Focussed Oral,Distinctive Patterns of Trace elements in Chronic Kidney Disease of Uncertain Etiology: A Case Control Study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1729,Not Relevant,Chronic kidney disease,Focussed Oral,Estimation of kidney function in Graves' disease using creatinine and cystatin C,,Graves' Disease,,,,,,,,
1730,Not Relevant,Chronic kidney disease,Focussed Oral,Influence of metabolism-related comorbidities and insulin resistance (estimated glucose disposal rate) on the development of chronic kidney disease in a health-checkup population: a retrospective cohort study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1731,Not Relevant,Chronic kidney disease,Focussed Oral,Increased left ventricular mass is caused by extracellular not intracellular expansion in advanced CKD,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
1732,Not Relevant,Chronic kidney disease,Focussed Oral,1111MicrosoftInternetExplorer402DocumentNotSpecified7.8 ?Normal0 Multi-modal Fusion Models for Classification and Risk Prognosis in Diabetic Kidney Disease,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,,,,
1733,Not Relevant,Chronic kidney disease,Focussed Oral,"Endothelin-1 and cardio-kidney events among patients with CKD, diabetes, and anemia",Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,,,,,
1734,Not Relevant,Chronic kidney disease,Focussed Oral,The Role of Trimethylamine N-oxide in Chronic Kidney Disease Progression and Mortality: Insights from the GCKD Study,Chronic Kidney Disease,Chronic Kidney Disease,Trimethylamine N-Oxide,,,Gut Derived Metabolite,,,GCKD,
1735,Not Relevant,Chronic kidney disease,Focussed Oral,A Positive Functional Modulator of ABCC6 Decreases Vascular Calcification and Improves Kidney Function in a Rat Adenine Diet Model of Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1736,Not Relevant,Chronic kidney disease,Focussed Oral,Development and validation of a prediction model for progression of CKD in European children,Kidney Diseases,Childhood Progressive Kidney Disease,,,,,,Childhood;Progressive,,
1737,Not Relevant,Chronic kidney disease,Focussed Oral,Elevated urine albumin-creatinine ratio associates with higher pulse-wave velocity in a population-based cohort,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1738,Not Relevant,Chronic kidney disease,Focussed Oral,Indicators of Vaccination Status in Patients with Chronic Kidney Disease: Importance of Healthcare Providers’ Recommendation,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1739,Not Relevant,Chronic kidney disease,Focussed Oral,Burden of Chronic Kidney Disease and Related Urinary Disorders on Healthcare Utilisation in Ireland: A National Inpatient Analysis,Chronic Kidney Disease;Urinary Disorders,Chronic Kidney Disease;Urinary Disorder,,,,,,,,
1740,Not Relevant,Chronic kidney disease,Focussed Oral,Influence of Age and GFR Thresholds on Kidney Failure and Death in the Irish Health System,Renal Failure,Kidney Failure,,,,,,,,
1741,Not Relevant,Chronic kidney disease,Focussed Oral,Impact of Adoption of European Kidney Consortium Equation (EKFC) equation compared to CKD-EPI Equations on CKD Prevalence and Staging in Irish Adults,Chronic Kidney Disease,Adult Chronic Kidney Disease,,,,,,Adult,,
1742,Not Relevant,Chronic kidney disease,Focussed Oral,Exercise Intervention In Patients With Metabolic Syndrome And Renal Disease: A Prospective Study (Exred),Kidney Diseases;Metabolic Syndrome,Metabolic Syndrome;Renal Disease,,,,,,,Exred,
1743,Not Relevant,Chronic kidney disease,Focussed Oral,Supplemented ketoanalogues (KAs) with plant versus animal based low protein diet (LPD) in non-dialysis CKD.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1744,Not Relevant,Chronic kidney disease,Focussed Oral,Renal function assessment with point of care creatinine and potassium in diverse populations (RAPID study): An interim analysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,NCT00943423;;RAPID,
1745,Not Relevant,Chronic kidney disease,Focussed Oral,Improving Medication Safety And Prescribing Of High-Risk Medications In Individuals With Chronic Kidney Disease: A Validation Study,Chronic Kidney Disease,High Risk Chronic Kidney Disease,,,,,,High-risk,,
1746,Not Relevant,Chronic kidney disease,Focussed Oral,The potential of Share Wave Elastography in renal imaging,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1747,Not Relevant,Chronic kidney disease,Focussed Oral,Optimal Timing for Dialysis Preparation in CKD; Modeling with Multiple Linear Regression,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1748,Not Relevant,Chronic kidney disease,Focussed Oral,Natriuretic response to an acute oral potassium load in healthy individuals and patients with chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1749,Not Relevant,Chronic kidney disease,Focussed Oral,Physical activity and incident chronic kidney disease: a systematic review and dose-response meta-analysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1750,Not Relevant,Chronic kidney disease,Focussed Oral,The effects of empagliflozin on fluid and eletrolyte balance,Chronic Kidney Disease,Chronic Kidney Disease,Empagliflozin,,,SGLT2-Inhibitor,,,,
1751,High,Chronic kidney disease,Focussed Oral,Zigakibart-treated patients with IgAN achieved high rates of proteinuria remission and stable eGFR over 76 weeks in a Phase 1/2 study,IgA Nephropathy,IgA Nephropathy,Zigakibart,,,APRIL-Targeted Monoclonal Antibody,,,,
1752,Not Relevant,Chronic kidney disease,Focussed Oral,Comparative Assessment of Endothelial Function in Patients with Chronic Kidney Disease Against the Background of Dyslipidemia,Chronic Kidney Disease;Dyslipidemia,Chronic Kidney Disease;Dyslipidaemia,,,,,Vivoryon Therapeutics,,,
1753,Not Relevant,Chronic kidney disease,Focussed Oral,SMART Stone MDT and patient care recommendations: The Nephrologist’s role in optimizing the adult high-risk kidney stone patient pathway,,Adult High Risk Kidney Stone,,,,,,Adult;High-risk,,
1754,Not Relevant,Chronic kidney disease,Focussed Oral,SGLT2 Inhibitors as a Strategy for Obesity Control in Non-Diabetic CKD Patients: Insights from a One-Year Study,Chronic Kidney Disease;Obesity,Chronic Kidney Disease;Obesity,,,,SGLT2-Inhibitor,,,,
1755,Not Relevant,Chronic kidney disease,Focussed Oral,Long-term effect of semaglutide on the glomerular filtration rate slope in high-risk patients with diabetic nephropathy: analysis in real-world clinical practice.,Diabetic Nephropathy,High Risk Diabetic Nephropathy,Semaglutide,,,GLP1 Receptor-Agonist,,High-risk,,
1756,Not Relevant,Chronic kidney disease,Focussed Oral,Varoglutamstat improves eGFR and offers a new approach to treat diabetic kidney disease (DKD): meta-analysis from two independent phase 2 studies,Diabetic Nephropathy,Diabetic Kidney Disease,Varoglutamstat,,,Glutaminyl Cyclase-Inhibitor,,,,
1757,Not Relevant,Dialysis,Focussed Oral,Peritoneal Dialysis Modality and Outcomes in The Peritoneal Dialysis Outcomes and Practice Patterns Study,Renal Failure,Kidney Failure,,,,,,,,
1758,Not Relevant,Dialysis,Focussed Oral,Ultrasound Guided Percutaneous Peritoneal Dialysis Catheter Insertion With Musculofacial Tunneling: An Innovative And Safe Technique,Renal Failure,Kidney Failure,,,,,,,,
1759,Not Relevant,Dialysis,Focussed Oral,Turning the Tide in Heart Failure Management: The Role of Peritoneal Ultrafiltration,Renal Failure,Kidney Failure,,,,,,,,
1760,Not Relevant,Dialysis,Focussed Oral,Catheter cleaning brush manipulations in peritoneal dialysis,Renal Failure,Kidney Failure,,,,,,,,
1761,Not Relevant,Dialysis,Focussed Oral,Comparison of Bacterial Culture Positivity Between Direct and Post-Centrifugation Inoculation into Blood Culture Bottles for Peritoneal Dialysis-Associated Peritonitis,Renal Failure,Kidney Failure,,,,,,,,
1762,Not Relevant,Dialysis,Focussed Oral,"Effect of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists on Peritoneal Dialysis-associated Peritonitis: A Territory-wide, Propensity-weighted Cohort in Hong Kong",Peritonitis;Renal Failure,Kidney Failure;Peritonitis,,,,H2 Receptor-Antagonist;Proton Pump-Inhibitor,,,,
1763,Not Relevant,Dialysis,Focussed Oral,"""PD-PREDICT"": A Machine Learning Tool to Predict Patient Survival in UK Peritoneal Dialysis Patients, with external Validation in Norway",Renal Failure,Kidney Failure,,,,,,,,
1764,Not Relevant,Dialysis,Focussed Oral,Cell-Free Plasma Dna (Cfdna) In Peritonitis Is Originated From Apoptotic Events And Caspase-3 Activation,Peritonitis,Peritonitis,,,,,,,,
1765,Not Relevant,Dialysis,Focussed Oral,Comparison and validation of two laboratory platforms for peritoneal NGAL in PD patients with and without peritonitis.,Peritonitis;Renal Failure,Kidney Failure;Peritonitis,,,,,,,,
1766,Not Relevant,Dialysis,Focussed Oral,Modifiable Factors Associated with Permanent Transfers from Peritoneal Dialysis: A Retrospective Study,Renal Failure,Kidney Failure,,,,,,,,
1767,Not Relevant,Dialysis,Focussed Oral,"Peritoneal Protein Loss: how does it relate to Fluid Overload, Sarcopenia and Nutrition on Renal Disease",Renal Failure;Sarcopenia,Kidney Failure;Sarcopenia,,,,,,,,
1768,Not Relevant,Dialysis,Focussed Oral,Evaluation of Peritoneal Dialysis Dropouts: A Single Centre Observational Study over 3-year follow-up,Renal Failure,Kidney Failure,,,,,,,,
1769,Not Relevant,Dialysis,Focussed Oral,Clinical events and Patient-Reported Outcome Measures in Peritoneal Dialysis,Renal Failure,Kidney Failure,,,,,,,,
1770,Not Relevant,Dialysis,Focussed Oral,Synbiotic Supplementation for Chronic Constipation in Patients under Peritoneal Dialysis: An Italian Multicenter Prospective Study,Constipation;Renal Failure,Chronic Constipation;Kidney Failure,Synbiotic,,,Synbiotic,,,,
1771,Not Relevant,Dialysis,Focussed Oral,Peritoneal immunometabolism links local inflammation to depressed immune cell function in peritoneal dialysis patients,Renal Failure,Kidney Failure,,,,,,,,
1772,Not Relevant,Dialysis,Focussed Oral,Pre-operative Vascular Mapping and the Prognostic Value of Vascular Calcification in Advanced CKD,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
1773,Not Relevant,Dialysis,Focussed Oral,Kidney transplantation with a functional AV fistula is associated to  long-term risk of de novo heart failure and atrial fibrillation,Atrial Fibrillation;Renal Failure,Atrial Fibrillation;Kidney Failure,,,,,,,,
1774,Not Relevant,Dialysis,Focussed Oral,Beyond calipers: predictive value of pre operative Peak Systolic Velocity on Arteriovenous Fistula maturation,Arterio-Venous Fistula,Arteriovenous Fistula,,,,,,,,
1775,Not Relevant,Dialysis,Focussed Oral,Fetuin-A as a Risk Factor for Arteriovenous Fistula (AFV) Failure in Chronic Kidney Disease Patients with Hemodialysis Through Vascular Calcification Mechanism: Systematic Review and Meta-Analysis,Arterio-Venous Fistula;Chronic Kidney Disease,Arteriovenous Fistula;Chronic Kidney Disease,,,,,,,,
1776,Not Relevant,Dialysis,Focussed Oral,Effect Of Excessive Salt Consumption On The Functional State Of Microvessels Of The Skin Of Rats With Experimental Kidney Dysfunction,,Kidney Dysfunction,,,,,,,,
1777,Not Relevant,Dialysis,Focussed Oral,The Role of Vascular Access Choice in Hemodialysis Outcomes: A Nationwide Romanian Study,Renal Failure,Kidney Failure,,,,,,,,
1778,Not Relevant,Dialysis,Focussed Oral,Are peripheral insertion catheters infrequent in hemodialysis patients?,Renal Failure,Kidney Failure,,,,,,,,
1779,Not Relevant,Dialysis,Focussed Oral,Postoperative doppler surveillance as a tool for improving Arteriovenous Fistula patency and first use rates: a single center experience,Arterio-Venous Fistula,Arterio-Venous Fistula,,,,,Fresenius,,,
1780,Not Relevant,Dialysis,Focussed Oral,Outcomes of endovascular AVF creation in a multiethnic Asian population,Renal Failure,Kidney Failure,,,,,,,,
1781,Not Relevant,Dialysis,Focussed Oral,A Multicenter Study On Two Major Challenges In Late Referral Patients: Outcomes Of Avfs And Tunneled Cvc-Related Infections,Infection;Renal Failure,Kidney Failure;Tunneled Cardiovascular Cavity Infection,,,,,,,,
1782,Not Relevant,Dialysis,Focussed Oral,Pre-Surgery Plasma Metabolites as Predictive Biomarkers of Arteriovenous Fistula Maturation Outcomes,Arterio-Venous Fistula,Arteriovenous Fistula,,,,,Fresenius,,,
1783,Not Relevant,Dialysis,Focussed Oral,Comparison of Standard versus High Dose Urokinase for Dysfunctional Tunneled Dialysis Catheters in Haemodialysis Patients: A Randomized Controlled Trial,Renal Failure,Kidney Failure,Urokinase,,,Serine Protease Plasminogen Activator,,,,
1784,Not Relevant,Dialysis,Focussed Oral,Chemotherapy Administration Via Arteriovenous Fistula In Hemodialysed Patients: Too Daring Of An Option?,Arterio-Venous Fistula;Renal Failure,Arterio-Venous Fistula;Kidney Failure,,,,,,,,
1785,Not Relevant,Dialysis,Focussed Oral,Obesity as a Predictor of Technique Survival in Peritoneal Dialysis,Renal Failure,Kidney Failure,,,,,,,,
1786,Not Relevant,FC 14:  About C3 and IgA Glomerulonephritis,Free Communication,Pegcetacoplan Treatment Effect in Patients With Nephrotic Range Proteinuria: Results From the VALIANT Phase 3 Study in Patients With C3G or Primary (Idiopathic) IC-MPGN,Glomerulopathy;Membranoproliferative Glomerulonephritis;Proteinuria,Complement 3 Glomerulopathy;Nephrotic Range Proteinuria;Primary (Idiopathic) Immune Complex-Mediated Membranoproliferative Glomerulonephritis,Pegcetacoplan,,,C3-Inhibitor,Apellis Pharmaceuticals;Sobi,,NCT05067127,VALIANT
1787,Not Relevant,FC 14:  About C3 and IgA Glomerulonephritis,Free Communication,Targeted Treatment With Pegcetacoplan for Adolescents With C3G or Primary (Idiopathic) IC-MPGN in the VALIANT Phase 3 Trial,Glomerulopathy;Membranoproliferative Glomerulonephritis,Complement 3 Glomerulopathy;Primary (Idiopathic) Immune Complex-Mediated Membranoproliferative Glomerulonephritis,Pegcetacoplan,,,C3-Inhibitor,Apellis Pharmaceuticals,,NCT05067127,VALIANT
1788,Not Relevant,FC 14:  About C3 and IgA Glomerulonephritis,Free Communication,Pegcetacoplan Demonstrates Clinically Significant Responses in C3G and Primary (Idiopathic) IC-MPGN Patients With or Without Concomitant Immunosuppression in VALIANT,Glomerulopathy;Membranoproliferative Glomerulonephritis,Complement 3 Glomerulopathy;Primary (Idiopathic) Immune Complex-Mediated Membranoproliferative Glomerulonephritis,Pegcetacoplan,,,C3-Inhibitor,Apellis Pharmaceuticals,,NCT05067127;;VALIANT,
1789,Not Relevant,FC 14:  About C3 and IgA Glomerulonephritis,Free Communication,The incidence and prevalence of IgAN from 2002-2023 in Denmark,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1790,Not Relevant,FC 14:  About C3 and IgA Glomerulonephritis,Free Communication,Nefecon provides kidney benefit irrespective of baseline eGFR in patients with IgAN: a subanalysis of the NefIgArd study,Glomerulonephritis;Nephropathy,Idiopathic Nephropathy;IgA Glomerulonephritis,Budesonide;Nefecon,,,Glucocorticoid,Calliditas Therapeutics,,NCT03643965;;NefIgArd,
1791,High,FC 14:  About C3 and IgA Glomerulonephritis,Free Communication,Effect of iptacopan discontinuation on proteinuria and complement biomarkers in patients with immunoglobulin A nephropathy (IgAN): a post hoc analysis from a Phase II trial,IgA Nephropathy;Proteinuria,IgA Nephropathy;Proteinuria,Iptacopan,,,C3-Inhibitor,,,,
1792,Not Relevant,FC 15: Novel CKD Treatments Beyond the Pillars,Free Communication,The nephropathy of sickle cell trait and sickle cell disease and CKD treatments,Chronic Kidney Disease;Sickle Cell Disease,Chronic Kidney Disease;Nephropathic Sickle Cell Syndrome;Sickle Cell Disease,,,,,,,,
1793,Not Relevant,FC 15: Novel CKD Treatments Beyond the Pillars,Free Communication,Iptacopan’s rapid and sustained inhibition of overactive complement alternative pathway in C3G: Exploratory analysis from the Phase 3 APPEAR-C3G study,Chronic Kidney Disease,Chronic Kidney Disease,Iptacopan,,,C3-Inhibitor,Novartis,,NCT04817618,APPEAR-C3G
1794,Not Relevant,FC 15: Novel CKD Treatments Beyond the Pillars,Free Communication,"Long-Term Efficacy and Safety in the 60-Month, Phase 3 ILLUMINATE-B Trial of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1",Primary Hyperoxaluria Type 1,Primary Hyperoxaluria Type 1,Lumasiran,,,RNA Interference Therapeutic,Alnylam Pharmaceuticals,,NCT03905694,ILLUMINATE-B
1795,Not Relevant,FC 15: Novel CKD Treatments Beyond the Pillars,Free Communication,Changes in proteinuria and kidney function in subgroups of patients with IgAN defined by baseline Gd-IgA1 levels in a Phase 1/2 study of zigakibart,Chronic Kidney Disease;Proteinuria,Chronic Kidney Disease;Proteinuria,Zigakibart,,,APRIL-Inhibitor,,,,
1796,Not Relevant,FC 15: Novel CKD Treatments Beyond the Pillars,Free Communication,Hospitalization for Congestive Heart Failure (CHF) Following Treatment With Roxadustat in Patients With or Without a History of CHF: Pooled Post Hoc Analysis of Phase 3 Studies,Heart Failure,Congestive Heart Failure,Roxadustat,,,HIF PH-Inhibitor,,,,
1797,Not Relevant,FC 15: Novel CKD Treatments Beyond the Pillars,Free Communication,A Win-Ratio Analysis of the Cardiovascular Safety of Vadadustat in Patients With CKD-Related Anemia Undergoing Dialysis,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,Vadadustat,,,HIF PH-Inhibitor,,,,
1798,Not Relevant,FC 15: Novel CKD Treatments Beyond the Pillars,Free Communication,"A multicenter, randomized, double-blind, placebo-controlled Phase 3 study in patients with idiopathic IC-MPGN: APPARENT protocol amendment",Membranoproliferative Glomerulonephritis,Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis,,,,,Novartis,,NCT05755386,APPARENT
1799,Not Relevant,FC 16: Acute Kidney Injury: Troubling our Minds,Free Communication,Hepatorenal syndrome and acute kidney injury (HRS-AKI) - what is new?,Acute Kidney Injury;Hepatorenal Syndrome,Acute Kidney Injury;Hepatorenal Syndrome,,,,,,,,
1800,Not Relevant,FC 16: Acute Kidney Injury: Troubling our Minds,Free Communication,Nitazoxanide alleviates kidney damage and restores renal function in disease models of acute-on-chronic liver failure,Liver Failure,Chronic Liver Failure,Nitazoxanide,,,Thiazolide Antiprotozoal,,,,
1801,Not Relevant,FC 16: Acute Kidney Injury: Troubling our Minds,Free Communication,Baseline Estimated GFR and the Prognostic Impact of Rapid Increases in Serum Creatinine After Major Elective Surgery: A Multicohort Study,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1802,Not Relevant,FC 16: Acute Kidney Injury: Troubling our Minds,Free Communication,Identification of heterogenous long-term kidney function trajectories after acute kidney injury reveals subgroups of patients at higher risk for long-term kidney dysfunction,Acute Kidney Injury,Acute Kidney Injury;Kidney Dysfunction,,,,,,,,
1803,Not Relevant,FC 16: Acute Kidney Injury: Troubling our Minds,Free Communication,Trajectories of Acute Kidney Injury Hospitalization Before and After Dementia Diagnosis: A Nationwide Cohort Study,Acute Kidney Injury;Dementia,Acute Kidney Injury;Dementia,,,,,,,,
1804,Not Relevant,FC 16: Acute Kidney Injury: Troubling our Minds,Free Communication,Association between Acute Kidney Injury and Dementia: A Multi-database Cohort Study,Acute Kidney Injury;Dementia,Acute Kidney Injury;Dementia,,,,,,,,
1805,Not Relevant,FC 17: Kidney transplantation: Interventions,Free Communication,Felzartamab in humoral rejection: an update,,,Felzartamab,,,CD38-Targeted Antibody,,,,
1806,Not Relevant,FC 17: Kidney transplantation: Interventions,Free Communication,The Efficacy and Safety of SGLT2 inhibitors in diabetic and non-diabetic kidney transplant recipients: a multicentric study,Diabetes,Diabetes,,,,SGLT2-Inhibitor,,,,
1807,Not Relevant,FC 17: Kidney transplantation: Interventions,Free Communication,Effectiveness and Safety of Tocilizumab Treatment for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients,,,Tocilizumab,,,IL6 Receptor-Antagonist,,,,
1808,Not Relevant,FC 17: Kidney transplantation: Interventions,Free Communication,Outcomes of Standard versus CYP3A5 Genotype-adapted Dosing of Tacrolimus in Renal Transplant Recipients: A Randomized Control Study,,,Tacrolimus,,,Calcineurin-Inhibitor,,,,
1809,Not Relevant,FC 17: Kidney transplantation: Interventions,Free Communication,Effect of felzartamab anti-CD38 treatment on the molecular phenotype of antibody-mediated rejection in kidney transplant biopsies,,,Felzartamab,,,CD38-Targeted Antibody,,,,
1810,Not Relevant,FC 17: Kidney transplantation: Interventions,Free Communication,Targeting TNFα signalling in deceased donor kidneys: A path to improve graft outcomes,,,,,,TNFa-Inhibitor,,,,
1811,Not Relevant,FC 17: Kidney transplantation: Interventions,Free Communication,Monitoring Anti-CD38 Treatment with Felzartamab in Antibody-Mediated Kidney Allograft Rejection,,,Felzartamab,,,CD38-Targeted Antibody,,,,
1812,Not Relevant,Game Changers in alloimmune risk stratification and organ allocation,Symposium,genome wide nonHLA vs HLA alloimmunity,,,,,,,,,,
1813,Not Relevant,Game Changers in alloimmune risk stratification and organ allocation,Symposium,"AI, machine learning",,,,,,,,,,
1814,Not Relevant,Game Changers in alloimmune risk stratification and organ allocation,Symposium,Monotoring the immune response in viral infection vs rejection,Viral Infection,Viral Infection,,,,,,,,
1815,Not Relevant,Game changers in prevention and treatment of AKI,Symposium,Amminoacids to prevent AKI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1816,Not Relevant,Game changers in prevention and treatment of AKI,Symposium,Treatment of AKI related to disasters,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1817,Not Relevant,Game changers in prevention and treatment of AKI,Symposium,Organoids for drugs screening in AKI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
1818,Not Relevant,Game changers in the diagnosis of podocytopathies,Symposium,Serum assays for diagnosis of autoimmune podocytopathies: is it time?,Podocytopathy,Autoimmune Podocytopathy,,,,,,,,
1819,Not Relevant,Game changers in the diagnosis of podocytopathies,Symposium,Autoimmunity in minimal change and FSGS: the same or different?,Focal Segmental Glomerulosclerosis,Focal Segmental Glomerulosclerosis,,,,,,,,
1820,Not Relevant,Game changers in the diagnosis of podocytopathies,Symposium,Recurrence after transplant: a sign of autoimmune podocytopathy?,Podocytopathy,Recurrent Autoimmune Podocytopathy,,,,,,Recurrent,,
1821,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Phenotypic analysis of the oral and intestinal microbiome reveals microbial signatures for disease classification and potential drivers of autoantibody production in IgA nephropathy,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1822,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Burden of illness in chronic primary glomerulonephritis: The patient perspective,Glomerulonephritis,Chronic Primary Glomerulonephritis,,,,,,,,
1823,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Characteristics of IgA Nephropathy patients treated with Mycophenolate Mofetil in the real world.,IgA Nephropathy,IgA Nephropathy,Mycophenolate Mofetil,,,IMPDH-Inhibitor,,,,
1824,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Socioeconomic and Psycho-emotional Impact of C3 Glomerulopathy and Immune Complex Membranoproliferative Glomerulonephritis in Adult Patients in Spain,C3 Glomerulopathy;Membranoproliferative Glomerulonephritis,Adult C3 Glomerulopathy;Adult Immune Complex Membranoproliferative Glomerulonephritis,,,,,,Adult,,
1825,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Exploring The Interaction Between The Complement System And Anca Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis,,,,,,,,
1826,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,The immunomodulatory role of neuroendothelial cells in lupus nephritis,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1827,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Comparative Outcome of Monthly Intra Venous Cyclophosphamide versus Daily Oral Mycophenolate Mofetil at Induction for Patients of Class III & IV Lupus Nephritis in a Population of Asian Ethnicity,Lupus Nephritis,Class III/IV Lupus Nephritis,Cyclophosphamide,,Mycophenolate Mofetil,Alkylating Agent,,,,
1828,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Long-term outcomes of patients with Primary FSGS treated with Rituximab,Focal Segmental Glomerulosclerosis,Primary Focal Segmental Glomerulosclerosis,Rituximab,,,CD20-Targeted Monoclonal Antibody,,,,
1829,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Biochemical Changes in ?-Glutamyl Cycle and Their Relevance in Systemic Lupus Erythematous,Systemic Lupus Erythematosus,Systemic Lupus Erythematosus,,,,,,,,
1830,Low,Glomerular & tubulo-interstitial diseases,Focussed Oral,Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy,Fibrosis;IgA Nephropathy,Primary IgA Nephropathy;Tubulointerstitial Fibrosis,,,,,,,,
1831,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Frailty as a proxy measure for infection risk and mortality in ANCA Glomerulonephritis,Glomerulonephritis,ANCA-Associated Glomerulonephritis,,,,,,,,
1832,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1833,Low,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Integrating Crescent Characteristics, Vascular Lesions, and Podocyte Injury into the MEST-C Framework: Enhanced Risk Stratification in IgA Nephropathy",IgA Nephropathy,IgA Nephropathy,,,,,,,,
1834,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Genetic Insights: delCFHR3-1 linked to de novo Thrombotic Microangiopathy in Kidney Transplant Recipients,Renal Failure;Thrombotic Microangiopathy,Kidney Failure;Thrombotic Microangiopathy,,,,,,,,
1835,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Histological Patterns, Prognostic Factors, and Treatment Impact in Renal Sarcoidosis: Insights from a Spanish Multicenter Study",Renal Sarcoidosis,Renal Sarcoidosis,,,,,,,,
1836,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Ultrastructural Patterns in Membranous Nephropathy: A Scanning Electron Microscopy Study,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
1837,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Rituximab for primary membranous nephropathy: a decade of experience,Primary Membranous Nephropathy,Primary Membranous Nephropathy,Rituximab,,,CD20-Targeted Monoclonal Antibody,,,,
1838,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Minimal Change Disease: A Novel Regimen of Glucocorticoids-induced Remission and then Rituximab as Maintenance Remission Therapy,Minimal Change Disease,Minimal Change Disease,Rituximab,,,CD20-Targeted Monoclonal Antibody,,,,
1839,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,An Observational Study of Treatment on IgA Nephropathy with Telitacicept and Immunosuppressive Regimens in a Single Center,IgA Nephropathy,IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor;Immunosuppressive Therapy,,,,
1840,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Albuminuria predicts GFR-decline in patients with Alport syndrome,Alport Syndrome;Glomerular Disease,Alport Syndrome;Glomerular Disease,,,,,,,,
1841,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Features Of Lithogenic And Anti-Lithogenic Factors In Urine In Stone Formation In Children.,Glomerular Disease;Tubulointerstitial Disease,Childhood Glomerular Disease;Childhood Tubulointerstitial Disease,,,,,,Childhood,,
1842,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,Efficacy and safety of low-dose Telitacicept in patients with primary IgA nephropathy: a retrospective cohort study,IgA Nephropathy,Primary IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
1843,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,Efficacy and safety of endothelin receptor antagonists in IgA nephropathy: A systematic review and meta-analysis of randomized controlled trials,IgA Nephropathy,IgA Nephropathy,,,,Endothelin Receptor Antagonist,,,,
1844,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Renal cysts in ADPKD patients can be distinguished by low and high sodium concentrations in vivo using 23Na magnetic resonance imaging,Autosomal Dominant Polycystic Kidney;Renal Cysts,Autosomal Dominant Polycystic Kidney Disease;Renal Cyst,,,,,,,,
1845,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Physician-directed nudge for glycemic and lipid management in older patients with glomerulonephritis treated with immunosuppressants,Glomerulonephritis,Elderly Glomerulonephritis,,,,Immunosuppressant,,Elderly,,
1846,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors in Adults With IgA Nephropathy in the Phase 2 SPARTACUS Trial,IgA Nephropathy,Adult IgA Nephropathy,Sparsentan,,,Endothelin Receptor Antagonist;SGLT2-Inhibitor,Travere Therapeutics,Adult,NCT05856760,SPARTACUS
1847,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,Effects of Sparsentan After Maximized Angiotensin Receptor Blocker (ARB) Treatment in Patients With IgA Nephropathy (IgAN) in the PROTECT Trial,IgA Nephropathy,IgA Nephropathy,Sparsentan,,,Endothelin Receptor-Antagonist,Novartis Pharmaceuticals,,NCT01235962;;PROTECT,
1848,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Native kidney biopsy in lateral position compared to prone position: technical aspects, diagnostic yield and complications",Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
1849,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Obinutuzumab alone may be an effective option for the initial therapy of adult minimal change disease,Minimal Change Disease,Adult Minimal Change Disease,Obinutuzumab,,,CD20-Targeted Monoclonal Antibody,,Adult,,
1850,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Antiproteinuric effect of SGLT2 inhibitors in non-diabetic glomerulopathies is dependent on body mass index.,Glomerulopathy,Non-Diabetic Glomerulopathy,,,,SGLT2-Inhibitor,,,,
1851,Not Relevant,Incremental PD and HD: a game changer?  In which patients?,Symposium,Economic considerations of individualization of dialysis prescription,Dementia;Renal Failure,Kidney Failure;Progressive Dementia,,,,,,Progressive,,
1852,Not Relevant,Incremental PD and HD: a game changer?  In which patients?,Symposium,Incremental hemodialysis and peritoneal dialysis: A promising and hallmark of individualized treatment,Renal Failure,Kidney Failure;Peritoneal Dialysis,,,,,,,,
1853,Not Relevant,Incremental PD and HD: a game changer?  In which patients?,Symposium,Quality of life in dialysis patients: Its importance in deciding dialysis dose,Dementia;Renal Failure,Kidney Failure;Progressive Dementia,,,,,,Progressive,,
1854,Not Relevant,Kidney Transplantation,Focussed Oral,Elevated Soluble ST2 at Day 7 as a Prognostic Biomarker for Adverse Outcomes in Kidney Transplant Recipients,,,,,,,,,,
1855,Not Relevant,Kidney Transplantation,Focussed Oral,"Incidence, Risk Factors, and Impact of Coronary artery disease Events after Kidney Transplantation",Coronary Artery Disease,Coronary Artery Disease,,,,,,,,
1856,Not Relevant,Kidney Transplantation,Focussed Oral,Predicting Graft Outcomes in Kidney Transplantation: The Strength of Standard Statistics Compared to Machine Learning Techniques,,,,,,,,,,
1857,Not Relevant,Kidney Transplantation,Focussed Oral,Association of Stigmatizing Language with Kidney Transplant Waitlisting,,,,,,,,,,
1858,Not Relevant,Kidney Transplantation,Focussed Oral,Relationship between intra-abdominal pressure early after surgery and long-term kidney graft function,,,,,,,,,,
1859,Not Relevant,Kidney Transplantation,Focussed Oral,Sex differences in transplant outcomes and survival for children on kidney replacement therapy: data from the ESPN/ERA Registry,,,,,,,,,,
1860,Not Relevant,Kidney Transplantation,Focussed Oral,Impact of HLA-Sensitization on Patient and Graft Outcomes in ABO-incompatible Living Donor Kidney Transplants: Single decade experience from North India,,,,,,,,,,
1861,Not Relevant,Kidney Transplantation,Focussed Oral,Comparative outcomes of Preemptive and Non-Preemptive Living Kidney Transplantation,,,,,,,,,,
1862,Not Relevant,Kidney Transplantation,Focussed Oral,Biopsy-based transcript diagnostics improves prognostication along the AMR continuum,,,,,,,,,,
1863,Not Relevant,Kidney Transplantation,Focussed Oral,Are There Gender Differences in Access to Kidney Transplantation in the Basque Country?,,,,,,,,,,
1864,Not Relevant,Kidney Transplantation,Focussed Oral,"Plasma Cadmium, Whole-Blood Cadmium and Late Graft Failure in Kidney Transplant Recipients",,,,,,,,,,
1865,Not Relevant,Kidney Transplantation,Focussed Oral,Glomerular Morphometry as a Predictor of Renal Graft Function,,,,,,,,,,
1866,Not Relevant,Kidney Transplantation,Focussed Oral,The Impact of Living Donor’s Pretransplant Clinical Features on 1st and 3rd Year Allograft Functions,,,,,,,,,,
1867,Not Relevant,Kidney Transplantation,Focussed Oral,Comparative analysis of glomerular filtration rate obtained by different methods in kidney transplanted patients,,,,,,,,,,
1868,Not Relevant,Metabolic management in CKD,Symposium,Real word data evidence for cardiovascular and renal outcome in DKD,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1869,Not Relevant,Metabolic management in CKD,Symposium,"Lipid optimization in chronic kidney disease, overcoming statin era",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
1870,Not Relevant,Metabolic management in CKD,Symposium,Hyperuricemia: to treat or not treat,Hyperuricemia,Hyperuricemia,,,,,,,,
1871,Not Relevant,New definitions in cardio – renal medicine,Symposium,Cardiovascular-kidney-metabolic (CKM) syndrome and its impacts on health.,,Cardiovascular Kidney Metabolism Syndrome,,,,,,,,
1872,Not Relevant,New definitions in cardio – renal medicine,Symposium,Selective glomerular hypofiltration syndrome: A critical appraisal.,,Glomerular Hypofiltration Syndrome,,,,,,,,
1873,Not Relevant,New definitions in cardio – renal medicine,Symposium,Novel prediction risk equations for assessing CVD incorporating CKM health: now a reality,Cardiovascular Disease,Cardiovascular Disease,,,,,,,,
1874,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Renal trajectories in the french RaDiCo Alport Syndrome  cohort,Alport Syndrome,Alport Syndrome,,,,,,,,
1875,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Evolutionary Origins of Polycystic Kidney Disease Genes: Insights from Emerging Phylogenomic Methodologies,Polycystic Kidney Diseases,Polycystic Kidney Disease,,,,,,,,
1876,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Dysregulated ion channel distribution promotes cyst formation in hereditary cystic kidney diseases,Cystic Kidney Diseases,Hereditary Cystic Kidney Disease,,,,,,,,
1877,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Mutant BCS1L patient urine derived renal epithelial cells: A Personalised Model of Mitochondrial Kidney Tubule dysfunction,,BCS1L-Mutated Mitochondrial Kidney Tubule Dysfunction,,,,,,,,
1878,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Exploring the Role of Mitochondrial Genomic Variants and Haplogroups in Clinical Phenotypes of Polycystic Kidney Disease,Polycystic Kidney Diseases,Polycystic Kidney Disease,,,,,,,,
1879,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Screening For Primary Hyperoxaluria Type 1 (Ph1) In Chronic Kidney Disease Patients Eligible For Kidney Transplantation – A Brazilian Multicenter Study,Chronic Kidney Disease;Primary Hyperoxaluria,Chronic Kidney Disease;Primary Hyperoxaluria Type I,,,,,,,,
1880,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,An external validation of polygenic risk scores in the general population using measured GFR – the Renal Iohexol Clearance Survey (RENIS),,Disease,,,,,,,,
1881,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Serological extracellular matrix fragments may serve as early kidney damage biomarkers in children with defects in Alport genes,,Childhood Kidney Damage,,,,,,Childhood,,
1882,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Metabolic control affects growth in dRTA: findings from the ESPN -ERKNet dRTA sub-registry.,Distal Renal Tubular Acidosis,Distal Renal Tubular Acidosis,,,,,,,,
1883,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Incidence and outcomes of kidney replacement therapy for kidney failure due to inherited tubulopathies in Europe: findings from the ERA Registry,Renal Failure,Kidney Failure,,,,,,,,
1884,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Autonomic Modulation in Normotensive ADPKD Patients,Autosomal Dominant Polycystic Kidney;Nephrosis,Autosomal Dominant Polycystic Kidney;Nephrotic Syndrome,,,,,,,,
1885,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Prenatal ultrasound features and long-term prognosis of Very-Early-Onset Autosomal Dominant Polycystic Kidney Disease,Autosomal Dominant Polycystic Kidney,Very Early Onset Autosomal Dominant Polycystic Kidney,,,,,,Early Onset,,
1886,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,aHUS Brazilian Registry: Phenotypic and Genotypic Characteristics of an Admixed Population with Diverse Ancestry,,,,,,,,,,
1887,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Effect of Female Sex Hormones on Liver Volume: Assessing the Safety of Preimplantation Genetic Diagnosis in Women with ADPKD,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
1888,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Renal Outcomes Of Kidney-Liver Transplantation And Liver Transplantation In Autosomal Dominant Polycystic Kidney Disease Patients,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney,,,,,,,,
1889,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Fabry Or Not Fabry? This Is The Problem: A Clinical Case.,Fabry Disease,Fabry Disease,,,,,,,,
1890,Not Relevant,Dialysis,Moderated e-Poster,A rare cause of orbital apex syndrome,,Orbital Apex Syndrome,,,,,,,,
1891,Not Relevant,Dialysis,Moderated e-Poster,Navigating Mental Health in Hemodialysis: Insights into Depression and Anxiety,Renal Failure,Anxiety;Kidney Failure,,,,,,,,
1892,Not Relevant,Dialysis,Moderated e-Poster,A Qualitative Study to Understand Cardiovascular Disease and Coronary Revascularization Treatment Strategies in Patients with Kidney Failure,Cardiovascular Disease;Renal Failure,Cardiovascular Disease;Kidney Failure,,,,,,,,
1893,Not Relevant,Dialysis,Moderated e-Poster,Parathyroidectomy for the treatment of Sagliker Syndrome: a cohort study based on Chinese population with refractory renal secondary hyperparathyroidism,Secondary Hyperparathyroidism,Refractory Renal Secondary Hyperparathyroidism;Sagliker Syndrome,,,,,Fresenius,Refractory,,
1894,Not Relevant,Dialysis,Moderated e-Poster,Home Medication in the US Based on the Assignment of NDC to ATC Codes,Renal Failure,Kidney Failure,,,,,,,,
1895,Not Relevant,Dialysis,Moderated e-Poster,Fragmented Physical Activity in Hemodialysis Patients – results from a prospective observational study,Renal Failure,Kidney Failure,,,,,,,,
1896,Not Relevant,Dialysis,Moderated e-Poster,CKD-associated pruritis and its impact on quality of life in a cohort of Russian patients on hemodialysis,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,,,,,,,,
1897,Not Relevant,Dialysis,Moderated e-Poster,Impact of Sarcopenia on Hospitalization and Mortality in Patients on Maintenance Hemodialysis,Renal Failure;Sarcopenia,Kidney Failure;Sarcopenia,,,,,,,,
1898,Not Relevant,Dialysis,Moderated e-Poster,Healthcare Team'S Opinion About An Exercise Program With Audiovisual Support During Hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
1899,Not Relevant,Dialysis,Moderated e-Poster,Evaluation of the Effect of Hemodialysis on Serum Uric Acid Levels and the Association with Cardiovascular Diseases in Patients with Chronic Kidney Disease.,Cardiovascular Disease;Chronic Kidney Disease,Cardiovascular Disease;Chronic Kidney Disease,,,,,,,,
1900,Not Relevant,Dialysis,Moderated e-Poster,Usefulness of nutritional ultrasound as an indicator of cardiovascular risk. Pilot study.,Renal Failure,Kidney Failure,,,,,,,,
1901,Not Relevant,Dialysis,Moderated e-Poster,A safety and survival analysis of sequential systemic anticancer treatment in patients with end-stage kidney disease and metastatic renal cell carcinoma,Kidney Diseases;Renal Cell Carcinoma,End Stage Kidney Disease;Metastatic Renal Cell Carcinoma,,,,,, End Stage,,
1902,Not Relevant,Dialysis,Moderated e-Poster,Multicentric validation of an Italian version of the Uremic Pruritus in Dialysis Patients (UP-Dial) questionnaire,Renal Failure;Uremia,Kidney Failure;Uremia,,,,,,,,
1903,Not Relevant,Dialysis,Moderated e-Poster,Prevalence and Predictors of Sarcopenia in Patients on Maintenance Hemodialysis and Its Relationship with Cathepsin D,Renal Failure;Sarcopenia,Kidney Failure;Sarcopenia,,,,,,,,
1904,Not Relevant,Dialysis,Moderated e-Poster,Unveiling Hormonal Dynamics: A Comparative Study of Hypothalamic-Pituitary-Gonadal Axis in Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
1905,Not Relevant,Dialysis,Moderated e-Poster,Body Composition as a Determinant of Erythropoietin Resistance in Hemodialysis Patients: Insights from a Serbian Single Center Cohort Study,Renal Failure,Kidney Failure,,,,,,,,
1906,Not Relevant,Dialysis,Moderated e-Poster,Investigating the Impact of Magnesium Levels on Adragão Score in Hemodialysis Patients,Renal Failure,Kidney Failure,Magnesium,,,Nutrient Supplement,,,,
1907,Not Relevant,Dialysis,Moderated e-Poster,Exploring the Relationship Between Nutritional Status and High Body Mass Index (BMI) in Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
1908,Not Relevant,Dialysis,Moderated e-Poster,Congestion parameters in a peritoneal dialysis program,Renal Failure,Kidney Failure,,,,,,,,
1909,Not Relevant,Dialysis,Moderated e-Poster,The prevalence of tunnelled line -associated MRSA and MSSA bacteraemias in a Maltese haemodialysis patient cohort between 2017 and 2024.,Methicillin-Resistant Staphylococcus Aureus Infection;Renal Failure;Staphylococcus Aureus Infection,Kidney Failure;Meticillin-Sensitive Staphylococcus Aureus Infection;Tunneled Line Associated Methicillin Resistant Staphylococcus Aureus Infection,,,,,,,,
1910,Not Relevant,Dialysis,Moderated e-Poster,Renal Replacement Therapy in a Patient with Severe Hemophilia A and ESRD: A Case Report,End-Stage Renal Disease;Hemophilia,End Stage Renal Disease;Severe Hemophilia,,,,,,Severe,,
1911,Not Relevant,Dialysis,Moderated e-Poster,Why are ultrasound parameters not sufficiently informative to predict the risk of primary AVF dysfunction?,Arterio-Venous Fistula,Primary Arterio-Venous Fistula Dysfunction,,,,,,,,
1912,Not Relevant,Dialysis,Moderated e-Poster,Intracardiac Catheter Implantation as a Salvage Therapy in Three Hemodialysis Patients : A Case Series,Renal Failure,Kidney Failure,,,,,,,,
1913,Not Relevant,Dialysis,Moderated e-Poster,Transition To Peritoneal Dialysis Due To Hemodialysis Vascular Access Failure. A Must With Few Trust.,Renal Failure,Kidney Failure,,,,,,,,
1914,Not Relevant,Dialysis,Moderated e-Poster,Vascular Access Difficulties in Patients of African Descent - Causes and Consequences,Renal Failure,Kidney Failure,,,,,,,,
1915,Not Relevant,Dialysis,Moderated e-Poster,Primary failure of Dialysis Vascular Access in the Elderly: Insights from a Retrospective Cohort,Renal Failure,Kidney Failure,,,,,,,,
1916,Not Relevant,Dialysis,Moderated e-Poster,Comparison of Pre- and Post-Dialysis Vascular Access Flow Measurements: Implications for Monitoring Strategies,Renal Failure,Kidney Failure,,,,,,,,
1917,Not Relevant,Dialysis,Moderated e-Poster,Turbulent Topography: Managing Individuals with Renal Disease During the Conflict of Genocidal Proportions Against Gaza: Palestine,Kidney Diseases,Kidney Disease,,,,,,,,
1918,Not Relevant,Dialysis,Moderated e-Poster,Home dialysis and hypertension: evaluating the role of the dialysate,Hypertension;Renal Failure,Hypertension;Kidney Failure,,,,,,,,
1919,Not Relevant,Dialysis,Moderated e-Poster,Peritoneal Dialysis in patients with Cardiorenal Syndrome: A systematic review and single-arm meta-analysis,Cardio-Renal Syndrome,Cardiorenal Syndrome,,,,,,,,
1920,Not Relevant,Dialysis,Moderated e-Poster,Clinician Usage and Perception of an AI-Based Model Predicting Peritoneal Dialysis Dropouts.,Renal Failure,Kidney Failure,,,,,,,,
1921,Not Relevant,Dialysis,Moderated e-Poster,Recurrent Liver Cyst Infections in an ADPKD Patient on Peritoneal Dialysis,Hepatic Cyst;Infection;Renal Failure,Kidney Failure;Recurrent Liver Cyst Infection,,,,,,Recurrent,,
1922,Not Relevant,Dialysis,Moderated e-Poster,Nt-Probnp And Serum Ca-125 In Peritoneal Dialysis: Developing A Decision Algorithm For Fluid Overload Assessment,Renal Failure,Kidney Failure,,,,,,,,
1923,Not Relevant,Dialysis,Moderated e-Poster,Efficacy and Safety of Recombinant Tissue Plasminogen Activator (r-TPA) in Assisted Home Hemodialysis: A Retrospective Study from Qatar,Renal Failure,Kidney Failure,,,,Recombinant Tissue Plasminogen Activator,,,,
1924,Not Relevant,Dialysis,Moderated e-Poster,Integrating Telemedicine into Peritoneal Dialysis: A Holistic Model for Palliative Care in Advanced CKD,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
1925,Not Relevant,Dialysis,Moderated e-Poster,National home hemodialysis (HHD) survey about organization of care and medical practices in France.,Renal Failure,Kidney Failure,,,,,,,,
1926,Not Relevant,Dialysis,Moderated e-Poster,Abdominal Wall Complications In Peritoneal Dialysis Patient With Autosomal Dominant Polycystic Kidney Disease,Autosomal Dominant Polycystic Kidney;Renal Failure,Autosomal Dominant Polycystic Kidney Disease;Kidney Failure,,,,,,,,
1927,Not Relevant,Dialysis,Moderated e-Poster,Impact of Peritoneal Ultrafiltration in Cardiorenal Syndrome,Cardio-Renal Syndrome,Cardiorenal Syndrome,,,,,,,,
1928,Not Relevant,Dialysis,Moderated e-Poster,Single Centre Experience With Daptomicin Sealing Of Tenckhoff Catheter In Relapsing And Refractory Peritonitis,Peritonitis,Relapsed/Refractory Peritonitis,Daptomycin,,,Cell Wall Inhibitor,,Relapsed/Refractory,,
1929,Not Relevant,Dialysis,Moderated e-Poster,Mr,Renal Failure,Kidney Failure,,,,,,,,
1930,Not Relevant,Dialysis,Moderated e-Poster,Successful Use of Glucagon-Like Peptide-1 Receptor Agonists (GLP1-RA) in A Patient WITH OBESITY and DIABETIC KIDNEY DISEASE UNDER Peritoneal Dialysis:  a Case Report,Obesity;Renal Failure,Kidney Failure;Obesity,,,,GLP1 Receptor-Agonist,,,,
1931,Not Relevant,Dialysis,Moderated e-Poster,Dynamic CA125 effluent levels as a potential biomarker for peritoneal membrane function,Renal Failure,Kidney Failure,,,,,,,,
1932,Not Relevant,Dialysis,Moderated e-Poster,Overhydration biomarkers in Peritoneal Dialysis,Renal Failure,Kidney Failure,,,,,,,,
1933,Not Relevant,Dialysis,Moderated e-Poster,"Changes in cardiac output and development, progression of pulmonary hypertension in patients on hemodialysis with an existing arteriovenous fistula",Arterio-Venous Fistula;Renal Failure,Arterio-Venous Fistula;Kidney Failure,,,,,,,,
1934,Not Relevant,Dialysis,Moderated e-Poster,Intimal hyperplasia rate as a predictor of hemodialysis arteriovenous fistula on the primary patency after percutaneous transluminal angioplasty,Renal Failure,Kidney Failure,,,,,,,,
1935,Not Relevant,Dialysis,Moderated e-Poster,Novel intradialytic system of monitoring vascular access. A monocentric experience,Renal Failure,Kidney Failure,,,,,,,,
1936,Not Relevant,Dialysis,Moderated e-Poster,Study the Role of Insulin Resistance In Arterial Calcification Among Incident Hemodialysis Patients.,Renal Failure,Kidney Failure,,,,,,,,
1937,Not Relevant,Dialysis,Moderated e-Poster,Mapping National Variation in Haemodialysis Central Venous Catheter Management: A UK-Wide Survey,Renal Failure,Kidney Failure,,,,,,,,
1938,Not Relevant,Dialysis,Moderated e-Poster,The Diagnostic value of Transoesophageal Echocardiography in Febrile patients with Cuffed Tunneled Catheter : A Clinical Perspective,Renal Failure,Kidney Failure,,,,,,,,
1939,Not Relevant,Dialysis,Moderated e-Poster,Influence Of Gender And Age On The Type Of Vascular Access In Spanish Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
1940,Not Relevant,Dialysis,Moderated e-Poster,Sex-Specific Arterial Remodeling in AVF Maturation: Implications for Personalized Vascular Access Management in ESKD in Young Women,Renal Failure,End Stage Kidney Failure,,,,,, End Stage,,
1941,Not Relevant,Dialysis,Moderated e-Poster,Evaluation of clinical consequences in diverse forms of fistula elevation procedure,Renal Failure,Kidney Failure,,,,,,,,
1942,Not Relevant,Dialysis,Moderated e-Poster,The effect of physical activity during hemodialysis on the condition of blood vessels in patients with stage 5 chronic kidney disease,Chronic Kidney Disease,Stage IV Chronic Kidney Disease,,,,,,Metastatic,,
1943,Not Relevant,Dialysis,Moderated e-Poster,Investigation of the correlation between the Hemodialysis Vascular Sound Index and conventional vascular access surveillance indexes,Renal Failure,Kidney Failure,,,,,,,,
1944,Not Relevant,Dialysis,Moderated e-Poster,Association between blood flow (Qa) monitored over time by ultrasound and the risk of thrombosis in autologous and prosthetic AV accesses,Renal Failure;Thrombosis,Kidney Failure;Thrombosis,,,,,,,,
1945,Not Relevant,Dialysis,Moderated e-Poster,Infrared Thermography: A Novel Method to Assess Hand Temperature and Its Association with Ischemic Signs and Symptoms in Dialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
1946,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Case series of seven patients with fibrillary glomerulonephritis-a single center experience,Fibromyalgia;Glomerular Disease,Fibromyalgia;Glomerular Disease,,,,,,,,
1947,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Renal Thrombotic Microangiopathy In Lupus Nephritis: A Case-Control Study,Lupus Nephritis;Thrombosis,Lupus Nephritis;Renal Thrombosis,,,,,,,,
1948,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Differences In The Clinical And Histological Presentation Of Interstitial Nephritis Acute  In Relation To The Use Of Drugs And Inhibitors Of The Check Point In The Nephrology Unit Of Our Center Between The Years 2008-2023,Interstitial Nephritis,Interstitial Nephritis,,,,,,,,
1949,Not Relevant,E-Posters,e-Poster,Monoclonal Gammopathy in ANCA-Associated Glomerulonephritis: Clinical Presentation and Outcomes,Glomerulonephritis;Monoclonal Gammopathy,ANCA-Associated Glomerulonephritis;Monoclonal Gammopathy,,,,,,,,
1950,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,A Comparative Study of Renal Limited and Systemic Pauci-immune Crescentic Glomerulonephritis : An observational study of patients presenting to the Nephrologist,Crescentic Glomerulonephritis,Systemic Pauci-Immune Crescentic Glomerulonephritis,,,,,,Systemic,,
1951,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Representation of women and sex-disaggregated outcomes of trials in ANCA-associated vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,,,,,,,,
1952,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Relapse of ANCA-Associated Vasculitis in Patients Undergoing Renal Replacement Therapy: A Rare but Severe Complication. Case Series.,Vasculitis,Relapsed Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis,,,,Antibody,,Relapsed,,
1953,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Recurrent Hypokalemia and Nephrotic Syndrome in a Patient with Renal Amyloidosis: A Case Report,Hypokalemia;Nephrosis;Renal Amyloidosis,Nephrotic Syndrome;Recurrent Hypokalemia;Renal Amyloidosis,,,,,,Recurrent,,
1954,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Lenvatinib-associated hyaline occlusive glomerular microangiopathy,,Hyaline Occlusive Glomerular Microangiopathy,,,,,,,,
1955,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,FSGS and Nephrotic Syndrome in Mantle Cell Lymphoma: An Exception or an Underrecognized Entity?,Focal Segmental Glomerulosclerosis;Mantle Cell Lymphoma;Nephrosis,Focal Segmental Glomerulosclerosis;Mantle Cell Lymphoma;Nephrotic Syndrome,,,,,,,,
1956,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Pregnancy-Associated aHUS: triggers, diagnosis, and outcomes",Hemolytic-Uremic Syndrome,Acute Hemolytic Uremic Syndrome,,,,,,,,
1957,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,ChatGPT put to the test: diagnosis and treatment of glomerular diseases in the real world - a pilot study,Glomerular Disease,Glomerular Disease,,,,,,,,
1958,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Importance of Renal Biopsy for the Early Diagnosis and Treatment of Primary Amyloidosis.,Light-Chain Amyloidosis,Primary Amyloidosis,,,,,,,,
1959,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Complement mediated thrombotic microangiopathy (C-TMA) clinical presentation and outcomes – single centre experience,Thrombotic Microangiopathy,Complement Mediated Thrombotic Microangiopathy,,,,,,,,
1960,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,CREBBP Gene Mutation in a Child with Steroid-Resistant Nephrotic Syndrome: A Rare Association,Nephritic Syndrome,CREBBP-Mutated Childhood Steroid Resistant Nephritic Syndrome,,,,,,Childhood;CREBBP-Mutated;Steroid-resistant,,
1961,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Terminal complement inhibition in atypical haemolytic uremic syndrome: a single-centre experience,Atypical Hemolytic-Uremic Syndrome,Atypical Hemolytic Uremic Syndrome,,,,,,,,
1962,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Navigating a Diagnostic Quandary of ANCA-Associated Vasculitis and Sweet's Syndrome A Case Report,Acute Febrile Neutrophilic Dermatosis;Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,ANCA-Associated Vasculitis;Sweet's Syndrome,,,,,,,,
1963,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Type II cryoglobulinemic vasculitis with renal involvement in a patient with lymphoplasmacytic lymphoma: a rare case report,Cryoglobulinemia;Waldenstrom Macroglobulinemia,Cryoglobulinemia;Lymphoplasmacytic Lymphoma,,,,,,,,
1964,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Clinical characteristics and outcomes of adults with IgA Nephropaty: a retrospective study,IgA Nephropathy,Adult IgA Nephropathy,,,,,,Adult,,
1965,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Belimumab use in patients with systemic erythematous lupus and lupus nephritis - cohort of a tertiary center,Systemic Lupus Erythematosus,Systemic Lupus Erythematosus,Belimumab,,,BAFF-Targeted Therapy,,,,
1966,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Granulomatous interstitial nephritis and immunodeficiency - a link to remember,Immune Deficiency;Interstitial Nephritis,Granulomatous Interstitial Nephritis;Immunodeficiency,,,,,,,,
1967,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Plasma cell infiltration predicts elevated steroid demand during short-term management of severe ANCA-associated renal vasculitides,Vasculitis,ANCA-Associated Renal Vasculitis,,,,Steroid,,,,
1968,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Rituximab Efficacy And Safety In Patients With Glomerular Diseases: A Single Centre Experience,Glomerular Disease,Glomerular Disease,Rituximab,,,CD20-Targeted Monoclonal Antibody,,,,
1969,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Predictors of Disease Progression in Primary Membranous Nephropathy,Primary Membranous Nephropathy,Primary Membranous Nephropathy,,,,,,,,
1970,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Predictors Of Kidney Outcomes In Anca-Associated Vasculitis: A Retrospective Cohort Study,Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,Anca-Associated Vasculitis,,,,,,,,
1971,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,An unusually aggressive case C3 glomerulonephritis,C3 Glomerulonephritis,C3 Glomerulonephritis,,,,,,,,
1972,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,CD4 cells and Peripheral T follicular cells may play a protective role in the development of cardiomyopathy in patients with SLE and LN,Systemic Lupus Erythematosus,Cardiofibroblastoma;Systemic Lupus Erythematosus,,,,,,,,
1973,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Efficacy And Safety Of Biologic Therapies For The Treatment Of Lupus Nephritis / Lupus Erythematosus: Experience Of Our Hospital,Lupus Nephritis;Systemic Lupus Erythematosus,Lupus Erythematosus;Lupus Nephritis,,,,Biologic Therapy,,,,
1974,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Distress Tolerance in Lupus Nephritis: The Relationship Between Psychological Resilience and Disease Severity,Lupus Nephritis,Lupus Nephritis,,,,,,,,
1975,Low,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Clinicopathological Characteristics and Prognostic Performance of the International IgA Nephropathy Prediction Tool in a Mexican Cohort.,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1976,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Extracapillary glomerulonephritis with mesangial IgA deposits in the presence of ANCA in a patient treated with Infliximab: A diagnostic challenge.,Glomerulonephritis,Extracapillary Glomerulonephritis,Infliximab,,,TNF Alpha-Inhibitor,,,,
1977,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Coagulation changes in the Coagulation System in Nephrotic Syndrom: A Clinical Multicenter Study,Nephrosis,Nephrotic Syndrome,,,,,,,,
1978,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Impact of SGLT2i on bone health in patients with lupus nephritis: randomized double blinded placebo controlled clinical trial.,Lupus Nephritis,Lupus Nephritis,,,,SGLT2-Inhibitor,,,,
1979,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Clinical utility of international IgA nephropathy prediction tool in Japanese patients,IgA Nephropathy,IgA Nephropathy,,,,,,,,
1980,Medium,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Long-term efficacy and safety of successful pregnancy in a patient with IgA nephropathy treated with telitacicept,IgA Nephropathy,IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
1981,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Renal, Cardiovascular, and Hematologic Outcomes of SGLT2 Inhibitors in Lupus Nephritis: Evidence from a Randomized Controlled Trial",Lupus Nephritis,Lupus Nephritis,,,,SGLT2-Inhibitor,,,,
1982,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The efficacy and safety of ripertamab in inducing remission of primary membranous nephropathy: a retrospective study,Primary Membranous Nephropathy,Primary Membranous Nephropathy,Ripertamab,,,CD20-Targeted Monoclonal Antibody,,,,
1983,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Successful Treatment of Steroid-Dependent Mesangial Proliferative Glomerulonephritis with Telitacicept: A Case Report,Glomerulonephritis,Steroid Dependent Mesangial Proliferative Glomerulonephritis,Telitacicept,,,BLyS/APRIL Dual-Inhibitor;Steroid,,,,
1984,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,A Systemic scoping review on Interventions for Cardiovascular Risk Management in Glomerulonephritis,Glomerulonephritis,Glomerulonephritis,,,,,,,,
1985,High,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Budesonide beyond NEFIGAN in IgA nephropathy,IgA Nephropathy,IgA Nephropathy,Budesonide,,,Glucocorticoid Receptor Agonist,Calliditas Therapeutics,,NCT01738035,NEFIGAN
1986,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Laboratory Markers Of Nephrolithiasis,Nephrolithiasis,Nephrolithiasis,,,,,,,,
1987,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Granulomatous interstitial nephritis in a patient with metastatic melanoma on target therapy with dabrafenib and trametinib: a case report,Interstitial Nephritis;Melanoma,Granulomatous Interstitial Nephritis;Metastatic Melanoma,Dabrafenib;Trametinib,,,BRAF-Inhibitor;MEK-Inhibitor,,Metastatic,,
1988,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Bevacizumab-associated Renal Events: Incidence, Risk Factors, and Relationship with Mortality",Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,Bevacizumab,,,VEGF-Targeted Therapy,,,,
1989,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Data from the single largest native kidney biopsy center in Croatia (1996-2023),Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
1990,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Clinical Manifestation and Prognosis of Membranous Nephropathy in Aged Patients with Primary Sjögren Syndrome,Membranous Nephropathy;Primary Sjogren Syndrome,Elderly Membranous Nephropathy;Primary Sjogren's Syndrome,,,,,,Elderly,,
1991,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Analysis of Iterative Renal Biopsies (PBR) in Adult Minimal Change Disease (MCD): Clinical Indications and Histopathological Outcomes,Minimal Change Disease,Adult Minimal Change Disease,,,,,,Adult,,
1992,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Renal Biopsy and Clinical Frailty in Elderly Renal Disease Patients,Kidney Diseases,Elderly Renal Disease,,,,,,Elderly,,
1993,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Role of Needle Size in Pediatric Kidney Biopsy: A Retrospective Analysis,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
1994,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Ten years of C3 Glomerulopathy: a nationwide cohort study,Glomerulopathy,Complement 3 Glomerulopathy,,,,,,,,
1995,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The clinico-pathologic characteristics of fibrillary glomerulonephritis: a Portuguese cohort,Fibrillary Glomerulonephritis,Fibrillary Glomerulonephritis,,,,,,,,
1996,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,The Association Between Complementary and Alternative Medicine and Membranous Nephropathy: A Systematic Review,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
1997,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Characterization of Membranous Glomerulonephritis in Adults presenting with Nephrotic Syndrome: A 13-Year Observational Study,Nephritic Syndrome,Adult Nephritic Syndrome,,,,,,Adult,,
1998,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Serum Phospholipase A2 Receptor Antibody Is Associated with Thrombogenesis in Patients with Membranous Nephropathy: A Systematic review and Meta-analysis.,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
1999,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,"Renal Manifestations of Thalassemia : A 17 Year Retrospective Study  Sahloul University Hospital , Tunisia.",Thalassemia,Thalassaemia,,,,,,,,
2000,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Evaluation of Association Between UMOD Gene Variants and Renal Outcomes in Children with Nephrotic Syndrome,Nephritic Syndrome,Childhood Nephritic Syndrome,,,,,,Childhood,,
2001,Not Relevant,Glomerular & tubulo-interstitial diseases,Moderated e-Poster,Effect Of Immunosuppressive Therapy With Cyclosporine On Arterial Stiffness In Patients With Glomerulonephritis,Glomerulonephritis,Glomerulonephritis,Cyclosporine,,,Calcineurin-Inhibitor,,,,
2002,Not Relevant,Kidney Transplantation,Moderated e-Poster,Immunotherapy In Kidney Transplant Patients With Cancer: The Latest Challenge.,Cancer,Cancer,,,,,,,,
2003,Not Relevant,Kidney Transplantation,Moderated e-Poster,Cat Scratch Disease In A Kidney Transplant Receipient: The Role Of Steroids In Persitent Systemic Symptoms,Cat Scratch Disease,Cat Scratch Disease,,,,Steroid,,,,
2004,Not Relevant,Kidney Transplantation,Moderated e-Poster,Kidney Transplantation and Cardiovascular Risk: The role of the Underlying Nephropathy,Nephropathy,Nephropathy,,,,,,,,
2005,Not Relevant,Kidney Transplantation,Moderated e-Poster,Fibrillary Glomerulonephritis: An unexpected diagnosis in a Kidney Transplant Patient,Fibrillary Glomerulonephritis,Fibrillary Glomerulonephritis,,,,,,,,
2006,Not Relevant,Kidney Transplantation,Moderated e-Poster,A surrogate marker for graft-to-recipient allocation could be identifying patients at risk of postoperative complications using donor data as predictors,,,,,,,,,,
2007,Not Relevant,Kidney Transplantation,Moderated e-Poster,The Impact Of Resistive Index On Kidney Allograft And Transplant Recipients’ Survival After Successful Transplant Renal Artery Stenosis Stenting,Renal Artery Stenosis,Renal Artery Stenosis,,,,,,,,
2008,Not Relevant,Kidney Transplantation,Moderated e-Poster,Management of Post-Trasplant Renal Graft Artery Stenosis and Outcomes: A Single-Center Experience,Stenosis,Renal Graft Artery Stenosis,,,,,,,,
2009,Not Relevant,Kidney Transplantation,Moderated e-Poster,Microwave thermoablation (MWA) for hypercalcemic hyperparathyroidism in pre- and post- renal transplant patients: a new minimally invasive therapeutic approach,Hyperparathyroidism,Hypercalcemic Hyperparathyroidism,,,,,,,,
2010,Not Relevant,Kidney Transplantation,Moderated e-Poster,Clinical characteristics and outcome of superficial fungal infection in kidney transplant recipients,Mycosis,Fungal Infection,,,,,,,,
2011,Not Relevant,Kidney Transplantation,Moderated e-Poster,Risk Factors of Mucocutaneous Manifestations in Kidney Transplant Recipients,,,,,,,,,,
2012,Not Relevant,Kidney Transplantation,Moderated e-Poster,Risk Of Infection In Patients Colonized With Extended-Spectrum Beta-Lactamase (Esbl)-Producing Enterobacteriaceae And Methicillin-Resistant Staphylococcus Aureus (Mrsa) In A Population Of A 106 Kidney And Pancreas-Kidney Transplant Recipients,Infection,Infection,,,,,,,,
2013,Not Relevant,Kidney Transplantation,Moderated e-Poster,Post Transplant Diarrhoea in ABO-incompatible Kidney Transplant – A nemesis for patient and nephrologist,Diarrhea,Diarrhea,,,,,,,,
2014,Not Relevant,Kidney Transplantation,Moderated e-Poster,Recurrence of Focal Segmental Glomerulosclerosis after kidney transplantation: Over 40 years of experience in our centre,Focal Segmental Glomerulosclerosis,Recurrent Focal Segmental Glomerulosclerosis,,,,,,Recurrent,,
2015,Not Relevant,Kidney Transplantation,Moderated e-Poster,Clinical Impact of Early Post-transplant Diabetes Mellitus in Kidney Transplant Recipients,Diabetes,Diabetes,,,,,,,,
2016,Not Relevant,Kidney Transplantation,Moderated e-Poster,Outcomes Of Acute Respiratory Failure In Post Transplant,Acute Respiratory Failure,Acute Respiratory Failure,,,,,,,,
2017,Not Relevant,Kidney Transplantation,Moderated e-Poster,Review of Vascular Access in Kidney Transplant Recipients: An Overlooked Topic. Experience of a non-transplant hospital,,,,,,,,,,
2018,Not Relevant,Kidney Transplantation,Moderated e-Poster,"Differences in PTLD risk and prognostic factors between kidney and other solid organ transplant recipients, a multicenter observational study.",Post-Transplant Lymphoproliferative Disorder,Post-Transplant Lymphoproliferative Disorder,,,,,,,,
2019,Not Relevant,Kidney Transplantation,Moderated e-Poster,Bioimpedance Analysis in Post-Kidney Transplant Patients,,,,,,,,,,
2020,Not Relevant,Kidney Transplantation,Moderated e-Poster,Perioperative Congestion Assessment in Kidney Transplant Recipients: The Role of Multiparametric Evaluation with Ultrasound and Biomarkers,,,,,,,,,,
2021,Not Relevant,Kidney Transplantation,Moderated e-Poster,Recipient BMI and the risk of medical and surgical complications after kidney transplantation,,,,,,,,,,
2022,Not Relevant,Kidney Transplantation,Moderated e-Poster,Potential Cardiovascular Benefits of Denosumab in Kidney Transplant Recipients: A Focus on Aortic Arch Calcification,,,Denosumab,,,RANKL-Inhibitor,,,,
2023,Not Relevant,E-Posters,e-Poster,Natural killer subpopulations in kidney transplant patients with BK viruria,BK Virus Infection,BK Virus Infection,,,,,,,,
2024,Not Relevant,Kidney Transplantation,Moderated e-Poster,Do Vexus Protocol And Lung Ultrasound (Lus) Help In The Evaluation Of Immediate Post Transplant (Posktx) Volemia?,,,,,,,,,,
2025,Not Relevant,Kidney Transplantation,Moderated e-Poster,Metabolomic Profiling of Urine in Post-Kidney Transplant Patients: Insights into Allograft Function and Creatinine Clearance,,,,,,,Fresenius,,,
2026,Not Relevant,Kidney Transplantation,Moderated e-Poster,A model for the care Management of pre-renal transplant as a basis for public decision-making in Brazil,,,,,,,,,,
2027,Not Relevant,Kidney Transplantation,Moderated e-Poster,"Prevalence, Risk Factors and Long-Term Outcomes of Diabetes Mellitus After Kidney Transplantation",Diabetes,Diabetes,,,,,,,,
2028,Not Relevant,Kidney Transplantation,Moderated e-Poster,Smartphone Addiction as a New Behavioral Risk Factor for Medication Non-Adherence in Renal Transplantation,,,,,,,,,,
2029,Not Relevant,Kidney Transplantation,Moderated e-Poster,Evaluating time zero biopsy findings and one year kidney function in live kidney donors and recipients in Sri Lanka,,,,,,,,,,
2030,Not Relevant,Kidney Transplantation,Moderated e-Poster,Long-Term Changes in Kidney Function Following Living Donor Nephrectomy: A Retrospective Cohort Study,,,,,,,,,,
2031,Not Relevant,Kidney Transplantation,Moderated e-Poster,"""Beyond Compatibility: ABO-Incompatible Pediatric Kidney Transplant, On Par with ABO-Compatible Controls""",,,,,,,,,,
2032,Not Relevant,Kidney Transplantation,Moderated e-Poster,Inference of donor-type proportions among the prevalent kidney-transplant population in the United States,,,,,,,,,,
2033,Not Relevant,Kidney Transplantation,Moderated e-Poster,Assessing Health-Related Quality of Life in Non-Directed Versus Directed Kidney Donors: Implications for the Promotion of Non-Directed Donation,,,,,,,,,,
2034,Not Relevant,Kidney Transplantation,Moderated e-Poster,A rare case of Cryptococcus skin and bloodstream infection in a kidney transplant recipient – a case report.,Cryptococcosis,Cryptococcosis,,,,,,,,
2035,Not Relevant,Kidney Transplantation,Moderated e-Poster,A decade of ABO incompatible kidney transplantation: results and lessons learned,,,,,,,,,,
2036,Not Relevant,E-Posters,e-Poster,Clinical implications of the PREVENT equations among kidney transplant recipients in Korea,,,,,,,,,,
2037,Not Relevant,Kidney Transplantation,Moderated e-Poster,Outcomes in Elderly Kidney Transplant Recipients: A National Multicentre Study,,,,,,,,,,
2038,Not Relevant,Kidney Transplantation,Moderated e-Poster,Breaking Barriers- Understanding Organ Donation Perceptions in the Indian Transplant Community,,,,,,,,,,
2039,Not Relevant,Kidney Transplantation,Moderated e-Poster,Dialysis Initiation After Renal Graft Failure: Do Outcomes Differ from Low-Clearance-Clinic Patients?,Renal Failure,Kidney Failure,,,,,,,,
2040,Not Relevant,Kidney Transplantation,Moderated e-Poster,Immunological Avalanches In Kidney Transplant Patients,,,,,,,,,,
2041,Not Relevant,Kidney Transplantation,Moderated e-Poster,How are people living with obesity and kidney failure supported to lose weight prior to kidney transplantation?: a national survey of kidney healthcare providers in the United Kingdom,Renal Failure,Kidney Failure,,,,,,,,
2042,Not Relevant,Kidney Transplantation,Moderated e-Poster,Using machine learning to develop a Kidney DQI for predicting transplant outcomes within the first three months post-procedure,,,,,,,,,,
2043,Not Relevant,Kidney Transplantation,Moderated e-Poster,Outcome of Simultaneous Pancreas-Kidney Transplant from a Tertiary care center in India,,,,,,,,,,
2044,Not Relevant,Kidney Transplantation,Moderated e-Poster,Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients,,,Tocilizumab,,,IL6 Receptor-Antagonist,,,,
2045,Not Relevant,Late breaking clinical trials I: Cutting-Edge Clinical trials in Nephrology,Symposium,A phase 2b trial of efficacy and safety of factor XI inhibition with MK-2060 for preventing arteriovenous graft thrombosis in haemodialysis patients,,,MK-2060,,,Factor XI-Inhibitor,,,,
2046,Not Relevant,Chronic kidney disease,Moderated e-Poster,Potential Inhibitors of Vascular Calcification of Plant Origin – Data from Systematic Review.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2047,Not Relevant,Chronic kidney disease,Moderated e-Poster,Use of Cystatin C to Estimate Glomerular Filtration Rate Based on Nutritional Status in Older Adults,Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,,,Elderly,,
2048,Not Relevant,Chronic kidney disease,Moderated e-Poster,Decline of kidney function is associated with lower sweat weight in patients with chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2049,Not Relevant,Chronic kidney disease,Moderated e-Poster,WNT signaling Pathway is Upregulated by Uremic Toxins P-cresyl Sulfate and Indoxyl Sulfate on the Advancement of Colorectal Cancer in Chronic Kidney Disease Patient,Chronic Kidney Disease;Colorectal Cancer,Chronic Kidney Disease;Colorectal Cancer,,,,,,,,
2050,Not Relevant,Chronic kidney disease,Moderated e-Poster,Genetic Determinants of Chronic Kidney Disease (CKD) in India: A Comprehensive Genome Wide Association studies (GWAS) Analysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2051,Not Relevant,Chronic kidney disease,Moderated e-Poster,Artificial Intelligence in optimizing nephrology outpatient managment: result of a pilot study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,Fresenius,,,
2052,Not Relevant,Chronic kidney disease,Moderated e-Poster,Association of Sunlight on Multiple Sclerosis Prevalence in Patients with Kidney Disease,Kidney Diseases;Multiple Sclerosis,Kidney Disease;Multiple Sclerosis,,,,,,,,
2053,Not Relevant,Chronic kidney disease,Moderated e-Poster,"CD24 upregulation aggravates renal damage in CRF in mice, a possible role for Klotho inhibition and FGF23 activation.",Chronic Kidney Disease,Chronic Renal Failure,,,,,,,,
2054,Not Relevant,Chronic kidney disease,Moderated e-Poster,Metabolomic Shifts in Advanced CKD Patients Starting Hemodialysis.,Renal Failure,Advanced Kidney Failure,,,,,,Advanced,,
2055,Not Relevant,Chronic kidney disease,Moderated e-Poster,Investigating The Role Of The Raw Bioelectrical Resistance Ratio In The Fluid Status Assessment Of Non-Dialysis Chronic Kidney Disease Patients,Chronic Kidney Disease,Non Dialysis Chronic Kidney Disease,,,,,,,,
2056,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Vadadustat Combination with Ferric Citrate, Compared to Either Agent Alone, Protects Against Inflammation-Induced Anaemia and Anaemia-Induced by Chronic Kidney Disease",Anemia;Chronic Kidney Disease,Anaemia;Chronic Kidney Disease,Ferric Citrate;Vadadustat,,,HIF PH-Inhibitor;Iron Supplement,,,,
2057,Not Relevant,Chronic kidney disease,Moderated e-Poster,Sustained and localized delivery of mesenchymal stem cells-derived extracellular vesicles by in situ forming PEG click hydrogel for diabetic nephropathy therapy,Diabetic Nephropathy,Diabetic Nephropathy,Mesenchymal Stem Cell,,,Stem Cell Therapy,,,,
2058,Not Relevant,Chronic kidney disease,Moderated e-Poster,Proteomic Insights into the Molecular Mechanisms of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Using mIMCD3 Cells,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
2059,Not Relevant,Chronic kidney disease,Moderated e-Poster,Serum miRNAs as Novel Biomarkers and Modulators of Rapidly Progressing Chronic Kidney Disease? in Patients with Diabetes,Chronic Kidney Disease;Diabetes,Chronic Kidney Disease;Diabetes,,,,,,,,
2060,Not Relevant,Chronic kidney disease,Moderated e-Poster,Uremic Toxicity Impairs the Endothelial Barrier Through Phosphorylation of Tyrosine 658 on VE-cadherin,Chronic Kidney Disease;Uremia,Chronic Kidney Disease;Uremia,,,,,,,,
2061,Not Relevant,Chronic kidney disease,Moderated e-Poster,The Role Of Centre Characteristics And Type Of Water Treatment Plant In The Environmental Impact Of Hemodialysis,Chronic Kidney Disease,Chronic Kidney Failure,,,,,,,,
2062,Not Relevant,Chronic kidney disease,Moderated e-Poster,Bariatric surgery reverses ORG and exhibits a distinct transcriptomic profile compared to weight loss through a low-fat diet,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2063,Not Relevant,Chronic kidney disease,Moderated e-Poster,Echographic Evaluation Over Time of Cardiovascular Disorders Related to Chronic Kidney Disease in a Rat Model,Chronic Kidney Disease,Cardiovascular Disorder;Chronic Kidney Disease,,,,,,,,
2064,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Adiposopathy, inflammation and perirenal fat",Chronic Kidney Disease;Inflammation,Adipose Tissue Inflammation;Chronic Kidney Disease,,,,,,,,
2065,Not Relevant,Chronic kidney disease,Moderated e-Poster,Kidney biopsy in moderate to severe chronic kidney disease: unmet needs and novel insights,Chronic Kidney Disease,Moderate/Severe Chronic Kidney Disease,,,,,,Moderate;Severe,,
2066,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Retinal vascular analysis, a systematic review",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2067,Not Relevant,Chronic kidney disease,Moderated e-Poster,The Adjustment Of Gfr By Body Surface Area: A Misleading Procedure In Trials Focused On Weight Reduction And Gfr Changes,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2068,Not Relevant,Chronic kidney disease,Moderated e-Poster,Serum Cystatin C: A Novel Biomarker for CKD Detection – A Meta-Analysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2069,Not Relevant,Chronic kidney disease,Moderated e-Poster,Prediction Model for Renal Aging/Chronic Kidney Disease in Chinese Elderly using Basic Indicators: A retrospective cohort study,Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,,,Elderly,,
2070,Not Relevant,Chronic kidney disease,Moderated e-Poster,Exploring the Interactions between Drugs and Metabolic Disturbances in CKD: An Example with Oral Anticoagulants,Chronic Kidney Disease,Chronic Kidney Disease,,,,Anticoagulant,,,,
2071,Not Relevant,Chronic kidney disease,Moderated e-Poster,A Southeast London Primary Care Allied Health Professional Led Point-of-Care Kidney Clinic to pharmacologically optimise people with chronic kidney disease (PROTECT KIDNEY),Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,PROTECT KIDNEY,
2072,Not Relevant,Chronic kidney disease,Moderated e-Poster,Survey on Nurse Practices in the Care Pathway within the CKD Stage 4 and 5 Multidisciplinary Package,Chronic Kidney Disease,Chronic Kidney Disease;Stage IV/V Chronic Kidney Disease,,,,,,Metastatic,,
2073,Not Relevant,Chronic kidney disease,Moderated e-Poster,Treatment Optimization and Standard of Care Adherence in CKD Primary Care: the TOSCA-CKD project,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,TOSCA-CKD,
2074,Not Relevant,Chronic kidney disease,Moderated e-Poster,Population Pharmacokinetic Modelling of Canagliflozin in Advanced Chronic Kidney Disease,Chronic Kidney Disease,Advanced Chronic Kidney Disease,Canagliflozin,,,SGLT2-Inhibitor,,Advanced,,
2075,Not Relevant,Chronic kidney disease,Moderated e-Poster,"I will present the results of a novel automated method for screening chronic kidney disease (CKD) in primary care, leveraging artificial intelligence and adherence to established clinical guidelines.",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2076,Not Relevant,Chronic kidney disease,Moderated e-Poster,The Role Of Pain In Reducing Quality Of Life In Patients With Stage 5 Ckd: A Systematic Review,Chronic Kidney Disease,Stage V Chronic Kidney Disease,,,,,,,,
2077,Not Relevant,Chronic kidney disease,Moderated e-Poster,Comparative Assessment of Renal Artery Blood Flow in Patients with Chronic Kidney Disease Against the Background of Dyslipidemia,Dyslipidemia,Dyslipidemia,,,,,,,,
2078,Not Relevant,Chronic kidney disease,Moderated e-Poster,Evaluating the Nutritional Accuracy and Practicality of ChatGPT-Generated Recipes for CKD Patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2079,Not Relevant,Chronic kidney disease,Moderated e-Poster,Assessment Of Metabolic Risk Of Exposure To Lithogenic Factors And Prevention Of Development Of Nephrolithiasis In Children,Nephrolithiasis,Childhood Nephrolithiasis,,,,,,Childhood,,
2080,Not Relevant,Chronic kidney disease,Moderated e-Poster,The Cardiac and Renal Safety of Semaglutide in Patients with Type 2 Diabetes: A Real-World Study,Type 2 Diabetes,Type 2 Diabetes,Semaglutide,,,GLP1 Receptor-Agonist,,,,
2081,Not Relevant,Chronic kidney disease,Moderated e-Poster,Comparative Outcomes on Kidney Function of Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers,Chronic Kidney Disease,Chronic Kidney Disease,,,,ACE-Inhibitor;Angiotensin Receptor-Blocker,,,,
2082,Not Relevant,Chronic kidney disease,Moderated e-Poster,Ensembling Survival Models to Optimize Renal Outcome Predictions in Chronic Kidney Disease Patients: A Retrospective Cohort Study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2083,Not Relevant,Chronic kidney disease,Moderated e-Poster,Effective interventions to manage the impact of climate change on cardio-renal health: a systematic literature review,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2084,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Sleep habits, sleep quality, and fatigue among people with chronic kidney disease",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2085,Not Relevant,Chronic kidney disease,Moderated e-Poster,Single-dose Pharmacokinetics of Extended-release Calcifediol in Healthy Japanese and non-Japanese Volunteers,Chronic Kidney Disease,Chronic Kidney Disease,Calcifediol,,,Vitamin D Analog,,,,
2086,Not Relevant,Chronic kidney disease,Moderated e-Poster,Therapeutic Potential of Omentum dECM in Promoting Angiogenesis and Reducing Fibrosis for Renal Tissue Regeneration and Failure Repair,Fibrosis,Fibrosis,,,,,,,,
2087,Not Relevant,Chronic kidney disease,Moderated e-Poster,TORCH infections in children: intrauterine infection and the incidence of renal anomalies,Pyelonephritis;Renal Failure,Childhood Kidney Failure;Kidney Infection,,,,,,Childhood,,
2088,Not Relevant,Chronic kidney disease,Moderated e-Poster,Understanding risk stratification of patients with chronic kidney disease (CKD) risk in primary care: a qualitative study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2089,Not Relevant,Chronic kidney disease,Moderated e-Poster,Changes In Microrna Expression In Urine And Kidneys Of Wistar Rats Feeding A High-Salt Diet,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2090,Not Relevant,Chronic kidney disease,Moderated e-Poster,Impact of Albuminuria Screening in Primary Care on the Detection and Management of Chronic Kidney Disease: Evidence from the ONDAAS Study,Albuminuria;Chronic Kidney Disease,Albuminuria;Chronic Kidney Disease,,,,,,,NCT06447038,ONDAAS
2091,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Dapagliflozin Improves Metabolic Profile in Non-Diabetic Chronic Kidney Disease: A randomized, double-blinded, placebo-controlled trial",Chronic Kidney Disease,Non-Diabetic Chronic Kidney Disease,Dapagliflozin,,,SGLT2-Inhibitor,,,,
2092,Not Relevant,Chronic kidney disease,Moderated e-Poster,Dapaglifozin and finerenone: real-world data on safety and efficacy in patients with diabetic chronic kidney disease (CKD).,Chronic Kidney Disease,Diabetic Chronic Kidney Disease,Dapagliflozin;Finerenone,,,Mineralocorticoid Receptor-Antagonist;SGLT2-Inhibitor,,,,
2093,Not Relevant,Chronic kidney disease,Moderated e-Poster,PDE5 Inhibitor LW1646 Improves Kidney Fibrosis by Alleviating ER Stress and Mitochondrial Calcium Overload,Fibrosis,Kidney Fibrosis,LW-1646,,,PDE5-Inhibitor,,,,
2094,Not Relevant,Chronic kidney disease,Moderated e-Poster,Association between proteinuria and clinically meaningful endpoints in patients with C3G / IC-MPGN: a Delphi consensus of European experts,Glomerulopathy;Membranoproliferative Glomerulonephritis;Proteinuria,Complement 3 Glomerulopathy;Immune Complex-Mediated Membranoproliferative Glomerulonephritis;Proteinuria,,,,,,,,
2095,Not Relevant,Chronic kidney disease,Moderated e-Poster,"Application of contrast enhanced ultrasound assessments of renal perfusion in younger and older age groups, and in those with and without CKD.",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2096,Not Relevant,Chronic kidney disease,Moderated e-Poster,Risk Score For Onset Of Kidney Failure  In Patients With Chronic Kidney Disease,Chronic Kidney Disease;Renal Failure,Chronic Kidney Disease;Kidney Failure,,,,,,,,
2097,Not Relevant,Chronic kidney disease,Moderated e-Poster,Development of a Scr-based estimating equation for the prediction of kidney fibrosis in patients with CKD,Chronic Kidney Disease;Fibrosis,Chronic Kidney Disease;Kidney Fibrosis,,,,,,,,
2098,Not Relevant,Chronic kidney disease,Moderated e-Poster,Dimethylaminoparthenolide as a new inhibitor of renal fibrosis in rat,Fibrosis,Renal Fibrosis,,,,,,,,
2099,Not Relevant,Chronic kidney disease,Moderated e-Poster,Increasing role of digital education - MARKUS@HOMe and the NDT Collaboration,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2100,Not Relevant,Chronic kidney disease,Moderated e-Poster,Efficacy and safety of low protein diet on top of SGLT2i regarding glycemic control in patients with CKD and type 2 DM,Chronic Kidney Disease;Type 2 Diabetes,Chronic Kidney Disease;Type 2 Diabetes,,,,SGLT2-Inhibitor,,,,
2101,Not Relevant,Chronic kidney disease,Moderated e-Poster,Early versus delayed anticoagulation in acute ischaemic stroke in those with chronic kidney disease: a pre-specified subgroup analysis of the OPTIMAS randomised controlled trial,Acute Ischemic Stroke;Chronic Kidney Disease,Acute Ischemic Stroke;Chronic Kidney Disease,,,,,,,NCT03759938;;OPTIMAS,
2102,Not Relevant,Chronic kidney disease,Moderated e-Poster,The Effect Of Dapagliflozin On Biomarkers Of Ckd Progression In Patients With ?-Thalassemia And/Or Sickle-Cell Disease.,Chronic Kidney Disease;Sickle Cell Disease;Thalassemia,Chronic Kidney Disease;Progressive Thalassaemia;Sickle Cell Disease,Dapagliflozin,,,SGLT2-Inhibitor,,Progressive,,
2103,Not Relevant,Chronic kidney disease,Moderated e-Poster,Asiaticoside alleviates renal fibrosis by regulating Th17/Treg cell homeostasis through binding to STAT3,Fibrosis,Renal Fibrosis,Asiaticoside,,,STAT3-Inhibitor,,,,
2104,Not Relevant,Chronic kidney disease,Moderated e-Poster,What do patients with kidney disease want? A survey of patient preferences in decision-making in Sri Lanka,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2105,Not Relevant,Chronic kidney disease,Moderated e-Poster,Combined Use Of Sraa Blockers And Sglt2 Inhibitors For Reduction Of Proteinuria In Paediatric Patients With Chronic Kidney Disease,Chronic Kidney Disease;Proteinuria,Paediatric Chronic Kidney Disease;Proteinuria,SGLT2,,,Renin-Angiotensin-Aldosterone System Blocker;SGLT2-Inhibitor,,Paediatric,,
2106,Not Relevant,Chronic kidney disease,Moderated e-Poster,"""Early experience with specialist palliative care services  in patients of advanced Chronic Kidney Disease in India """,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
2107,Not Relevant,Chronic kidney disease,Moderated e-Poster,Effect Of Dapagliflozin On Arterial Stiffness And Cognitive Impairment In Patients With Chronic Kidney Disease,Chronic Kidney Disease;Cognitive Impairment,Chronic Kidney Disease;Cognitive Impairment,Dapagliflozin,,,SGLT2-Inhibitor,,,,
2108,Not Relevant,Chronic kidney disease,Moderated e-Poster,Dr,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2109,Not Relevant,Chronic kidney disease,Moderated e-Poster,Evaluating the Reliability and Accuracy of ChatGPT in Guideline-Based Clinical Decision Support: Insights from KDIGO 2024 Chronic Kidney Disease Management Guideline,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2110,Not Relevant,Chronic kidney disease,Moderated e-Poster,The Implementation of a Multi-Faceted Cardio-renal service on Heart Failure and Renal Outcomes: A Retrospective Cohort Study,Heart Failure,Heart Failure,,,,,,,,
2111,Not Relevant,Chronic kidney disease,Moderated e-Poster,The Effect of an Integrated Community Nephrology Multi-Disciplinary Clinic on Patients with Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2112,Not Relevant,Chronic kidney disease,Moderated e-Poster,Association of Fibroblast Growth Factor-23 with Vascular Stiffness in Diabetic and Non-Diabetic Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2113,Not Relevant,Chronic kidney disease,Moderated e-Poster,Dose-Dependent Effects of Tolvaptan on Serum Uric Acid Levels in ADPKD Patients,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,Tolvaptan,,,Vasopressin V2 Receptor-Antagonist,,,,
2114,Not Relevant,Chronic kidney disease,Moderated e-Poster,Central Obesity: A Key Concern in Chronic Kidney Disease Patients,Chronic Kidney Disease;Obesity,Central Obesity;Chronic Kidney Disease,,,,,,,,
2115,Not Relevant,Chronic kidney disease,Moderated e-Poster,The role of a Mediterranean-like controlled protein diet (MCPD) in the conservative management of kidney disease in uro-oncological patients,Kidney Diseases,Kidney Disease,,,,,,,,
2116,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Investigating Alkaline Phosphatase Variability As A Key Predictor of All-Cause Mortality in Chronic Kidney Disease Patients: Multi-Nation Retrospective Cohort Study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2117,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Hyperkalaemia Prevalence and Risk Factors in Chronic Kidney Disease and Heart Failure: Insights from iCaReMe Registry Latin America Cohort,Heart Failure,Heart Failure,,,,,AstraZeneca,,NCT03549754,iCaReMe
2118,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Decoding the CKD-MASLD Connection in Diabetes: A Prospective Study,Chronic Kidney Disease;Diabetes;Liver Disease,Chronic Kidney Disease;Diabetes;Metabolic Dysfunction-Associated Steatotic Liver Disease,,,,,,,,
2119,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Trends of congestive heart failure in patients with non-dialysis and dialysis-dependent chronic kidney disease: a nationwide study,Chronic Kidney Disease;Heart Failure,Chronic Kidney Disease;Congestive Heart Failure,,,,,,,,
2120,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Patient Reported Outcome Measures and Individualized Strategies using Electronic Feedback (PROMISE): implementation outcomes,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,PROMISE
2121,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,"Frailty and Kidney Replacement Therapy Choice, a single centre, observational study",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2122,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Chronic Kidney disease (CKD) in patients with obesity who underwent bariatric surgery,Chronic Kidney Disease;Obesity,Chronic Kidney Disease;Obesity,,,,,,,,
2123,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Progression of renal disease and mortality in patients with CKD who do or do not receive loop diuretics,Chronic Kidney Disease;Kidney Diseases,Chronic Kidney Disease;Renal Disease,,,,Loop Diuretic,,,,
2124,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Early detection of Chronic Kidney Disease Using Facial and Hand Image Recognition: A Machine Learning Approach,Chronic Kidney Disease,Chronic Kidney Disease,,,,,Fresenius,,,
2125,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Insights into patients’ sexual-related symptom burden and (un)met information and support needs in routine nephrology care,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2126,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Application of ChatGPT 4o to Implement Local Registries in Low-Resourced Countries. A Proof of Concept for the Jamaican Registry Initiative,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2127,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Efficacy and Safety of Aldosterone Antagonists in Heart Failure Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Cardiovascular and Renal Outcomes.,Chronic Kidney Disease;Heart Failure,Chronic Kidney Disease;Heart Failure,,,,Aldosterone Antagonist,,,,
2128,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Outcomes of young adults in an advanced kidney care service in the United Kingdom,Chronic Kidney Disease,Young Adult Advanced Chronic Kidney Disease,,,,,,Advanced;Young Adult,,
2129,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The Comparison Of Cognitive Function In Chronic Kidney Disease Patients On Renal Replacement Therapy In Albania,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2130,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The Role Of Social Media In Nephrology Training And Continuous Education: A Survey-Based Analysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2131,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Tangential Ultrasound-Guided Renal Biopsy Of Native Kidneys (Kb): An Innovative Technique,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2132,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Nutritional status and outcomes after one year in older patients with advanced CKD,Chronic Kidney Disease,Elderly Advanced Chronic Kidney Disease,,,,,,Advanced;Elderly,,
2133,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Acute-on Chronic Kidney Disease. Factors Associated to CKD Progression,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2134,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Urinary collagen-derived peptides as a potential read-out of kidney fibrosis in UUO mouse model,Fibrosis,Kidney Fibrosis,,,,,,,,
2135,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Early Diagnosis Of Chronic Kidney Damage In Chronic Heart Failure,Heart Failure,Chronic Heart Failure;Early Onset Chronic Kidney Damage,,,,,,Early Onset,,
2136,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,the relation between uric acid level and vascular calcification in patients with chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2137,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The Role of CX3CR1-T280M in the Progression to End-Stage Renal Disease: a Long-Term Prospective Study,End-Stage Renal Disease,End Stage Renal Disease,,,,,,,,
2138,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Inflammatory states affect composition of peripheral blood immune cell compartment in stage 5 CKD patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2139,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The Association between Changes of the Difference Between Cystatin C and Creatinine-Based Estimated GFR and Intrinsic Capacity: An Analysis of the China Health and Retirement Longitudinal Study (CHARLS),Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,CHARLS
2140,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Comparison of Urinary Biomarkers in Different Diabetic Kidney Disease Phenotypes,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,,,,
2141,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The implication of zinc deficiency on renal and overall survival in patients with chronic kidney disease.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2142,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Low Urinary Marinobufagenin (uMBG) Levels as a Prognostic Marker for Accelerated Progression in Non-Advanced CKD,Chronic Kidney Disease,Non Advanced Chronic Kidney Disease,,,,,,Advanced,,
2143,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Beyond the Scalpel: How Postoperative AKI and Comorbidities Shape CKD Progression After Partial Nephrectomy,Acute Kidney Injury;Chronic Kidney Disease,Acute Kidney Injury;Chronic Kidney Disease,,,,,,,,
2144,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The Correlation Between Tubulointerstitial Inflammation and Leukocyturia: A Classic Revisited,Inflammation,Leukocyturia;Tubulointerstitial Inflammation,,,,,,,,
2145,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Is testosterone a risk factor for age-related loss of kidney function in men? the Renal Iohexol Study,Chronic Kidney Disease,Chronic Kidney Disease,Testosterone,,,Hormonal Therapy,,,,
2146,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Protein Intake and the Risk of Age-Related Kidney Function Decline in the General Population – the Renal Iohexol Clearance Survey,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2147,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The role of oxalate in end-stage kidney disease,Kidney Diseases,End Stage Kidney Disease,,,,,, End Stage,,
2148,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Association Between Simple Renal Cyst and Renal Function: A Retrospective Cohort Study,Renal Cysts,Renal Cyst,,,,,,,,
2149,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Alterations in physical performance and body composition are already present in patients with chronic kidney disease stage G3.,Chronic Kidney Disease,Stage III Chronic Kidney Disease,,,,,,Stage III,,
2150,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Investigating the Skeletal Muscle and Kidney Function Crosstalk in Survivors of Critical Illness,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2151,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Preliminary Metabolomic and Proteomic Data Indicate Lactate as a Potential Biomarker for CKD in High-Altitude Patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2152,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Validation of the IgA Nephropathy Prediction Tool: A Portuguese Center's Experience,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2153,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Online Education Improved Nephrologists’ Knowledge of The Immunopathogenesis of Immunoglobulin A Nephropathy and Rationale for Novel Therapies,Nephropathy,Immunoglobuline A Nephropathy,,,,,,,,
2154,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Effect Of Soy Diet On The State Of Microvessels Of The Skin Of Cyvallean Macaques That Have Received A High-Salt Diet For A Long Time.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2155,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The creatinine triples after a Whipple: a case of chronic kidney disease due to secondary oxalate nephropathy 27 years post-pancreaticoduodenectomy,Chronic Kidney Disease;Oxalate Nephropathy,Chronic Kidney Disease;Secondary Oxalate Nephropathy,,,,,,,,
2156,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Albuminuria as a Marker of Kidney Damage in Individuals with Previously Undiagnosed Chronic Kidney Disease Based on Data Of AURA Registry,Albuminuria;Chronic Kidney Disease,Albuminuria;Chronic Kidney Disease,,,,,,,,AURA
2157,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Relationship of the 'Kidney Failure Risk Equation' with Disease Progression and Cost in Chronic Kidney Disease Stages 3-5,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2158,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Predictors of Complications in Percutaneous Kidney Biopsy: A Single-Center Experience,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2159,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Clinical characteristics and prognosis of IgAVN in Chinese Adult patients,Acute Lymphocytic Leukemia;Chronic Kidney Disease,Adult Acute Lymphocytic Leukemia;Chronic Kidney Disease,,,,,,Adult,,
2160,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Pregnancy In Patients With Chronic Glomerulonephritis And Late Stages Of Ckd,Chronic Glomerulonephritis;Chronic Kidney Disease,Chronic Glomerulonephritis;Late Stage Chronic Kidney Disease,,,,,,Late-Stage,,
2161,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Risk Factors for Albuminuria in Patients with Previously Undiagnosed Chronic Kidney Disease – AURA Registry Data,Albuminuria;Chronic Kidney Disease,Albuminuria;Previously Undiagnosed Chronic Kidney Disease,,,,,,,,AURA
2162,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Cardio-renal butterfly effect: myocardial infarction with coronary reperfusion triggers kidney disease and induces interstitial fibrosis,Chronic Kidney Disease;Myocardial Infarction,Chronic Kidney Disease;Myocardial Infarction,,,,,,,,
2163,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Longitudinal Study In A Population With Cakut And Risk Factors,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2164,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The Association Between Estimated Glomerular Filtration Rate (eGFR) and Disability Worsening in Patients with Multiple Sclerosis,Multiple Sclerosis,Multiple Sclerosis,,,,,,,,
2165,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Predicting Chronic Kidney Disease Progression in Elderly Patients with Acute Kidney Injury : A 10-Year Retrospective Analysis,Acute Kidney Injury;Chronic Kidney Disease,Elderly Acute Kidney Injury;Elderly Chronic Kidney Disease,,,,,,Elderly,,
2166,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Shear Wave Elastography: A Non-Invasive Tool for Assessing Chronicity and Predicting Recovery of Kidney Function.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2167,Not Relevant,E-Posters,e-Poster,Is higher resting heart rate only explanation to an increased risk for cardiovascular events and mortality in patients with predialysis chronic kidney disease?,Cardiovascular Disease;Chronic Kidney Disease,Cardiovascular Disease;Chronic Kidney Disease,,,,,,,,
2168,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Identifying risk factors for chronic kidney disease progression in sickle cell disease.,Chronic Kidney Disease;Sickle Cell Disease,Chronic Kidney Disease;Sickle Cell Disease,,,,,,,,
2169,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,ATTR V30M amyloidosis and kidney-heart axis: how DPD-scan cover a misleading interpretation,Transthyretin Amyloid Cardiomyopathy,V30M Transthyretin Amyloidosis,,,,,,,,
2170,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Urinary Incontinence in Systemic Lupus Erythematosus,Chronic Kidney Disease;Systemic Lupus Erythematosus,Chronic Kidney Disease;Systemic Lupus Erythematosus,,,,,,,,
2171,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Changes in non-invasive bone specific biomarkers after 12 months of self-administered exercise in patients with chronic kidney disease: sub study of RENEXC- a randomized controlled trial,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,NCT02041156;;RENEXC,
2172,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Structural And Functional Capillary Integrity In Ckd Patients With And Without Nocturnal Hypertension,Chronic Kidney Disease;Hypertension,Chronic Kidney Disease;Nocturnal Hypertension,,,,,,,,
2173,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Analysis of Heart Rate Variability in Patients with End-Stage Chronic Kidney Disease,Chronic Kidney Disease,End Stage Chronic Kidney Disease,,,,,, End Stage,,
2174,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Changes in Heart Rate Variability in Patients with End-Stage Chronic Kidney Disease,Chronic Kidney Disease,End Stage Chronic Kidney Disease,,,,,, End Stage,,
2175,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Effect Of Hydration Status On Fat Mass Assessment In Patients With Advanced Chronic Kidney Disease,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
2176,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,"Clinical characteristics and healthcare resource utilization associated with mild, moderate and severe Hyperkalemia in Spain: IBERIK+ Study",Chronic Kidney Disease;Hyperkalemia,Chronic Kidney Disease;Mild/Moderate/Severe Hyperkalemia,,,,,,Mild;Moderate;Severe,,IBERIK+
2177,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Study Of Progression Of Ckd Course Taking Into Account The Lipid Spectrum And Composition Of Intestinal Microbiota,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2178,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,"HK-QIP study design: A prospective, multicenter, single-arm study to evaluate the impact on the implementation of standardized hyperkalemia management in CKD patients",Chronic Kidney Disease;Hyperkalemia,Chronic Kidney Disease;Hyperkalemia,,,,,AstraZeneca,,NCT06884267,HK-QIP
2179,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Gut-lung-kidney axis: gut microbiota and kidney disfunction in patients with COPD.,Chronic Obstructive Pulmonary Disease;Renal Failure,Chronic Obstructive Pulmonary Disease;Kidney Failure,,,,,,,,
2180,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Treatment With Inclisiran In Patients With Nonfamilial Hypercholesterolemia And Chronic Kidney Disease,Chronic Kidney Disease;Type II Hyperlipoproteinemia,Chronic Kidney Disease;Non Familial Hypercholesterolemia,Inclisiran,,,PCSK9-Inhibitor,,,,
2181,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,The impact of metabolic syndrome components on renal function in patients with heart failure,Heart Failure,Heart Failure,,,,,,,,
2182,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Cardiorenal relationships: correlation analysis of the effect of metabolic syndrome components on renal and cardiac function in heart failure patients with mid-range ejection fraction,Heart Failure;Metabolic Syndrome,Heart Failure With Mid-Range Ejection Fraction;Metabolic Syndrome,,,,,,,,
2183,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Assessment Of CKD Progression Taking Into Account Metabolic Changes,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2184,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Monitoring of atrial indicators in patients with chronic kidney disease  and atrial fibrillation after radio-frequency ablation,Atrial Fibrillation;Chronic Kidney Disease,Atrial Fibrillation;Chronic Kidney Disease,,,,,,,,
2185,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Lipoprotein(a) and chronic kidney disease: a descriptive study in a Spanish cohort.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2186,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Cardiovascular risk surveillance and management among older patients with glomerulonephritis treated with immunosuppressive therapy,Glomerulonephritis,Elderly Glomerulonephritis,,,,Immunosuppressive Therapy,,Elderly,,
2187,Not Relevant,Chronic Kidney Disease,Moderated e-Poster,Association between Bone Mineral Density and C-Reactive Protein in Patients with Kidney Failure,Renal Failure,Kidney Failure,,,,,,,,
2188,Not Relevant,Kidney Transplantation,Moderated e-Poster,“Evaluation of Kidney Biopsy Quality: A Single-Center Comparative Analysis of Direct Core Microscopy-Controlled and Non-Microscopically Controlled Techniques.”,,,,,,,,,,
2189,Not Relevant,Kidney Transplantation,Moderated e-Poster,Antibody mediated rejection is the main factor  for the graft loss: Impact  of 12 months  protocol kidney biopsies on the 10 years graft survivall,,,,,,,,,,
2190,Not Relevant,Kidney Transplantation,Moderated e-Poster,Impact On Accessibility To Renal Transplantation In Hipersensitized Recipients With Antigen Avoidance Based Allocation In Argentina,,,,,,,,,,
2191,Not Relevant,Kidney Transplantation,Moderated e-Poster,High Donor-Derived Cell-Free DNA Levels Do Not Reflect Kidney Allograft Status in aHUS Patient,Hemolytic-Uremic Syndrome,Acute Hemolytic Uremic Syndrome,,,,,,,,
2192,Not Relevant,Kidney Transplantation,Moderated e-Poster,Experiences of performing ABO-incompatible kidney transplantation in Argentina,,,,,,,,,,
2193,Not Relevant,Kidney Transplantation,Moderated e-Poster,"Biopsy-based transcriptomics allow earlier detection of rejection, gradual phenotyping and monitoring of anti-rejection treatment interventions in kidney transplant recipients: lessons from follow-up biopsies",,,,,,,,,,
2194,Not Relevant,Kidney Transplantation,Moderated e-Poster,Bridging the Gap: The Effect of Proximity on Transplant Care in a Remote Island Community,,,,,,,,,,
2195,Not Relevant,Kidney Transplantation,Moderated e-Poster,Simultaneous liver - kidney transplantation: A single-center experience in Croatia,,,,,,,,,,
2196,Not Relevant,Kidney Transplantation,Moderated e-Poster,Kidney transplantation in patient with ureteral and renal agenesis in Sirenomelia: five years of experience.,,Renal Agenesis;Ureteral Agenesis,,,,,,,,
2197,Not Relevant,Kidney Transplantation,Moderated e-Poster,The Unexplored Impact of SGLT2 Inhibitors in Diabetic Kidney Donors: A Multicenter Retrospective Study,Diabetes,Diabetes,,,,SGLT2-Inhibitor,,,,
2198,Not Relevant,Kidney Transplantation,Moderated e-Poster,Outcomes Of Abo-Incompatible Living Kidney Donor Transplantation According To Isoagglutinin Titers,,,,,,,,,,
2199,Not Relevant,Kidney Transplantation,Moderated e-Poster,Expanding Pre-Implantation Renal Biopsy Criteria For Expanded Criteria Donors,,,,,,,,,,
2200,Not Relevant,Kidney Transplantation,Moderated e-Poster,Long-term cardiovascular and skeletal effects of bisphosphonate treatment in the first year after kidney transplantation; a 13-year prospective follow-up of a randomized controlled study of ibandronate vs placebo,,,Ibandronate,,,Bisphosphonate,,,,
2201,Not Relevant,Kidney Transplantation,Moderated e-Poster,Graft survival of donated kidneys with latent mesangial IgA deposition in Korea,,,,,,,,,,
2202,Not Relevant,Kidney Transplantation,Moderated e-Poster,Vitamin D supplementation can reduce the levels of soluble T-cell Ig-mucin-3 and HMGB1 in kidney transplant recipients,,,Vitamin D,,,Vitamin D Analog,,,,
2203,Not Relevant,Kidney Transplantation,Moderated e-Poster,Erythropoietin Modulates Redox Homeostasis and Immunomodulatory Functions of Monocytes in Kidney Transplant Recipients,,,Erythropoietin,,,Erythropoiesis Stimulating Agent,,,,
2204,Not Relevant,Kidney Transplantation,Moderated e-Poster,Urine Exosomal Proteome analysis to identify significantly deregulated proteins post   Renal Transplant : An Observational Study,,,,,,,,,,
2205,Not Relevant,Kidney Transplantation,Moderated e-Poster,5-HT2 /5-HT2B Inhibitor Attenuate Fibrotic Phenotype of Renal Allograft Fibroblasts via Non-Canonical Pathway,,,,,,5 HT2/5 HT2B-Inhibitor,,,,
2206,Not Relevant,Kidney Transplantation,Moderated e-Poster,Torque Teno Virus as an Immunometer in Kidney Transplantation: A prospective Observational Study,,,,,,,,,,
2207,Not Relevant,Kidney Transplantation,Moderated e-Poster,Factors associated with allosensitization from kidney allograft failure to retransplantation,,Kidney Allograft Failure,,,,,,,,
2208,Not Relevant,Kidney Transplantation,Moderated e-Poster,Torque Teno Virus Loads and Leukocyte Populations in Stable Outpatient Kidney Transplant Recipients,,,,,,,,,,
2209,Not Relevant,Kidney Transplantation,Moderated e-Poster,Semaglutide enabled waitlisting and transplantation of otherwise unlisted obese renal transplant candidates.,Obesity,Obesity,Semaglutide,,,GLP1 Receptor-Agonist,,,,
2210,Not Relevant,Kidney Transplantation,Moderated e-Poster,Impact Of SLGT2 Inhibitors In Kidney Transplant Patients: A Single Center Experience,,,,,,SGLT2-Inhibitor,,,,
2211,Not Relevant,Kidney Transplantation,Moderated e-Poster,Impact of vitamin D supplementation on kidney transplant recipients: a systematic review and meta-analysis,,,Vitamin D,,,Vitamin D Supplement,,,,
2212,Not Relevant,Kidney Transplantation,Moderated e-Poster,"“That’s just part of having a transplant, that’s the price you pay” Perceived Barriers and Facilitators of Immunosuppressant Medication Adherence among Transplant Recipients: A Qualitative Study “That’s just part of having a transplant, that’s the price you pay” Perceived Barriers and Facilitators of Immunosuppressant Medication Adherence among Transplant Recipients: A Qualitative Study",,,,,,,,,,
2213,Not Relevant,Kidney Transplantation,Moderated e-Poster,Genetic and clinical factors affecting tacrolimus variability and its influence on kidney graft function,,,Tacrolimus,,,Calcineurin-Inhibitor,,,,
2214,Not Relevant,Kidney Transplantation,Moderated e-Poster,Evaluation of the relationship between post-transplant graft elastographic findings and cardiac strain in renal transplant patients,,,,,,,,,,
2215,Not Relevant,Kidney Transplantation,Moderated e-Poster,Eculizumab Withdrawal in Kidney Transplant Recipients With Atypical Hemolytic Uremic Syndrome,Atypical Hemolytic-Uremic Syndrome,Atypical Hemolytic Uremic Syndrome,Eculizumab,,,Complement-Inhibitor,,,,
2216,Not Relevant,Kidney Transplantation,Moderated e-Poster,Dapagliflozin is a potentially safe and effective antidiabetic in diabetic renal transplant patients. Randomised controlled clinical trial.,Diabetes,Diabetes,Dapagliflozin,,,Antidiabetic Agent;SGLT2-Inhibitor,,,,
2217,Not Relevant,Kidney Transplantation,Moderated e-Poster,Roxadustat versus erythropoietin-stimulating agents (ESAs) in kidney transplant patients: a monocentric experience.,,,Roxadustat,,,Erythropoietin-Stimulating Agent;HIF-PH Inhibitor,,,,
2218,Not Relevant,Kidney Transplantation,Moderated e-Poster,Evaluation of Rosuvastatin Use and Its Association with Proteinuria and Kidney Function Impairment in Kidney Transplant Recipients,Proteinuria;Renal Failure,Kidney Failure;Proteinuria,Rosuvastatin,,,HMG CoA Reductase-Inhibitor,,,,
2219,Not Relevant,Kidney Transplantation,Moderated e-Poster,Can ALC be used  to optimise ATLG dose inkidney transplant patients ?,,,Anti-T-Lymphocyte Globulin,,,Immunosuppressant,,,,
2220,Not Relevant,Kidney Transplantation,Moderated e-Poster,Obesity and Renal Transplantation- A Scoping Review,Obesity,Obesity,,,,,,,,
2221,Not Relevant,Kidney Transplantation,Moderated e-Poster,"Efficacy and Safety of SGLT2 Inhibitors in Kidney Transplant Recipients with Proteinuria, Irrespective of Diabetes Status",Diabetes;Proteinuria,Diabetes;Proteinuria,,,,SGLT2-Inhibitor,,,,
2222,Not Relevant,Kidney Transplantation,Moderated e-Poster,Perioperative dapagliflozin does not associate increased risk of urinary tract infections in incident kidney transplant patients,Urinary Tract Infection,Urinary Tract Infection,Dapagliflozin,,,SGLT2-Inhibitor,,,,
2223,Not Relevant,Kidney Transplantation,Moderated e-Poster,A nested qualitative study to evaluate the acceptability of the Multidisciplinary Support To Access living donor Kidney Transplant (MuST AKT) intervention in a pilot randomized controlled trial (RCT),,,,,,,,,NCT04666545,MuST AKT
2224,Not Relevant,Kidney Transplantation,Moderated e-Poster,Less Is More? Evaluating Lower Thymoglobulin Induction In Kidney Transplantation,,,Thyminoglobulin,,,T Cell Depleting Therapy,,,,
2225,Not Relevant,Kidney Transplantation,Moderated e-Poster,Incidence and Outcome of BK Virus-Associated Nephropathy in Renal Transplant Recipients - A Single Centre Experience Over Fifteen Years,Nephropathy,BK Virus Associated Nephropathy,,,,,,,,
2226,Not Relevant,Kidney Transplantation,Moderated e-Poster,Cardiovascular Risk Stratification in Kidney Transplant Candidates: A Retrospective Analysis from a Tertiary Care Centre in Sri Lanka,,,,,,,,,,
2227,Not Relevant,Kidney Transplantation,Moderated e-Poster,Failing kidney transplants: Baseline measures of personalised care before institution of a dedicated service in West London Renal and Transplant Centre,,,,,,,,,,
2228,Not Relevant,Kidney Transplantation,Moderated e-Poster,"Association and Cumulative Incidence of Renal Graft Dysfunction Among Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease: A Single-Center, Single-Arm Retrospective Cohort Study",Liver Disease,Metabolic Dysfunction-Associated Steatotic Liver Disease,,,,,,,,
2229,Not Relevant,Kidney Transplantation,Moderated e-Poster,Hydroxyproline As A Urinary Biomarker In Renal Transplantation,,,,,,,,,,
2230,Not Relevant,Kidney Transplantation,Moderated e-Poster,Dynamic assessment of cardiovascular risk factors in kidney transplant recipients,,,,,,,,,,
2231,Not Relevant,Kidney Transplantation,Moderated e-Poster,Glycemic variability in early post-transplant period and its impact on the development of later metabolic complications,,,,,,,,,,
2232,Not Relevant,Kidney Transplantation,Moderated e-Poster,Diagnostic Performance of Gene Expression and dd-cfDNA in Multiorgan Transplant Recipients,,,,,,,,,,
2233,Not Relevant,Kidney Transplantation,Moderated e-Poster,Factors Associated with Anemia Two Years Post-Kidney Transplantation: A Multicenter Study,Anemia,Anemia,,,,,,,,
2234,Not Relevant,Kidney Transplantation,Moderated e-Poster,Two cases of hyperacute rejection after AB0 incompatible kidney transplantation – unexpected antibodies,,,,,,,,,,
2235,Not Relevant,Kidney Transplantation,Moderated e-Poster,Initial results after the implementation of an immunoguided cytomegalovirus prevention protocol in kidney transplant recipients,,,,,,,,,,
2236,Not Relevant,Kidney Transplantation,Moderated e-Poster,Comparative Effects of GLP-1RAs on Kidney Transplant Recipients and Chronic Kidney Disease Patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,GLP-1 Receptor Agonist,,,,
2237,Not Relevant,"Plenary Lecture 2 - Cell and gene therapy in clinical practice: feasible, but available?",Plenary Lecture,"Cell and gene therapy in clinical practice: feasible, but available?",,,,,,,,,,
2238,Not Relevant,Chronic kidney disease,Focussed Oral,Investigating the CKD Sex Paradox: Biomarkers and the Biological Basis of Sex Differences in CKD Progression and Mortality,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2239,Not Relevant,Chronic kidney disease,Focussed Oral,Magnetic resonance imaging assessment of kidney morphometry in chronic kidney disease: baseline data from the AFiRM study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,AFiRM;;NCT04238299,
2240,Not Relevant,Chronic kidney disease,Focussed Oral,Plasma and Urinary KIM-1 in Chronic Kidney Disease: Prognostic Value and Implications for Kidney Failure and Mortality,Chronic Kidney Disease;Renal Failure,Chronic Kidney Disease;Kidney Failure,,,,,,,,
2241,Not Relevant,Chronic kidney disease,Focussed Oral,Sentinel CKD Screening In At-Risk Patients: Six-Month Follow-Up And Impact On Nephroprotective Treatment,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2242,Not Relevant,Chronic kidney disease,Focussed Oral,Clinical Practice Gaps in the Diagnosis and Management of Immunoglobulin A Nephropathy,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2243,Not Relevant,Chronic kidney disease,Focussed Oral,The relationship between the central obesity and early kidney injury in a community cohort,Obesity,Central Obesity;Early Kidney Injury,,,,,,Early Onset,,
2244,Not Relevant,Chronic kidney disease,Focussed Oral,Impact of Glomerular Hyperfiltration on Albuminuria in Populations with Obesity: An Analysis on NHANES （1999-2018）,Albuminuria;Obesity,Albuminuria;Obesity,,,,,,,,
2245,Not Relevant,Chronic kidney disease,Focussed Oral,AARPRI is associated with chronic kidney disease (CKD) and the construction of risk prediction model based on AARPRI: Evidence from NHANES 2013-2018,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2246,Not Relevant,Chronic kidney disease,Focussed Oral,Brain Changes in a Long-Term Rat Model of Chronic Kidney Disease (CKD),Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2247,Not Relevant,Chronic kidney disease,Focussed Oral,CT coronary angiography to identify patients at increased risk of developing chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2248,Not Relevant,Chronic kidney disease,Focussed Oral,Targeted Plasma Proteomics Links Inflammation with Progression of Chronic Kindey Disease in a multi-national pediatric cohort,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2249,Not Relevant,Chronic kidney disease,Focussed Oral,Association between nephrotoxic drugs and the development of chronic kidney disease based on french real-world data,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2250,Not Relevant,Chronic kidney disease,Focussed Oral,Change in mGFR following bariatric surgery: A case-crossover study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2251,Not Relevant,Chronic kidney disease,Focussed Oral,The effect of GLP-1 receptor agonists on renal outcomes: A systematic review and meta-analysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,GLP-1 Receptor Agonist,,,,
2252,Not Relevant,Chronic kidney disease,Focussed Oral,Novel Therapeutic for Diabetic Kidney Disease through Targeting Lp-PLA2 in Immune Cells and Damaged Renal Parenchymal Cell,Chronic Kidney Disease;Diabetes,Chronic Kidney Disease;Diabetes,,,,,,,,
2253,Not Relevant,Chronic kidney disease,Focussed Oral,Efficacy of ß-lactams versus fluoroquinolones for empirical antibiotic treatment of kidney cyst infections in polycystic kidney disease,Infection,Kidney Cyst Infection,,,,Beta-Lactam Antibiotic;Fluoroquinolone,,,,
2254,Medium,Chronic kidney disease,Focussed Oral,Impact of Systemic Glucocorticoids on Gd-IgA1 Levels in Immunoglobulin A Nephropathy: Insights from the TESTING Trial,IgA Nephropathy,IgA Nephropathy,,,,Glucocorticoid,,,NCT01560052,TESTING
2255,Not Relevant,Chronic kidney disease,Focussed Oral,Effect of SGLT2 Inhibitor (Dapagliflozin) on Coronary Calcification and Cardiac Parameters in Non-Diabetic CKD Patients: A Randomized Controlled Trial.,Chronic Kidney Disease,Chronic Kidney Disease,Dapagliflozin,,,SGLT2-Inhibitor,,,,
2256,Not Relevant,Chronic kidney disease,Focussed Oral,"A cross-sectional, multinational, survey on current practices and patterns in telenephrology among nephrologists",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2257,Not Relevant,Chronic kidney disease,Focussed Oral,"Impact of a plant-based food basket on uremic toxins, dietary patterns and carbon footprint in patients with chronic kidney disease",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2258,Not Relevant,Chronic kidney disease,Focussed Oral,Exploring the second line agent of choice in the management of Chronic Kidney Disease-associated Pruritus: A global cross-sectional study of clinician experience and preference,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2259,Not Relevant,Chronic kidney disease,Focussed Oral,"Impact of Synbiotics on Chronic Kidney Disease Patients: A Randomized, Placebo-Controlled Study.",Chronic Kidney Disease,Chronic Kidney Disease,,,,Synbiotic,,,,
2260,Not Relevant,Chronic kidney disease,Focussed Oral,Effects of a nutrition education program on quality of life and morphofunctional status in patients with advanced chronic kidney disease: ERCANUT Randomized Clinical Trial,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,NCT05072574,ERCANUT
2261,Not Relevant,Chronic kidney disease,Focussed Oral,Effect of Mediterranean Diet and Exercise on Patients with Chronic Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2262,Not Relevant,Dialysis,Focussed Oral,Incremental hemodialysis is a cost-effective and patient-centered approach to renal replacement therapy for initiating outpatient dialysis.,Renal Failure,Kidney Failure,,,,,,,,
2263,Not Relevant,Dialysis,Focussed Oral,The Emboless® venous chamber extensively reduce air contamination passing into HD patients blood,Renal Failure,Kidney Failure,,,,,,,,
2264,Not Relevant,Dialysis,Focussed Oral,Comparison of the effect of nitric oxide gas supplied from the dialysate and from the replacement fluid on its antithrombotic effects during hemodialysis or hemodiafiltration,Renal Failure,Kidney Failure,Nitric Oxide,,,Vasodilator,,,,
2265,Not Relevant,Dialysis,Focussed Oral,Evaluation of microcirculation by surface blood flow imaging of the tibialis anterior muscle in a rat dialysis model,Renal Failure,Kidney Failure,,,,,,,,
2266,Not Relevant,Dialysis,Focussed Oral,Is A Green Nephrology Possibile? A Lower Dialysate Flow Could Not Affect Therapeutic Efficacy In Selected Patients While Saving Billions Of Litres Of Water,Renal Failure,Kidney Failure,,,,,,,,
2267,Not Relevant,Dialysis,Focussed Oral,Predicting Fluid Overload Hospitalizations in Hemodialysis Patients Using a Foundational Model and Large Language Model Techniques,Renal Failure,Kidney Failure,,,,,,,,
2268,Not Relevant,Dialysis,Focussed Oral,"Achievement of hemodiafiltration (HDF) convective volumes (CV) > 23 L/session in a dialysis center without selection of ""healthy"" patients : is it really possible?",Renal Failure,Kidney Failure,,,,,,,,
2269,Not Relevant,Dialysis,Focussed Oral,Rationalising the targets in Haemodiafiltration: Convection volume or ß2-Microglobulin clearance?,Renal Failure,Kidney Failure,,,,,,,,
2270,Not Relevant,Dialysis,Focussed Oral,Efficiency of haemodiafiltration in middle molecules clearance at different levels of residual kidney functions.,Renal Failure,Kidney Failure,,,,,,,,
2271,Not Relevant,Dialysis,Focussed Oral,Perdialytic infusion of sodium octanoate improves the dialytic clearance of protein-bound uremic toxins in anephric pigs,Renal Failure,Kidney Failure,Sodium Octanoate,,,Protein Stabilizer,,,,
2272,Not Relevant,Dialysis,Focussed Oral,Impact of Intradialytic Exercise on Cardiopulmonary Parameters Assessed by Cycle Ergometer Exercise Test.,Renal Failure,Kidney Failure,,,,,,,,
2273,Not Relevant,Dialysis,Focussed Oral,Drop-out and mortality in peritoneal dialysis patients: a 18 years single center experience,Renal Failure,Kidney Failure,,,,,,,,
2274,Not Relevant,Dialysis,Focussed Oral,Real costs of daily home hemodialysis compared to in-center hemodialysis in France,Renal Failure,Kidney Failure,,,,,,,,
2275,Not Relevant,Dialysis,Focussed Oral,MOTS-c Levels and Sarcopenia Risk in Patients on Chronic Peritoneal Dialysis: A Pilot Study,Chronic Kidney Disease;Sarcopenia,Chronic Kidney Failure;Sarcopenia,,,,,,,,
2276,Not Relevant,Dialysis,Focussed Oral,Daily home hemodialysis is associated with a lower mortality rate compared with in-center hemodialysis in French patients.,Renal Failure,Kidney Failure,,,,,,,,
2277,Not Relevant,Dialysis,Focussed Oral,Changes in Quality of Life and Caregiver Burden after Starting Peritoneal Dialysis: First Results from the SKIP-SH Cohort Study,Renal Failure,Kidney Failure,,,,,,,DRKS00032983;;SKIP-SH,
2278,Not Relevant,Dialysis,Focussed Oral,A Biomarker-Based Predictive Model For Overhydration In Peritoneal Dialysis,Renal Failure,Kidney Failure,,,,,,,,
2279,Not Relevant,Dialysis,Focussed Oral,Tracing The Evolution Of Peritoneal Transport: Insights From Four Years Of Therapy,Renal Failure,Kidney Failure,,,,,,,,
2280,Not Relevant,Dialysis,Focussed Oral,Ultrafiltration capacity on automated peritoneal dialysis: impact of prescription and real-world treatment response on clinical outcomes,Renal Failure,Kidney Failure,,,,,,,,
2281,Not Relevant,Dialysis,Focussed Oral,Urgent Start Hemodialysis Versus Immediate-Start Automated Peritoneal Dialysis (Apd-Is) In Chronic Kidney Disease Patients Initiating Unplanned Dialysis,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2282,Not Relevant,Dialysis,Focussed Oral,"Experiences and health-related quality of life worsen over time in caregivers of dialysis patients, irrespective of home or in-centre dialysis: an observational cohort study",Renal Failure,Kidney Failure,,,,,,,,
2283,Not Relevant,Dialysis,Focussed Oral,The Thiolomic Profile Of Peritoneal Membrane Fibrosis: A Hypothesis-Driven Research,Renal Failure,Kidney Failure,,,,,,,,
2284,Not Relevant,Dialysis,Focussed Oral,cofilin-1 modulates peritoneal dialysis-related fibrosis by targeting mitochondrial fragmentation,Renal Failure,Kidney Failure,,,,,,,,
2285,Not Relevant,Dialysis,Focussed Oral,In Vitro Evaluation of the Antithrombotic Properties of a Urokinase-Coated Indwelling Hemodialysis Catheter,Renal Failure,Kidney Failure,,,,Antithrombotic Agent,,,,
2286,Not Relevant,Dialysis,Focussed Oral,Evaluation of Vascular Access via a TRIAGE System for Hemodialysis: A Tool to Assess Clinical Risk in Hemodialysis Patients,Renal Failure,Kidney Failure,,,,,,,,
2287,Not Relevant,Dialysis,Focussed Oral,Antibacterial and anticoagulant strategies on catheter surfaces for preventing catheter-related bloodstream infection and catheter thrombosis during hemodialysis,Renal Failure,Kidney Failure,,,,Antibacterial;Anticoagulant,,,,
2288,Not Relevant,Dialysis,Focussed Oral,A Safe Guidewire-Assisted Exchange Technique for the Management of CRBSIs in Hemodialysis Patients: A Single-Center Study,Renal Failure,Kidney Failure,,,,,,,,
2289,Not Relevant,Dialysis,Focussed Oral,Comparison Of 70% Ethanol Versus Heparin Lock In Treating Tunnelled Jugular Catheter-Related Bloodstream Infections In Hemodialysis Patients-A Randomized  Controlled Trial,Renal Failure,Kidney Failure,Ethanol,,Heparin,Anticoagulant;Antiseptic,,,,
2290,Not Relevant,Dialysis,Focussed Oral,Effect of Arteriovenous fistula creation and maturation on chronic kidney disease patients' microcirculation,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2291,Not Relevant,Dialysis,Focussed Oral,Early Outcomes of KiteLock (EDTA 4%): A New CVC Locking Solution,Renal Failure,Kidney Failure,,,,,,,,
2292,Not Relevant,Dialysis,Focussed Oral,"""Radiocephalic fistulas and Vascular doppler ultrasound (DUS): Beyond Conventional Limits""",Renal Failure,Kidney Failure,,,,,,,,
2293,Not Relevant,Dialysis,Focussed Oral,Gender disparity in autologous arteriovenous access for hemodialysis,Renal Failure,Kidney Failure,,,,,,,,
2294,Not Relevant,Dialysis,Focussed Oral,Optimizing Timing for Vascular Access Creation: The Role of Kidney Failure Risk Equation and eGFR in Predicting Dialysis Initiation,Renal Failure,Kidney Failure,,,,,,,,
2295,Not Relevant,FC 18: What a Graft Can Tell You,Free Communication,"Correlation of activity, and chronicity indices derived from Banff lesion scores with injury dimension scores from biopsy-based transcript diagnostics",,,,,,,,,,
2296,Not Relevant,FC 18: What a Graft Can Tell You,Free Communication,Urinary and blood mRNA biomarkers for detecting kidney allograft rejection (The KTD-Innov study: NCT03582436),,,,,,,,,KTD-Innov;;NCT03582436,
2297,Not Relevant,FC 18: What a Graft Can Tell You,Free Communication,Detection of kidney allograft rejection using urinary chemokines: a prospective multicenter cohort study (KTD-Innov),,,,,,,,,KTD-Innov;;NCT03582436,
2298,Not Relevant,FC 18: What a Graft Can Tell You,Free Communication,Torque teno virus load in kidney transplantation: association with donor and recipient characteristics and clinical follow-up data,,,,,,,,,,
2299,Not Relevant,FC 18: What a Graft Can Tell You,Free Communication,Torque Teno virus is associated with an increased risk for malignancies after kidney transplantation,Tumors,Malignant Tumor,,,,,,Malignant,,
2300,Not Relevant,FC 18: What a Graft Can Tell You,Free Communication,Deep Learning Model for Predicting Delayed Graft Function Using Pre-Implantation Kidney Images: Interim Results from the DeepGraft Project,,,,,,,,,,
2301,Not Relevant,FC 19: Hypertensive Derangements of Pregnancy and Volume Homeostasis,Free Communication,UMOD hypertension and the genetic of CKD,Chronic Kidney Disease;Hypertension,Chronic Kidney Disease;Hypertension,,,,,,,,
2302,Not Relevant,FC 19: Hypertensive Derangements of Pregnancy and Volume Homeostasis,Free Communication,A Klotho Gene Variant (Rs9536314) Correlates With Development Of Hypertensive Disorders Of Pregnancy And Higher Rates Of Miscarriage,Hypertension,Hypertension;Pregnancy,,,,,,,,
2303,Not Relevant,FC 19: Hypertensive Derangements of Pregnancy and Volume Homeostasis,Free Communication,Pregnancy and Kidney Outcomes for Individuals with Rare Kidney Diseases,Kidney Diseases,Kidney Disease,,,,,,,,
2304,Not Relevant,FC 19: Hypertensive Derangements of Pregnancy and Volume Homeostasis,Free Communication,Pregnancy and Kidney Outcomes for Individuals receiving Kidney Replacement Therapy,,,,,,,,,,
2305,Not Relevant,FC 19: Hypertensive Derangements of Pregnancy and Volume Homeostasis,Free Communication,Body water conservation increases blood pressure independently of Na+ balance,Hypertension,Hypertension,,,,,,,,
2306,Not Relevant,FC 19: Hypertensive Derangements of Pregnancy and Volume Homeostasis,Free Communication,Heterogeneity Of Clinical Response To Low Salt Diet In Naïve Essential Hypertensive Patients,Essential Hypertension,Essential Hypertension,,,,,,,,
2307,Not Relevant,FC 19: Hypertensive Derangements of Pregnancy and Volume Homeostasis,Free Communication,Subclinical Kidney Remodeling and ACE-Inhibitor Resistance in Early Salt-Induced Hypertension,Hypertension,Early Onset Salt-Induced Hypertension,,,,,,Early Onset,,
2308,Not Relevant,FC 20: Peritoneal Dialysis: Epidemiological Insights,Free Communication,IRON DEFICIENCY and Mortality Risk in Patients STARTING Peritoneal Dialysis,Renal Failure,Kidney Failure,,,,,,,,
2309,Not Relevant,FC 20: Peritoneal Dialysis: Epidemiological Insights,Free Communication,The increase in ultrafiltration volume correlates strongly with an increase in sodium removal during steady concentration peritoneal dialysis with the Carry Life UF system,Renal Failure,Kidney Failure,,,,,,,,
2310,Not Relevant,FC 20: Peritoneal Dialysis: Epidemiological Insights,Free Communication,Prevalence and risk factors for low bone mineral density in peritoneal dialysis patients,Renal Failure,Kidney Failure,,,,,,,,
2311,Not Relevant,FC 20: Peritoneal Dialysis: Epidemiological Insights,Free Communication,Thirst in peritoneal dialysis patients.,Renal Failure,Kidney Failure,,,,,,,,
2312,Not Relevant,FC 20: Peritoneal Dialysis: Epidemiological Insights,Free Communication,"Peritoneal Dialysis Outcomes in Relation to Ultrasonographic Peritoneal Thickness, IL-6, and MCP-1 Levels: A Prospective Study",Renal Failure,Kidney Failure,,,,,,,,
2313,Not Relevant,FC 20: Peritoneal Dialysis: Epidemiological Insights,Free Communication,The proinflammatory CD14++CD16+ monocytes and lymphocytes subsets are independently associated with technique failure in peritoneal dialysis patients.,Renal Failure,Kidney Failure,,,,,,,,
2314,Not Relevant,FC 21: What Cystatin C and Machines can teach us,Free Communication,"Outcomes and risk factors of widened difference in estimated glomerular filtration rate by creatinine or cystatin C: adjust model development with > 300,000 UK Biobank participants",,,,,,,,,,
2315,Not Relevant,FC 21: What Cystatin C and Machines can teach us,Free Communication,Estimated GFR in clinical practise: rolling the dice,,,,,,,,,,
2316,Not Relevant,FC 21: What Cystatin C and Machines can teach us,Free Communication,"Accuracy of GFR estimating equations based on creatinine, cystatin C or both in people with underweight or obesity: the Stockholm CREAtinine Measurements (SCREAM) project",Obesity,Obesity,,,,,,,NCT06239129;;SCREAM,
2317,Not Relevant,FC 21: What Cystatin C and Machines can teach us,Free Communication,Deep learning survival model to predict Renal Outcome for Chronic Kidney Disease (CKD) patients: a retrospective cohort study,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2318,Not Relevant,FC 21: What Cystatin C and Machines can teach us,Free Communication,Predicting absolute time to kidney failure in chronic kidney disease patients using machine learning,Chronic Kidney Disease;Renal Failure,Chronic Kidney Disease;Kidney Failure,,,,,,,,
2319,Not Relevant,FC 21: What Cystatin C and Machines can teach us,Free Communication,Machine learning identifies variables associated with risk of hospitalisation in a national in-centre hemodialysis patient cohort,Renal Failure,Kidney Failure,,,,,,,,
2320,Not Relevant,FC 22: Peritoneal Diaysis: Interventions,Free Communication,Novel Insights Into Pharmacokinetics Of Intraperitoneal Cefepime During Automated Peritoneal Dialysis,Renal Failure,Kidney Failure,Cefepime,,,Antibiotic,,,,
2321,Not Relevant,FC 22: Peritoneal Diaysis: Interventions,Free Communication,The clinical evaluation of an antimicrobial impregnated catheter for the prevention of peritoneal dialysis catheter-related infections – initial results,Renal Failure,Kidney Failure,,,,,,,,
2322,Not Relevant,FC 22: Peritoneal Diaysis: Interventions,Free Communication,Blood Pressure-Lowering Effects of Hydrochlorothiazide in Chronic Peritoneal Dialysis Patients with Residual Urine Output,Renal Failure,Kidney Failure,Hydrochlorothiazide,,,Thiazide Diuretic,,,,
2323,Not Relevant,FC 22: Peritoneal Diaysis: Interventions,Free Communication,Role of Sildenafil and SB204741 in suppressing fibrotic potential of peritoneal fibroblasts obtained from PD patients,Renal Failure,Kidney Failure,SB204741;Sildenafil,,,5HT2B Receptor-Antagonist;PDE5-Inhibitor,,,,
2324,Not Relevant,FC 22: Peritoneal Diaysis: Interventions,Free Communication,The protective effect of Xylocore in diabetes mellitus: pre-clinical and clinical evidences,Diabetes,Diabetes Mellitus,Xylocore,,,Glucose Sparing Agent,,,,
2325,Not Relevant,FC 22: Peritoneal Diaysis: Interventions,Free Communication,Integrated Conservative Therapy-Low Dose Peritoneal Dialysis In Patients With Severe Ckd (I-Cope Ckd): Multicentre Prospective Controlled Study In Italian Nephrology Units,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,I-Cope Ckd,
2326,Not Relevant,Game changers in IgA Nephropathy,Symposium,B cell targeting therapy,IgA Nephropathy,IgA Nephropathy,,,,B Cell-Targeted Therapy,,,,
2327,Not Relevant,Game changers in IgA Nephropathy,Symposium,Dual RAS/endothelin inhibition,IgA Nephropathy,IgA Nephropathy,,,,Renin-Angiotensin System/Endothelin Dual Inhibitor,,,,
2328,Low,Game changers in IgA Nephropathy,Symposium,Complement inhibitors,IgA Nephropathy,IgA Nephropathy,,,,Complement-Inhibitor,,,,
2329,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Safety, Tolerability, and Efficacy of Mezagitamab (TAK-079) as Add-on to Standard of Care Therapy in Individuals with Primary IgA Nephropathy: Results from a Phase 1b Study",IgA Nephropathy,Primary IgA Nephropathy,Megazagitamab,,,CD38-Targeted Monoclonal Antibody,,,,
2330,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,Real-world insights on the use of ACEi/ARB and SGLT2is and their impact on proteinuria levels in IgAN patients across five European countries,IgA Nephropathy,IgA Nephropathy,,,,ACE Inhibitor;Angiotensin Receptor Blocker;SGLT2 Inhibitor,,,,
2331,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Novel Bruton’s Tyrosine Kinase Inhibitor EVER001 in Chinese Patients With Primary Membranous Nephropathy: Preliminary Results From a Phase 1b/2a Study,Primary Membranous Nephropathy,Primary Membranous Nephropathy,EVER-001,,,BTK-Inhibitor,,,,
2332,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Efficacy and safety of apixaban in patients with nephrotic syndrome: a prospective longitudinal cohort study,Nephrosis,Nephrotic Syndrome,Apixaban,,,Factor Xa-Inhibitor,,,,
2333,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,A mid-study update on the ACTION3 pivotal Phase 3 trial assessing DMX-200 in patients with focal segmental glomerulosclerosis (FSGS),Focal Segmental Glomerulosclerosis,Focal Segmental Glomerulosclerosis,DMX-200,,,Chemokine Receptor-Antagonist,Dimerix Bioscience,,ACTION3;;NCT05183646,
2334,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Evaluation of C3 deposition in patients with C3G: insights from the APPEAR-C3G Phase 3 study in patients treated with iptacopan,Glomerulopathy,Complement 3 Glomerulopathy,Iptacopan,,,C3-Inhibitor,Novartis,,APPEAR-C3G;;NCT04817618,
2335,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,The Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA Nephropathy: A central Pathology Review from the TESTING Study in China,IgA Nephropathy,IgA Nephropathy,,,,Glucocorticoid,,,NCT01560052,TESTING
2336,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,Predicting individual patient response to corticosteroids in IgA nephropathy: A secondary analysis from the TESTING cohort,IgA Nephropathy,IgA Nephropathy,,,,Corticosteroid,,,NCT01560052;;TESTING,
2337,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Sex Differences across Treatment Response to Corticosteroids and Kidney Outcomes in IgA Nephropathy: Insights from the TESTING Trial,IgA Nephropathy,IgA Nephropathy,,,,Corticosteroid,,,NCT01560052,TESTING
2338,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Plasma Apixaban Concentrations and their Effect on Thrombin Generation in Nephrotic Syndrome,Nephrosis,Nephrotic Syndrome,Apixaban,,,Factor Xa-Inhibitor,,,,
2339,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,Efficacy and Safety of Telitacicept in IgA Nephropathy: A Systematic Review and Meta-Analysis,IgA Nephropathy,IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
2340,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Impact of SGLT2 inhibitors on kidney function and proteinuria in patients with membranous nephropathy,Membranous Nephropathy;Proteinuria,Membranous Nephropathy;Proteinuria,,,,SGLT2-Inhibitor,,,,
2341,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"A Phase 3, Open-Label, Multicenter Study of Ravulizumab in Pediatric Patients With IgA Nephropathy or IgA Vasculitis-Associated Nephritis",IgA Nephropathy;IgA Vasculitis;Nephritis,Paediatric IgA Vasculitis-Associated Nephritis;Pediatric IgA Nephropathy,Ravulizumab,,,C5-Inhibitor,,Paediatric,,
2342,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Suppression of complement alternative pathway by monthly dosing of sefaxersen, a novel antisense oligonucleotide therapy in development for IgAN",IgA Nephropathy,IgA Nephropathy,Sefaxersen,,,Antisense Oligonucleotide,,,,
2343,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,Nefecon provides kidney benefit irrespective of time since diagnosis in patients with IgAN: a subanalysis of the NefIgArd study,IgA Nephropathy,IgA Nephropathy,Budesonide;Nefecon,,,Glucocorticoid,Calliditas Therapeutics,,NCT03643965,NefIgArd
2344,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,"The NefXtend trial, investigating extended nefecon treatment beyond 9 months in patients with IgAN",IgA Nephropathy,IgA Nephropathy,Nefecon,,,Corticosteroid Release-Modulator,Calliditas Therapeutics,,NCT06712407,NefXtend
2345,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Pegcetacoplan Treatment Appears to Halt Disease Progression in C3G and Primary (Idiopathic) IC-MPGN Patients: Results from the Phase 3 VALIANT Study,Glomerulopathy;Membranoproliferative Glomerulonephritis,Complement 3 Glomerulopathy;Primary (Idiopathic) Immune Complex-Mediated Membranoproliferative Glomerulonephritis,Pegcetacoplan,,,C3-Inhibitor,Apellis Pharmaceuticals,,NCT05067127;;VALIANT,
2346,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Comprehensive Treatment Program For Children With Urolithiasis,Urolithiasis,Childhood Urolithiasis,,,,,,Childhood,,
2347,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Factors Associated With Intradialysis Hypotension,Hypotension,Dialysis-Induced Hypotension,,,,,,,,
2348,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Real-world evidence for efficacy and safety of Iptacopan and Pegcetacoplan in patients with primary membranoproliferative glomerulonephritis (MPGN),Membranoproliferative Glomerulonephritis,Primary Membranoproliferative Glomerulonephritis,Iptacoplan;Pegcetacoplan,,,C3-Inhibitor;Complement Factor B-Inhibitor,,,,
2349,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Real-world effectiveness of ravulizumab in adults with aHUS who switched to ravulizumab within 3 months of eculizumab treatment (aHUS IMPACT),Hemolytic-Uremic Syndrome,Adult Acute Hemolytic Uremic Syndrome,Eculizumab;Ravulizumab,,,Complement C5-Inhibitor,,Adult,aHUS IMPACT,
2350,Low,Glomerular & tubulo-interstitial diseases,Focussed Oral,Immunosuppression combined with tonsillectomy is effective in Caucasian patients with high-risk primary IgA-nephropathy,IgA Nephropathy,High Risk Primary IgA Nephropathy,,,,,,High-risk,,
2351,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Targeted Treatment With Pegcetacoplan for Post-Transplant Recurrent C3G or Primary (idiopathic) IC-MPGN in the VALIANT Phase 3 Trial,Glomerulopathy;Membranoproliferative Glomerulonephritis,Post-Transplant Recurrent Complement 3 Glomerulopathy;Post-Transplant Recurrent Primary (Idiopathic) Immune Complex-Mediated Membranoproliferative Glomerulonephritis,Pegcetacoplan,,,C3-Inhibitor,Apellis Pharmaceuticals,Recurrent,NCT05067127,VALIANT
2352,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Safety and mid-term efficacy of switching from Eculizumab to Ravulizumab in a cohort of adult patients with atypical hemolytic uremic syndrome,Atypical Hemolytic-Uremic Syndrome,Adult Atypical Hemolytic Uremic Syndrome,Eculizumab;Ravulizumab,,,C5-Inhibitor,,Adult,,
2353,Not Relevant,How to manage a greener dialysis program,Symposium,Water consumption,Renal Failure,Kidney Failure,,,,,,,,
2354,Not Relevant,How to manage a greener dialysis program,Symposium,Waste reduction,Renal Failure,Kidney Failure,,,,,,,,
2355,Not Relevant,How to manage a greener dialysis program,Symposium,Green CRRT- is there a way?,Renal Failure,Kidney Failure,,,,,,,,
2356,Not Relevant,Hypertension & Diabetes,Focussed Oral,"The association between analogue compared to human insulin, prescribed dialysate glucose load, body mass index and mortality in people with kidney failure and type 2 diabetes on peritoneal dialysis",Renal Failure;Type 2 Diabetes,Kidney Failure;Type 2 Diabetes,,,,,,,,
2357,Not Relevant,Hypertension & Diabetes,Focussed Oral,Comparative Effectiveness of Angiotensin-converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers: Multi-database Target Trial Emulation Studies,Diabetes;Hypertension,Diabetes;Hypertension,,,,ACE-Inhibitor;Angiotensin Receptor-Blocker,,,,
2358,Not Relevant,Hypertension & Diabetes,Focussed Oral,Major Risk Factors For Cardiovascular Disease In Young Children,Cardiovascular Disease;Hypertension,Childhood Cardiovascular Disease;Hypertension,,,,,,Childhood,,
2359,Not Relevant,Hypertension & Diabetes,Focussed Oral,"Continuous Glucose Monitoring (CGM) Use in People with Diabetes (PwD) on Dialysis: A Retrospective, Cross-Sectional, Observational Study",Diabetes,Diabetes,,,,,,,,
2360,Not Relevant,Hypertension & Diabetes,Focussed Oral,How to screen for diabetes mellitus before kidney transplantation?- the Norwegian experience,Diabetes,Diabetes,,,,,,,,
2361,Not Relevant,Hypertension & Diabetes,Focussed Oral,Effect of Reducing Dialysate Sodium Concentration on Blood Pressure Variability in Hemodialysis Patients: A Randomized Controlled Trial,Renal Failure,Kidney Failure,,,,,,,,
2362,Not Relevant,Hypertension & Diabetes,Focussed Oral,Research kidney biopsies in type 2 diabetes: clinical and laboratory parameters alone are not enough to identify candidates for kidney biopsy,Diabetes,Diabetes,,,,,,,,
2363,Not Relevant,Hypertension & Diabetes,Focussed Oral,Assessing the neutrophil to lymphocyte ratio as a marker for diabetic nephropathy in type 2 diabetes mellitus patients,Diabetic Nephropathy;Type 2 Diabetes,Diabetic Nephropathy;Type II Diabetes,,,,,,,,
2364,Not Relevant,Hypertension & Diabetes,Focussed Oral,Effect of Dapagliflozin and Empagliflozin on Phosphate-FGF23 Homeostasis in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis,Type 2 Diabetes,Type 2 Diabetes,Dapagliflozin;Empagliflozin,,,SGLT2-Inhibitor,,,,
2365,Not Relevant,Hypertension & Diabetes,Focussed Oral,The effects of self-performed dietary sodium reduction on blood pressure and the renin-angiotensin-aldosterone system,Diabetes;Hypertension,Diabetes;Hypertension,,,,,,,,
2366,Not Relevant,Hypertension & Diabetes,Focussed Oral,Early clinical experience of finerenone in patient with chronic kidney disease and type 2 diabetes in real Life. Comparison with FIDELITY Pooled,Chronic Kidney Disease;Type 2 Diabetes,Chronic Kidney Disease;Type 2 Diabetes,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,FIDELITY,
2367,Not Relevant,Hypertension & Diabetes,Focussed Oral,Evaluating the Role of Wearable Technology and Geo-Fencing in Physiological Monitoring and Quality of Life for Adolescents Undergoing Bariatric Surgery and Managing Chronic Kidney Disease,Chronic Kidney Disease;Hypertension,Adolescent Chronic Kidney Disease;Adolescent Hypertension,,,,,,Adolescent,,
2368,Not Relevant,Kidney Transplantation,Focussed Oral,Deep phenotyping of urinary cells with cytometry by time of flight reveals CD8+CD38+ T cells as biomarker to detect T cell-mediated rejection,,,,,,,,,,
2369,Not Relevant,Kidney Transplantation,Focussed Oral,Multimodal spatial profiling of microvascular inflammation in kidney allografts,Inflammation,Microvascular Inflammation,,,,,,,,
2370,Not Relevant,Kidney Transplantation,Focussed Oral,PCSK9 inhibitors protect kidney from ischemia-reperfusion injury reducing oxidative stress and enhancing tissue resistance: a metabolomics analysis,Ischemia,Ischemia-Reperfusion Injury,,,,PCSK9-Inhibitor,,,,
2371,Not Relevant,Kidney Transplantation,Focussed Oral,Complement system evaluation in blood group incompatible living donor kidney transplantation,,,,,,,,,,
2372,Not Relevant,Kidney Transplantation,Focussed Oral,Gut microbiome alterations precede graft rejection in kidney transplantation patients,,,,,,,,,,
2373,Not Relevant,Kidney Transplantation,Focussed Oral,Human Leukocyte Antigen Alleles Associated With Acute Antibody-Mediated Rejection In Kidney Transplantation In A Mexican Population.,,,,,,,,,,
2374,Not Relevant,Kidney Transplantation,Focussed Oral,Pre-Transplant Anti-Hla Igm Antibodies And Kidney Transplant Outcomes,,,,,,,,,,
2375,Not Relevant,Kidney Transplantation,Focussed Oral,Reprogramming innate immune memory using tacrolimus-loaded nanobiologics promotes organ transplant acceptance,,,Tacrolimus,,,Calcineurin-Inhibitor,,,,
2376,Not Relevant,Kidney Transplantation,Focussed Oral,Hypothermic Oxygenated Perfusion of Marginal Kidneys with Extracellular Vesicles from Mesenchymal Stromal Cells: A Proteomic Analysis,,,Mesenchymal Stromal Cell,,,Stem Cell Therapy,,,,
2377,Not Relevant,Kidney Transplantation,Focussed Oral,Engineered ATP-Loaded Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Novel Strategy to Counteract Cell ATP Depletion in an In Vitro Model,,,Mesenchymal Stem Cell,,,Stem Cell Therapy,,,,
2378,Not Relevant,Kidney Transplantation,Focussed Oral,Plasma Uromodulin dynamics in deceased kidney donors and the association with transplant outcomes,,,,,,,,,,
2379,Not Relevant,Kidney Transplantation,Focussed Oral,Health-Related Quality of Life in the First Year Post Kidney Transplantation – a Cohort Study,,,,,,,,,,
2380,Not Relevant,Kidney Transplantation,Focussed Oral,Longitudinal analysis of the urinary Dickkopf-related protein 3 and its association with kidney function following kidney transplantation,,,,,,,,,,
2381,Not Relevant,Kidney Transplantation,Focussed Oral,Automated Segmentation and Quantification of Arterial Intimal Fibrosis for Remuzzi Score Calculation in Kidney Transplant Process,Fibrosis,Arterial Intimal Fibrosis,,,,,,,,
2382,Not Relevant,Kidney Transplantation,Focussed Oral,The Impact of First Year eGFR and Sebsequent eGFR decline on Kidney Transplant Outcomes – a single centre experience,,,,,,,,,,
2383,Not Relevant,Kidney Transplantation,Focussed Oral,Physician Communication and the Patient-Provider Relationship as Factors for Non-Adherence in Kidney Transplant Recipients,,,,,,,,,,
2384,Not Relevant,Long term consequence of AKI,Symposium,Quality over Creatinine,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
2385,Not Relevant,Long term consequence of AKI,Symposium,Recovery after AKI in children,Acute Kidney Injury,Childhood Acute Kidney Injury,,,,,,Childhood,,
2386,Not Relevant,Long term consequence of AKI,Symposium,Recovery after AKI in obesity,Acute Kidney Injury;Obesity,Acute Kidney Injury;Obesity,,,,,,,,
2387,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Two novel heterozygous missense variants of CYP24A1 gene in families with kidney cysts and stones,,Kidney Stone,,,,,,,,
2388,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Hydrogel embedding of iPSC-derived kidney organoids to enable imaging-based high-throughput screening,,Genetic Disease,,,,,,,,
2389,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Syntaxin 3 regulates apical membrane integrity in proximal tubule epithelial cells and prevents Fanconi syndrome development,Fanconi Syndrome,Fanconi Syndrome,,,,,,,,
2390,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Effect of Tyrosine Kinase Inhibitors on Hyperfiltration Response and Renal Functions in Nephrectomized Renal Cell Carcinoma Patients,Renal Cell Carcinoma,Nephrectomy Renal Cell Carcinoma,,,,Tyrosine Kinase-Inhibitor,,,,
2391,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,How should we prioritise genetic testing for kidney stone disease?,,Kidney Stone Disease,,,,,,,,
2392,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Frequency of 24-hour urine test application in adult patients with kidney stone disease: a population-based study in primary care in Italy,,Adult Kidney Stone Disease,,,,,,Adult,,
2393,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,KDASDB: A Comprehensive and User-Friendly Database for Alternative Splicing in Kidney Diseases,Kidney Diseases,Kidney Disease,,,,,,,,
2394,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Lanthanum carbonate does not reduce urinary oxalate excretion in hyperoxaluric kidney stone formers,Hyperoxaluria,Hyperoxaluria;Kidney Stone,Lanthanum Carbonate,,,Phosphate-Binder,,,,
2395,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Pharmacogenetic analysis from exome data and pharmaco-clinico-biological co-interpretation enable personalized care in nephrology and kidney transplantation,,Disease,,,,,,,,
2396,Not Relevant,"Physiology, cell biology & genetic diseases",Focussed Oral,Impaired renal function in patients with spinal muscular atrophy: a longitudinal cohort study,Spinal Muscular Atrophy,Spinal Muscular Atrophy,,,,,,,,
2397,Not Relevant,Understanding ADPKD and its consequences,Symposium,Adult human organoids of PKD,Polycystic Kidney Diseases,Adult Pediatric Polycystic Kidney Disease,,,,,,Adult;Paediatric,,
2398,Not Relevant,Understanding ADPKD and its consequences,Symposium,ADPKD in children,Autosomal Dominant Polycystic Kidney,Childhood Autosomal Dominant Polycystic Kidney,,,,,,Childhood,,
2399,Not Relevant,Understanding ADPKD and its consequences,Symposium,The primary cilium ias a target for new ADPKD treatments,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,Fresenius,,,
2400,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,The impact of an Acute Kidney Injury Service on patient outcomes at a large district general hospital in the United Kingdom,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
2401,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Renoprotective Effect of Intravenous Amino Acid Infusion in Adult Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
2402,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Associations between Lymphopenia and the Development/Recovery of Acute Kidney Injury among Patients Hospitalized with Respiratory Virus Infections,Acute Kidney Injury;Lymphopenia,Acute Kidney Injury;Lymphopenia,,,,,,,,
2403,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,"Plasma Free Hemoglobin, Haptoglobin, and Risk of CSA-AKI.  A Translational Systematic Review and Meta-Analysis.",Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
2404,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Clinical performance of the new Plasma Filter PX2 in Therapeutic Plasma Exchange: An interventional Multicenter Study,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
2405,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,The generalized application of VExUS does not provide clinically relevant information for the treatment of hospitalized patients with hyponatremia: an observational study,,Hyponatremic Syndrome,,,,,,,,
2406,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Reducing the incidence and severity of acute kidney injury in people with ileostomies - a nurse-led trifecta approach in a district general hospital in the United Kingdom,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
2407,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Targeting M2b Macrophages by Selenium Nanomedicine for the Treatment of Lupus Nephritis,Lupus Nephritis,Lupus Nephritis,Selenium,,,M2b-Targeted Therapy,,,,
2408,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Regional Citrate Anticoagulation is a safe and effective strategy for treating critically ill patients undergoing Kidney Replacement Therapy for Metformin-Associated Lactic Acidosis (MALA): definitive documentation through serum citrate measurements,Acidosis,Metformin Associated Lactic Acidosis,,,,,,,,
2409,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Ravulizumab in atypical haemolytic uraemic syndrome: analysis of quality of life outcomes in adult and paediatric phase 3 trials,Hemolysis,Adult Paediatric Atypical Hemolytic Urinary Syndrome,Ravulizumab,,,C5-Inhibitor,,Adult;Atypical;Paediatric,,
2410,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Rechallenge of Immune Checkpoint Inhibitors in cancer patients with biopsy-confirmed renal injury: a case series.,Cancer;Renal Injury,Cancer;Renal Injury,,,,Immune Checkpoint Inhibitors,,,,
2411,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Contrast-Induced Nephropathy: A Prospective Comparative Study Using Capillary Blood Sampling with Point of care Creatinine Measurement,Nephropathy,Contrast-Induced Nephropathy,,,,,,,,
2412,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Results of the COVID-19 patients treated with the Seraph® 100 Microbind® Affinity filter (COSA) registry,Coronavirus Infection,COVID-19,,,,,,,NCT04361500,COSA
2413,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura,Thrombotic Thrombocytopenic Purpura,Immune Thrombotic Thrombocytopenic Purpura,,,,,,,,
2414,Not Relevant,Chronic kidney disease,Focussed Oral,Association between Healthy Dietary Patterns and Chronic Kidney Disease: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES) 2019-2021,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2415,Not Relevant,Chronic kidney disease,Focussed Oral,Screening In The General Adult Population With Risk Factors For Chronic Kidney Disease,Chronic Kidney Disease,Adult Chronic Kidney Disease,,,,,,Adult,,
2416,Not Relevant,Chronic kidney disease,Focussed Oral,"Diagnosis Challenges for Chronic Kidney Disease in Irish Primary Care: A Real-world Study Comparing eGFR, uACR and Diagnosis Coding in 66 Irish General Practices",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2417,Not Relevant,Chronic kidney disease,Focussed Oral,High urinary TFF3 is a significant risk factor for rapid age-related loss of GFR in the general population,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2418,Not Relevant,Chronic kidney disease,Focussed Oral,Program For Early Detection And Management Of Chronic Kidney Disease In Croatia – First Results,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2419,Not Relevant,Chronic kidney disease,Focussed Oral,Implications of Integrating the Kidney Failure Risk Equation into Nephrology Referrals from Primary Care,Renal Failure,Kidney Failure,,,,,,,,
2420,Not Relevant,Chronic kidney disease,Focussed Oral,Influenza Vaccination Uptake and Determinants Among Korean Chronic Kidney Disease Patients: A Nationwide Cohort Analysis,Chronic Kidney Disease,Chronic Kidney Disease,Influenza Vaccine,,,Vaccine,,,,
2421,Not Relevant,Chronic kidney disease,Focussed Oral,"The associations of cardiac and stress bio-markers NT-proBNP and growth differentiation factor 15 (GDF-15), with incidence and progression of CKD among people, living in war-affected region (Kharkiv, Ukraine). Save Kidneys Study, granted by Clinical Research Program of the ISN.",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,Save Kidneys,
2422,Not Relevant,Chronic kidney disease,Focussed Oral,Geriatric Assessment use to frailty prediction in older CKD patients,Chronic Kidney Disease,Elderly Chronic Kidney Disease,,,,,,Elderly,,
2423,Not Relevant,Chronic kidney disease,Focussed Oral,Integrated Proteomic and Radiomic Signatures to Predict Ejection Fraction Improvement in CKD Patients Listed for Kidney Transplantation,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2424,Not Relevant,Chronic kidney disease,Focussed Oral,Real-world performance of two mortality scores designed for elderly patients with advanced CKD,Chronic Kidney Disease,Elderly Advanced Chronic Kidney Disease,,,,,,Advanced;Elderly,,
2425,Not Relevant,Chronic kidney disease,Focussed Oral,CKD Stage 3 Patient Monitoring: Evaluating Current Practices in General Practice,Chronic Kidney Disease,Chronic Kidney Disease;Stage III Chronic Kidney Disease,,,,,,Stage III,,
2426,Not Relevant,Chronic kidney disease,Focussed Oral,The association between dexa-measured visceral fat and age-related iohexol-clearance decline -a population-based cohort study-,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2427,Not Relevant,Chronic kidney disease,Focussed Oral,"The SPIRIT study : A multicenter prospective observational study of patients with CKD to assess therapeutic algorithms,disease management and quality of life in Greece",Chronic Kidney Disease,Chronic Kidney Disease,,,,,Myovant,,NCT03204318;;SPIRIT,
2428,Not Relevant,Chronic kidney disease,Focussed Oral,Capturing Service Users' Experience of the Integrated Community Conservative Palliative Renal Care Services,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2429,Not Relevant,Chronic kidney disease,Focussed Oral,Developing a Risk Prediction Model for Progression Events in Chronic Kidney Disease Patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2430,Not Relevant,Chronic kidney disease,Focussed Oral,Dapagliflozin’s effect on kidney oxygenation: analysis of functional MRI data from the Randomized GLUTREPRO Trial,Chronic Kidney Disease,Chronic Kidney Disease,Dapagliflozin,,,SGLT2-Inhibitor,AstraZeneca,,GLUTREPRO;;NCT05998837,
2431,Not Relevant,Chronic kidney disease,Focussed Oral,"The effect of prophylactic anticoagulation on major bleeding events in hospitalized chronic kidney disease and lower limb fracture patients. A phase 2, Randomized, Double Blind, Control Trial.",Chronic Kidney Disease,Chronic Kidney Disease;Lower Limb Fracture,,,,,,,,
2432,Not Relevant,Chronic kidney disease,Focussed Oral,"ALIGN post-hoc analyses: Reduction in proteinuria with atrasentan across subgroups by MEST-C score, baseline hematuria and baseline UPCR",Chronic Kidney Disease;Hematuria,Chronic Kidney Disease;Hematuria,Atrasentan,,,Endothelin Receptor-Antagonist,Chinook Therapeutics,,NCT04573478,ALIGN
2433,Not Relevant,Chronic kidney disease,Focussed Oral,Changes in albuminuria and the effect of finerenone on cardiovascular outcomes: Insights from FINEARTS-HF,Albuminuria;Heart Failure,Albuminuria;Heart Failure,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,Bayer,,FINEARTS-HF;;NCT04435626,
2434,Not Relevant,Chronic kidney disease,Focussed Oral,Real-world impact of finerenone on albuminuria in patients with diabetes and CKD,Albuminuria;Chronic Kidney Disease;Diabetes,Albuminuria;Chronic Kidney Disease;Diabetes,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist,,,,
2435,Not Relevant,Chronic kidney disease,Focussed Oral,Implementation of quadruple therapy in heart failure with reduce ejection fraction in patients with advance chronic kidney disease: Challenges and experience in our Cardiorenal Unit,Chronic Kidney Disease;Heart Failure,Advanced Chronic Kidney Disease;Heart Failure,,,,,,Advanced,,
2436,Not Relevant,Chronic kidney disease,Focussed Oral,Effects of vicadrostat with and without empagliflozin in people with chronic kidney disease by baseline BMI,Chronic Kidney Disease,Chronic Kidney Disease,Vicadrostat,Empagliflozin,,Aldosterone Synthase-Inhibitor,,,,
2437,Not Relevant,Chronic kidney disease,Focussed Oral,Guideline adherence in primary and nephrology care for older patients with advanced chronic kidney disease and the association with social and clinical characteristics,Chronic Kidney Disease,Elderly Advanced Chronic Kidney Disease,,,,,,Advanced;Elderly,,
2438,Not Relevant,Chronic kidney disease,Focussed Oral,Bringing Kidney Disease Prevention Into Schools: Impact Of A Pilot Health Education Programme To Improve Kidney Health,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2439,Not Relevant,Chronic kidney disease,Focussed Oral,How Does Intradialytic Exercise Influence Emotional Well-Being And Quality Of Life In Renal Dialysis Patients?,Renal Failure,Kidney Failure,,,,,,,,
2440,Not Relevant,Chronic kidney disease,Focussed Oral,Safety and Tolerability of ABBV-CLS-628: Results From a Phase 1 First-in-Human Study,Chronic Kidney Disease,Chronic Kidney Disease,ABBV-CLS-628,,,EIF2b-Activator,,,,
2441,Not Relevant,Chronic kidney disease,Focussed Oral,Demographics and Comorbidities of Dialysis Patients Using SGLT2 Inhibitors and GLP-1 Agonists,Renal Failure,Kidney Failure,,,,GLP-1-Receptor Agonist;SGLT2-Inhibitor,,,,
2442,Not Relevant,Chronic kidney disease,Focussed Oral,Ketogenic Diet as a Therapeutic Approach in ADPKD,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,,,,,
2443,Not Relevant,Chronic kidney disease,Focussed Oral,Albuminuria A3 in a central district of Madrid: current situation,Albuminuria,Albuminuria,,,,,,,,
2444,Not Relevant,Chronic kidney disease,Focussed Oral,Effect of CKD and hemodialysis on the epigenetic clock: implications for the reverse epidemiology,Chronic Kidney Disease;Renal Failure,Chronic Kidney Disease;Kidney Failure,,,,,,,,
2445,Not Relevant,Chronic kidney disease,Focussed Oral,Etiological Analysis of Early-Onset Chronic Kidney Disease: A Study on Dent Disease in Chinese Pediatric Patients,Chronic Kidney Disease,Early Onset Chronic Kidney Disease,,,,,,Early Onset,,
2446,Not Relevant,Chronic kidney disease,Focussed Oral,Validation of a new simplified method for quick and easy quantification of iohexol as part of precise kidney function measurement,Chronic Kidney Disease,Chronic Kidney Disease,Iohexol,,,X-Ray Contrast Agent,,,,
2447,Not Relevant,Chronic kidney disease,Focussed Oral,Implementation of an iohexol-based GFR-measurement in clinical routine,Chronic Kidney Disease,Chronic Kidney Disease,Iohexol,,,X-Ray Contrast Agent,,,,
2448,Not Relevant,Chronic kidney disease,Focussed Oral,Measured Gfr In Oncological Solitary Kidney: A Critical Parameter For Precision Management In Onconephrology,Cancer,Cancer,,,,,,,,
2449,Not Relevant,Chronic kidney disease,Focussed Oral,"Cerebrovascular changes, cognitive functioning, depressive symptoms and apathy in older adults with advanced CKD",Chronic Kidney Disease,Advanced Elderly Chronic Kidney Disease,,,,,,Advanced;Elderly,,
2450,Not Relevant,Chronic kidney disease,Focussed Oral,Inflammatory cytokine clusters are associated with adverse outcomes in patients with CKD,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2451,Not Relevant,Chronic kidney disease,Focussed Oral,Adjustment of glomerular filtration rate by BSA: an unnecesary error in estimating renal function,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2452,Not Relevant,Chronic kidney disease,Focussed Oral,Evaluating the Clinical Applicability of KFRE in Advanced Chronic Kidney Disease: Insights from a Spanish Cohort,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
2453,Not Relevant,Chronic kidney disease,Focussed Oral,Precision Medicine in Onco-Nephrology: Unveiling the Gap Between Measured and Estimated GFR,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2454,Not Relevant,Chronic kidney disease,Focussed Oral,Comparative Analysis of GFR Estimation Equations in Oncologic Patients,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2455,Not Relevant,Chronic kidney disease,Focussed Oral,#BloodyAmazingKidneys - A national awareness campaign to alert the general public about the risks of CKD,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2456,Not Relevant,Chronic kidney disease,Focussed Oral,"Hemostasis abnormalities in patients across different stages of chronic kidney disease, after evaluating a wide spectrum of coagulation parameters.",Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2457,Not Relevant,Chronic kidney disease,Focussed Oral,Size-selective glomerular filtration is a hallmark of premature kidney ageing,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2458,Not Relevant,Chronic kidney disease,Focussed Oral,Obstructive sleep apnea accelerates CKD progression in type 2 diabetes,Chronic Kidney Disease;Obstructive Sleep Apnea,Chronic Kidney Disease;Obstructive Sleep Apnea,,,,,,,,
2459,Not Relevant,Dialysis,Focussed Oral,Clinical impact of catheter insertion method: a single-center retrospective study using propensity score analysis,Renal Failure,Kidney Failure,,,,,,,,
2460,Not Relevant,Dialysis,Focussed Oral,Relationship Between Tissue Hydration and Peritoneal Membrane Transport,Renal Failure,Kidney Failure,,,,,,,,
2461,Not Relevant,Dialysis,Focussed Oral,Association between healthcare expenditure per capita and adoption of early home dialysis and kidney transplantation,Renal Failure,Kidney Failure,,,,,,,,
2462,Not Relevant,Dialysis,Focussed Oral,Long-term impact of peritoneal dialysis ultrafiltration on cardiorenal patients,Renal Failure,Kidney Failure,,,,,,,,
2463,Not Relevant,Dialysis,Focussed Oral,Development of a Support System for Patients on Dialysis: Examining the Implementation and Continuation of Exercise Therapy,Renal Failure,Kidney Failure,,,,,,,,
2464,Not Relevant,Dialysis,Focussed Oral,"PD-peritonitis diagnosis using novel, rapid diagnostic assay RenoTact®: a study on pre-clinical performance and usability.",Peritonitis;Renal Failure,Kidney Failure;Peritonitis,,,,,,,,
2465,Not Relevant,Dialysis,Focussed Oral,The Risk Factors and Outcomes of Peritoneal Dialysis-Associated Culture-Negative Peritonitis: A 10-Year Single Center Experience,Peritonitis;Renal Failure,Culture-Negative Peritonitis;Kidney Failure,,,,,,,,
2466,Not Relevant,Dialysis,Focussed Oral,"Novel Tidal, Steady-Concentration Sorbent-Based PD (Viva Kompact) Reduces Glucose Exposure and Maintains Target Weight: A Comparative Pilot Study vs. Conventional PD",Renal Failure,Kidney Failure,,,,,,,,
2467,Not Relevant,Dialysis,Focussed Oral,A Practical Approach For Performing Remote Monitoring In The Care Of Patients With Automated Peritoneal Dialysis Using Sharesource Analytics 1.0,Renal Failure,Kidney Failure,,,,,,,,
2468,Not Relevant,Dialysis,Focussed Oral,"Design of a prospective, multicenter, randomized, crossover study of the Carry Life UF system in continuous ambulatory peritoneal dialysis (CAPD) patients in the home setting",Renal Failure,Kidney Failure,,,,,,,,
2469,Not Relevant,Dialysis,Focussed Oral,Evaluating Leukocyte Test Strips for Peritonitis Diagnosis in Peritoneal Dialysis Patients,Peritonitis;Renal Failure,Kidney Failure;Peritonitis,,,,,,,,
2470,Not Relevant,E-Posters,e-Poster,MSC exosomes inhibit peritoneal fibroblast transdifferentiation by entering fibroblasts via CD44-EGFR binding,,,,,,,,,,
2471,Not Relevant,Dialysis,Focussed Oral,Importance Of Characterizing Intradialytic Hemodynamic Changes Using Bioreactance And Echocardiography Methods,Renal Failure,Kidney Failure,,,,,,,,
2472,Not Relevant,Dialysis,Focussed Oral,"Evaluation of regional citrate anticoagulation in 230 intermittent dialysis, 165 plasma exchange treatments and 95 liver replacement procedures",Renal Failure,Kidney Failure,Citrate,,,Anticoagulant,,,,
2473,Not Relevant,Dialysis,Focussed Oral,Efficacy and Safety of an Innovative Polymethylmethacrylate Membrane Used for Post Dilution On-Line Hemodiafiltration.  A Crossover Randomised Controlled Study.,Renal Failure,Kidney Failure,,,,,,,,
2474,Not Relevant,Dialysis,Focussed Oral,Vascular Access Of Incident Dialysis Patients With Polycystic Kidney Disease. A Registry-Based Study Using Propensity Score Matching Methodology,Polycystic Kidney Diseases,Polycystic Kidney Disease,,,,,,,,
2475,Not Relevant,Dialysis,Focussed Oral,Arteriovenous fistula and pulmonary hypertension in patients on hemodialysis,Arterio-Venous Fistula;Pulmonary Hypertension;Renal Failure,Arterio-Venous Fistula;Kidney Failure;Pulmonary Hypertension,,,,,,,,
2476,Not Relevant,Dialysis,Focussed Oral,Vascular Access-Associated Excess Mortality,Renal Failure,Kidney Failure,,,,,,,,
2477,Not Relevant,Dialysis,Focussed Oral,Prediction of Fistula Maturation Using Central Venous Oxygen Saturation and Upper Body Blood Flow,Renal Failure,Kidney Failure,,,,,,,,
2478,Not Relevant,Dialysis,Focussed Oral,"Critchley-Critchley Analysis of DBB-EXA™ vs. Transonic® HD02: Accuracy, Reproducibility, and Clinical Implications in Vascular Access Flow Measurement",Renal Failure,Kidney Failure,,,,,,,,
2479,Not Relevant,Dialysis,Focussed Oral,Dialysis with a permanent catheter is associated with higher levels of IL-6 and myostin compared to dialysis fistula.,Renal Failure,Kidney Failure,,,,,,,,
2480,Not Relevant,Dialysis,Focussed Oral,AVF Elective Ligation In Kidney Transplant Recipients Is Not Associated With An Acceleration Of Kidney Function Decline,Renal Failure,Kidney Failure,,,,,,,,
2481,Not Relevant,Dialysis,Focussed Oral,Clinical Impact of Teledialysis in Automated Peritoneal Dialysis vs. Hemodialysis: A Retrospective Comparison,Renal Failure,Kidney Failure,,,,,,,,
2482,Not Relevant,Dialysis,Focussed Oral,Personalizing Peritoneal Dialysis Prescriptions Using Q-Learning: An AI-Based Approach to Optimize Renal Replacement Therapy,Renal Failure,Kidney Failure,,,,,,,,
2483,Not Relevant,Dialysis,Focussed Oral,Peritoneal dialysis induced hepatic glucotoxicity results in metabolic inflammation and oxidative stress,Inflammation,Metabolic Inflammation,,,,,,,,
2484,Not Relevant,Dialysis,Focussed Oral,Peritoneal Infusion of Microplastics Induces Over-Expression of GDF-15 in Kidney and Heart in Mice,Renal Failure,Kidney Failure,,,,,,,,
2485,Not Relevant,Dialysis,Focussed Oral,Value Of The Nutritional Prognostic Index As An Indicator Of Cardiovascular Risk In Peritoneal Dialysis,Renal Failure,Kidney Failure,,,,,,,,
2486,Not Relevant,Dialysis,Focussed Oral,"Rationale and study design of EXCITE, a pilot study to evaluate safety and efficacy of PolyCore, a ternary combination of xylitol, L-carnitine and polydextrIn, to treat end-stage kidney disease patients starting peritoneal dialysis.",Renal Failure,End Stage Kidney Failure,L-Carnitine;PolyCore;Polydextrin;Xylitol,,,Dietary Supplement;Polysaccharide;Sugar Substitute,, End Stage,EXCITE,
2487,Not Relevant,ERAC symposium: Improving patient care with the Real world data insights,Symposium,Current landscape in nephrology,,,,,,,,,,
2488,Not Relevant,ERAC symposium: Improving patient care with the Real world data insights,Symposium,Bridging regulatory and reimbursement pathways,,,,,,,,,,
2489,Not Relevant,ERAC symposium: Improving patient care with the Real world data insights,Symposium,Future Directions,,,,,,,,,,
2490,Not Relevant,FC 23: Hemodialysis: Interventions,Free Communication,"Antiplatelet and anticoagulant agent use in advanced CKD, dialysis and renal transplantation",Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,Anticoagulant Agent;Antiplatelet Agent,,Advanced,,
2491,Not Relevant,FC 23: Hemodialysis: Interventions,Free Communication,Hemodiafiltration versus high-flux Hemodialysis on mortality of dialysis patients: A systematic review and meta-analysis,Renal Failure,Kidney Failure,,,,,,,,
2492,Not Relevant,FC 23: Hemodialysis: Interventions,Free Communication,Association Of Incident Dialysis Modality With Patient Survival: A Systematic Review And Meta-Analysis,Renal Failure,Kidney Failure,,,,,,,,
2493,Not Relevant,FC 23: Hemodialysis: Interventions,Free Communication,Gallic acid carbon dot-supported heparin-like polymer as an optimized membrane-anchored antioxidant and anticoagulant for hemodialysis treatment,Renal Failure,Kidney Failure,,,,,,,,
2494,Not Relevant,FC 23: Hemodialysis: Interventions,Free Communication,Stronger Together: Sodium and chemical displacers combine to improve uremic toxin clearance beyond individual effects,Renal Failure,Kidney Failure,,,,,,,,
2495,Not Relevant,FC 23: Hemodialysis: Interventions,Free Communication,"Effect of Remote Ischemic Preconditioning on Hemodialysis Adequacy, Hematological, and Cardiovascular Parameters in Hemodialysis Patients: A Randomized Controlled Trial",Renal Failure,Kidney Failure,,,,,,,,
2496,Not Relevant,FC 23: Hemodialysis: Interventions,Free Communication,"Oral sucrosomal iron versus intravenous iron sucrose in participants on hemodialysis: a randomized, single-blind, placebo-controlled, crossover study.",Renal Failure,Kidney Failure,Iron Sucrose,,,Iron Replacement Therapy,,,,
2497,Not Relevant,FC 24: CKD and Public Health: Part 1,Free Communication,Latin America: From Early Detection to Access to Treatment of Kidney Disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2498,Not Relevant,FC 24: CKD and Public Health: Part 1,Free Communication,Comparison of healthcare utilization between CKD and non-CKD patients: an observational study in the West region of France.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2499,Not Relevant,FC 24: CKD and Public Health: Part 1,Free Communication,Impact of targeted screening in high-risk individuals and guideline-directed medical therapy on CKD burden in Europe: projections from IMPACT CKD,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,IMPACT CKD
2500,Not Relevant,FC 24: CKD and Public Health: Part 1,Free Communication,Care processes and clinical reactions to newly detected albuminuria; the Stockholm CREAtinine Measurements (SCREAM) project,Albuminuria,Newly Diagnosed Albuminuria,,,,,,Newly Diagnosed,NCT06239129;;SCREAM,
2501,Not Relevant,FC 24: CKD and Public Health: Part 1,Free Communication,Insights from CDC NHANES survey among self-reported Chronic Kidney Disease patients and their outcomes: A National database mortality analysis of United States Population from 2001-2020.,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2502,Not Relevant,FC 24: CKD and Public Health: Part 1,Free Communication,Patient and Carer Treatment Preferences for Chronic Kidney Disease (CKD): A Discrete Choice Experiment (DCE) across Eight Countries,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2503,Not Relevant,FC 24: CKD and Public Health: Part 1,Free Communication,Clinical utility of a risk-based referral model to nephrologist-specialist care; the Stockholm CREAtinine Measurements (SCREAM) project,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,NCT06239129;;SCREAM,
2504,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Uromodulin p.His36Tyr mutation actuates kidney injury by activating ferroptosis via down-regulating FoxO3a expression,,Kidney Injury,,,,,,,,
2505,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Dose-dependent NSAID effects on autophagy and fibrosis pathways in renal tubular epithelial cells,Fibrosis,Fibrosis,,,,Nonsteroidal Anti-inflammatory Drug,,,,
2506,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,An Expanded Proteomic Workflow Using Data-Independent Acquisition Mass Spectrometry for the Identification of Target Antigens in Membranous Nephropathy,Membranous Nephropathy,Membranous Nephropathy,,,,,,,,
2507,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,The protective effects of a ketogenic diet in experimental glomerulonephritis are independent of the Hca2 receptor.,Glomerulonephritis,Glomerulonephritis,,,,,,,,
2508,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Exploring A Novel Renoprotective Protein TMEM52B: Insights into Its Role and Mechanisms in Renal Fibrosis,Fibrosis,Renal Fibrosis,,,,,,,,
2509,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Decoding Podocyte Effacement: A High-Resolution Approach Using STED Microscopy and Spatial Transcriptomics,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
2510,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Effect of Desmopressin on Post-Kidney Biopsy Bleeding: A Randomized, Double-Blind, Placebo-Controlled Study",Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,Desmopressin,,,Vasopressin Analog,,,,
2511,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Adult renal progenitor cells can decrease the inflammatory and immunological triggering in IgA Nephropathy patients at renal tissue level.,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2512,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Investigation of the Rac1-SGK1 Pathway and Therapeutic Effects of Finerenone and Rac1 Inhibition in a Fabry Disease Podocyte Model,Fabry Disease,Fabry Disease,Finerenone,,,Nonsteroidal Mineralocorticoid Receptor-Antagonist;RAC1-Inhibitor,,,,
2513,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Characterizing the NIH Activity and Chronicity Indices in Two Independent Lupus Nephritis Cohorts: A Critical Analysis,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2514,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Free Light Chains in Light Chain Proximal Tubulopathy: De Novo Sequencing and Resistance to Lysosomal Proteases,Light Chain Proximal Tubulopathy,Light Chain Proximal Tubulopathy,,,,,,,,
2515,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Podocyte-specific YAP activation triggers crescentic glomerulonephritis through a crosstalk with parietal epithelial cells,Crescentic Glomerulonephritis,Crescentic Glomerulonephritis,,,,,,,,
2516,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Specific Urinary Peptidomic Profiling in Patients with Post-COVID-19: a Case-Control Study (UriCoV),Coronavirus Infection,Post COVID-19,,,,,,,NCT05699889;;UriCoV,
2517,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Repurposing Disulfiram to target neutrophil extracellular traps in experimental ANCA associated vasculitits,Vasculitis,Anti-Neutrophil Cytoplasmic Antibody Associated Vasculitis,Disulfiram,,,Aldehyde Dehydrogenase-Inhibitor;Antibody,,,,
2518,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Urinary Metabolomics In Nephrotic Syndrome: The Experience Of “Fondazione Policlinico Universitario A. Gemelli”,Nephrosis,Nephrotic Syndrome,,,,,,,,
2519,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Macula Densa Cell Targeting Kidney Tissue Regenerative Therapeutic Approaches,Glomerular Disease;Tubulointerstitial Disease,Glomerular Disease;Tubulointerstitial Disease,,,,,,,,
2520,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Imlifidase a new treatment for severe minimal change disease?,Minimal Change Disease,Severe Minimal Change Disease,Imlifidase,,,Immunostimulant,,Severe,,
2521,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Discovery and Characterization of JADE101, an Ultra-High Affinity, Half-Life Extended Anti-APRIL Monoclonal Antibody for the Treatment of IgAN",IgA Nephropathy,IgA Nephropathy,JADE101,,,APRIL-Targeted Monoclonal Antibody,,,,
2522,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Patients With Focal Segmental Glomerulosclerosis (FSGS) Achieved Low Proteinuria Targets Earlier and More Often With Sparsentan (SPAR) vs Irbesartan (IRB) in DUPLEX,Focal Segmental Glomerulosclerosis,Focal Segmental Glomerulosclerosis,Sparsentan,,Irbesartan,Endothelin Receptor-Antagonist,Travere Therapeutics,,DUPLEX;;NCT03493685,
2523,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Long-term stabilization of kidney function (estimated glomerular filtration rate) with iptacopan in patients with native C3 glomerulopathy,C3 Glomerulopathy,Native C3 Glomerulopathy,Iptacopan,,,Complement Factor B-Inhibitor,,,,
2524,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Reduction of hematuria and albuminuria with iptacopan in C3G: Findings from APPEAR-C3G study,Albuminuria;Hematuria,Albuminuria;Hematuria,Iptacopan,,,C3-Inhibitor,Novartis,,APPEAR-C3G;;NCT04817618,
2525,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Effects of nefecon on Hits 1, 2, and 3 of the pathogenic cascade of IgA nephropathy: a full NefIgArd analysis",IgA Nephropathy,IgA Nephropathy,Nefecon,,,Glucocorticoid Receptor Agonist,Calliditas Therapeutics,,NCT03643965;;NefIgArd,
2526,Medium,Glomerular & tubulo-interstitial diseases,Focussed Oral,Exploring the gut-targeted mechanism of nefecon: effects on GALT-associated and systemic IgA markers in IgA nephropathy,IgA Nephropathy,IgA Nephropathy,Nefecon,,,Glucocorticoid,,,,
2527,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,Sustainability and depth of UPCR reduction in patients with primary IgAN treated with nefecon: a secondary analysis of the Phase 3 NefIgArd trial,IgA Nephropathy,Primary IgA Nephropathy,Nefecon,,,Glucocorticoid Receptor Agonist,Calliditas Therapeutics,,NCT03643965;;NefIgArd,
2528,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,Rituximab in treating steroid-sensitive nephrotic syndrome in children—experience from Uzbekistan.,Nephrosis,Childhood Steroid Sensitive Nephrotic Syndrome,Rituximab,,,CD20-Targeted Monoclonal Antibody;Steroid,,Childhood,,
2529,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,"Clinical and histological response of proliferative, crescentic IgA nephropathy to 6-month methylprednisolone course: a repeat biopsy study",IgA Nephropathy,IgA Nephropathy,Methylprednisolone,,,Glucocorticoid,,,,
2530,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,ORIGIN 2b: Changes in Gd-IgA1 and eGFR After Discontinuation of Atacicept Treatment in IgA Nephropathy,IgA Nephropathy,IgA Nephropathy,,,,,Vera Therapeutics,,NCT04716231;;ORIGIN 2b,
2531,High,Glomerular & tubulo-interstitial diseases,Focussed Oral,Efficacy and safety of Telitacicept treatment for proliferative sclerosis IgA nephropathy: A real-world retrospective study,IgA Nephropathy;Sclerosis,IgA Nephropathy;Proliferative Sclerosis,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,,,
2532,Not Relevant,Glomerular & tubulo-interstitial diseases,Focussed Oral,A PK/PD Analysis and Population PK Modeling of Ravulizumab Using Data from the Phase 2 Trial in Adults with IgA Nephropathy (SANCTUARY),IgA Nephropathy,Adult IgA Nephropathy,Ravulizumab,,,C5-Inhibitor,Alexion Pharmaceuticals,Adult,NCT04564339,SANCTUARY
2533,Not Relevant,Hypertension diagnosis and treatment in specific populations,Symposium,2025 update on resistant hypertension in CKD: where do we stand and where do we go?,Chronic Kidney Disease;Hypertension,Chronic Kidney Disease;Hypertension,,,,,,,,
2534,Not Relevant,Hypertension diagnosis and treatment in specific populations,Symposium,BP Control in Patients with Advanced CKD,Chronic Kidney Disease,Advanced Chronic Kidney Disease,,,,,,Advanced,,
2535,Not Relevant,Hypertension diagnosis and treatment in specific populations,Symposium,Intradialytic hypertension: newer insights into epidemiology and management,Hypertension,Intradialytic Hypertension,,,,,,,,
2536,Not Relevant,Kidney Transplantation,Focussed Oral,The Impact of Early vs Delayed Immunosuppressive Agents on Delayed Graft Function and Rejection: A Meta-Analysis,,,,,,,,,,
2537,Not Relevant,Kidney Transplantation,Focussed Oral,Exercise And Prediabetes After Renal Transplantation: Expred-II,,Prediabetes,,,,,,,Expred-II;;NCT06576531,
2538,Medium,Kidney Transplantation,Focussed Oral,Telitacicept Therapy in Recurrent IgA Nephropathy Post-Kidney Transplantation: A Case Series and Literature Review,IgA Nephropathy,Recurrent IgA Nephropathy,Telitacicept,,,BLyS/APRIL Dual-Inhibitor,,Recurrent,,
2539,Not Relevant,Kidney Transplantation,Focussed Oral,Kidney Transplant Outcomes in Highly Sensitized Patients with Preformed Donor-Specific Antibodies Using a DELISTING Strategy,,,,,,,,,,
2540,Not Relevant,Kidney Transplantation,Focussed Oral,Role of high plasma levels of VWF and Ristocetin Cofactor in Kidney Transplant Recipients,,,Ristocetin,,,Glycopeptide-Antibiotic,,,,
2541,Not Relevant,Kidney Transplantation,Focussed Oral,Basiliximab Induction Alone vs. a Dual ATG-Basiliximab Approach in First Living Non-Sensitized Renal Transplant Recipients with Reduced HLA Matching,,,Basiliximab,,Anti-Thymocyte Globulin;Basiliximab,CD25-Targeted Monoclonal Antibody;Immunosuppressant,,,,
2542,Not Relevant,Kidney Transplantation,Focussed Oral,Higher daily protein intake can reduce the risk of infections in kidney transplant recipients during the early post-transplant period,Infection,Infection,,,,,,,,
2543,Not Relevant,Kidney Transplantation,Focussed Oral,Comparative Efficacy of Therapeutic Hypothermia versus Normothermia in Kidney Transplantation: A Meta-Analysis and Trial Sequential Analysis,,,,,,,,,,
2544,Not Relevant,Kidney Transplantation,Focussed Oral,Who Says No? Profiles of Participants and Nonparticipants in an Exercise and Physical Activity Intervention Study After Kidney Transplantation,,,,,,,,,,
2545,Not Relevant,Kidney Transplantation,Focussed Oral,Dapaglifozin in kidney transplant recipients with diabetes mellitus and urine metabolomics analysis,Diabetes,Diabetes Mellitus,Dapaglifozin,,,SGLT2-Inhibitor,,,,
2546,Not Relevant,Kidney Transplantation,Focussed Oral,Immunosuppression reduction in kidney transplantation: can we rest assured?,,,,,,,,,,
2547,Not Relevant,Kidney Transplantation,Focussed Oral,Shall We Go For a Walk? A Comparative Study of the Six-Minute Walk Test and Cardiopulmonary Exercise Test in De Novo Kidney Transplant Recipients,,,,,,,,,,
2548,Not Relevant,Kidney Transplantation,Focussed Oral,Recombinant zoster vaccine (RZV) confers persistent immune responses with no safety concerns 4 to 8 years after vaccination of adults with renal transplant,,,Recombinant Zoster Vaccine,,,Vaccine,,,,
2549,Not Relevant,Kidney Transplantation,Focussed Oral,Molecular Profiling of Renal Function after Liver Transplantation,,,,,,,,,,
2550,Not Relevant,Kidney Transplantation,Focussed Oral,Immunosuppression Management After Kidney Transplant Failure and Its Impact on Sensitization: Where Do We Stand in 2025? A Systematic Review with Meta-Analysis,Renal Failure,Kidney Failure,,,,,,,,
2551,Not Relevant,Kidney Transplantation,Focussed Oral,The Role Of Protocol Biopsies In Kidney Transplantation: Clinical Impact And Prognostic Value Of Banff Criteria,,,,,,,,,,
2552,Not Relevant,Kidney Transplantation,Focussed Oral,Temporal trends in the risk of fractures in adult kidney transplant recipients,,,,,,,,,,
2553,Not Relevant,Kidney Transplantation,Focussed Oral,Increase in the use of expanded criteria living donors to facilitate preemptive kidney transplantation for our patients,,,,,,,,,,
2554,Not Relevant,Kidney Transplantation,Focussed Oral,Long-term outcomes of renal transplantation from expanded criteria living donors,,,,,,,,,,
2555,Not Relevant,Kidney Transplantation,Focussed Oral,Living Kidney Donation Practices in Europe: A Survey of DESCaRTES and EKITA Transplantation Working Groups,,,,,,,,,,
2556,Not Relevant,Kidney Transplantation,Focussed Oral,"Is Preemptive Kidney Transplantation Beneficial in Elderly Kidney Recipients?: A Comparative, Multicentre National Study",,,,,,,,,,
2557,Not Relevant,Kidney Transplantation,Focussed Oral,Dialysis After Graft Failure: Clinical Patterns and One-Year Outcomes,Renal Failure,Kidney Failure,,,,,,,,
2558,Not Relevant,Kidney Transplantation,Focussed Oral,Post-transplant metabolomics: Early prediction of renal function and possible therapeutic target discovery,,,,,,,,,,
2559,Not Relevant,Kidney Transplantation,Focussed Oral,Factors affecting senescent and regulatory T-cell numbers within the first year following kidney transplantation,,,,,,,,,,
2560,Not Relevant,Kidney Transplantation,Focussed Oral,Monitoring of Adherence to Immunosuppressive Drugs by Electronic Healthcare Data in Kidney Transplant Recipients,,,,,,,,,,
2561,Not Relevant,Kidney Transplantation,Focussed Oral,"Prognosis of the kidney transplant patient: the role of ""traditional"" risk",,,,,,,,,,
2562,Not Relevant,Kidney Transplantation,Focussed Oral,Prevalence and Correlates of Hepatic Steatosis and Fibrosis in Chronic Kidney Disease Patients Prior of Kidney Transplantation: A Retrospective Cohort Study,Chronic Kidney Disease;Fatty Liver Disease;Fibrosis,Chronic Kidney Disease;Fibrosis;Hepatic Steatosis,,,,,,,,
2563,Not Relevant,Kidney Transplantation,Focussed Oral,Impact of low dose thymoglobulin-basiliximab induction therapy on acute rejection and post-transplant neoplasia in kidney transplant recipients,Cancer,Acute Rejection;Neoplasia,Basiliximab;Thymoglobulin,,,CD25-Targeted Monoclonal Antibody;T Cell Depleting Therapy,,,,
2564,Not Relevant,Kidney Transplantation,Focussed Oral,Identifying Risk Factors for Bone Fractures in Kidney Trasplant Recipients: A Clinical Data Perspective,,Bone Fracture,,,,,,,,
2565,Not Relevant,Kidney Transplantation,Focussed Oral,Maternal kidney disease and Offspring Neurodevelopmental Outcomes: A Nationwide Population-based Study,Kidney Diseases,Kidney Disease,,,,,,,,
2566,Not Relevant,Kidney Transplantation,Focussed Oral,Uremic burden as a predictor of preemptive kidney transplant outcome: Insight from a  decision tree analysis in France,,,,,,,,,,
2567,Not Relevant,Potassium Dietary Restrictions for Dialysis Patients: pro and cons dabate,Symposium,Potassium Dietary Restrictions for Dialysis Patients: CON,Renal Failure,Kidney Failure,,,,,,,,
2568,Not Relevant,Potassium Dietary Restrictions for Dialysis Patients: pro and cons dabate,Symposium,Potassium Dietary Restrictions for Dialysis Patients: PRO,Renal Failure,Kidney Failure,,,,,,,,
2569,Not Relevant,Pro and Cons: Shock and AKI- is citrate safe?,Symposium,Shock and AKI- is citrate safe? PRO,Acute Kidney Injury,Acute Kidney Injury,Citrate,,,Anticoagulant,,,,
2570,Not Relevant,Pro and Cons: Shock and AKI- is citrate safe?,Symposium,Shock and AKI- is citrate safe? CON,Acute Kidney Injury,Acute Kidney Injury,Citrate,,,Anticoagulant,,,,
2571,Not Relevant,Pro/Con HLA-i desensitization,Symposium,Predicting the clinical efficacy of desensitisation,,,,,,,,,,
2572,Not Relevant,Pro/Con HLA-i desensitization,Symposium,Pro - what protocols?,,,,,,,,,,
2573,Not Relevant,Pro/Con HLA-i desensitization,Symposium,Con - international KPD program (STEP),,Knee Pain Disorder,,,,,,,,
2574,Not Relevant,Pro/Cons Should we sreen the population for albuminuria?,Symposium,Should we screen the population for albuminuria? PRO,Albuminuria,Albuminuria,,,,,,,,
2575,Not Relevant,Pro/Cons Should we sreen the population for albuminuria?,Symposium,Should we screen the population for albuminuria? CON,Albuminuria,Albuminuria,,,,,,,,
2576,Not Relevant,Pro-Cons: Can advanced microscopies help in clinical routine?,Symposium,Pro: High resolution microscopy in daily clinics,,,,,,,,,,
2577,Not Relevant,Pro-Cons: Can advanced microscopies help in clinical routine?,Symposium,Cons: Problems and pitfalls for advanced microscopies in daily clincs,,,,,,,,,,
2578,Not Relevant,Women of ERA,Symposium,Welcome and introducing remarks,,,,,,,,,,
2579,Not Relevant,Women of ERA,Symposium,"Sex differences in the epidemiology, management and outcomes of kidney disease",Kidney Diseases,Kidney Disease,,,,,,,,
2580,Not Relevant,Women of ERA,Symposium,Gender balance in artificial intelligence: hidden barriers to overcome,,,,,,,,,,
2581,Not Relevant,Women of ERA,Symposium,Exploring Gender Equity in Nephrology: The WERA survey,,,,,,,,,,
2582,Not Relevant,Young Awardees,Symposium,Basic science,,,,,,,,,,
2583,Not Relevant,Young Awardees,Symposium,Translational science,,,,,,,,,,
2584,Not Relevant,Young Awardees,Symposium,Translational science,,,,,,,,,,
2585,Not Relevant,Young Awardees,Symposium,Clinical science,,,,,,,,,,
2586,Not Relevant,Young Awardees,Symposium,Clinical science,,,,,,,,,,
2587,Not Relevant,Cardiovascular Outcomes in CKD: Focus on Sex Differences and Dietary Solutions,Symposium,Sex disparities in cardiovascular disease outcomes in chronic kidney disease,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2588,Not Relevant,Cardiovascular Outcomes in CKD: Focus on Sex Differences and Dietary Solutions,Symposium,Unlocking Cardiovascular Benefits in CKD through Plant-Based Diet,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2589,Not Relevant,Cardiovascular Outcomes in CKD: Focus on Sex Differences and Dietary Solutions,Symposium,Low salt diet,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2590,Not Relevant,Game changers for managing hypertension and diabetes in dialysis in 2025,Symposium,Choosing the right antihypertensive drug to avoid intrahemodialysis hypotension,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,,,,
2591,Not Relevant,Game changers for managing hypertension and diabetes in dialysis in 2025,Symposium,"GLP-1 agonists in diabetes management in dialysis patients: Can it be a solution for obesity, blood pressure control?",Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,GLP-1 Agonist,,,,
2592,Not Relevant,Game changers for managing hypertension and diabetes in dialysis in 2025,Symposium,Evaluation of glycemic control in dialysis patients,Diabetes;Renal Failure,Diabetes;Kidney Failure,,,,,,,,
2593,Not Relevant,Game changers in cAMR,Symposium,Complement inhibitors,,,,,,Complement-Inhibitor,,,,
2594,Not Relevant,Game changers in cAMR,Symposium,anti-CD38 sufficient?,,,,,,CD38-Targeted Therapy,,,,
2595,Not Relevant,Game changers in cAMR,Symposium,NK Cells in AMR – A Therapeutic Target?,,,NK Cell,,,NK Cell Therapy,,,,
2596,Not Relevant,How to raise kidney disease awareness,Symposium,Social Media as a new tool for spreading kidney health.,Kidney Diseases,Kidney Disease,,,,,,,,
2597,Not Relevant,How to raise kidney disease awareness,Symposium,Strong kidneys campaigns: understanding unmet needs for a better kidney health.,Kidney Diseases,Kidney Disease,,,,,,,,
2598,Not Relevant,How to raise kidney disease awareness,Symposium,Raising Kidney Disease Awareness Through Publishing Research,Kidney Diseases,Kidney Disease,,,,,,,,
2599,Low,Navigating IgA Nephropathy Management in the Era of New KDIGO Guidance,Symposium,Mechanistic and Therapeutic Advances in IgAN: New and Upcoming Agents,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2600,Low,Navigating IgA Nephropathy Management in the Era of New KDIGO Guidance,Symposium,Case-based illustrations of key concepts and applications of KDIGO guidance,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2601,Low,Navigating IgA Nephropathy Management in the Era of New KDIGO Guidance,Symposium,Special considerations: Different patient populations call for different approaches,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2602,Not Relevant,Tubulopathy and Interstitial Nephritis,Symposium,RNAinterference for Primary Hyperoxaluria,Primary Hyperoxaluria,Primary Hyperoxaluria,,,,,,,,
2603,Not Relevant,Tubulopathy and Interstitial Nephritis,Symposium,IgG4-Related Kidney Disease: targeting B cells makes the difference,IgG4-Related Kidney Disease,IgG4 Related Kidney Disease,,,,,,,,
2604,Not Relevant,Tubulopathy and Interstitial Nephritis,Symposium,The changing spectrum of acute interstitial nephritis,Acute Tubulo-Interstitial Nephritis,Acute Interstitial Nephritis,,,,,,,,
2605,Not Relevant,Use of common drugs in rare kidney diseases,Symposium,SGLT2i and RAS blockade in ADPKD,Autosomal Dominant Polycystic Kidney,Autosomal Dominant Polycystic Kidney Disease,,,,RAS-Blocker;SGLT2-Inhibitor,,,,
2606,Not Relevant,Use of common drugs in rare kidney diseases,Symposium,SGLT2i and RAS blockade in Alport syndrome,Alport Syndrome,Alport Syndrome,,,,RAS-Blocker;SGLT2-Inhibitor,,,,
2607,Not Relevant,Use of common drugs in rare kidney diseases,Symposium,Treatment of tubulopathies with cheap drugs,,Tubulopathy,,,,,,,,
2608,Not Relevant,What's new in CRRT,Symposium,Extracorporal strategies/therapy for cast-induced AKI,Acute Kidney Injury,Cast-Induced Acute Kidney Injury,,,,,,,,
2609,Not Relevant,What's new in CRRT,Symposium,CRRT vs IDH in critically ill patients with AKI,Acute Kidney Injury,Acute Kidney Injury,,,,,,,,
2610,Not Relevant,What's new in CRRT,Symposium,Inequalities in CRRT access and practice around the world,,,,,,,,,,
2611,Not Relevant,Plenary Lecture 3 - Obesity: now a treatable disease,Plenary Lecture,Obesity: now a treatable disease,Obesity,Obesity,,,,,,,,
2612,Not Relevant,Nephrology Pearls,Symposium,Introduction,,,,,,,,,,
2613,Not Relevant,Nephrology Pearls,Symposium,Congress Passage Ceremony,,,,,,,,,,
2614,Not Relevant,Nephrology Pearls,Symposium,Take home message introduction,,,,,,,,,,
2615,Not Relevant,Nephrology Pearls,Symposium,Where to go in the future: the cutting edge message from the president,,,,,,,,,,
2616,Medium,Seismic shifts in the immunoglobulin A nephropathy (IgAN) treatment paradigm,Industry Sponsored Symposium,Groundbreaking innovation: exploring advancements in IgAN treatment,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2617,Not Relevant,Nephrologists driving early intervention in CKD: championing urgency of care across specialities,Industry Sponsored Symposium,Welcome and introduction,Chronic Kidney Disease,,,,,,,Early Onset,,
2618,Not Relevant,Nephrologists driving early intervention in CKD: championing urgency of care across specialities,Industry Sponsored Symposium,Taking the first step: the importance of communication in primary care,Chronic Kidney Disease,,,,,,,Early Onset,,
2619,Not Relevant,Nephrologists driving early intervention in CKD: championing urgency of care across specialities,Industry Sponsored Symposium,From primary to secondary care: role of the cardiologist in treating people with CKD,Chronic Kidney Disease,,,,,,,Early Onset,,
2620,Not Relevant,Nephrologists driving early intervention in CKD: championing urgency of care across specialities,Industry Sponsored Symposium,"A cardiologist, a nephrologist and a PCP walk into an MDT meeting...",Chronic Kidney Disease;Pulmonary Pneumocystosis,,,,,,,Early Onset,,
2621,Not Relevant,Nephrologists driving early intervention in CKD: championing urgency of care across specialities,Industry Sponsored Symposium,Panel discussion and audience Q&A,Chronic Kidney Disease,,,,,,,Early Onset,,
2622,Not Relevant,Nephrologists driving early intervention in CKD: championing urgency of care across specialities,Industry Sponsored Symposium,Summary,Chronic Kidney Disease,,,,,,,Early Onset,,
2623,Low,Seismic shifts in the immunoglobulin A nephropathy (IgAN) treatment paradigm,Industry Sponsored Symposium,Welcome and introduction,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2624,Low,Seismic shifts in the immunoglobulin A nephropathy (IgAN) treatment paradigm,Industry Sponsored Symposium,Laying the foundations: recognizing the need for a shift in the IgAN treatment paradigm,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2625,Low,Seismic shifts in the immunoglobulin A nephropathy (IgAN) treatment paradigm,Industry Sponsored Symposium,Tectonic drivers: understanding the complexities of IgAN pathophysiology,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2626,Low,Seismic shifts in the immunoglobulin A nephropathy (IgAN) treatment paradigm,Industry Sponsored Symposium,"Q&A, summary and close",IgA Nephropathy,IgA Nephropathy,,,,,,,,
2627,Medium,FC 2: More about the New Pillars of Treatment,Free Communication,Sustained long term efficacy and safety of zigakibart over 100 weeks in patients with IgAN,IgA Nephropathy,IgA Nephropathy,Zigakibart,,,APRIL-Antibody,,,,
2628,Low,From theory to practice – embracing early and targeted interventions in IgAN,Industry Sponsored Symposium,Simultaneous Action: A New Paradigm in IgAN Management,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2629,Low,From theory to practice – embracing early and targeted interventions in IgAN,Industry Sponsored Symposium,Navigating IgAN Management Over a Patient's Lifetime,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2630,Not Relevant,Expanding the Living Donor Pool in Kidney Transplantation,Industry Sponsored Symposium,"Desensitization in Kidney Transplantation: Who, What, When, Where, and Why",,,,,,,,,,
2631,Not Relevant,Expanding the Living Donor Pool in Kidney Transplantation,Industry Sponsored Symposium,ABO-Incompatible Kidney Transplants: Breaking Blood Group Barriers,,,,,,,,,,
2632,Not Relevant,Expanding the Living Donor Pool in Kidney Transplantation,Industry Sponsored Symposium,Acceptable Mismatch Transplantation in Highly Sensitized with a Hybrid Approach,,,,,,,,,,
2633,Not Relevant,Expanding the Living Donor Pool in Kidney Transplantation,Industry Sponsored Symposium,Panel Discussion: Optimizing Induction Therapy in Kidney Transplantation: Balancing Efficacy and Safety,,,,,,,,,,
2634,Not Relevant,Initial combination therapy in lupus nephritis: goal to achieve kidney preservation.,Industry Sponsored Symposium,Welcome and introduction,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2635,Not Relevant,Initial combination therapy in lupus nephritis: goal to achieve kidney preservation.,Industry Sponsored Symposium,Advancing lupus nephritis care: where are we now?,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2636,Not Relevant,Initial combination therapy in lupus nephritis: goal to achieve kidney preservation.,Industry Sponsored Symposium,Preserving the kidney: what are the practical considerations?,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2637,Not Relevant,Initial combination therapy in lupus nephritis: goal to achieve kidney preservation.,Industry Sponsored Symposium,Panel discussion and audience Q&A,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2638,Not Relevant,Initial combination therapy in lupus nephritis: goal to achieve kidney preservation.,Industry Sponsored Symposium,Panel discussion and audience Q&A,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2639,Not Relevant,Initial combination therapy in lupus nephritis: goal to achieve kidney preservation.,Industry Sponsored Symposium,Panel discussion and audience Q&A,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2640,Not Relevant,Initial combination therapy in lupus nephritis: goal to achieve kidney preservation.,Industry Sponsored Symposium,Closing remarks,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2641,Not Relevant,Nephrologists at the Forefront: Enhancing Apheresis for Metabolic and Immune-Mediated Diseases,Industry Sponsored Symposium,ABO-incompatible kidney transplantation – always a challenge in routine care,,,,,,,,,,
2642,Not Relevant,Nephrologists at the Forefront: Enhancing Apheresis for Metabolic and Immune-Mediated Diseases,Industry Sponsored Symposium,Major indications for lipoprotein apheresis,,,,,,,,,,
2643,Not Relevant,Nephrologists at the Forefront: Enhancing Apheresis for Metabolic and Immune-Mediated Diseases,Industry Sponsored Symposium,Autoantibody associated diseases of the central nervous system – the role of therapeutic apheresis,,,,,,,,,,
2644,Not Relevant,Reducing aldosterone: can we protect kidneys and hearts?,Industry Sponsored Symposium,Welcome and introductions,,,,,,,,,,
2645,Not Relevant,Reducing aldosterone: can we protect kidneys and hearts?,Industry Sponsored Symposium,The role of aldosterone in heart and kidney health and disease,,,,,,,,,,
2646,Not Relevant,Reducing aldosterone: can we protect kidneys and hearts?,Industry Sponsored Symposium,Targeting aldosterone: emerging clinical data,,,,,,Aldosterone-Targeted Therapy,,,,
2647,Not Relevant,Reducing aldosterone: can we protect kidneys and hearts?,Industry Sponsored Symposium,Exploring interconnectivity in heart and kidney disease,Kidney Diseases,,,,,,,,,
2648,Not Relevant,Reducing aldosterone: can we protect kidneys and hearts?,Industry Sponsored Symposium,Panel discussion and Q&A,,,,,,,,,,
2649,Not Relevant,Reducing aldosterone: can we protect kidneys and hearts?,Industry Sponsored Symposium,Summary and closing remarks,,,,,,,,,,
2650,Low,Therapeutic advances in C3G: What we know and what it means,Industry Sponsored Symposium,Introduction,C3 Glomerulopathy,,,,,,,Advanced,,
2651,Low,Therapeutic advances in C3G: What we know and what it means,Industry Sponsored Symposium,Great expectations: From pathophysiological insights to a new treatment landscape,C3 Glomerulopathy,,,,,,,Advanced,,
2652,Low,Therapeutic advances in C3G: What we know and what it means,Industry Sponsored Symposium,Great expectations: From pathophysiological insights to a new treatment landscape,C3 Glomerulopathy,,,,,,,Advanced,,
2653,Low,Therapeutic advances in C3G: What we know and what it means,Industry Sponsored Symposium,Great expectations: From pathophysiological insights to a new treatment landscape,C3 Glomerulopathy,,,,,,,Advanced,,
2654,Low,Therapeutic advances in C3G: What we know and what it means,Industry Sponsored Symposium,C3G in clinical practice: Translating endpoints to outcomes (Panel discussion),C3 Glomerulopathy,,,,,,,Advanced,,
2655,Low,Therapeutic advances in C3G: What we know and what it means,Industry Sponsored Symposium,Q&A,C3 Glomerulopathy,,,,,,,Advanced,,
2656,Low,Therapeutic advances in C3G: What we know and what it means,Industry Sponsored Symposium,Summary and close,C3 Glomerulopathy,,,,,,,Advanced,,
2657,Not Relevant,Treatment of acute and chronic hyperkalaemia in patients with kidney disease,Industry Sponsored Symposium,"Treatment of acute, non-life-threatening hyperkalaemia",Hyperkalemia,Acute Hyperkalaemia,,,,,,,,
2658,Not Relevant,Treatment of acute and chronic hyperkalaemia in patients with kidney disease,Industry Sponsored Symposium,Management of hyperkalaemia in patients with CKD and/or heart failure,Chronic Kidney Disease;Hyperkalemia,Chronic Kidney Disease;Hyperkalaemia,,,,,,,,
2659,Not Relevant,Treatment of acute and chronic hyperkalaemia in patients with kidney disease,Industry Sponsored Symposium,Experience from the Swedish Database: hyperkalaemia events and treatment patterns,Hyperkalemia,Hyperkalemia,,,,,,,,
2660,Not Relevant,Treatment of acute and chronic hyperkalaemia in patients with kidney disease,Industry Sponsored Symposium,Heart failure and oedema events in patients with hyperkalaemia,Edema;Hyperkalemia,Hyperkalaemia;Oedema,,,,,,,,
2661,Not Relevant,Treatment of acute and chronic hyperkalaemia in patients with kidney disease,Industry Sponsored Symposium,Audience Q&A and meeting summary,Hyperkalemia;Kidney Diseases,Acute Hyperkalemia;Chronic Hyperkalemia;Kidney Disease,,,,,,,,
2662,Low,Seismic shifts in perspectives: the challenges of living with immunoglobulin A nephropathy (IgAN),Industry Square talk,Welcome and introduction,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2663,Low,Seismic shifts in perspectives: the challenges of living with immunoglobulin A nephropathy (IgAN),Industry Square talk,Understanding patient perspectives: videos and discussion,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2664,Not Relevant,Late breaking clinical trials I: Cutting-Edge Clinical trials in Nephrology,Symposium,The Confidence Trial: Efficacy/Safety Of Combining Finerenone With Empagliflozin In People With Chronic Kidney Disease And Type 2 Diabetes,Chronic Kidney Disease;Type 2 Diabetes,,Empagliflozin;Finerenone,,,Mineralocorticoid Receptor-Antagonist;SGLT2-Inhibitor,Bayer,,NCT05254002,Confidence 
2665,Not Relevant,Late breaking clinical trials I: Cutting-Edge Clinical trials in Nephrology,Symposium,Exploring the Margins of Survival Benefit in Deceased Donor Kidney Transplantation: An International Target Trial Emulation,,,,,,,,,,
2666,Not Relevant,Aldosterone Dysregulation: Looking Beyond the Cornerstone in Hypertension,Industry Sponsored Symposium,Case Study Presentation,Hypertension,Hypertension,,,,,,,,
2667,Not Relevant,Aldosterone Dysregulation: Looking Beyond the Cornerstone in Hypertension,Industry Sponsored Symposium,Understanding Aldosterone Dysregulation in Hypertension and CKD,Chronic Kidney Disease;Hypertension,Chronic Kidney Disease;Hypertension,,,,,,,,
2668,Not Relevant,Aldosterone Dysregulation: Looking Beyond the Cornerstone in Hypertension,Industry Sponsored Symposium,How Can We Address Aldosterone Dysregulation Therapeutically?,Hypertension,Hypertension,,,,,,,,
2669,Not Relevant,Aldosterone Dysregulation: Looking Beyond the Cornerstone in Hypertension,Industry Sponsored Symposium,Moving Towards Personalised Management of Hypertension,Hypertension,Hypertension,,,,,,,,
2670,Not Relevant,Aldosterone Dysregulation: Looking Beyond the Cornerstone in Hypertension,Industry Sponsored Symposium,Audience Q&A,Hypertension,Hypertension,,,,,,,,
2671,Not Relevant,HIF-PHIs in Renal Anaemia Management: How to Identify Patients Who Will Benefit the Most,Industry Sponsored Symposium,Introduction,Anemia,Renal Anaemia,,,,,,,,
2672,Not Relevant,HIF-PHIs in Renal Anaemia Management: How to Identify Patients Who Will Benefit the Most,Industry Sponsored Symposium,HIF-PHIs: An Effective Treatment Option for ESA-Resistant Patients?,Anemia,,,,,Hypoxia-inducible factor prolyl hydroxylase inhibitor,,ESA Resistant,,
2673,Not Relevant,HIF-PHIs in Renal Anaemia Management: How to Identify Patients Who Will Benefit the Most,Industry Sponsored Symposium,The Nurse´s View: Challenges in the Management of Dialysis Patients with Anaemia,Anemia,,,,,,,,,
2674,Not Relevant,HIF-PHIs in Renal Anaemia Management: How to Identify Patients Who Will Benefit the Most,Industry Sponsored Symposium,"HIF-PHIs in Europe: Trials, Indications and Guidelines",Anemia,Renal Anaemia,,,,Hypoxia-inducible factor prolyl hydroxylase inhibitor,,,,
2675,Not Relevant,HIF-PHIs in Renal Anaemia Management: How to Identify Patients Who Will Benefit the Most,Industry Sponsored Symposium,Closing,Anemia,Renal Anaemia,,,,,,,,
2676,Not Relevant,How terminal complement inhibition continues to change the landscape of atypical haemolytic uraemic syndrome (aHUS),Industry Sponsored Symposium,Chair’s welcome and introduction,Atypical Hemolytic-Uremic Syndrome,Atypical Hemolytic-Uremic Syndrome,,,,,,,,
2677,Not Relevant,How terminal complement inhibition continues to change the landscape of atypical haemolytic uraemic syndrome (aHUS),Industry Sponsored Symposium,Altering the natural history of aHUS,Atypical Hemolytic-Uremic Syndrome,Atypical Hemolytic-Uremic Syndrome,,,,,,,,
2678,Not Relevant,How terminal complement inhibition continues to change the landscape of atypical haemolytic uraemic syndrome (aHUS),Industry Sponsored Symposium,Ravulizumab in the ongoing evolution of aHUS management,Atypical Hemolytic-Uremic Syndrome,Atypical Hemolytic-Uremic Syndrome,Ravulizumab,,,Complement-Inhibitor,,,,
2679,Not Relevant,How terminal complement inhibition continues to change the landscape of atypical haemolytic uraemic syndrome (aHUS),Industry Sponsored Symposium,High-risk patients with aHUS: the enduring challenge,Atypical Hemolytic-Uremic Syndrome,High-Risk Atypical Hemolytic-Uremic Syndrome,,,,,,High-risk,,
2680,Not Relevant,How terminal complement inhibition continues to change the landscape of atypical haemolytic uraemic syndrome (aHUS),Industry Sponsored Symposium,Wrap-up Q&A session and closing remarks,Atypical Hemolytic-Uremic Syndrome,Atypical Haemolytic Uraemic Syndrome,,,,,,,,
2681,Not Relevant,Multi-target treatments and a multidisciplinary approach: How they can improve care for patients with lupus nephritis,Industry Sponsored Symposium,Introduction,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2682,Not Relevant,Multi-target treatments and a multidisciplinary approach: How they can improve care for patients with lupus nephritis,Industry Sponsored Symposium,Histopathology and its impact on Lupus Nephritis: what can a biopsy tell us?,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2683,Not Relevant,Multi-target treatments and a multidisciplinary approach: How they can improve care for patients with lupus nephritis,Industry Sponsored Symposium,"Treatment goals, the new guidelines/recommendations and focus on safety and renal outcomes",Lupus Nephritis,Lupus Nephritis,,,,,,,,
2684,Not Relevant,Multi-target treatments and a multidisciplinary approach: How they can improve care for patients with lupus nephritis,Industry Sponsored Symposium,Exploring patient cases and latest therapies in Lupus Nephritis treatment.,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2685,Not Relevant,Multi-target treatments and a multidisciplinary approach: How they can improve care for patients with lupus nephritis,Industry Sponsored Symposium,Closing,Lupus Nephritis,Lupus Nephritis,,,,,,,,
2686,Medium,"Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies",Industry Sponsored Symposium,Welcome and Introductions,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2687,Medium,"Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies",Industry Sponsored Symposium,Early Intervention and Evolving Guidelines,IgA Nephropathy,,,,,,,Early Onset,,
2688,Medium,"Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies",Industry Sponsored Symposium,Case-Based Presentation: Application of Nephroprotective Therapies,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2689,Medium,"Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies",Industry Sponsored Symposium,Emerging Therapies and Future Directions in IgAN Management,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2690,Medium,"Revolutionizing IgAN Care in the Era of Precision Medicine: Diagnostic Approaches, Evolving Guidelines, and Novel Therapies",Industry Sponsored Symposium,Summary and Q&A,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2691,Low,Targeting the Source of IgA Nephropathy: Focus on B-Cell Modulation.,Industry Sponsored Symposium,Overview of the Unmet Need in IgA Nephropathy,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2692,Low,Targeting the Source of IgA Nephropathy: Focus on B-Cell Modulation.,Industry Sponsored Symposium,The Role of B-Cells in the Pathogenesis of IgAN,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2693,Medium,Targeting the Source of IgA Nephropathy: Focus on B-Cell Modulation.,Industry Sponsored Symposium,Future and Emerging Disease-modifying Therapies Targeting B cell in IgAN,IgA Nephropathy,IgA Nephropathy,,,,B-cell Targeted Therapy,,,,
2694,Low,Targeting the Source of IgA Nephropathy: Focus on B-Cell Modulation.,Industry Sponsored Symposium,Q&A,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2695,Not Relevant,Turning points in rare diseases: harnessing monitoring for improved outcomes in Fabry disease and cystinosis,Industry Sponsored Symposium,Welcome & introduction,Cystinosis;Fabry Disease;Rare Disease,,,,,,,,,
2696,Not Relevant,Turning points in rare diseases: harnessing monitoring for improved outcomes in Fabry disease and cystinosis,Industry Sponsored Symposium,Early signs in Fabry disease: structural and functional findings,Cystinosis;Fabry Disease;Rare Disease,,,,,,,Early Onset,,
2697,Not Relevant,Turning points in rare diseases: harnessing monitoring for improved outcomes in Fabry disease and cystinosis,Industry Sponsored Symposium,Driving treatment decisions in Fabry disease: how monitoring can optimize patient management,Cystinosis;Fabry Disease;Rare Disease,,,,,,,,,
2698,Not Relevant,Turning points in rare diseases: harnessing monitoring for improved outcomes in Fabry disease and cystinosis,Industry Sponsored Symposium,Elevating Cystinosis Therapy: Strategies for Improved Patient Outcomes,Cystinosis;Fabry Disease;Rare Disease,,,,,,,,,
2699,Not Relevant,Turning points in rare diseases: harnessing monitoring for improved outcomes in Fabry disease and cystinosis,Industry Sponsored Symposium,Closing and Remarks,Cystinosis;Fabry Disease;Rare Disease,,,,,,,,,
2700,Not Relevant,Be CONFIDENT with the initial combination use of finerenone and SGLT-2 inhibitors,Industry Square talk,Be CONFIDENT with the initial combination use of finerenone and SGLT-2 inhibitors,,,Finerenone,,,Mineralocorticoid Receptor-Antagonist;SGLT2-Inhibitor,,,,
2701,Not Relevant,Act now: The case for early intervention and disease modification in LN,Industry Square talk,Act now: The case for early intervention and disease modification in LN,,,,,,,,Early Onset,,
2702,Not Relevant,FC 16: Acute Kidney Injury: Troubling our Minds,Free Communication,Early ACE-inhibition in paediatric CKD is superior to angiotensin-receptor blockade in delaying kidney failure,,,,,,ACE-Inhibitor;Angiotensin Receptor-Inhibitor,,,,
2703,Low,Cracking the complement sequence: Shifting towards new treatment paradigms in C3G and primary IC-MPGN,Industry Sponsored Symposium,Chair’s welcome,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,C3 Glomerulopathy;Primary Immune-Complex Membranoproliferative Glomerulonephritis,,,,,,,,
2704,Low,Cracking the complement sequence: Shifting towards new treatment paradigms in C3G and primary IC-MPGN,Industry Sponsored Symposium,C3G and primary IC-MPGN: An urgent need to improve patient care,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,C3 Glomerulopathy;Primary Immune-Complex Membranoproliferative Glomerulonephritis,,,,,,,,
2705,Low,Cracking the complement sequence: Shifting towards new treatment paradigms in C3G and primary IC-MPGN,Industry Sponsored Symposium,Focusing on C3: The common disease mechanism in a heterogeneous patient population,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,C3 Glomerulopathy;Primary Immune-Complex Membranoproliferative Glomerulonephritis,,,,,,,,
2706,Medium,Cracking the complement sequence: Shifting towards new treatment paradigms in C3G and primary IC-MPGN,Industry Sponsored Symposium,A new treatment paradigm: Complement inhibition in C3G and primary IC-MPGN,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,C3 Glomerulopathy;Primary Immune-Complex Membranoproliferative Glomerulonephritis,,,,Complement-Inhibitor,,,,
2707,Low,Cracking the complement sequence: Shifting towards new treatment paradigms in C3G and primary IC-MPGN,Industry Sponsored Symposium,Closing remarks and Q&A,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,C3 Glomerulopathy;Primary Immune-Complex Membranoproliferative Glomerulonephritis,,,,,,,,
2708,Not Relevant,Spotlight on roxadustat: lessons from the clinic,Industry Sponsored Symposium,Introduction,,,,,,,,,,
2709,Not Relevant,Spotlight on roxadustat: lessons from the clinic,Industry Sponsored Symposium,Spotlight on roxadustat: lessons from the clinic,,,Roxadustat,,,HIF PH-Inhibitor,,,,
2710,Not Relevant,"Navigating the cardio, renal and metabolic (CRM) patient journey: overcoming obstacles to effective SGLT2 inhibitor initiation",Industry Sponsored Symposium,Welcome and introduction,,,,,,,,,,
2711,Not Relevant,"Navigating the cardio, renal and metabolic (CRM) patient journey: overcoming obstacles to effective SGLT2 inhibitor initiation",Industry Sponsored Symposium,The path to better outcomes: optimising clinical practice for people with CRM conditions,,,,,,,,,,
2712,Not Relevant,"Navigating the cardio, renal and metabolic (CRM) patient journey: overcoming obstacles to effective SGLT2 inhibitor initiation",Industry Sponsored Symposium,Bridging the gap between evidence and implementation: addressing clinical inertia,,,,,,,,,,
2713,Not Relevant,"Navigating the cardio, renal and metabolic (CRM) patient journey: overcoming obstacles to effective SGLT2 inhibitor initiation",Industry Sponsored Symposium,Taking data into the clinic: a patient case study,,,,,,,,,,
2714,Not Relevant,"Navigating the cardio, renal and metabolic (CRM) patient journey: overcoming obstacles to effective SGLT2 inhibitor initiation",Industry Sponsored Symposium,Panel discussion and audience Q&A,,,,,,,,,,
2715,Not Relevant,"Navigating the cardio, renal and metabolic (CRM) patient journey: overcoming obstacles to effective SGLT2 inhibitor initiation",Industry Sponsored Symposium,Summary and close,,,,,,,,,,
2716,Not Relevant,New ERA for Managing CKD Anemia: Focus on HIF-PHIs,Industry Sponsored Symposium,Evolving Landscape of CKD Anemia Management: ESAs to HIF-PHIs,Anemia;Chronic Kidney Disease,,,,,Erythropoiesis Stimulating Agent;HIF PH-Inhibitor,,,,
2717,Not Relevant,New ERA for Managing CKD Anemia: Focus on HIF-PHIs,Industry Sponsored Symposium,Evidence Based Best Clinical Practices with HIF-PHIs- Insights from the Indian Experience,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,HIF PH-Inhibitor,,,,
2718,Not Relevant,New ERA for Managing CKD Anemia: Focus on HIF-PHIs,Industry Sponsored Symposium,Panel Discussion- HIF-PHIs in CKD Anemia & Beyond: Journey so far and Future Directions,Anemia;Chronic Kidney Disease,Anemia;Chronic Kidney Disease,,,,HIF PH-Inhibitor,,,,
2719,Not Relevant,Patient-centred care for CKD-associated Pruritus: a PARADIGM shift for patients in need of dialysis,Industry Sponsored Symposium,Welcome and introduction,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,,,,,,,,
2720,Not Relevant,Patient-centred care for CKD-associated Pruritus: a PARADIGM shift for patients in need of dialysis,Industry Sponsored Symposium,Diagnosing CKD-associated Pruritus and initiating treatment: experience from Austria,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,,,,,,,,
2721,Not Relevant,Patient-centred care for CKD-associated Pruritus: a PARADIGM shift for patients in need of dialysis,Industry Sponsored Symposium,Clinical experience with difelikefalin: 3 years after launch in Germany,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,Difelikefalin,,,KOR-Agonist,,,,
2722,Not Relevant,Patient-centred care for CKD-associated Pruritus: a PARADIGM shift for patients in need of dialysis,Industry Sponsored Symposium,Addressing CKD-associated Pruritus and optimising treatment,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,,,,,,,,
2723,Not Relevant,Patient-centred care for CKD-associated Pruritus: a PARADIGM shift for patients in need of dialysis,Industry Sponsored Symposium,Clinical trials and future outlook,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,,,,,,,,
2724,Not Relevant,"Tackling dialysis challenges through patient-centered care – New evidence, new strategies",Industry Sponsored Symposium,Tackling dialysis challenges through patient centered care - Introduction,,,,,,,,,,
2725,Not Relevant,"Tackling dialysis challenges through patient-centered care – New evidence, new strategies",Industry Sponsored Symposium,Let’s hear what really matters to dialysis patient - Interview with Ibrahim Aksu,,,,,,,,,,
2726,Not Relevant,"Tackling dialysis challenges through patient-centered care – New evidence, new strategies",Industry Sponsored Symposium,When Clinical Outcomes and Quality of Life Converge,,,,,,,,,,
2727,Not Relevant,"Tackling dialysis challenges through patient-centered care – New evidence, new strategies",Industry Sponsored Symposium,The role of the patient experience on home dialysis,,,,,,,,,,
2728,Not Relevant,"Tackling dialysis challenges through patient-centered care – New evidence, new strategies",Industry Sponsored Symposium,Discussion (All) and Q&A,,,,,,,,,,
2729,Medium,Targeting complement factor B using antisense technology - a novel modality in treating IgAN,Industry Square talk,Targeting complement factor B using antisense technology - a novel modality in treating IgAN,IgA Nephropathy,IgA Nephropathy,,,,Complement Factor B-Targeted Agent,,,,
2730,High,Late breaking clinical trials II,Symposium,Sibeprenlimab for Patients With IgA Nephropathy: Results From a Prespecified Interim Analysis of the Phase 3 VISIONARY Study,IgA Nephropathy,,Sibeprenlimab,,,APRIL-Targeted Monoclonal Antibody ,Otsuka,,NCT05248646,VISIONARY
2731,Not Relevant,Late breaking clinical trials II,Symposium,Impact Of Acute Egfr Dips And Markers Of Disease Severity On Effects Of Empagliflozin On Acute Kidney Outcome,,,Empagliflozin,,,SGLT2-Inhibitor,,,,
2732,Not Relevant,Late breaking clinical trials II,Symposium,Spironolactone in patients undergoing maintenance dialysis: the ACHIEVE trial,,,Spironolactone,,,Aldosterone-Antagonist,,,NCT03020303,ACHIEVE
2733,Not Relevant,Late breaking clinical trials II,Symposium,Mineralocorticoid receptor antagonists in patients with kidney failure receiving dialysis: an updated systematic review and meta-analysis,Renal Failure,Kidney Failure,,,,Mineralocorticoid Receptor-Antagonist,,,,
2734,Not Relevant,"Journey to implementation: a case study of SGLT2 inhibitors in patients with cardio, renal and metabolic (CRM) conditions",Industry Square talk,Start of the patient journey,,,,,,,,,,
2735,Not Relevant,"Journey to implementation: a case study of SGLT2 inhibitors in patients with cardio, renal and metabolic (CRM) conditions",Industry Square talk,The road to effective treatment implementation: an audience discussion,,,,,,,,,,
2736,Not Relevant,"Journey to implementation: a case study of SGLT2 inhibitors in patients with cardio, renal and metabolic (CRM) conditions",Industry Square talk,Summary,,,,,,,,,,
2737,Not Relevant,"Adsorptive dialysis with PMMA membrane ""Why we should consider it""",Industry Sponsored Symposium,Harnessing PMMA Adsorption for Uremic Toxin-Related Systemic Disorders,,Uremic Toxin-Related Systemic Disorder,,,,,,Systemic,,
2738,Not Relevant,"Adsorptive dialysis with PMMA membrane ""Why we should consider it""",Industry Sponsored Symposium,Clinical benefits of postdilution on-line hemodiafiltration using adsorptive dialysis membrane,,,,,,,,,,
2739,Not Relevant,"Adsorptive dialysis with PMMA membrane ""Why we should consider it""",Industry Sponsored Symposium,Improvement of immune responses by PMMA on hemodialysis patients,,,,,,,,,,
2740,Not Relevant,Breaking clinical inertia: Recognizing and managing infection risks in patients with CKD or kidney transplant,Industry Sponsored Symposium,Introduction by Chair,,,,,,,,,,
2741,Not Relevant,Breaking clinical inertia: Recognizing and managing infection risks in patients with CKD or kidney transplant,Industry Sponsored Symposium,The increased burden of infectious diseases in CKD and kidney transplant recipients,Chronic Kidney Disease;Infection,,,,,,,,,
2742,Not Relevant,Breaking clinical inertia: Recognizing and managing infection risks in patients with CKD or kidney transplant,Industry Sponsored Symposium,Vaccine advances for patients with CKD or a kidney transplant,,,,,,Vaccine,,,,
2743,Not Relevant,Breaking clinical inertia: Recognizing and managing infection risks in patients with CKD or kidney transplant,Industry Sponsored Symposium,Overcoming barriers to vaccination in kidney disease care,Chronic Kidney Disease;Infection;Kidney Diseases,,,,,Vaccine,,,,
2744,Not Relevant,Breaking clinical inertia: Recognizing and managing infection risks in patients with CKD or kidney transplant,Industry Sponsored Symposium,Q&A,,,,,,,,,,
2745,Not Relevant,Dynamic Duo in Action: Elevating CKD Treatment with Finerenone and SGLT-2 Inhibitors,Industry Sponsored Symposium,Welcome and introduction,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2746,Not Relevant,Dynamic Duo in Action: Elevating CKD Treatment with Finerenone and SGLT-2 Inhibitors,Industry Sponsored Symposium,The Matching Pair: When Finerenone & SGLT-2 Inhibitors join forces in CONFIDENCE,Chronic Kidney Disease,,Finerenone,,,Mineralocorticoid Receptor-Inhibitor;SGLT2-Inhibitor,Bayer,,NCT05254002,Confidence
2747,Not Relevant,Dynamic Duo in Action: Elevating CKD Treatment with Finerenone and SGLT-2 Inhibitors,Industry Sponsored Symposium,From Promise to Practice: Finerenone's Real-World Experience,Chronic Kidney Disease,Chronic Kidney Disease,Finerenone,,,Mineralocorticoid Receptor-Inhibitor,,,,
2748,Not Relevant,Dynamic Duo in Action: Elevating CKD Treatment with Finerenone and SGLT-2 Inhibitors,Industry Sponsored Symposium,Next Chapter: Expanding The Path of Finerenone,Chronic Kidney Disease,Chronic Kidney Disease,Finerenone,,,Mineralocorticoid Receptor-Inhibitor,,,,
2749,Not Relevant,Dynamic Duo in Action: Elevating CKD Treatment with Finerenone and SGLT-2 Inhibitors,Industry Sponsored Symposium,Q&A,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2750,Not Relevant,Dynamic Duo in Action: Elevating CKD Treatment with Finerenone and SGLT-2 Inhibitors,Industry Sponsored Symposium,Summary and Close,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2751,Low,IgA Nephropathy Global Burden and Changing Therapeutic Landscape,Industry Sponsored Symposium,Introduction,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2752,Low,IgA Nephropathy Global Burden and Changing Therapeutic Landscape,Industry Sponsored Symposium,IgA nephropathy pathogenesis – The multi-hit hypothesis,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2753,Low,IgA Nephropathy Global Burden and Changing Therapeutic Landscape,Industry Sponsored Symposium,Burden of IgA Nephropathy disease,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2754,Medium,IgA Nephropathy Global Burden and Changing Therapeutic Landscape,Industry Sponsored Symposium,Novel paradigms in IgA Nephropathy management,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2755,Low,IgA Nephropathy Global Burden and Changing Therapeutic Landscape,Industry Sponsored Symposium,Patient cases with audience voting,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2756,Not Relevant,Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies,Industry Sponsored Symposium,Welcome and Introductions,,,,,,,,,,
2757,Not Relevant,Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies,Industry Sponsored Symposium,Long-Term Outcomes of Kidney Function in Patients With AAV,,,,,,,,,,
2758,Not Relevant,Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies,Industry Sponsored Symposium,Evolving Treatment Landscape in AAV,,,,,,,,,,
2759,Not Relevant,Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies,Industry Sponsored Symposium,Case-Based Presentation for Evidence-Based Treatment Strategies to Mitigate the Burden of AAV and Preserve Kidney Function,,,,,,,,,,
2760,Not Relevant,Preserving Renal Function in AAV: From Novel Therapies to Practice-Changing Strategies,Industry Sponsored Symposium,Summary and Q&A,,,,,,,,,,
2761,Not Relevant,Preventing Flare and Protecting Function: What Progress is Being Made in Active Lupus Nephritis?,Industry Sponsored Symposium,Introduction and Welcome,Active Lupus Nephritis,Active Lupus Nephritis,,,,,,,,
2762,Not Relevant,Preventing Flare and Protecting Function: What Progress is Being Made in Active Lupus Nephritis?,Industry Sponsored Symposium,Lupus Nephritis: Why Guidelines are Calling for Innovation,Active Lupus Nephritis;Lupus Nephritis,,,,,,,,,
2763,Not Relevant,Preventing Flare and Protecting Function: What Progress is Being Made in Active Lupus Nephritis?,Industry Sponsored Symposium,Balancing Efficacy and Safety: The Rationale for Triple Therapy in Lupus Nephritis,Active Lupus Nephritis;Lupus Nephritis,,,,,,,,,
2764,Not Relevant,Preventing Flare and Protecting Function: What Progress is Being Made in Active Lupus Nephritis?,Industry Sponsored Symposium,Identifying When Patients Need More Than Standard of Care: Biopsies and Biomarkers in Lupus Nephritis,Active Lupus Nephritis;Lupus Nephritis,,,,,,,,,
2765,Not Relevant,Preventing Flare and Protecting Function: What Progress is Being Made in Active Lupus Nephritis?,Industry Sponsored Symposium,Triple Therapy for Active Disease: Reflecting on Current Experience and Emerging Strategies,Active Lupus Nephritis,Active Lupus Nephritis,,,,,,,,
2766,Not Relevant,Preventing Flare and Protecting Function: What Progress is Being Made in Active Lupus Nephritis?,Industry Sponsored Symposium,"Final Remarks, Conclusions and Closing",Active Lupus Nephritis,Active Lupus Nephritis,,,,,,,,
2767,Not Relevant,Unlocking the Potential of Personalised Care for Patients with CKD,Industry Sponsored Symposium,Welcome and introduction,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2768,Not Relevant,Unlocking the Potential of Personalised Care for Patients with CKD,Industry Sponsored Symposium,Rethinking CKD care to meet individual patient needs,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2769,Not Relevant,Unlocking the Potential of Personalised Care for Patients with CKD,Industry Sponsored Symposium,Optimising CKD management through personalised strategies,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2770,Not Relevant,Unlocking the Potential of Personalised Care for Patients with CKD,Industry Sponsored Symposium,Putting personalised strategies into practice,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2771,Not Relevant,Unlocking the Potential of Personalised Care for Patients with CKD,Industry Sponsored Symposium,Closing remarks,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2772,Not Relevant,Managing kidney disease: from exome diagnosis to post-transplant molecular biomarkers,Industry Square talk,Managing Kidney Disease : genetic diagnosis,Kidney Diseases,Kidney Disease,,,,,,,,
2773,Not Relevant,Managing kidney disease: from exome diagnosis to post-transplant molecular biomarkers,Industry Square talk,Managing Kidney Disease: post-transplant molecular biomarkers,Kidney Diseases,Kidney Disease,,,,,,,,
2774,High,Innovative Kidney Trials,Symposium,Pegcetacoplan for C3G and primary (idiopathic) IC-MPGN: 52-week results from the phase 3 VALIANT trial show sustained efficacy,C3 Glomerulopathy;Immune-Complex Membranoproliferative Glomerulonephritis,,Pegcetacoplan,,,C3-Inhibitor,Apellis Pharmaceuticals,Primary,NCT05067127,VALIANT
2775,Not Relevant,Innovative Kidney Trials,Symposium,A phase I/IIa trial of regulatory T cell therapy together with donor bone marrow infusion in HLA-mismatched kidney transplantation.,,,,,,T Cell Therapy,,,,
2776,Medium,Innovative Kidney Trials,Symposium,"ARO-C3, an investigational RNAi Therapeutic Targeting Complement C3, Reduces Proteinuria, Hematuria, and Complement Activity in IgAN Patients",Hematuria;IgA Nephropathy;Proteinuria,Hematuria;IgA Nephropathy;Proteinuria,ARO-C3,,,C3-Inhibitor,,,,
2777,Not Relevant,One Year after FLOW and more from SOUL,Symposium,Oral Semaglutide and Kidney Outcomes in Type 2 Diabetes: A Prespecified Analysis of the SOUL Randomised Cardiovascular Outcomes Trial,Type 2 Diabetes,,Semaglutide,,,GLP1R-Agonist,Novo Nordisk,,NCT03914326,SOUL
2778,Not Relevant,One Year after FLOW and more from SOUL,Symposium,Semaglutide For The Treatment Of Type 2 Diabetes And Chronic Kidney Disease: The Impact Of Maintaining Renal Function On Long-Term Cost-Effectiveness In Denmark,Chronic Kidney Disease;Type 2 Diabetes,,Semaglutide,,,GLP1R-Agonist,Novo Nordisk,,NCT03819153;;NCT03914326,FLOW;;SOUL
2779,Not Relevant,One Year after FLOW and more from SOUL,Symposium,Effects of semaglutide on KDIGO risk category in participants with type 2 diabetes and chronic kidney disease: The FLOW trial,Chronic Kidney Disease;Type 2 Diabetes,,Semaglutide,,,GLP1R-Agonist,Novo Nordisk,,NCT03819153,FLOW
2780,Not Relevant,One Year after FLOW and more from SOUL,Symposium,Reduced kidney function decline with semaglutide across kidney risk categories: analyses from the FLOW trial,,,Semaglutide,,,GLP1R-Agonist,Novo Nordisk,,NCT03819153,FLOW
2781,Not Relevant,Equity in Kidney Care; Bridging the Gap in Dialysis Access,Industry Square talk,Equity in Kidney Care; Bridging the Gap in Dialysis Access,,,,,,,,,,
2782,Not Relevant,Equity in Kidney Care; Bridging the Gap in Dialysis Access,Industry Square talk,Equity in Kidney Care; Bridging the Gap in Dialysis Access,,,,,,,,,,
2783,Not Relevant,AKI & Critical Care Nephrology,Focussed Oral,Epidemiology and mortality risk factors for cirrhosis - associated - acute kidney injury,Acute Kidney Injury;Liver Cirrhosis,Acute Kidney Injury;Liver Cirrhosis,,,,,,,,
2784,Not Relevant,ERAC symposium: Improving patient care with the Real world data insights,Symposium,ERAC Awards ‘Innovation in Nephrology in the Age of Digital Revolution ‘ Ceremony,,,,,,,,,,
2785,Not Relevant,Nephrology Innovations: Trials and Results,Symposium,The long-term effect of marine n-3 polyunsaturated fatty acid supplementation in kidney transplantation: A randomized controlled trial,,,Marine N-3 Polyunsaturated Fatty Acid,,,Anti-Inflammatory,,,,
2786,Not Relevant,Nephrology Innovations: Trials and Results,Symposium,Evaluating Cardiovascular Safety of Peroxisome Proliferator Activator Receptor-Gamma (PPAR-g) Agonist in Kidney Failure Patients receiving Peritoneal Dialysis (PROOF Trial): a Prospective Double-Blind Randomized controlled trial,Renal Failure,Kidney Failure,,,,PPARg-Agonist ,,,NCT00745225,PROOF
2787,Not Relevant,Nephrology Innovations: Trials and Results,Symposium,Empagliflozin for urinary supersaturation reduction in non-diabetic patients with calcium and uric acid kidney stones (SWEETSTONE),,,Empagliflozin,,,SGLT2-Inhibitor,Boehringer Ingelheim,,NCT04911660,SWEETSTONE
2788,Not Relevant,Nephrology Innovations: Trials and Results,Symposium,A Nationwide Trial of Electronic Nudges to General Practices of Patients with Chronic Kidney Disease for Increasing Guideline-Directed Medical Therapy,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2789,Not Relevant,Nephrology Innovations: Trials and Results,Symposium,A Nationwide Trial of Electronic Nudges to Patients with Chronic Kidney Disease for Increasing Guideline-Directed Medical Therapy,Chronic Kidney Disease,Chronic Kidney Disease,,,,,,,,
2790,Not Relevant,CME 2 - Kidney Transplantation,CME,Practical Guide to Assessing Frailty and Sarcopenia,Sarcopenia,Sarcopenia,,,,,,,,
2791,Not Relevant,Pro & Cons: Organ donation after assisted suicide/euthanasia,Symposium,Discussion,,,,,,,,,,
2792,Not Relevant,ERAC symposium: Improving patient care with the Real world data insights,Symposium,Round table discussion,,,,,,,,,,
2793,Low,From theory to practice – embracing early and targeted interventions in IgAN,Industry Sponsored Symposium,Welcome and Introduction,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2794,Low,From theory to practice – embracing early and targeted interventions in IgAN,Industry Sponsored Symposium,Questions&Answers,IgA Nephropathy,IgA Nephropathy,,,,,,,,
2795,Not Relevant,Nephrologists at the Forefront: Enhancing Apheresis for Metabolic and Immune-Mediated Diseases,Industry Sponsored Symposium,Welcome message,,,,,,,,,,
2796,Not Relevant,Patient-centred care for CKD-associated pruritus: A PARADIGM shift      for patients in need of dialysis,Industry Sponsored Symposium,Audience Q&A and meeting summary,Chronic Kidney Disease;Pruritus,Chronic Kidney Disease;Pruritus,,,,,,,,